date,open,high,low,close,volume,title,description,title_sentiment,desc_sentiment,daily_change_pct,market_sentiment,next_day_change_pct,next_day_sentiment
2017-12-19 13:01:20.989,270.0,269.95,263.27,266.0,3238606.0,Biocon to invest in Uttar Pradesh health sector,"During a road show organized by UP government in Bengaluru on Monday as a precursor to the investors' summit in February 2018, Majumdar-Shaw met UP's industrial development minister Satish Mahana.",neutral,neutral,-1.4814814814814816,negative,1.491359879789642,positive
2017-12-19 18:01:04.349,270.0,269.95,263.27,266.0,3238606.0,"Market Update: CNX Auto rallies as Maruti, Hero Moto jumps 4%, Jain Irrigation zooms over 10%; HUL, Biocon hit 52-week high","The market breadth was in favour of the advances on Tuesday afternoon with 1308 stocks advancing as against 383 declines while 298 remained unchanged. On the other hand, 1831 stocks advanced and 775 stocks declined while 175 remained unchanged on the BSE.",positive,positive,-1.4814814814814816,negative,1.491359879789642,positive
2017-12-22 13:01:31.601,272.0,272.7,268.05,270.1,3392860.0,Biocon’s biosimilar arm may raise $500 m to fund clinical development,New entity likely to unlock value for Biocon shareholders,positive,positive,-0.6985294117646975,neutral,-0.6378350477454626,neutral
2017-12-28 13:01:52.681,270.5,272.5,266.3,269.5,4814698.0,Indian pharma sees traction in novel biologics,"While Glenmark is betting on its biologic for atorpic dermatitis, Biocon was the first to develop and introduce two novel biologics in the Indian market",positive,neutral,-0.3696857670979667,neutral,-0.1592120853080594,neutral
2017-12-29 18:01:32.726,270.5,272.5,266.3,269.5,4814698.0,Mylan-Biocon's breast cancer biosimilar gets ANVISA nod,"Biosimilar trastuzumab, indicated for breast cancer treatment, has been co-developed by Biocon and Mylan.",neutral,neutral,-0.3696857670979667,neutral,-0.1592120853080594,neutral
2018-01-04 13:01:26.428,271.4,272.77,268.73,271.25,1631708.0,"Lawsuits of big firms of telecom, pharma kept HC busy in 2017",The decision consequently allowed pharma firms Biocon and Mylan to sell their version of Roche's drug for treating two kinds of breast cancer and metastatic gastric cancer.,neutral,neutral,-0.0552689756816423,neutral,1.9000367511943987,positive
2018-01-08 13:01:09.085,276.77,279.12,271.92,272.65,1427198.0,"Buy Bharat Forge, Biocon, Shriram Transport Finance: Sudarshan Sukhani","Sudarshan Sukhani of s2analytics.com suggests buying Bharat Forge, Biocon and Shriram Transport Finance.",neutral,neutral,-1.4886006431332892,negative,-0.1834862385321101,neutral
2018-01-11 13:00:21.858,273.5,273.73,267.52,270.38,1701014.0,"Budget 2018: Expecting a greater spend on healthcare, says Biocon chairman","'India has affordable access to healthcare, but the need of the hour is a greater investment in this sector'",positive,positive,-1.1407678244972594,negative,-0.5286897367642734,neutral
2018-01-16 18:01:08.495,267.25,277.0,262.62,276.5,2722558.0,Budget 2018: India Inc's expectations,"As we head closer towards Budget 2018, CNBC-TV18's Priya Sheth and Rukmini Rao caught up with Adi Godrej, Chairman of Godrej Group, Harsh Mariwala, Chairman of Marico, and Kiran Mazumdar Shaw, Chairperson and MD of Biocon on what they expect from Budget 2018.",neutral,positive,3.4611786716557527,positive,-2.720230589083052,negative
2018-01-18 18:01:36.138,274.5,287.45,272.7,284.4,17455868.0,Biocon collaborates with Sandoz for next-gen biosimilars,"Both companies will share responsibility for end-to-end development, manufacturing and global regulatory approvals for a number of products and will have a cost and profit share arrangement globally. ",positive,neutral,3.606557377049172,positive,5.818245737387946,positive
2018-01-19 13:04:13.825,274.5,287.45,272.7,284.4,17455868.0,Biocon inks deal with Novartis after US nod for biologic drug,"Biocon says the tie-up with Novartis’s generics unit Sandoz will focus on developing copies, or biosimilars, of biologic drugs in immunology and oncology",positive,neutral,3.606557377049172,positive,5.818245737387946,positive
2018-01-24 13:19:11.039,300.5,308.7,300.2,303.38,15417614.0,"Canara Bank, Idea, Concor results on Wednesday","AB Money, Arfin India, Bharat Bijlee, Biocon, Canara Bank, Capital First, Cheviot, Con",neutral,neutral,0.9584026622296158,positive,0.6525285481239804,neutral
2018-01-25 13:02:04.297,300.5,308.7,300.2,303.38,15417614.0,Biocon profit down 46% to Rs91.9 crore in December quarter,"Biocon’s net sales rose 1.3% to Rs1,057.9 crore during the December quarter from a year earlier",negative,positive,0.9584026622296158,positive,0.6525285481239804,neutral
2018-01-30 13:02:58.160,315.5,314.95,304.55,307.48,5232658.0,EU committee recommends approval of Biocon-Mylan’s insulin glargine,"The European committee’s positive opinion will be considered by the European Commission and the regulator’s decision on approval of insulin glargine injection is expected in April, Biocon and Mylan said in a joint statement",positive,positive,-2.541996830427886,negative,0.974025974025974,positive
2018-02-21 13:02:02.744,290.5,314.45,288.02,312.27,29069426.0,Biocon gets 6 observations from USFDA for Malaysia facility,Biocon says USFDA has completed a pre-approval inspection of its manufacturing facility in Malaysia and issued a Form 483 with six observations,neutral,positive,7.4939759036144515,positive,0.4479999999999927,neutral
2018-02-26 13:01:42.551,312.6,319.3,310.17,312.25,3655606.0,I personally feel NHPS has not been thought through fully: Kiran Mazumdar-Shaw,"The National Health Protection Scheme needs to be integrated with primary healthcare to make it viable and sustainable, says the Biocon chairman Kiran Mazumdar-Shaw",neutral,positive,-0.1119641714651384,neutral,1.3473344103392622,positive
2018-03-06 13:02:20.253,317.95,317.5,301.2,303.5,5250270.0,"Top intraday trading ideas for afternoon trade for Tuesday, 6 March 2018",Biocon is a 'Buy' call with a target price of Rs 655 and a stop loss of Rs 624.,neutral,neutral,-4.544739738952662,negative,-0.9046052631578948,negative
2018-03-07 18:00:58.020,304.0,307.7,295.52,301.25,5467528.0,Eight Indian women in Forbes billionaires list 2018; Savitri Jindal richest,Biocon chief Kiran Mazumdar-Shaw is the second richest Indian woman,neutral,neutral,-0.9046052631578948,negative,-1.1960132890365525,negative
2018-03-13 13:02:13.290,301.85,308.5,300.75,302.77,6294584.0,"USFDA finds discrepancies in production, quality and lab control systems at Biocon's Malaysian insulin site","The USFDA inspected Biocon's insulins facility in Johar, Malaysia last month",negative,neutral,0.304787145933397,neutral,-0.99009900990099,negative
2018-03-20 13:02:03.314,291.5,294.73,288.88,290.75,3254292.0,Biocon sees approvals unlocking $1 billion biosimilar sales,Three more approvals Biocon now expects this year in the US and Europe would expand its presence in the pioneering field of biosimilars,neutral,positive,-0.2572898799313894,neutral,-0.6861063464837049,neutral
2018-03-27 13:01:41.185,304.0,308.95,295.25,296.95,9312412.0,Biocon's Syngene inks pact with GSK for new drug discovery,"Biocon's contract research arm Syngene International today said it has inked a drug discovery agreement with global drug firm GSK.
The multi-year R&D agreement between the two companies will focus on accelerating the discovery of new drug candidates",positive,positive,-2.319078947368425,negative,-0.913621262458472,negative
2018-03-27 13:02:38.471,304.0,308.95,295.25,296.95,9312412.0,"Buy Biocon, Maruti Suzuki: Rajat Bose",Rajat Bose of rajatkbose.com recommends buying Biocon March Futures and Maruti Suzuki March Futures.,neutral,positive,-2.319078947368425,negative,-0.913621262458472,negative
2018-03-28 13:03:16.035,304.0,308.95,295.25,296.95,9312412.0,"Biocon gains 2% on European Commission, TGA Australia approval","Semglee 100 units/ml 3 mL prefilled disposable pen for people with diabetes, is the first biosimilar from Biocon and Mylan's joint portfolio to be approved in Europe.",positive,positive,-2.319078947368425,negative,-0.913621262458472,negative
2018-04-12 13:01:37.936,312.45,314.48,309.23,312.6,3276356.0,Will Biocon's biosimilar deal act as booster?, Mylan and Biocon have agreed to accelerate introduction of adalimumab biosimilar in Europe through Mylan’s in-licensing arrangement with Fujifilm Kyowa Kirin Biologics (FKB). The product is at an adv,positive,positive,0.0480076812290075,neutral,0.5604483586869495,neutral
2018-04-12 18:01:09.464,312.45,314.48,309.23,312.6,3276356.0,Biocon jumps to over 1-month high,"Shares of Biocon jumped as the company’s partner Mylan and FKB have signed a deal for arthritis drug in the European Union. Biocon stock rose as much as 2.8 per cent to Rs 629.85, highest in over a mo",positive,positive,0.0480076812290075,neutral,0.5604483586869495,neutral
2018-04-27 14:27:33.688,334.5,337.0,324.0,330.5,7472898.0,Biocon Q4 profit rises 2.2% to Rs130 crore,"Biocon’s revenue from operations rose 20.4% to Rs1,237 crore in the March quarter",positive,positive,-1.195814648729447,negative,0.9030303030303084,positive
2018-05-01 10:01:12.641,334.0,335.98,329.25,332.55,2633420.0,"The obvious opportunity is biosimilars, says Biocon's Kiran Mazumdar-Shaw","A month ago, Biocon announced that its biosimilar insulin glargine trademarked as Semglee received marketing approval from the European Commission",positive,positive,-0.4341317365269427,neutral,-4.244274809160299,negative
2018-05-03 10:02:03.135,327.5,327.5,311.02,313.6,6121550.0,Biocon gets 7 USFDA observations for Bengaluru drug facility,Biocon said the US health regulator has made seven observations after inspection of its sterile drug product manufacturing facility in Bengaluru this week,neutral,neutral,-4.244274809160299,negative,-0.5821906913116738,neutral
2018-05-03 13:01:02.683,314.33,317.4,310.2,312.5,2684512.0,"Biocon shares fall 5% after US, European regulators issue observations",Biocon shares decline 5% to Rs629.10 after the USFDA and a European regulator issued observations after inspection of its facility in Bengaluru,negative,negative,-0.5821906913116738,neutral,-0.3720190779014359,neutral
2018-05-10 10:01:15.975,314.95,316.85,307.85,313.48,3040202.0,"Are midcaps losing sheen? Maybe not, here are 15 stocks which rose up to 130% in 1 year","As many as 15 midcaps rose by 50 percent to 136 percent in the last one-year. These include: Jindal Steel & Power, L&T Infotech, Ashok Leyland, Tata Global Beverages, Divi’s Laboratories, 3M India, Biocon, Mphasis, Page Industries, Future Retail and Gruh Finance.",positive,positive,-0.4667407525003875,neutral,0.1685482588646937,neutral
2018-05-15 18:01:14.601,318.5,324.23,316.6,322.48,1782286.0,Four cos added to MSCI India index,"InterGlobe soared 5 percent to Rs 1,248.55 and Biocon went up 2.49 percent to Rs 650.",positive,positive,1.2496075353218268,positive,-0.1555209953343701,neutral
2018-05-15 23:00:53.045,318.5,324.23,316.6,322.48,1782286.0,MSCI India Index to add four firms,"As many as four companies — Avenue Supermarts, Biocon, HDFC Standard Life Insurance Company and InterGlobe Aviation — will be added to the MSCI India Index effective June 1. The news triggered buying",positive,neutral,1.2496075353218268,positive,-0.1555209953343701,neutral
2018-05-18 18:00:19.694,315.62,329.05,315.25,325.75,6041602.0,Biocon sells 1.88% stake in Syngene for Rs230 crore,"Syngene International promoter Biocon says it has sold 37,65,574 equity shares of Syngene amounting to 1.88% through open market sale",neutral,neutral,3.209555794943285,positive,-2.492008813580371,negative
2018-05-20 23:00:56.379,322.23,325.92,308.1,314.2,3403608.0,"Biocon bets on R&D, biosimilars business to boost growth in FY19","Bengaluru-based Biocon is expecting significant growth in 2018-19, after reporting a marginal rise in net profit in Q4 FY18",positive,positive,-2.492008813580371,negative,2.840764331210196,positive
2018-05-29 18:00:53.854,336.5,341.5,335.17,336.95,3288556.0,"D-Mart, Varun Beverages, Radico Khaitan, Edelweiss Financial hit new highs","Biocon, Hexaware Technologies, Kotak Mahindra Bank and MM Forgings were among 13 stocks from the S&P BSE 500 and Smallcap index hitting new high on the BSE in otherwise range-bound market",positive,neutral,0.1337295690936073,neutral,-1.031172217612901,negative
2018-06-04 23:00:31.097,347.5,348.3,287.83,304.3,34809910.0,Tata Memorial team gets nod for therapeutic option in head and neck cancer,"Biocon said that a team from Mumbai in Tata Memorial Hospital, led by Kumar Prabhash, Head, Solid Unit, Medical Oncology, has given a green signal for the company's moleclue Nimotuzumab as an alternat",neutral,neutral,-12.43165467625899,negative,-1.6181229773462782,negative
2018-06-05 10:01:33.697,347.5,348.3,287.83,304.3,34809910.0,Biocon shares hit record high as cancer drug Pegfilgrastim gets USFDA nod,"The stock hit a record high of Rs 695, up 6% on the BSE in opening deal in otherwise weak market.",positive,positive,-12.43165467625899,negative,-1.6181229773462782,negative
2018-06-05 13:01:28.298,309.0,309.0,295.5,304.0,16291252.0,USFDA approves Mylan-Biocon’s biosimilar for cancer drug,The US health regulator has approved Mylan’s cancer treating biosimilar Fulphila co-developed with Biocon. Fulphila is the first US Food and Drug Administration (USFDA) approved biosimilar to Neulasta,positive,positive,-1.6181229773462782,negative,-0.3848684210526368,neutral
2018-06-05 13:01:44.205,309.0,309.0,295.5,304.0,16291252.0,Biocon hits record high as USFDA approves Mylan’s biosimilar for cancer drug,Shares of Biocon Ltd jumped as much as 6.4 per cent to a record high of Rs 696.60 as the company's partner Mylan N.V. has received approval for its first biosimilar of cancer medicine pegfilgrastim fr,positive,positive,-1.6181229773462782,negative,-0.3848684210526368,neutral
2018-06-11 10:03:04.121,305.0,307.7,301.08,301.33,2905212.0,"Street signs: MFs place contra bets in pharma, Biocon sees rise, and more",Shares of Avenue Supermarts get a lot of market attention as they have soared more than five times over their IPO price,positive,neutral,-1.2032786885245954,negative,1.5663643858202805,positive
2018-06-18 18:02:24.866,309.6,311.0,303.48,304.0,2048984.0,"‘By turning an entrepreneur, I have been able to create nearly 10,000 direct jobs’","“Skills acquired by the youth will be a defining factor in building a strong future,” said Kiran Mazumdar Shaw, CMD at Biocon Limited.Addressing AACSB accredited IFIM Business School 22nd Annual Convo",positive,positive,-1.8087855297157691,negative,2.883376820688978,positive
2018-06-24 00:17:54.846,318.38,322.5,316.0,316.05,8130436.0,Biocon receives EIR from USFDA for its Bengaluru facility producing sterile,Biocon said it has received Establishment Inspection Report (EIR) from the US health regulator on closure of inspection of its sterile drug product manufacturing facility in Bengaluru,neutral,negative,-0.7318298888121064,neutral,0.949367088607595,positive
2018-06-25 13:00:12.028,316.0,320.45,315.4,319.0,2738790.0,Biocon hits near 3-week high,"Shares of Biocon hit near 3-week high as the company has got an establishment inspection report from USFDA. The stock climbed as much as 2.44 per cent to Rs 645, its since June 5. The stock posted big",positive,positive,0.949367088607595,positive,-0.8789365799118085,neutral
2018-06-25 23:01:41.949,316.0,320.45,315.4,319.0,2738790.0,India's biotech queen Shaw tells IISc to inspire society,"Bengaluru, June 25 (IANS) India's biotechnology queen and Biocon Chairperson Kiran Mazumdar-Shaw on Monday told the students of Indian Institute of Science (IISc) here to step out of the laboratories and inspire society.",positive,neutral,0.949367088607595,positive,-0.8789365799118085,neutral
2018-06-28 23:02:53.540,309.12,310.95,302.17,308.77,3357846.0,Kiran Mazumdar Shaw elected as a member of MIT,"BENGALURU: Kiran Mazumdar Shaw, chairman and managing director of Biocon, has been elected as a full-term member of the U.S.-based MIT Corporation, or the Massachusetts Institute of Technology (MIT),",neutral,neutral,-0.1132246376811667,neutral,-0.8336025848142115,neutral
2018-06-29 18:00:18.902,309.12,310.95,302.17,308.77,3357846.0,"After Market: IDBI Bank's spurt, Gallant stock split & block deals","IDBI Bank saw the biggest spurt in OI at 37.44%, followed by Bata India 31.11% and Biocon 30.60%.",neutral,positive,-0.1132246376811667,neutral,-0.8336025848142115,neutral
2018-07-05 10:01:15.472,318.25,318.98,312.92,313.55,3920560.0,"RIL, Biocon and YES Bank among top stocks to track today",Here is a list of top stocks that are likely to be in focus in today's trading session. ,neutral,neutral,-1.4768263943440656,negative,0.3179650238473768,neutral
2018-07-09 18:01:43.344,319.55,320.33,314.62,316.55,2076790.0,"Here are the stocks which have undergone changes in their classification of large, mid and smallcaps","A few names that form a part of the changes are Biocon, Shriram Transport Finance, MRF, Colgate Palmolive, ACC, ABB, and Punjab National Bank",neutral,neutral,-0.9388202159286496,negative,-1.1374407582938462,negative
2018-07-10 10:01:07.055,319.55,320.33,314.62,316.55,2076790.0,"Kiran Shaw, Kannada Development Authority spar over English medium classes","Biocon chief Kiran Shaw calls Kannada Development Authority ""an insignifacnt group of naysayers"" for opposing state govt's proposal to introduce English medium classes in 1,000 primary schools",neutral,neutral,-0.9388202159286496,negative,-1.1374407582938462,negative
2018-07-10 10:02:19.510,319.55,320.33,314.62,316.55,2076790.0,"For Biocon, regulatory nod to give boost to biosimilar monetisation","EU's clearance to firm's Bengaluru plant increases chances of its drug approval, launches",neutral,positive,-0.9388202159286496,negative,-1.1374407582938462,negative
2018-07-10 13:00:20.242,316.5,317.38,312.17,312.9,1915490.0,Bengaluru city debates over what can be the best mobility solution,Biocon CMD Kiran Mazumdar Shaw believe Bengaluru needs multi-modal transport options including long flyovers.,neutral,neutral,-1.1374407582938462,negative,-2.660661811677522,negative
2018-07-11 13:01:54.912,313.08,315.0,304.58,304.75,3460658.0,Biocon puts arthritis drug on backburner,"Biocon and Mylan have been working for a decade on a biosimilar version of the drug, originally sold by Amgen under brand name Enbrel.",neutral,neutral,-2.660661811677522,negative,-1.8806214227309892,negative
2018-07-16 13:02:47.752,291.33,299.98,288.73,296.0,2965926.0,A collector’s passion for art and science comes together at Biocon,"Kiran Mazumdar-Shaw on why she has displayed nearly 1,500 works of art across the company’s offices and research centre",neutral,neutral,1.602993169258235,positive,-1.6902356902356843,negative
2018-07-23 23:02:25.504,285.02,291.23,281.5,287.5,4325228.0,Biocon arm Syngene expands scope of R&D work with Baxter Health Corp,"Syngene International, the contract research arm of Biocon has expanded the scope of its research and development (R&D) efforts with Baxter Health Corporation.This development comes on the heels o",positive,positive,0.8701143779383966,neutral,-4.223494707617546,negative
2018-07-25 23:00:22.281,275.92,282.73,271.65,278.75,4510192.0,"ITC, Bharti Airtel, Biocon, Maruti, SBI Life results","Aptech, Agro Tech Foods, Alembic Pharma, Biocon, CESC, Cholamandalam Investment, Bharat Financial, Bharti Airtel, Colgate, Concor, CUB, Dr Reddy’s, Eveready, Heidelberg, ITC, Jubilant, J&K Bank, L",neutral,neutral,1.025659611481583,positive,2.5964912280701675,positive
2018-07-26 13:01:55.755,285.0,307.23,284.5,292.4,30969622.0,Biocon Q1 preview: Net profit seen rising 44% on last year's low base,"The company's performance in the June quarter is also expected to augmented by the performance of its biologics, branded formulations and research services segments",positive,positive,2.5964912280701675,positive,-1.2767975073661333,negative
2018-07-26 23:01:54.692,285.0,307.23,284.5,292.4,30969622.0,"Biocon Q1 profit jumps 47%, beats estimates",Revenue from operations rose 20.4 percent to 11.24 billion rupees.,positive,positive,2.5964912280701675,positive,-1.2767975073661333,negative
2018-07-27 13:01:34.562,285.0,307.23,284.5,292.4,30969622.0,"Buzzing stocks: ITC, Idea Cellular, PNB, SBI, Biocon",ITC was leading the pack of most active stocks in value terms too. ,neutral,neutral,2.5964912280701675,positive,-1.2767975073661333,negative
2018-07-29 23:01:50.013,295.27,295.27,288.6,291.5,4718940.0,Biocon: Consider going short," The stock of Biocon (₹586.8) rules at a crucial level. Though the long-term outlook appears bright, the stock needs to close above ₹623 to regain the bull run. The stock finds an immediate support at",neutral,positive,-1.2767975073661333,negative,0.3191270331480361,neutral
2018-07-30 10:00:58.632,295.27,295.27,288.6,291.5,4718940.0,"New Launches Will Help Meet $200-Billion Sales Target, Says Biocon’s Kiran Mazumdar-Shaw",Biocon plans to launch its Insulin Glargine drug in Europe and Australia by the year-end.,neutral,positive,-1.2767975073661333,negative,0.3191270331480361,neutral
2018-08-01 10:01:03.027,293.4,295.95,290.38,291.52,2755710.0,Biocon targets $200 mn revenue from biosimilars on the back of EMs growth,The approval of Biocon's biosimilar insulin Glargine in about 25 countries will be a revenue-driving force,neutral,positive,-0.6407634628493509,neutral,0.1816935207404969,neutral
2018-08-23 10:01:55.976,307.5,309.98,304.3,306.12,3123300.0,"Check out insider trades for August 21; Tata Motors, Axis Bank, Biocon, RIL in focus","Shashikant Rathi sold 11,500 shares of Axis Bank through market sale on August 20, 2018. K.V.N.Yesubabu sold 26,600 shares of Yes Bank through market sale on August 20, 2018. Deepak Datta sold 42,824 shares of Reliance Industries through market sale on August 20, 2018",neutral,neutral,-0.4487804878048765,neutral,-1.0379267576212567,negative
2018-08-23 18:01:29.198,306.38,310.83,301.35,303.2,2280934.0,"PM Modi, Priyanka Chopra, Binny Bansal in LinkedIn most viewed profiles list","LinkedIn’s influencers list features PM Narendra Modi, actor Priyanka Chopra, Biocon chief Kiran Mazumdar-Shaw, venture capitalist Vani Kola, Nobel laureate and child rights activist Kailash Satyarthi",neutral,neutral,-1.0379267576212567,negative,-0.4646292781886054,neutral
2018-08-29 13:00:35.949,306.5,310.27,301.58,303.35,2628346.0,"JSW Steel hits 52-week high, Lupin falls 2% after NSE announces rejig of Nifty","The Nifty Midcap 50 index also underwent some changes as Adani Power, Biocon, Engineers India, IDFC and PC Jeweller will be replaced with Cummins India, Jubilant Foodworks, Power Finance Corporation, Punjab National Bank and Rural Electrification Corporation.",neutral,neutral,-1.0277324632952618,negative,2.9901427488214134,positive
2018-08-29 18:01:36.096,306.5,310.27,301.58,303.35,2628346.0,"D-Street Buzz: Realty, metal stocks outperform with HDIL & JSW Steel up 9%; Intellect Design jumps 14%","The Nifty midcap index continues to trade on the positive side and is up over 1 percent led by IFCI, GMR Infra, Biocon, India Cements, Jain Irrigation, Power Finance, Mcleod Russel, Reliance Infra, Reliance Power and Indraprastha Gas among others.",positive,positive,-1.0277324632952618,negative,2.9901427488214134,positive
2018-09-03 10:02:00.841,313.4,315.0,306.52,306.83,3882594.0,"'BUY' or 'SELL' ideas from experts for Monday, 3 September 2018","Biocon is a 'Buy' call with a target price of Rs 633 and a stop loss of Rs 615.
",neutral,neutral,-2.0963624760689195,negative,-3.712108931755549,negative
2018-09-10 18:01:54.567,320.45,329.8,313.95,320.98,7569342.0,"D-Street Buzz: Midcaps fall with Biocon down 4%; BPCL hits new 52-week low, PSU banks drag","The breadth of the market favoured declines, with 548 stocks advancing, 1177 declining and 353 remaining unchanged. On BSE, 1026 stocks advanced, 1658 declined and 175 remained unchanged.",negative,positive,0.1653924169137243,neutral,-0.3678304239401517,neutral
2018-09-12 13:02:15.292,320.8,322.42,306.5,319.62,6372228.0,Syngene drops 1.5% after Biocon cuts stake,The stock touched an intraday high of Rs 610.45 and an intraday low of Rs 600.50.,neutral,negative,-0.3678304239401517,neutral,3.33333333333333,positive
2018-09-21 23:01:00.322,340.5,345.75,328.62,339.9,11871640.0,Biocon closer to Europe approval of biosimilar pegfilgrastim,"Amgen's Neulasta had brand sales of more than $450 million in Europe for the 12 months ending June 30, 2018, according to market research firm IQVIA.",neutral,neutral,-0.1762114537445001,neutral,-2.7656477438136826,negative
2018-09-24 21:17:52.850,334.0,354.42,330.0,353.0,8867460.0,USFDA inspection of Biocon's drug substance unit at Bengaluru complete,"The week-long audit concluded without any observations and no Form 483 was issued, it added.",neutral,neutral,5.688622754491018,positive,-0.8169014084506978,neutral
2018-09-25 18:00:28.925,355.0,359.0,348.12,352.1,8998308.0,"Repco Home, M&M Financial, Balrampur Chini, Biocon top gainers among BSE Group A stocks","The breadth of the market favoured declines, with 583 stocks advancing, 1173 declining and 296 remaining unchanged",positive,positive,-0.8169014084506978,neutral,0.7806955287437899,neutral
2018-09-25 18:03:14.942,355.0,359.0,348.12,352.1,8998308.0,D-Street Buzz: Realty stocks plunge with Indiabulls Real Estate down 13%; Biocon hits new 52-week high,"The breadth of the market favoured declines, with 494 stocks advancing, 1248 declining and 310 remaining unchanged. On BSE, 819 stocks advanced, 1798 declined and 157 remained unchanged.",negative,positive,-0.8169014084506978,neutral,0.7806955287437899,neutral
2018-09-26 13:00:16.030,352.25,355.98,347.75,355.0,5291198.0,"D-Street Buzz: Realty stocks gain with Unitech up 5%; HUL, ITC shed 1-2%, Biocon at new 52-week high","The breadth of the market favoured advances, with 946 stocks advancing, 744 declining and 359 remaining unchanged. On BSE, 1222 stocks advanced, 1113 declined and 134 remained unchanged.",positive,positive,0.7806955287437899,neutral,-2.9014084507042286,negative
2018-09-26 13:01:42.151,352.25,355.98,347.75,355.0,5291198.0,Biocon hits new high; stock zooms 109% in one year,"The stock hit a new high of Rs 718, rallying 8% in two days after the company's drug substance manufacturing site at Bengaluru campus by the US health regulator has concluded without any observations.",neutral,positive,0.7806955287437899,neutral,-2.9014084507042286,negative
2018-10-12 18:01:54.282,306.25,310.0,299.62,304.15,3622562.0,Biocon Q2 PAT seen up 105.9% YoY to Rs. 141.6 cr: ICICI Direct,"Net Sales are expected to increase by 28.6 percent Y-o-Y (up 10.8 percent Q-o-Q) to Rs. 1,245.4 crore, according to ICICI Direct.",positive,positive,-0.6857142857142932,neutral,3.0491803278688563,positive
2018-10-15 13:00:39.000,314.5,317.0,310.33,314.05,2501610.0,"Pharma shares in focus; Dr Reddy's, Biocon, Lupin, Natco Pharma up over 3%","Nifty Pharma index, the largest gainer among sectoral indices, was up 1.7% as compared to 0.17% decline in Nifty 50 index at 09:36 am.",positive,positive,-0.1430842607313159,neutral,0.151649184885637,neutral
2018-10-16 23:02:32.910,316.52,322.5,311.42,317.0,5458404.0,Biocon Q2 PAT seen up 38.2% YoY to Rs. 123 cr: Sharekhan,"Net Sales are expected to increase by 19.1 percent Y-o-Y (up 2.7 percent Q-o-Q) to Rs. 1,154 crore, according to Sharekhan.",positive,positive,0.151649184885637,neutral,4.708038422649133,positive
2018-10-19 23:01:48.414,316.48,332.9,315.73,331.38,7933212.0,Biocon one step closer to Europe nod for biosimilar of breast cancer drug,"Firm obtains positive opinion on approval of Ogivri, a biosimilar to Roche's Herceptin (trastuzumab); final decision by year-end",neutral,positive,4.708038422649133,positive,0.5820895522388025,neutral
2018-10-22 13:02:08.484,335.0,335.75,311.25,313.62,6008940.0,Biocon gains nearly 4% on positive CHMP opinion for Ogivri; Citi maintains buy,Research house Citi has maintained buy call on Biocon with a target of Rs 800 per share.,positive,positive,-6.3820895522388055,negative,2.700636942675165,positive
2018-10-23 18:01:11.611,314.0,323.92,314.0,322.48,4623368.0,"Kansai Nerolac, Biocon, IIFL Holdings, Greaves Cotton top losers among BSE Group A stocks","From BSE Group A stocks, Indian Energy Exchange shed 7.85 percent and witnessed spurt in volume by more than 5.66 times. Kansai Nerolac on the other hand was down 8 percent trading at a new 52-week low",neutral,negative,2.700636942675165,positive,-3.209411764705888,negative
2018-10-24 23:01:14.132,318.75,325.15,306.0,308.52,5259446.0,"Bharti Airtel, JSW Steel, Maruti, YES Bank results","About 60 firms will declare their July-September quarter results on Thursday. Among them are 63 moons, Bharti Airtel, Biocon, Crompton Greaves Consumer, DB Corp, Dish TV, GMDC, HCL Infosys, Heldelberg",neutral,neutral,-3.209411764705888,negative,-6.1526479750778815,negative
2018-10-25 23:00:37.104,321.0,322.2,300.0,301.25,15534592.0,Biocon Q2 net profit surges five-fold on exceptional income,Biocon's revenue rose 35 per cent to Rs 13.75 billion from Rs 10.19 billion in the second quarter of the previous financial year,positive,positive,-6.1526479750778815,negative,2.6224641266699806,positive
2018-10-26 13:02:24.677,321.0,322.2,300.0,301.25,15534592.0,"Biocon Consolidated September 2018 Net Sales at Rs 1,321.00 crore, Up 36.38% Q-o-Q.","Biocon Consolidated September 2018 Net Sales at Rs 1,321.00 crore, Up 36.38% Q-o-Q.",neutral,neutral,-6.1526479750778815,negative,2.6224641266699806,positive
2018-10-26 23:01:53.187,321.0,322.2,300.0,301.25,15534592.0,Biocon Q2 net soars 167% to ₹355 crore,"Biocon has reported a strong second quarter numbers, on the back of good performance across its biologics, small molecules and research services segment.The bio-tech major showed net profit growth of",neutral,positive,-6.1526479750778815,negative,2.6224641266699806,positive
2018-10-31 23:01:25.187,327.52,333.48,320.65,322.75,4605676.0,"Biologics business more than doubled in Q2, says Biocon CFO","Biocon reported better-than-expected revenue and profit in the second quarter of FY19 on the back of good performance by its Biologics, Research Services and Small Molecules business segments. Siddha",positive,positive,-1.4563996091841664,negative,-2.897657213316886,negative
2018-11-07 10:30:10.305,317.58,318.0,315.15,316.3,328738.0,Biocon's Malaysia insulin facility on the path to break even in FY19,Insulin Glargine is the first biosimilar from India to be approved and launched in Japan,positive,neutral,-0.4030480508848079,neutral,0.0531250000000049,neutral
2018-11-09 10:01:03.951,320.0,321.0,315.02,320.17,3426308.0,Biocon opens higher as Citi maintains buy rating,Citi added that Biocon is one of its top picks. Risk-reward ratio is favourable at current levels,positive,positive,0.0531250000000049,neutral,-3.5168903285515896,negative
2018-11-12 10:00:51.968,324.15,325.0,311.48,312.75,4280614.0,Biocon clears USFDA audit of Bengaluru plant with zero observations,The USFDA inspection was triggered after Biocon filed for an abbreviated new drug application in the US. The company didn't disclose details of the product.,neutral,neutral,-3.5168903285515896,negative,-0.8653846153846118,neutral
2018-11-12 13:02:42.561,312.0,315.38,303.3,309.3,4323002.0,Biocon falls 1%; Bengaluru unit completes USFDA inspection,The audit concluded without any observations and no Form 483 was issued.,neutral,neutral,-0.8653846153846118,neutral,0.6549443458622454,neutral
2018-11-19 18:00:42.544,312.5,318.92,305.12,305.75,3912518.0,Biocon looks to bridge industry skill gap through internal academy,There is a talent shortage in the biotechnology sector in India,neutral,negative,-2.16,negative,3.1639344262295004,positive
2018-11-29 10:01:29.843,299.0,305.27,295.33,301.55,5148598.0,Biocon aims to be global biopharma leader in 20 yrs: MD Kiran Mazumdar-Shaw,"'
While the company's insulin business recorded a strong growth in several emerging markets, its cancer biosimilar Fulphila became the first pegfilgrastim biosimilar to be available to patients in US",positive,positive,0.8528428093645523,neutral,2.98679867986799,positive
2018-11-29 18:02:25.928,303.0,313.2,301.33,312.05,5171738.0,Biocon chief bats for easing controls on biotech sector,Biotech company Biocon chief Kiran Mazumdar-Shaw said in a statement on Thursday that the previous UPA and the ruling Narendra Modi-headed governments have taken some good steps but could have done mo,neutral,positive,2.98679867986799,positive,-2.6107594936708862,negative
2018-11-30 23:01:00.177,303.0,313.2,301.33,312.05,5171738.0,"Biocon, Mylan joint product gets approval in EU",Biosimilar Pegfilgrastim treatment can be used to stimulate bone marrow to produce more neutrophils to fight infection in patients undergoing chemotherapy.,positive,positive,2.98679867986799,positive,-2.6107594936708862,negative
2018-12-12 13:01:42.052,320.0,322.85,316.5,321.1,2968052.0,"YES Bank, Biocon, TVS among 38 stocks readying to rally, shows MACD","NSEs Nifty50 index closed 60.70 points, or 0.58 per cent, higher at 10,549 on Tuesday.",positive,positive,0.3437500000000071,neutral,1.1700468018720749,positive
2018-12-17 10:00:17.400,325.5,327.45,314.17,317.25,7924736.0,"Stocks in the news: Biocon, Vedanta, Jet Airways and L&T","Asian stocks Hang Seng and Nikkei were also trading in green in the morning trade. 
",neutral,neutral,-2.5345622119815667,negative,1.0567823343848652,positive
2018-12-17 13:00:31.664,317.0,320.5,316.9,320.35,2035720.0,USFDA completes Biocon's Telangana plant inspection,"The inspection was concluded without any observations and no Form 483 was issued, the company said. ",neutral,neutral,1.0567823343848652,positive,-0.9739347588575008,negative
2018-12-19 10:00:13.334,320.35,323.4,315.5,317.23,3677158.0,"Stocks in the news: Reliance Communications, YES Bank, IDFC Bank, BSE, Piramal and Biocon",Here's a look at the top stocks that may hog the limelight in today's session.,neutral,neutral,-0.9739347588575008,negative,0.5448818897637853,neutral
2018-12-24 13:00:50.080,310.45,311.15,304.0,305.75,2725738.0,"Biocon, One Of 2018’s Top Pharma Stocks, Won’t Focus On India","“I don’t want to play a bloodbath game in the Indian market, for now,” says Biocon’s Kiran Mazumdar-Shaw.",neutral,neutral,-1.5139313899178577,negative,1.0101672679567206,positive
2018-12-26 13:00:30.664,309.45,310.5,305.02,305.48,3029146.0,Three Nifty Pharma stocks that can rise up to 10% from the current levels,"The year 2018 witnessed three pharma stocks scaling their lifetime high. They are Divi's Laboratories, Biocon and Piramal Enterprises (PEL).",positive,neutral,-1.282921312005161,negative,1.49161172400287,positive
2018-12-26 13:01:18.740,309.45,310.5,305.02,305.48,3029146.0,"3 top banks, Biocon, Maruti & CEAT among 89 stocks set to crack, shows MACD",MACD is known for signalling trend reversals in traded securities or indices.,neutral,neutral,-1.282921312005161,negative,1.49161172400287,positive
2019-01-04 13:00:48.726,306.55,309.92,303.62,308.55,2019040.0,Steady performers: 11 stocks that gave double-digit returns for 4 straight years,"Aarti Industries, Bajaj Finance, Biocon and HDFC Bank, among others, feature in the list of 11 stocks that gave positive, double-digit return in the past four years in BSE 500 stocks list.",positive,positive,0.6524221171097699,neutral,-0.3215434083601286,neutral
2019-01-04 18:02:40.044,306.55,309.92,303.62,308.55,2019040.0,Steady performers: 11 stocks that gave double-digit returns for 4 straight years,"Aarti Industries, Bajaj Finance, Biocon and HDFC Bank, among others, feature in the list of 11 stocks that gave positive, double-digit return in the past four years in BSE 500 stocks list.",positive,positive,0.6524221171097699,neutral,-0.3215434083601286,neutral
2019-01-11 18:02:51.737,315.42,321.83,314.05,321.05,3550302.0,Biocon Q3 PAT seen up 105.4% YoY to Rs. 188.7 cr: ICICI Direct,"Net Sales are expected to increase by 30.7 percent Y-o-Y (up 4.6 percent Q-o-Q) to Rs. 1,382.4 crore, according to ICICI Direct.",positive,positive,1.7849216917126356,positive,0.1550387596899224,neutral
2019-01-11 23:02:09.740,315.42,321.83,314.05,321.05,3550302.0,Kiran Mazumdar-Shaw gets second term as Infosys' lead independent director,Mazumdar-Shaw also serves as the chairperson and managing director of biopharmaceutical company Biocon.,neutral,neutral,1.7849216917126356,positive,0.1550387596899224,neutral
2019-01-14 10:00:40.670,322.5,323.88,319.12,323.0,3713768.0,"Top trading ideas by Angel Broking: Buy Biocon, Max Financial Services","Stock calls and outlook on Nifty by Sameet Chavan, Chief Analyst- Technical & Derivatives, Angel Broking.",neutral,neutral,0.1550387596899224,neutral,-0.1845869866174504,neutral
2019-01-14 13:00:23.599,325.05,325.73,321.52,324.45,2434648.0,Biocon chief Kiran Mazumdar-Shaw: Dent vehicle bonnets to discipline violators,"“If our traffic police can enforce lane discipline like they do in Chennai & Mumbai half of Bengalurus traffic gridlock will be eliminated"", Shaw tweeted.",neutral,neutral,-0.1845869866174504,neutral,0.4006780705809867,neutral
2019-01-16 10:00:16.319,324.45,327.5,322.5,325.75,1871632.0,Biocon likely to channelise investments towards non-insulin biologics,"Globally, the insulin business has come under pressure",neutral,negative,0.4006780705809867,neutral,0.9047692071768098,positive
2019-01-21 18:00:24.661,332.35,335.95,330.05,335.5,2368558.0,Biocon chief Kiran Mazumdar-Shaw wants Congress to commit to growth of digital economy,Mazumdar gave this suggestion to the Congress during the party's 'manifesto consultation meeting on IT and BT Economy.,neutral,neutral,0.9477959981946674,positive,-0.4216778025241324,neutral
2019-01-23 23:01:01.644,336.85,336.85,332.62,334.2,3026370.0,"YES Bank, Colgate, RPower, results eyed"," About 50 companies, including Bharat Bijlee, Biocon, Century Enka, Colgate, Edelweiss, Hatsun Agro, ICRA, Jindal Saw, Jyothy Laboratories, Kokuyo, KRBL, Mphasis, NIIT, Nelco, Newgen, Onward Tech, Pfi",neutral,neutral,-0.7867003117114543,neutral,-2.643171806167401,negative
2019-01-24 10:00:13.351,336.85,336.85,332.62,334.2,3026370.0,"InterGlobe Aviation, Biocon, Vodafone-Idea and USL top stocks to track",Here's a look at the top stocks that may remain in focus today -,positive,neutral,-0.7867003117114543,neutral,-2.643171806167401,negative
2019-01-24 23:01:10.454,340.5,341.23,328.15,331.5,16855470.0,Biocon Q3 profit zooms twofold to Rs 217 crore,"Consolidated revenue from operations stood at Rs 1,540.8 crore for the quarter, against Rs 1,057.9 crore.",positive,negative,-2.643171806167401,negative,-2.030075187969925,negative
2019-01-25 10:00:45.711,340.5,341.23,328.15,331.5,16855470.0,"Maruti, L&T, Biocon, Mphasis and YES Bank among top stocks to track",Here's a look at the top stocks that may remain in focus today -,neutral,neutral,-2.643171806167401,negative,-2.030075187969925,negative
2019-01-25 10:01:45.503,340.5,341.23,328.15,331.5,16855470.0,"Buzzing stocks: YES Bank, RIL,ICICI Bank, Biocon, RCom ","The NSE Nifty index was trading 74.05 points up at 10,923.85 while the BSE Sensex was up 250.67 points at 36,445.77 around 09:23 am. ",neutral,positive,-2.643171806167401,negative,-2.030075187969925,negative
2019-02-08 10:02:48.609,328.0,331.85,323.1,328.0,2065416.0,"Cash Market | Biocon at inflection point, can post a sharp rally",Biocon is at the confluence of multiple technical indicators and post a smart rally ,positive,neutral,0.0,neutral,-1.4964116659031843,negative
2019-02-18 10:01:14.334,310.95,312.95,302.0,303.73,4083166.0,"Stocks in the news: YES Bank, TechM, Dr Reddy's Labs, Biocon, Jet Airways and DHFL","Meanwhile, Reliance Group has reached an understanding with lenders on shares pledged. ",neutral,positive,-2.321916706866046,negative,0.8119658119658211,neutral
2019-02-22 23:00:26.224,311.2,313.9,309.3,310.95,1406948.0,"Not getting enough women for leadership roles, says Kiran Mazumdar Shaw","Biocon chairperson Kiran Mazumdar Shaw has lamented that she is struggling to find enough women to play leadership roles, even though there is a significant rise in their number in junior management r",neutral,negative,-0.0803341902313624,neutral,-1.0017659335366846,negative
2019-02-28 23:00:07.630,312.0,317.2,311.5,315.5,1695500.0,Infosys fines Kiran Mazumdar-Shaw for breach of insider trading norms,Biocon chairman & lead independent director at Infy fined ~9.5 lakh for selling firm's shares without intimation,negative,neutral,1.1217948717948718,positive,-1.137081490840184,negative
2019-03-01 23:01:23.176,312.0,317.2,311.5,315.5,1695500.0,Biocon appoints Christiane Hamacher as CEO of Biocon Biologics India,"Hamacher comes with more than 20 years of leadership experience in both strategic and operational roles across the value chain in global pharma spanning Asia, Europe and the US, Biocon said in a BSE filing.

",neutral,neutral,1.1217948717948718,positive,-1.137081490840184,negative
2019-03-06 10:01:22.072,315.2,317.2,312.12,313.5,2314998.0,"From Sun Pharma to Biocon, US to remain a challenge for Indian drug firms",Indian firms with specialty product portfolios will do better than peers,positive,positive,-0.5393401015228391,neutral,0.6852925672113999,neutral
2019-03-06 23:00:21.225,303.52,310.67,303.52,305.6,9727642.0,Biocon gets 6 observations from USFDA after inspection of its Bengaluru plant,"Biocon is confident of addressing these expeditiously and remains committed to global standards of quality and compliance, the statement added. ",neutral,positive,0.6852925672113999,neutral,0.2120717781402862,neutral
2019-03-06 23:01:07.826,303.52,310.67,303.52,305.6,9727642.0,Biocon gets 6 observations from USFDA after inspection of its Bengaluru plant,"Biocon is confident of addressing these expeditiously and remains committed to global standards of quality and compliance, the statement added. ",neutral,positive,0.6852925672113999,neutral,0.2120717781402862,neutral
2019-03-07 10:00:10.647,303.52,310.67,303.52,305.6,9727642.0,"Buzzing stocks: Suzlon Energy, Biocon, RIL, DHFL,Endurance Technologies  ",Endurance Technologies (Rs 23.73 crore) was leading the pack of most active stocks in value terms.,neutral,positive,0.6852925672113999,neutral,0.2120717781402862,neutral
2019-03-07 10:00:59.648,303.52,310.67,303.52,305.6,9727642.0,"Stocks in the news: Eveready Ind, Lux Ind, Biocon, Endurance Tech, HDFC and Lakshmi Vilas Bank",Vedanta board has approved second interim dividend of Rs 1.85 per equity share  for FY 19.,neutral,neutral,0.6852925672113999,neutral,0.2120717781402862,neutral
2019-03-12 13:02:00.526,318.48,318.48,308.0,308.85,2258810.0,"Airtel, Titan, Biocon among 20 stocks that look ready to rally, shows MACD",Many of these stocks have been witnessing strong trading volumes of late. ,positive,positive,-3.023737754333081,negative,0.0647249190938474,neutral
2019-04-03 10:00:47.194,308.02,309.25,303.3,304.0,1262718.0,"Jet Airways, HEG, Biocon and Emami among top stocks to track today",Here's a look at the top stocks that may remain in focus today -,neutral,neutral,-1.3051100577884496,negative,1.1532125205930808,positive
2019-04-05 10:01:31.580,307.1,307.88,305.05,305.4,1243276.0,‘Breakthrough innovation is taking place but we’re not leveraging it’,"In an interview, the chairperson and managing director of Biocon, Shaw explains her vision for the future of healthcare innovation in India.We need to use digital technologies so that we can map health parameters of the nation, says Shaw",neutral,neutral,-0.5535656138065924,neutral,-1.5996106424399763,negative
2019-04-17 18:01:20.119,312.0,312.45,306.2,307.67,1608356.0,Biocon Q4 PAT seen up 35.2% YoY to Rs. 176.2 cr: Kotak,"Net Sales are expected to increase by 31.6 percent Y-o-Y (down 0.1 percent Q-o-Q) to Rs. 1,538.7 crore, according to Kotak.",positive,positive,-1.387820512820508,negative,-1.1372867587327375,negative
2019-04-25 10:01:10.795,310.52,311.85,307.25,310.08,4635000.0,"Maruti, Ipca Labs, Tata Steel, M&M Finance and Biocon may hog the limelight",Here's a look at the top stocks that may remain in focus today -,neutral,neutral,-0.141697797243333,neutral,-1.0350318471337578,negative
2019-04-25 23:00:31.182,314.0,314.0,305.55,310.75,8817428.0,Biocon Q4 profit up 64% at Rs 214 crore,Biocon's board has also approved issue of bonus shares in the proportion of 1:1.,positive,neutral,-1.0350318471337578,negative,-4.0012907389480405,negative
2019-04-26 10:00:32.690,314.0,314.0,305.55,310.75,8817428.0,"Axis Bank, YES Bank, Hero MotoCorp, Tata Steel, Biocon top stocks to track",Here's a look at the top stocks that may remain in focus today -,positive,neutral,-1.0350318471337578,negative,-4.0012907389480405,negative
2019-04-30 13:00:25.834,309.9,309.9,292.7,297.5,7931602.0,Biocon falls 2% despite strong Q4 earnings,"At 1114 hrs, Biocon was quoting Rs 606.50, down 2.15 percent on the BSE.",negative,negative,-4.0012907389480405,negative,-6.549924229668291,negative
2019-05-02 18:00:44.971,279.0,281.5,274.6,275.7,8852654.0,"Biocon nears 52-week low, falls 5% after reporting mixed numbers in Q4","In the past three trading days, the stock has slipped 10 per cent, as compared to a per cent rise in the benchmark S&P BSE Sensex",negative,negative,-1.1827956989247352,negative,-0.6386861313868614,neutral
2019-05-13 18:00:26.118,262.6,268.98,259.1,265.0,3460978.0,"Eicher Motors, M&M, Sun Pharma hit 52-week low","Biocon, Cadila Healthcare, SPARC and Wockhardt from the pharma and Amara Raja Batteries, Bharat Forge, Motherson Sumi, and TVS Srichakra Tyres auto-related sectors hit 52-week lows on Monday",negative,neutral,0.9139375476009052,positive,-0.6798632761146385,neutral
2019-05-20 10:00:53.334,266.5,266.5,254.38,261.0,5640978.0,"Biologics to boost Biocon business over the next 3 years, say analysts",Biologics accounted for 27% of total revenue in FY19,positive,neutral,-2.063789868667917,negative,-1.882797731569005,negative
2019-05-22 23:01:32.167,262.98,263.0,254.25,255.52,3677216.0,Biocon and Mylan get Canadian nod for biosimilar cancer drug Ogivri,Mylan will launch the product during this quarter; global market size of the generic is $7 billion,neutral,neutral,-2.8367176211118745,negative,4.6770601336302775,positive
2019-06-04 10:01:06.038,278.65,280.25,270.0,270.52,4734390.0,"Top trading ideas by Prabhudas Lilladher: Buy Bata India, Biocon","Market outlook and top trading ideas by Vaishali Parekh, research analyst - technical research at Prabhudas Lilladher.",neutral,neutral,-2.9176386147496847,negative,0.2757352941176471,neutral
2019-06-10 23:01:28.818,266.75,272.17,262.75,268.1,7101260.0,Biocon to turn ex-bonus on Wednesday," Shares of Biocon will remain in focus, as they turn ex-bonus on Wednesday. That means, investors wishing to receive the bonus shares need to own the company’s shares by Tuesday. Biocon is rewarding i",neutral,neutral,0.5060918462980404,neutral,-4.779547980733597,negative
2019-06-14 18:00:22.257,257.3,258.55,247.0,247.0,3787942.0,Boost to Biocon's biosimilar business as Bengaluru units get European nod,Facilities were inspected by the European Medicines Agency in March; Analysts foresee firm posting double-digit growth in revenue and profits despite rising competition,neutral,positive,-4.003109211037703,negative,-1.2499999999999976,negative
2019-06-14 23:02:25.789,257.3,258.55,247.0,247.0,3787942.0,Biocon Biologics unit in Bengaluru gets EU GMP certification; stock down 2%,"These facilities, used for the manufacture of Biocon's portfolio of biosimilars, were inspected by the European agency in March 2019, the company said.",negative,neutral,-4.003109211037703,negative,-1.2499999999999976,negative
2019-06-17 23:01:08.917,247.05,247.4,239.0,242.65,3112020.0,Biocon board approves sale of branded formulations business to subsidiary,The Board of Directors in its meeting approved the sale of Branded Formulations India (BFI) business to Biocon Biologics India (BBIL).,neutral,positive,-1.7810159886662642,negative,2.518427518427521,positive
2019-06-18 10:01:04.949,247.05,247.4,239.0,242.65,3112020.0,Biocon to sell branded formulations India business to unit,"The company has fixed July 01, 2019, as the expected date of completion of the sale and the consideration to be received is Rs45cr.",neutral,neutral,-1.7810159886662642,negative,2.518427518427521,positive
2019-06-18 10:02:13.461,247.05,247.4,239.0,242.65,3112020.0,"Top stocks in focus: HDFC AMC, Jet Airways, RCom, Biocon",Check out the companies which will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-1.7810159886662642,negative,2.518427518427521,positive
2019-06-19 10:01:07.647,244.2,252.5,242.7,250.35,4022336.0,Biocon Ltd. ADR (BCNQY) Management on Q4 2019 Results - Earnings Call Transcript,"Biocon Ltd. ADR (OTC:BCNQY) Q4 2019 Results Earnings Conference Call April 25, 2019, 11:30 PM ET Company Participants Saurabh Paliwal - Head of IR Kiran Mazumda",neutral,neutral,2.518427518427521,positive,0.8567443713887253,neutral
2019-06-26 13:00:09.836,252.95,253.0,247.35,248.0,2116638.0,"Nifty Pharma index gains 2% led by Aurobindo, Sun Pharma","Aurobindo jumped 4% and among top gainer in the pharma index, followed by shares of Sun Pharma, Cadila, Biocon and Lupin rose 3-2% respectively, were also among top contributors.",positive,positive,-1.956908479936742,negative,1.0670424803704472,positive
2019-07-05 23:00:09.400,249.0,250.35,238.85,239.4,2033635.0,"Budget is holistic, say tech industry leaders",Biocon managing director Kiran Mazumdar Shaw gave full marks to the finance minister.,neutral,neutral,-3.8554216867469857,negative,4.782608695652174,positive
2019-07-08 18:01:08.432,240.7,247.15,238.6,244.95,2055098.0,USFDA issues 12 observations for 3 Biocon units in Malaysia,US health regulator has issued 12 observations after the inspection of three of  Biocon's units in Malaysia.,neutral,negative,1.7656834233485668,positive,0.4884998982291832,neutral
2019-07-18 10:00:27.224,263.0,265.5,260.5,263.4,2701907.0,'BUY' or 'SELL' ideas from experts for Thursday 18 July 2019,Biocon is a 'Buy' call with a target price of Rs 272 and a stop loss of Rs 258.,neutral,neutral,0.152091254752843,neutral,-8.660968660968665,negative
2019-07-19 18:01:44.487,263.25,264.7,238.0,240.45,17947632.0,"After Market: Biocon drops 9%, RIL 1%, HDFC AMC hits new record; 517 stocks hit 52-week lows",Midcaps and smallcaps suffered more as their sectoral indices plunged up to 2 per cent on BSE.,neutral,negative,-8.660968660968665,negative,2.687499999999995,positive
2019-07-22 10:00:57.765,240.0,247.3,236.6,246.45,4148695.0,"Buzzing stocks: YES Bank, Biocon, RCom, Dish TV, Federal Bank  ","The NSE Nifty index was trading 45.60 points down at 11,373.65.",neutral,negative,2.687499999999995,positive,-1.897456600726681,negative
2019-07-22 10:01:11.696,240.0,247.3,236.6,246.45,4148695.0,"Stock pick of week: Biocon is on fast track to growth, making it analysts' top bet","Strong annual results for 2018-19 including improvement in net profit, growth momentum in its biosimilars business and recent price correction have made it favourite.",positive,positive,2.687499999999995,positive,-1.897456600726681,negative
2019-07-25 10:01:45.588,238.2,239.9,233.0,238.8,3108683.0,"Board Meetings Today: Ambuja Cements, Biocon, Bank of Baroda, PVR and Gurh Finance",It makes sense to have a look at the corporate agendas for the days as announced to the stock exchanges. ,neutral,neutral,0.2518891687657526,neutral,-3.5209866719713525,negative
2019-07-25 13:00:43.785,251.35,251.6,240.2,242.5,10197654.0,"Tata Motors, Biocon stocks drop; Bajaj Finance gains ahead of Q1 numbers","Shares of Tata Motors, Bank of Baroda and Biocon slipped, while Bajaj Finance, Ambuja Cements and Bajaj Finserv dropped in the late morning trade.",positive,negative,-3.5209866719713525,negative,-2.424989724619813,negative
2019-07-26 10:01:17.061,251.35,251.6,240.2,242.5,10197654.0,"Stocks in the news: Tata Motors, Bank of Baroda, Biocon, PVR, Trident, TRF, Techno Electric",Biocon | South Indian Bank | PVR | Trident | TRF | Techno Electric | Shriram Transport Finance and Maruti Suzuki are stocks which are in the news today.,neutral,neutral,-3.5209866719713525,negative,-2.424989724619813,negative
2019-07-26 10:02:11.903,251.35,251.6,240.2,242.5,10197654.0,Biocon posts stellar 86% yoy rise in PAT in Q1FY20,"Comapany's revenue for Q1FY20 came in at Rs1,490cr, up 25% yoy.",positive,positive,-3.5209866719713525,negative,-2.424989724619813,negative
2019-07-26 23:00:58.916,251.35,251.6,240.2,242.5,10197654.0,"F&O: Option data points to wider Nifty range at 11,000-11,650","Builtup of long position were seen in Biocon, Maruti Suzuki, Berger Paints and YES Bank.",neutral,neutral,-3.5209866719713525,negative,-2.424989724619813,negative
2019-07-30 10:01:04.745,240.0,243.6,232.8,233.6,3064397.0,Our aim is to be a global leader in biosimilars biz: Biocon Biologics CEO,Margins of biologics stood at 38% in Q1 as compared to 33% in the preceding quarter,positive,neutral,-2.6666666666666687,negative,-2.7896995708154506,negative
2019-07-31 23:01:10.575,226.0,226.45,221.25,223.9,3421752.0,India Inc remembers CCD's Siddhartha as a humble man,"Industry leaders such as Kiran Mazumdar Shaw of Biocon, automobile czar Anand Mahindra remembered Siddhartha as a 'humble and soft speaking' man.The body of the Cafe Coffee Day founder was found on Wednesday in the Netravati river in Dakshina Kannada district of Karnataka after 36 hours of intense search",neutral,neutral,-0.9292035398230064,negative,4.97737556561086,positive
2019-08-01 23:01:57.707,221.0,234.0,217.05,232.0,5716053.0,Biocon's partner Mylan launches first biosimilar of trastuzumab in Australia,"The company will be selling the drug under brand name Ogivri, which will be used for the treatment of HER2 sub-type breast cancer and metastatic stomach cancer.",neutral,neutral,4.97737556561086,positive,-0.0219250164437673,neutral
2019-08-05 10:00:48.926,228.05,235.25,223.1,228.0,3723602.0,Biocon Ltd. ADR (BCNQY) Q1 2020 Results - Earnings Call Transcript,"Biocon Ltd. ADR (OTC:BCNQY) Q1 2020 Earnings Conference Call July 25, 2019, 11:30 PM ET Company Participants Saurabh Paliwal - Head of IR Kiran Mazumdar-Shaw -",positive,neutral,-0.0219250164437673,neutral,-0.8149779735682794,neutral
2019-09-09 18:00:58.916,236.95,237.2,232.0,232.7,2259601.0,Biocon Chairperson and Managing Director Kiran Mazumdar Shaw on Monday said measures are required to save jobs in the automotive sector which represents 50 percent of the manufacturing sector jobs in the country,Biocon Chairperson and Managing Director Kiran Mazumdar Shaw on Monday said measures are required to save jobs in the automotive sector which represents 50 percent of the manufacturing sector jobs in the country,positive,positive,-1.7936273475416755,negative,0.0856164383561716,neutral
2019-09-12 23:00:15.027,237.5,237.5,230.45,231.75,4256879.0,Biocon enters into pact with CMS to sell 3 generic products in China,"Biocon will be responsible for the development, manufacturing and supply of the products while CMS will be responsible for registration and commercialisation of the products in China. ",positive,neutral,-2.421052631578948,negative,0.0867490782910382,neutral
2019-09-13 10:01:19.533,237.5,237.5,230.45,231.75,4256879.0,"Biocon forays into China, signs pact with CMS to sell 3 generic products","According to data, the total market size for these three generic products in China is about $0.8 billion",positive,neutral,-2.421052631578948,negative,0.0867490782910382,neutral
2019-09-13 10:01:50.370,237.5,237.5,230.45,231.75,4256879.0,"Stocks to watch: HUL, Biocon, M&M, Dr Reddy's, autos, Adani Transmission",Here's a look at the top stocks that may remain in focus today.,neutral,neutral,-2.421052631578948,negative,0.0867490782910382,neutral
2019-09-13 13:01:52.781,237.5,237.5,230.45,231.75,4256879.0,Biocon expands footprint to Chinese pharmaceuticals market with generic formulations,"Bengaluru (Karnataka) [India], Sep 13 (ANI): Biopharmaceutical major Biocon has signed a license and supply agreement with a subsidiary of China Medical System (CMS) Holdings Ltd for three generic formulation products in Greater China.",positive,positive,-2.421052631578948,negative,0.0867490782910382,neutral
2019-09-19 18:02:39.591,228.0,232.9,223.5,227.75,4508112.0,FM response to Kiran Mazumdar Shaw’s tweet gets thumbs up from Biocon CMD,The Biocon CMD thanked the Finance Minister for the response on Twitter. ,neutral,neutral,-0.1096491228070175,neutral,-1.2499999999999976,negative
2019-09-20 10:00:31.782,228.0,232.9,223.5,227.75,4508112.0,FM versus Biocon chief on Twitter over e-cigarettes settles amicably,"Shaw, head of Biocon, had earlier wondered why the finance minister, and not the health minister, addressed the press conference",neutral,neutral,-0.1096491228070175,neutral,-1.2499999999999976,negative
2019-09-20 23:00:35.603,228.0,232.9,223.5,227.75,4508112.0,Biocon gets 8 observations for 2 new units in Bengaluru,Biotechnology major Biocon on Friday said it has received a total of eight observations from the US health regulator for its two new biologics manufacturing facilities in Bengaluru.The United States F,neutral,neutral,-0.1096491228070175,neutral,-1.2499999999999976,negative
2019-09-22 13:01:00.585,228.0,229.95,224.15,225.15,3100933.0,USFDA completes pre-approval inspection of two new Biocon biologics facilities in Bengaluru,"At the conclusion of the inspection it received a Form 483 with four observations for the new OS facility, three observations for the new DP facility and one general observation.",neutral,neutral,-1.2499999999999976,negative,-0.7522123893805259,neutral
2019-09-23 10:00:29.815,228.0,229.95,224.15,225.15,3100933.0,"Top stocks in focus: Biocon, Cipla, Reliance Capital, Future Consumer",Check out the companies which will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-1.2499999999999976,negative,-0.7522123893805259,neutral
2019-09-23 10:00:40.103,228.0,229.95,224.15,225.15,3100933.0,"Stocks to watch: Dr Reddy's, Petronet LNG, Biocon, Cipla, Alkem Labs, autos",Here's a look at the top stocks that may remain in focus today -,neutral,neutral,-1.2499999999999976,negative,-0.7522123893805259,neutral
2019-09-24 10:02:47.957,226.0,228.0,224.0,224.3,2025925.0,Biocon Biologics acquires R&D assets from Pfizer Healthcare; stock rises ~1%,"Biocon Biologics, Biocon's subsidiary, acquired R&D capital assets for a 60,000 sq. ft. state-of-the-art 'bench to pilot scale' Biologics research facility at TICEL Bio Park in Chennai, India.",positive,neutral,-0.7522123893805259,neutral,-3.222938430762392,negative
2019-09-24 13:02:30.929,224.95,225.5,216.5,217.7,4209851.0,Biocon Biologics expands R&D footprint by acquiring assets of Pfizer Healthcare India,"Bengaluru (Karnataka) [India], Sep 24 (ANI): Biopharmaceuticals major Biocon Ltd said on Tuesday that its subsidiary has acquired research and development capital assets from Pfizer Healthcare India Ltd.",positive,neutral,-3.222938430762392,negative,-0.985334555453702,negative
2019-09-25 14:31:34.752,218.2,220.05,214.5,216.05,3934077.0,Biocon denies reports of stake sale in subsidiary,"The clarification referred to news reports that appeared in Economic Times and on moneycontrol.com on August 21, 2019, which said that ",neutral,neutral,-0.985334555453702,negative,1.1111111111111138,positive
2019-09-30 10:01:17.820,219.45,224.45,217.1,224.0,4670669.0,Why Biocon's 10 cents insulin offer could be a game changer in fighting diabetes,"Currently, blended median patient prices in LMICs are $9 per 10 ml vial translating to 36 US cents per day",positive,neutral,2.0733652312599733,positive,-0.269058295964123,neutral
2019-10-03 13:04:25.891,233.3,235.95,230.25,230.9,3920309.0,"Biocon, Mylan launch insulin biosimilar in Australia",The biotechnology major and pharmaceutical company Mylan N V announced the launch of their insulin biosimilar Semglee. ,neutral,positive,-1.028718388341194,negative,-2.04257149000215,negative
2019-10-04 10:02:42.533,233.3,235.95,230.25,230.9,3920309.0,"Biocon, Mylan launch insulin biosimilar Semglee in Australia market","Insulin Glargine is used for the treatment of type 1 diabetes mellitus in adults, adolescents, and children",neutral,neutral,-1.028718388341194,negative,-2.04257149000215,negative
2019-10-10 18:01:53.479,241.75,250.4,239.25,246.5,9016407.0,Biocon Biologics & Just - Evotec Biologics sign licensing deal for biosimilar asset,"Biocon Biologics will take this biosimilar asset through end-to-end development, IND filing, manufacturing and commercialization post-regulatory approval, under its own label in global markets.",positive,neutral,1.9648397104446744,positive,2.0161290322580645,positive
2019-10-11 10:01:59.162,241.75,250.4,239.25,246.5,9016407.0,"Stocks to watch: Infosys, Biocon, GM Breweries, TCS, Fortis Healthcare, ITI",Here's a look at the top stocks that may remain in focus today -,neutral,neutral,1.9648397104446744,positive,2.0161290322580645,positive
2019-10-11 10:03:38.617,241.75,250.4,239.25,246.5,9016407.0,Biocon (₹240.2): Buy,"Investors with a short-term perspective can buy the stock of Biocon at current levels. Following an intermediate-term downtrend, the stock found support at ₹211 in mid-August which is also the 52-week",neutral,positive,1.9648397104446744,positive,2.0161290322580645,positive
2019-10-11 18:00:37.304,241.75,250.4,239.25,246.5,9016407.0,"F&O: Nifty50 trading range shifts to 11,000-11,600 zone; Vix slips 0.52%","There was long buildup in Biocon, Indiabulls Housing, Tata Global, PVR and Cipla.",neutral,neutral,1.9648397104446744,positive,2.0161290322580645,positive
2019-10-23 10:02:18.273,256.85,258.9,253.55,257.95,2576982.0,"Q2 show: Bajaj Auto, L&T, HCLT, Indian Bank"," Wednesday will see a host of high-profile companies unveiling their July-September results. Among these are Aarti Drugs, Bajaj Auto, Bajaj Holdings, Biocon, Castrol, CG Consumer, Dishman, GHCL, Havel",neutral,neutral,0.4282655246252543,neutral,-1.842948717948716,negative
2019-10-23 23:01:11.674,249.6,250.9,241.2,245.0,8605671.0,Biocon posts 39% fall in net profit Q2 even as biologics business booms,"Excluding the impact of the one-time gain last year, the profit would have been higher by 3% at  ₹189 crores.Biocon’s R&D cost increased 36% to  ₹104 crores for expansion of its portfolio, while its employee benefit expenses grew 22%",negative,positive,-1.842948717948716,negative,-0.880606184722509,neutral
2019-10-23 23:01:33.991,249.6,250.9,241.2,245.0,8605671.0,"Biocon CEO Arun Chandavarkar to retire on  30 Nov, CFO Mittal to replace him","Chandavarkar will be replaced by Siddharth Mittal, its current chief financial officer and president – finance, the company said.The company also announced the resignation of Jeremy Levin as an independent director from its board at the conclusion of October-December board meeting in January",neutral,neutral,-1.842948717948716,negative,-0.880606184722509,neutral
2019-10-24 10:04:11.636,249.6,250.9,241.2,245.0,8605671.0,Biocon posts profit before tax of Rs 354 cr for quarter ended September 30,"Excluding the exceptional item, the PBT grew 9 per cent on year-on-year basis",neutral,positive,-1.842948717948716,negative,-0.880606184722509,neutral
2019-10-24 18:04:34.739,244.15,245.05,236.15,242.0,8084102.0,Biocon eyes $1 billion biologics sales target with 10 cents/day insulin shot,"The company is also looking at India as an opportunity to provide cheaper recombinant human insulin.At 10 cents per day, or roughly 7 rupees, the price would be less than one-third of 36 cents, which is median cost for daily dosage",positive,neutral,-0.880606184722509,neutral,-1.0820743160473685,negative
2019-10-26 10:00:53.018,244.9,245.05,240.0,242.25,346710.0,Insulin at Rs 7 will be a gamechanger for us: Biocon's Kiran Mazumdar-Shaw,"'We are trying to develop a strategy where we could make people to stop using disposable plastic devices', said Shaw",neutral,neutral,-1.0820743160473685,negative,0.4732510288065867,neutral
2019-10-28 18:00:15.961,243.0,246.25,240.4,244.15,3418504.0,Biocon moves up to rank 6th on Science careers' top 20 global pharma list,"Bengaluru (Karnataka) [India], Oct 28 (ANI): Biopharmaceuticals major Biocon Ltd said on Monday it has moved up in top 10 global biotech employers ranking for 2019 and continues to be the only company from Asia to feature on the US-based Science magazine's annual careers top 20 employers' list.",neutral,positive,0.4732510288065867,neutral,1.2287528158918697,positive
2019-10-30 10:03:29.603,244.15,249.6,244.0,247.15,3231566.0,"Processes must be robust; merely being better no longer an option: Siddharth Mittal, Managing Director, Biocon","We have a very good track record on GMP compliance. We are taking a digital journey in strengthening our quality system, which will help us be dependent on systems and processes and less on people, says Siddharth Mittal, MD, Biocon.",neutral,positive,1.2287528158918697,positive,-1.544943820224717,negative
2019-11-05 10:03:57.204,264.5,272.6,254.25,254.95,9078675.0,"ICICI Lombard, Biocon, Hindalco: Three stocks Anand Rathi is bullish on","As regards Biocon, the stock has provided a breakout from the inverse head and shoulders pattern with an increase in volume. There is a buy crossover in its oscillators as well",positive,positive,-3.61058601134216,negative,1.4832162373146025,positive
2019-11-05 13:02:31.885,256.2,262.25,255.1,260.0,3790529.0,Biocon's Biologics drug products facility gets nod from US FDA,"Bengaluru (Karnataka) [India], Nov 5 (ANI): Biopharmaceuticals major Biocon Ltd said on Tuesday it has received an establishment inspection report from the US Food and Drug Administration (FDA) for its biologics drug product facility here, reaffirming its global scale manufacturing capability for high quality, affordable biosimilars for the US market.",neutral,positive,1.4832162373146025,positive,1.4609765474817202,positive
2019-11-06 18:03:33.669,260.1,264.85,256.05,263.9,5658720.0,Competition Hots Up For Biocon In $3.6-Billion Neulasta Biosimilar Market,The U.S. FDA approved the third biosimilar for Neulasta drug. What does it mean for Biocon?,neutral,neutral,1.4609765474817202,positive,0.4358537047564818,neutral
2019-11-15 18:01:54.663,255.0,262.0,253.1,257.3,1928462.0,"D-Street Buzz: Pharma stocks gain led by Aurobindo Pharma, Glenmark; Airtel surges 8%, IOC drags","The pharma index gained 2 percent led by Glenmark Phrama, Divis Labs, Cipla, Aurobindo Pharma, Biocon and Piramal Enterprises.",positive,positive,0.90196078431373,positive,0.7928833881260922,neutral
2019-11-19 13:04:11.217,258.85,265.25,255.5,262.0,3354319.0,Kiran Mazumdar Shaw conferred with lifetime achievement award by ICMR,"Bengaluru (Karnataka) [India], Nov 19 (ANI): Biocon Ltd's Chairperson and Managing Director Kiran Mazumdar Shaw has been conferred with the lifetime achievement award for outstanding achievement in healthcare by the Indian Council of Medical Research (ICMR).",positive,neutral,1.216920996716236,positive,-3.6018957345971563,negative
2019-11-25 10:02:13.150,256.3,260.4,255.05,258.1,3107046.0,"We're innovating, now we need to monetize: Kiran Mazumdar-Shaw",Biocon chairperson shares her five ideas to take India to a leadership position in life sciences technology in the next decade,positive,positive,0.7023019898556423,neutral,2.464583737628575,positive
2019-11-27 10:06:20.212,269.95,279.3,268.1,276.3,13464873.0,USFDA approves Biocon drug Pegfilgrastim from new Bengaluru facility,"""This is a significant milepost in our journey of serving 5 million patients by FY22 and crossing a revenue milestone of $1 billion,"" said Christiane Hamacher, CEO, Biocon Biologics.",neutral,positive,2.352287460640868,positive,3.4169392948018817,positive
2019-11-27 13:02:48.498,275.1,284.9,273.85,284.5,7457934.0,"Biocon, Mylan get USFDA nod for pegfilgrastim drug substance licence",This additional approval of its new manufacturing facility for pegfilgrastim in Bengaluru will enable the biotechnology major to enable its arm Biocon Biologics and Mylan to scale up capacity multi-fold and address the growing market opportunities in US and other global markets.,neutral,positive,3.4169392948018817,positive,-0.423728813559318,neutral
2019-11-27 13:03:16.056,275.1,284.9,273.85,284.5,7457934.0,"Market betting on growth, not m-caps, for giving robust multiples: Pankaj Pandey","
ICICI Direct research head explains stand on YES Bank, Zee, Biocon & more.",neutral,neutral,3.4169392948018817,positive,-0.423728813559318,neutral
2019-11-27 18:04:47.566,275.1,284.9,273.85,284.5,7457934.0,Biocon gets US FDA approval for new facility in Bengaluru,The US FDA conducted a pre-approval inspection of the new manufacturing facility from 10-19 September.Biocon also produces pegfilgrastim biosimilar at another plant in Bengaluru,positive,neutral,3.4169392948018817,positive,-0.423728813559318,neutral
2019-11-29 23:03:03.623,283.2,288.4,280.55,282.0,3740845.0,GDP shocker: India Inc expects growth to rebound in Q3 on stimulus measures,Biocon CMD Kiran Mazumdar-Shaw opined that few pragmatic policies can help put India on the top again,positive,neutral,-0.423728813559318,neutral,1.67725988700565,positive
2019-12-02 10:06:08.611,283.2,291.95,282.45,287.95,5936983.0,Volume with low cost is Biocon Biologics’ big plan," The Biocon subsidiary will chart a path that ensures high volumes and low costs, unlike competitors. The company plans to create an ecosystem where patients not only have access to the right medicine, but also gets the right care without always reaching a hospital. ",neutral,neutral,1.67725988700565,positive,-4.966555183946496,negative
2019-12-02 13:00:38.528,299.0,299.0,282.85,284.15,14028830.0,"Soon after Bajaj’s comment, Biocon chief Kiran Mazumdar Shaw tweeted her views on the same lines.","Soon after Bajaj’s comment, Biocon chief Kiran Mazumdar Shaw tweeted her views on the same lines.",neutral,neutral,-4.966555183946496,negative,1.091549295774656,positive
2019-12-02 13:02:32.697,299.0,299.0,282.85,284.15,14028830.0,Syngene International to appoint Sibaji Biswas as CFO,"Biswas will succeed M B Chinappa, current CFO, who will stay within the Biocon group of companies and join Biocon Biologics India Ltd in a new role.",neutral,neutral,-4.966555183946496,negative,1.091549295774656,positive
2019-12-03 10:00:49.104,299.0,299.0,282.85,284.15,14028830.0,"Top stocks in focus: DHFL, Biocon, RBL Bank, Yes Bank, NMDC",Check out the companies which will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-4.966555183946496,negative,1.091549295774656,positive
2019-12-03 10:01:58.309,299.0,299.0,282.85,284.15,14028830.0,"Stocks to watch: YES Bank, Biocon, RBL Bank, Bharti Airtel, Voda Idea, Gati",Here's a list of stocks that may remain in focus today.,neutral,neutral,-4.966555183946496,negative,1.091549295774656,positive
2019-12-03 10:03:14.406,299.0,299.0,282.85,284.15,14028830.0,"Stocks in the news: YES Bank, Tata Motors, RBL Bank, Biocon and Dish TV","Tata Motors, a Tata Group firm, said it has bagged an order for over 2,300 buses. ",neutral,positive,-4.966555183946496,negative,1.091549295774656,positive
2019-12-03 10:03:44.986,299.0,299.0,282.85,284.15,14028830.0,Latest launches to help Biocon reach billion-dollar biosimilar sales by 2022: Kiran Mazumdar Shaw,"
Herceptin is a biosimilar trastuzumab is going to be a major launch for both Biocon & Mylan.",positive,positive,-4.966555183946496,negative,1.091549295774656,positive
2019-12-03 13:04:29.849,284.0,289.0,281.15,287.1,3775130.0,"Biotechnology major Biocon and drug firm Mylan NV on Monday announced the launch of biosimilar Ogivri, used for treatment of certain breast and gastric cancers, in the US market.
","Biotechnology major Biocon and drug firm Mylan NV on Monday announced the launch of biosimilar Ogivri, used for treatment of certain breast and gastric cancers, in the US market.
",positive,positive,1.091549295774656,positive,-0.1566852367687982,neutral
2019-12-03 13:05:43.949,284.0,289.0,281.15,287.1,3775130.0,"Biocon elevates Siddharth Mittal to CEO, Joint MD's position","Bengaluru (Karnataka) [India], Dec 3 (ANI): Biopharmaceuticals major Biocon said on Tuesday that Siddharth Mittal has been elevated to the position of Chief Executive Officer and Joint Managing Director.",positive,neutral,1.091549295774656,positive,-0.1566852367687982,neutral
2019-12-04 10:04:50.899,284.0,289.0,281.15,287.1,3775130.0,US launch of second oncology biosimilar to boost Biocon's earnings,"Even as the Street will monitor product ramp-up, commercialisation of more biosimilars will drive prospects further",positive,positive,1.091549295774656,positive,-0.1566852367687982,neutral
2019-12-05 10:05:40.928,287.2,289.25,283.9,286.75,2281355.0,Biocon sees a sweet spot with its affordable insulin in US,"The biotech firm is also planning to provide its rh-insulin to middle- and low-income countries at less than 10 cents a day. Biocon Biologics is chasing a revenue target of $1 billion in financial year 2021-22. In the previous fiscal year, its revenue had topped $200 million.",positive,positive,-0.1566852367687982,neutral,0.3640145605824272,neutral
2019-12-12 23:02:27.225,294.0,295.0,290.6,291.7,2875504.0,Biocon and Equillium Inc. expand license agreement for itolizumab,The companies have expanded their collaboration and license agreement,positive,positive,-0.7823129251700719,neutral,1.3027082619129282,positive
2019-12-12 23:03:14.896,294.0,295.0,290.6,291.7,2875504.0,Biocon extends licensing pact with Equillium for itolizumab,"Itolizumab, a first-in-class humanized anti-CD6 monoclonal antibody, is developed by Biocon and launched in 2013 in India under the brand name ALZUMAb to treat moderate to severe plaque psoriasis, a skin disease. ",positive,neutral,-0.7823129251700719,neutral,1.3027082619129282,positive
2019-12-12 23:04:38.458,294.0,295.0,290.6,291.7,2875504.0,"Biocon extends licensing pact for Itolizumab with Equillium for Australia, NZ","Equillium had secured exclusive rights to develop and commercialize Biocon’s novel biologic, itolizumab, for the U.S. and Canada markets, in May 2017",positive,positive,-0.7823129251700719,neutral,1.3027082619129282,positive
2019-12-13 10:01:51.707,294.0,295.0,290.6,291.7,2875504.0,Biocon & Equillium expand exclusive licensing agreement for Itolizumab,"Equillium had originally secured exclusive rights to develop and commercialize Biocon’s novel biologic, itolizumab, for the U.S. and Canada markets, in May 2017.",positive,positive,-0.7823129251700719,neutral,1.3027082619129282,positive
2019-12-13 10:02:16.168,294.0,295.0,290.6,291.7,2875504.0,"Stocks to watch: Metal stocks, Wipro, IndiGo, Bank of Baroda, Biocon",Here's a list of companies whose shares are expected to trade actively in today's session.,neutral,neutral,-0.7823129251700719,neutral,1.3027082619129282,positive
2019-12-13 10:03:11.396,294.0,295.0,290.6,291.7,2875504.0,"Top stocks in focus: Tata Motors, Wipro, Cipla, Biocon",Check out the companies which will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-0.7823129251700719,neutral,1.3027082619129282,positive
2019-12-13 10:06:34.061,294.0,295.0,290.6,291.7,2875504.0,"HDFC, Biocon, TCS, Infosys, Bank of Baroda, Wipro, Khadim among others are the top stocks to watch out for Friday's trading session","HDFC, Biocon, TCS, Infosys, Bank of Baroda, Wipro, Khadim among others are the top stocks to watch out for Friday's trading session",neutral,neutral,-0.7823129251700719,neutral,1.3027082619129282,positive
2019-12-13 13:02:09.167,294.0,295.0,290.6,291.7,2875504.0,"Finance Minister Nirmala Sitharaman, HCL Corporation CEO and Executive Director Roshni Nadar Malhotra and Biocon Founder Kiran Mazumdar-Shaw have been named among the world's 100 most powerful women by Forbes","Finance Minister Nirmala Sitharaman, HCL Corporation CEO and Executive Director Roshni Nadar Malhotra and Biocon Founder Kiran Mazumdar-Shaw have been named among the world's 100 most powerful women by Forbes",neutral,neutral,-0.7823129251700719,neutral,1.3027082619129282,positive
2019-12-13 23:03:50.185,294.0,295.0,290.6,291.7,2875504.0,Watch | The World’s 100 Most Powerful Women: Forbes 2019,"Finance Minister Nirmala Sitharaman, HCL Corporation CEO and Executive Director Roshni Nadar Malhotra and Biocon Founder Kiran Mazumdar-Shaw have been named among the world’s 100 most powerful women b",neutral,neutral,-0.7823129251700719,neutral,1.3027082619129282,positive
2019-12-26 18:02:45.617,289.5,293.0,288.0,292.7,1509009.0,"BRIEF-Biocon Ltd -Incorporation Of Biocon Biosphere Limited, Wholly Owned Subsidiary Of Co - Investing.com India
","Read BRIEF-Biocon Ltd -Incorporation Of Biocon Biosphere Limited, Wholly Owned Subsidiary Of Co By Reuters on Investing.com",neutral,neutral,1.1053540587219306,positive,-0.3761969904240649,neutral
2019-12-27 10:00:55.102,289.5,293.0,288.0,292.7,1509009.0,"Top stocks in focus: Gujarat Gas, Can Fin Homes, Biocon, HG Infra",Check out the companies which will be in focus during trade today based on recent and latest news developments.,neutral,neutral,1.1053540587219306,positive,-0.3761969904240649,neutral
2019-12-27 10:04:03.599,289.5,293.0,288.0,292.7,1509009.0,Biocon incorporates ,The business of subsidiary company is in line with the main business activities of the company.,neutral,neutral,1.1053540587219306,positive,-0.3761969904240649,neutral
2020-01-06 10:02:54.713,301.0,301.0,285.05,288.2,4724611.0,"Stocks to watch: Oil-linked cos,Titan, Biocon, Karur Vysya Bk, Adani Ports",Here's a look at the top stocks that may trade actively in today's trading session.,neutral,neutral,-4.252491694352163,negative,-3.040655961735557,negative
2020-01-06 10:04:36.182,301.0,301.0,285.05,288.2,4724611.0,"Stocks in the news: YES Bank, Titan Company, Biocon, Future Retail and UCO Bank","AMFI on Friday reclassified Adani Transmission, Info Edge, Kansai Nerolac Paints, Muthoot Finance and REC as largecap stocks. ",neutral,neutral,-4.252491694352163,negative,-3.040655961735557,negative
2020-01-06 18:00:33.980,292.7,294.7,275.2,283.8,14774735.0,True North to acquire 2.4% stake in Biocon Biologics,"Post the completion of this transaction with True North, Biocon will hold 96.07% stake in Biocon Biologics.",neutral,neutral,-3.040655961735557,negative,-0.1950354609929118,neutral
2020-01-06 18:01:52.133,292.7,294.7,275.2,283.8,14774735.0,True North to buy 2.44% stake in Biocon Biologics at $3 billion valuation,"The fresh equity infusion, at a valuation of around  ₹21,450 crore, is the 1st stake dilution by Biocon after hiving off the biopharmaceutical firm last year.The biologics arm aims to achieve an annual sales target of $1 billion by 2021-22",neutral,positive,-3.040655961735557,negative,-0.1950354609929118,neutral
2020-01-06 18:02:25.858,292.7,294.7,275.2,283.8,14774735.0,True North to invest Rs536.25cr in Biocon Biologics for 2.44% stake,"Post the completion of this transaction, Biocon will hold 96.07% stake in Biocon Biologics.",neutral,neutral,-3.040655961735557,negative,-0.1950354609929118,neutral
2020-01-06 18:03:06.332,292.7,294.7,275.2,283.8,14774735.0,True North to acquire 2.44% stake in Biocon Biologics,Biocon said it would use the proceeds of stake sale for expansion of R&D and manufacturing capabilities.,neutral,neutral,-3.040655961735557,negative,-0.1950354609929118,neutral
2020-01-06 18:04:05.781,292.7,294.7,275.2,283.8,14774735.0,True North to invest Rs 536.25 crore in Biocon Biologics for 2.44% stake,"This values Biocon Biologics at Rs 21,450 crore or around $3 billion, on a pre-money equity basis",neutral,neutral,-3.040655961735557,negative,-0.1950354609929118,neutral
2020-01-06 18:04:10.763,292.7,294.7,275.2,283.8,14774735.0,True North to invest Rs 536 crore in Biocon Biologics for 2.4 pc stake,"Bengaluru (Karnataka) [India], Jan 6 (ANI): Biopharmaceuticals major Biocon said on Monday the board of its subsidiary Biocon Biologics has approved a primary equity investment by True North which will invest Rs 536.25 crore to pick 2.44 per cent minority stake in the biosimilars business.",neutral,positive,-3.040655961735557,negative,-0.1950354609929118,neutral
2020-01-06 23:00:39.156,292.7,294.7,275.2,283.8,14774735.0,Biocon elevates M B Chinappa as CFO of biosimilar subsidiary,"M B Chinappa, who is going to play an important role in Biocon Biologics journey towards becoming a global leader in biologics, has been tasked to drive financial performance of the company and improve profitability and manage anticipated risks in the journey of achieving the $1 billion revenue target in FY22, said the company in a press release. ",neutral,positive,-3.040655961735557,negative,-0.1950354609929118,neutral
2020-01-06 23:02:50.056,292.7,294.7,275.2,283.8,14774735.0,True North to pick 2.44% stake for Rs 536.25 crore in Biocon Biologics,Deal values Biocon Biologics at $ 3 billion,neutral,neutral,-3.040655961735557,negative,-0.1950354609929118,neutral
2020-01-07 10:02:22.746,292.7,294.7,275.2,283.8,14774735.0,Biocon appoints M.B. Chinappa as CFO of arm Biocon Biologics,"Mr. M.B. Chinappa joins Biocon Biologics from Biocon’s subsidiary company Syngene International Ltd, where he was President (Finance) and CFO since 2008.",neutral,neutral,-3.040655961735557,negative,-0.1950354609929118,neutral
2020-01-07 10:03:23.451,292.7,294.7,275.2,283.8,14774735.0,Biocon appoints MB Chinappa as CFO of Biocon Biologics,"Chinappa joins Biocon Biologics from another subsidiary company Syngene International, where he was President (Finance) and CFO since 2008",neutral,neutral,-3.040655961735557,negative,-0.1950354609929118,neutral
2020-01-07 10:05:19.900,292.7,294.7,275.2,283.8,14774735.0,"Stocks in the news: ITI Ltd, Biocon Ltd, HDFC Bank, Sagar Cements, Coffee Day, Avenue Supermarts among others are the top stocks to watch out for Tuesday's trading session","Stocks in the news: ITI Ltd, Biocon Ltd, HDFC Bank, Sagar Cements, Coffee Day, Avenue Supermarts among others are the top stocks to watch out for Tuesday's trading session",neutral,neutral,-3.040655961735557,negative,-0.1950354609929118,neutral
2020-01-07 13:02:03.723,282.0,286.15,279.1,281.45,2806044.0,Biocon Biologics appoints M B Chinappa as new CFO,"Bengaluru (Karnataka) [India], Jan 7 (ANI): Biocon Ltd has appointed M B Chinappa as the Chief Financial Officer of its subsidiary Biocon Biologics India Ltd.",neutral,neutral,-0.1950354609929118,neutral,-2.3356401384083045,negative
2020-01-07 18:00:33.337,282.0,286.15,279.1,281.45,2806044.0,Biocon Biologics can achieve $1 bn revenue by 2022: Kiran Mazumdar Shaw,"""We might raise little more private equity prior to IPO. This basically gives an idea of where we believe we can unlock the value in terms of Biocon Biologics in the next few years,"" she said.",neutral,positive,-0.1950354609929118,neutral,-2.3356401384083045,negative
2020-01-07 18:03:14.839,282.0,286.15,279.1,281.45,2806044.0,"Chinappa joins Biocon Biologics from Biocon's subsidiary company Syngene International Ltd, where he was President (Finance) and CFO since 2008, the company said in a filing to the BSE.","Chinappa joins Biocon Biologics from Biocon's subsidiary company Syngene International Ltd, where he was President (Finance) and CFO since 2008, the company said in a filing to the BSE.",neutral,neutral,-0.1950354609929118,neutral,-2.3356401384083045,negative
2020-01-07 23:03:06.048,282.0,286.15,279.1,281.45,2806044.0,Biocon Biologics IPO: Syngene encore on the cards,"Syngene, which was listed in August 2015, raised Rs 550 crore. The IPO was subscribed 32 times. Incidentally, True North was an investor in Syngene before it was listed.",neutral,positive,-0.1950354609929118,neutral,-2.3356401384083045,negative
2020-01-17 10:03:17.362,288.5,291.95,286.0,289.6,2989659.0,"Stocks that Prabhudas Lilladher is bullish on: Buy Biocon, Eicher Motors",Biocon has maintained a strong base near 280 levels which is a good support level and currently has indicated a positive bullish candle pattern to imply strength,positive,positive,0.3812824956672522,neutral,-0.2905982905982983,neutral
2020-01-20 11:52:11.496,292.5,294.6,288.5,291.65,2564731.0,Biocon gains as USFDA PAI at Bengaluru facility results in zero observations,"The inspection of the Bengaluru facility took place between January 13-17, 2020.",positive,neutral,-0.2905982905982983,neutral,0.8573388203017831,neutral
2020-01-20 11:54:13.080,292.5,294.6,288.5,291.65,2564731.0,Biocon Bengaluru unit pre-approval inspection by USFDA concludes with zero observations,"The US Food and Drug Administration (USFDA) conducted a pre-approval inspection of the oral solid dosage manufacturing facility of Biocon Pharma, a subsidiary of Biocon, which was triggered by the submission of an abbreviated new drug application, the company said in a regulatory filing.",neutral,neutral,-0.2905982905982983,neutral,0.8573388203017831,neutral
2020-01-20 11:55:32.299,292.5,294.6,288.5,291.65,2564731.0,Biocon Bengaluru unit pre-approval inspection by USFDA concludes with zero observations,Biocon on Monday said that pre-approval inspection of the Bengaluru facility of its arm conducted by US health regulator was concluded with zero observations.,neutral,neutral,-0.2905982905982983,neutral,0.8573388203017831,neutral
2020-01-22 10:02:49.087,295.55,297.0,290.1,292.5,2043261.0,Biocon receives Rs536.25cr as subscription money from True North Fund,"Consequently, the Board of Biocon Biologics has approved the allotment of 50,25,463 equity shares of Rs10 each at a price of Rs1,067.07 per equity share (including a premium of Rs1,057.07 per equity share) to Activ Pine LLP.",neutral,neutral,-1.0319742852309293,negative,0.1020408163265344,neutral
2020-01-22 13:00:29.489,294.0,296.8,291.25,294.3,2502571.0,"Slideshow | HDFC Bank, RIL, Biocon among 10 stocks with 11-45% return","HDFC Bank, RIL and Biocon are among 10 stocks which are likely to give return between 11-45 percent in medium to long term",neutral,neutral,0.1020408163265344,neutral,2.083333333333333,positive
2020-01-22 18:03:40.938,294.0,296.8,291.25,294.3,2502571.0,"In short, medium & long term, be cautious on auto stocks: Dipan Mehta","
We would like to play the healthcare companies focussed on India and that would include hospitals. The best way to play the Indian healthcare story would be through the hospitals.  There is great earnings visibility for hospital companies and investors are prepared to pay higher PE multiples. Also good are companies with a different business model like Divis and Biocon. ",neutral,positive,0.1020408163265344,neutral,2.083333333333333,positive
2020-01-23 10:00:21.653,294.0,296.8,291.25,294.3,2502571.0,"Stocks to watch: RBL Bank, Axis Bank, Biocon, PVR Ltd, L&T, Canara Bank",Here's a look at the top stocks that may remain in focus today.,neutral,neutral,0.1020408163265344,neutral,2.083333333333333,positive
2020-01-23 10:00:34.866,294.0,296.8,291.25,294.3,2502571.0,"Stocks to watch today on January 23: Biocon, Canara Bank, PVR, PNB Housing, HDFC Life, L&T, SBI Life, Axis Bank among others are the top stocks to watch out for in Thursday's trading session","Stocks to watch today on January 23: Biocon, Canara Bank, PVR, PNB Housing, HDFC Life, L&T, SBI Life, Axis Bank among others are the top stocks to watch out for in Thursday's trading session",neutral,neutral,0.1020408163265344,neutral,2.083333333333333,positive
2020-01-23 10:01:05.698,294.0,296.8,291.25,294.3,2502571.0,"Board Meetings Today: HDFC Life, Biocon, Canara Bank, PNB Housing and OBC","Nippon Life and JM Financial are among companies, which will report their December quarter earnings today.",neutral,neutral,0.1020408163265344,neutral,2.083333333333333,positive
2020-01-23 10:04:28.018,294.0,296.8,291.25,294.3,2502571.0,"Top stocks in focus: Asian Paints, L&T, Ceat, Cipla, Axis Bank, Biocon, Tata Motors",Check out the companies which will be in focus during trade today based on recent and latest news developments.,neutral,neutral,0.1020408163265344,neutral,2.083333333333333,positive
2020-01-23 10:06:42.707,294.0,296.8,291.25,294.3,2502571.0,"HDFC Life, Canara Bank, PVR, Biocon results","Thursday will see about 40 firms declaring their Q3 FY20 results. These include Apar Ind, Automotive Samplings, Biocon, Canara Bank, Cholamandalam Inv, CDSL, DB Corp, Dishman Carbogen, EIH Associated,",neutral,neutral,0.1020408163265344,neutral,2.083333333333333,positive
2020-01-23 23:00:17.617,288.0,296.3,282.45,294.0,8969699.0,Biocon Q3 net profit dips 7 per cent to Rs 203 cr,"Biotechnology major Biocon on Thursday reported a 6.62 per cent fall in consolidated net profit at Rs 202.8 crore for the quarter ended December 31, 2019 on account of higher expenses. The company had",neutral,negative,2.083333333333333,positive,0.3460207612456747,neutral
2020-01-23 23:02:35.471,288.0,296.3,282.45,294.0,8969699.0,Biocon Q3 profit down 7% at Rs 203 crore,Revenues rose YoY 14 percent to Rs 1784 crore in the third quarter.,negative,positive,2.083333333333333,positive,0.3460207612456747,neutral
2020-01-23 23:03:01.725,288.0,296.3,282.45,294.0,8969699.0,"Biocon Q3 profit dips 7% on R&D cost, tax impact; topline jumps 14%",Biocons profit before exceptional item at Rs 225 crore reported a 6% growth. It reported an operating margin (EBITDA) of 27%.,positive,positive,2.083333333333333,positive,0.3460207612456747,neutral
2020-01-23 23:03:25.308,288.0,296.3,282.45,294.0,8969699.0,Biocon posts 7% decline in Q3 net profit at  ₹203 crore,"The Bengaluru-based biopharmaceutical firm posted a 71% increase in R&D expenses at  ₹131 crore, which weighed on the company’s bottomline .However, Biocon’s operational performance for the quarter was steady",negative,positive,2.083333333333333,positive,0.3460207612456747,neutral
2020-01-23 23:04:34.277,288.0,296.3,282.45,294.0,8969699.0,Biocon pre-tax profit zooms 9% to Rs 315 crore for quarter ended Dec 31,The consolidated Ebitda margin stood at 27 per cent in Q3FY20.,positive,neutral,2.083333333333333,positive,0.3460207612456747,neutral
2020-01-24 10:01:09.164,288.0,296.3,282.45,294.0,8969699.0,Biocon's net profit dips 7% yoy to Rs203cr in Q3FY20,Biocon's net profit was impacted due to higher R&D expenses and tax impact of an exceptional item.,negative,negative,2.083333333333333,positive,0.3460207612456747,neutral
2020-01-24 10:01:55.813,288.0,296.3,282.45,294.0,8969699.0,"Stocks to watch: Indiabulls Housing, BoB, UltraTech Cement, M&M, Biocon",Here's a look at the top stocks that may remain in focus today -,neutral,neutral,2.083333333333333,positive,0.3460207612456747,neutral
2020-01-24 10:03:56.459,288.0,296.3,282.45,294.0,8969699.0,Biocon appoints Kiran Mazumdar Shaw as the Executive Chairperson; stock slips 2.5%,Designation of Mr. Siddharth Mittal changed to Managing Director of the Company.,neutral,neutral,2.083333333333333,positive,0.3460207612456747,neutral
2020-01-24 23:03:23.694,288.0,296.3,282.45,294.0,8969699.0,US to lead Biocon Biologics' drive towards $1 billion revenue,The company is uniquely positioned in the US as it is the only Indian pharmaceutical firm with two commercialised biosimilars in the market,positive,positive,2.083333333333333,positive,0.3460207612456747,neutral
2020-01-27 10:00:25.943,289.0,297.9,286.0,290.0,4281053.0,"Biocon Biologics eyes $200m, plans IPO in 2 years: Mazumdar-Shaw", It looks to build a pipeline of 28 biosimilars across global markets in three phases.,neutral,neutral,0.3460207612456747,neutral,-0.5515339538090391,neutral
2020-01-27 13:04:53.390,290.1,292.5,286.25,288.5,2283459.0,USFDA issues Form 483 with 5 observations to Biocon's Bengaluru facility,"As per the USFDA, a Form 483 is issued to Biocon's management at the conclusion of an inspection when investigator has observed any conditions that in its judgement may constitute violations of the Food Drug and Cosmetic Act and related Acts. At the conclusion of the inspection of the Bengaluru facility, USFDA  issued a Form 483, with 5 observations.",neutral,neutral,-0.5515339538090391,neutral,2.698495070057087,positive
2020-01-27 13:06:42.940,290.1,292.5,286.25,288.5,2283459.0,USFDA issues Form 483 with 5 observations to Biocon's Bengaluru facility,Form 483 is issued to a firm's management at the conclusion of an inspection when investigator has observed any conditions that in its judgement may constitute violations of the FD&C Act,neutral,neutral,-0.5515339538090391,neutral,2.698495070057087,positive
2020-01-27 13:09:31.007,290.1,292.5,286.25,288.5,2283459.0,Biocon tumbles 3% on 5 USFDA observations for Bengaluru unit,"Inspection of the Bengaluru facility took place between January 20 and January 24, 2020,",negative,neutral,-0.5515339538090391,neutral,2.698495070057087,positive
2020-01-27 18:01:44.437,290.1,292.5,286.25,288.5,2283459.0,USFDA issues Form 483 with five observations to Biocon’s Bengaluru facility,"Biocon Ltd on Monday said the US health regulator conducted a pre-approval inspection and good manufacturing practice (GMP) examination of the API manufacturing facility and has issued a Form 483, wit",neutral,neutral,-0.5515339538090391,neutral,2.698495070057087,positive
2020-01-27 18:03:17.217,290.1,292.5,286.25,288.5,2283459.0,Share price of Biocon has lost 11% in the last one year,Share price of Biocon has lost 11% in the last one year,negative,negative,-0.5515339538090391,neutral,2.698495070057087,positive
2020-01-27 23:02:45.922,290.1,292.5,286.25,288.5,2283459.0,New launches to help Biocon Biologics reach $1 bn revenue target by FY22: Christiane Hamacher,"The biologics segment grew 50 percent year-on-year (YoY) in nine-month period to Rs 1594 crores, led primarily by contributions from Pegfilgrastim and Trastuzumab in US market. ",positive,positive,-0.5515339538090391,neutral,2.698495070057087,positive
2020-01-28 10:07:08.007,290.1,292.5,286.25,288.5,2283459.0,Biocon to scale up investments in small molecules business,"The firm plans to invest a part of the funds from the IPO of its biologics arm back into its small molecules biz.Biocon Biologics plans to go for an IPO in about two years, its chief financial officer M.B. Chinappa said in an interview earlier this month",neutral,neutral,-0.5515339538090391,neutral,2.698495070057087,positive
2020-02-02 18:00:23.330,288.0,307.0,288.0,299.65,6388685.0,Budget has sent a very positive signal to India Inc: Kiran Mazumdar Shaw,"Statement on bringing an end to tax terrorism and making the whole tax environment much more business friendly augur well for India Inc, says Kiran Mazumdar Shaw, CMD of Biocon.",positive,positive,4.04513888888888,positive,-3.1130347927418085,negative
2020-02-04 10:01:53.840,300.35,301.5,279.0,291.0,12882089.0,"Biocon, Asian Paints, Nestle among 11 stocks readying to rally, shows MACD",The momentum indicator formed a bullish crossover on these counters.,neutral,positive,-3.1130347927418085,negative,1.6809605488850694,positive
2020-02-10 10:06:47.833,311.95,316.8,307.7,308.0,5937169.0,"'BUY' or 'SELL' ideas from experts for Monday, 10 February, 2020","Biocon is a 'Buy' call with a target price of Rs 320 and a stop loss of Rs 300.
",neutral,neutral,-1.266228562269591,negative,-1.7041800643086853,negative
2020-02-17 10:00:47.104,309.05,311.5,302.3,303.3,3199569.0,Donald Trump set to meet India Inc captains in Delhi on Feb 25,"The probable list of attendees includes Reliance Industries chairman Mukesh Ambani, Bharti Airtel chairman Sunil Mittal, Tata Sons chairman N Chandrasekaran, Mahindra Group chairman Anand Mahindra, Larsen & Toubro chairman AM Naik and Biocon CMD Kiran Mazumdar-Shaw, ET has learnt from diplomatic sources. The CEOs roundtable will also be attended by bureaucrats.",neutral,neutral,-1.8605403656366284,negative,-0.4948861761794786,neutral
2020-02-17 10:04:54.114,309.05,311.5,302.3,303.3,3199569.0,"Tata Global, Lupin, Biocon among top 12 money-making ideas for next few weeks",Market direction remains uncertain but analysts see stock-picking opportunities everywhere.,neutral,neutral,-1.8605403656366284,negative,-0.4948861761794786,neutral
2020-02-19 23:02:49.333,305.95,319.0,305.8,315.25,6987923.0,Biocon Chairman Kiran Mazumdar Shaw gets EY’s ‘Entrepreneur of the Year’ award,Biocon’s Chairman and Managing Director Kiran Mazumdar Shaw has been declared EY Entrepreneur of the Year 2019. Shaw will now represent India at the EY World Entrepreneur of the Year Award (WEOY) to b,neutral,neutral,3.0397123713025045,positive,2.0588235294117685,positive
2020-02-19 23:03:09.608,305.95,319.0,305.8,315.25,6987923.0,Niti Aayog holds meeting with pharma sector on impact of coronavirus,"The meeting was chaired by Niti Aayog CEO Amitabh Kant and attended by Pharmaceutical Department Secretary P D Vaghela and Biocon Chairperson and Managing Director Kiran Mazumdar Shaw, among others.

",neutral,neutral,3.0397123713025045,positive,2.0588235294117685,positive
2020-02-23 10:00:30.193,306.0,323.5,303.3,312.3,9990028.0,Biocon gets 3 USFDA observations for insulin facility in Malaysia,"USFDA had conducted a pre-approval inspection of Biocon's subsidiary Biocon Sdn BHd's manufacturing facility in Malaysia for Insulin Glargine between February 10 and 21. ""At the conclusion of the inspection, the agency issued a Form 483 with three observations which we believe are procedural in nature,"" a Biocon spokesperson said in a regulatory filing.",neutral,neutral,2.0588235294117685,positive,-3.650793650793651,negative
2020-02-23 10:00:47.927,306.0,323.5,303.3,312.3,9990028.0,Biocon gets 3 USFDA observations for insulin facility in Malaysia,Biocon on Saturday said it has received three observations from the US health regulator following inspection of its insulin manufacturing facility in Malaysia.The US Food and Drug Administration (USFD,neutral,neutral,2.0588235294117685,positive,-3.650793650793651,negative
2020-02-23 10:00:50.630,306.0,323.5,303.3,312.3,9990028.0,Biocon gets 3 USFDA observations for insulin facility in Malaysia,"""At the conclusion of the inspection, the agency issued a Form 483 with three observations which we believe are procedural in nature,"" a Biocon spokesperson said in a regulatory filing.",neutral,neutral,2.0588235294117685,positive,-3.650793650793651,negative
2020-02-23 10:00:55.297,306.0,323.5,303.3,312.3,9990028.0,Biocon gets 3 observations from US health regulator for Malaysia facility,The FDA has set a target action date for its Insulin Glargine application in June 2020,neutral,neutral,2.0588235294117685,positive,-3.650793650793651,negative
2020-02-23 10:02:43.774,306.0,323.5,303.3,312.3,9990028.0,The USFDA had conducted a pre-approval inspection of Biocon's subsidiary Biocon Sdn BHd's manufacturing facility in Malaysia for Insulin Glargine between February 10 and 21,The USFDA had conducted a pre-approval inspection of Biocon's subsidiary Biocon Sdn BHd's manufacturing facility in Malaysia for Insulin Glargine between February 10 and 21,neutral,neutral,2.0588235294117685,positive,-3.650793650793651,negative
2020-02-24 10:00:42.046,306.0,323.5,303.3,312.3,9990028.0,Biocon's Malaysia facility issued Form 483 with 3 observations by USFDA,"As per the USFDA, Form 483 is issued to firm management at the conclusion of an inspection when investigators have observed any conditions that in their judgment may constitute violations of the Food Drug and Cosmetic Act and related Acts.",neutral,neutral,2.0588235294117685,positive,-3.650793650793651,negative
2020-02-24 13:02:00.928,315.0,315.7,295.6,303.5,10224591.0,Biocon hits 52-wk high as Malaysian unit gets 3 observations from US FDA,"The stock of India's biggest biotechnology company was trading higher for the third straight day, and has surpassed it's previous high of Rs 321 touched on February 15, 2019 in the intra-day trade.",neutral,positive,-3.650793650793651,negative,-0.6335445148382719,neutral
2020-02-25 13:00:40.644,299.9,307.7,297.65,298.0,4960351.0,Biocon shares decline 6% after USFDA observations for Bengaluru unit,The USFDA had issued a Form 483 with five observations for Bengaluru unit.,negative,neutral,-0.6335445148382719,neutral,0.608108108108112,neutral
2020-02-25 13:05:24.300,299.9,307.7,297.65,298.0,4960351.0,"Nifty Pharma index drops led by Biocon, Sun Pharma","The index is trading lower 2% or 140 points at 8,005.40 levels. Shares of Biocon are trading under pressure, down 3% on the pharma index.",negative,negative,-0.6335445148382719,neutral,0.608108108108112,neutral
2020-02-27 10:03:07.332,296.0,302.0,292.45,297.8,6119094.0,Biocon share price falls 2% on observations from USFDA,The USFDA conducted a post-approval and GMP inspection of the small-molecule API manufacturing facility in the Biocon Campus in Bengaluru between February 20 and 26.,negative,neutral,0.608108108108112,neutral,-0.9916224995725688,negative
2020-02-27 10:03:19.685,296.0,302.0,292.45,297.8,6119094.0,Biocon's Bengaluru API unit gets two observations by USFDA; stock slips 1%,USFDA issues Form 483 with 2 observations to Biocon's Bengaluru API unit.,negative,neutral,0.608108108108112,neutral,-0.9916224995725688,negative
2020-02-27 13:02:45.666,292.45,294.9,285.0,289.55,5345065.0,Biocon shares fall as USFDA issues Form 483 for Bengaluru facility,"Biocon said that the observations are procedural in nature. 
",negative,neutral,-0.9916224995725688,negative,-1.68907273354017,negative
2020-02-27 18:01:39.461,292.45,294.9,285.0,289.55,5345065.0,Share price of Biocon lost up to 2.07% to Rs 292.50 against previous close of Rs 298.70 on BSE,Share price of Biocon lost up to 2.07% to Rs 292.50 against previous close of Rs 298.70 on BSE,negative,negative,-0.9916224995725688,negative,-1.68907273354017,negative
2020-02-27 23:02:06.030,292.45,294.9,285.0,289.55,5345065.0,Biocon gets two observations from USFDA for Bengaluru-based API plant,Biocon shares on Thurday ended 0.17 per cent up at Rs 299.20 apiece on the BSE.,neutral,positive,-0.9916224995725688,negative,-1.68907273354017,negative
2020-03-03 18:01:31.100,305.85,307.0,297.4,303.6,4470676.0,"Pharma shares in focus; Pfizer hits record high, Sun Pharma rallies 6%","Metropolis Healthcare, Bliss GVS Pharma, RPG Life Sciences, Dr. Lal PathLabs, Biocon, Albert David and FDC from the index were up more than 3 per cent.",positive,positive,-0.7356547327121137,neutral,2.648026315789477,positive
2020-03-06 10:02:51.374,305.5,312.4,302.6,308.1,3437915.0,Derivatives strategy for Biocon by Nandish Shah of HDFC Securities,The long build-up is seen in the Biocon Futures' on Thursday where we have seen a rise in the Open Interest with price moving up by 3 per cent,neutral,positive,0.8510638297872415,neutral,-1.688247828224892,negative
2020-03-09 13:01:55.308,305.05,309.25,298.5,299.9,3585154.0,"USFDA accepts proposed biosimilar application by Mylan, Biocon for review",The application seeks approval of Bevacizumab for the first-line and second-line treatment of patients with metastatic colorectal cancer in combination with fluorouracil-based chemotherapy,neutral,positive,-1.688247828224892,negative,-2.31023102310231,negative
2020-03-09 13:04:44.322,305.05,309.25,298.5,299.9,3585154.0,US FDA accepts Biocon's cancer drug application for review,"Biocon and Mylans proposed biosimilar bevacizumab, a cancer drug, is expected to be the third biosimilar from the partnered portfolio for patients in the US.",neutral,positive,-1.688247828224892,negative,-2.31023102310231,negative
2020-03-10 18:04:21.841,303.0,312.5,293.0,296.0,6483947.0,Biocon partner's Cancer drug licence application gets USFDA approval,The application sought approval of Mylan's drug for treatment of patients with metastatic colorectal cancer with fluorouracil-based chemotherapy,positive,positive,-2.31023102310231,negative,-6.684764166949436,negative
2020-03-12 10:01:39.871,294.7,294.7,267.25,275.0,7951865.0,"Top stocks in focus: SBI, Biocon, Yes Bank, Canara Bank, CG Power and Industrial Solutions",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-6.684764166949436,negative,15.369059656218404,positive
2020-03-12 10:01:44.114,294.7,294.7,267.25,275.0,7951865.0,Biocon: Insulin drug's patent hurdle cleared," Shares of Biocon may see buying interest, as the company won a major ruling for insulin drug in the US. According to Biocon, the US District Court of New Jersey invalidated Sanofi’s patent suit again",positive,positive,-6.684764166949436,negative,15.369059656218404,positive
2020-03-12 10:01:50.638,294.7,294.7,267.25,275.0,7951865.0,Biocon and Mylan win patent case asserted by Sanofi for insulin Glargin device in USA,Biocon remains confident of being able to commercialize the product in the calendar year 2020.,positive,positive,-6.684764166949436,negative,15.369059656218404,positive
2020-03-12 10:02:01.141,294.7,294.7,267.25,275.0,7951865.0,"Biocon, Mylan win patent case for insulin device against Sanofi in US",Development takes Biocon a step closer to commercialise its glargine biosimilar Semglee in America,positive,neutral,-6.684764166949436,negative,15.369059656218404,positive
2020-03-12 10:03:38.706,294.7,294.7,267.25,275.0,7951865.0,"Stocks to watch today on March 12: Biocon, Torrent Pharma, Cyient, Cadila, Canara Bank among others are the top stocks to watch out for in Thurdsday's trading session","Stocks to watch today on March 12: Biocon, Torrent Pharma, Cyient, Cadila, Canara Bank among others are the top stocks to watch out for in Thurdsday's trading session",neutral,neutral,-6.684764166949436,negative,15.369059656218404,positive
2020-03-12 10:04:42.223,294.7,294.7,267.25,275.0,7951865.0,"Biocon, Mylan win patent litigation against Sanofi in US for insulin glargine device","Biotechnology major Biocon on Wednesday said a US court has invalidated a Sanofi patent on the insulin glargine device, thus removing a legal hurdle to commercialising Semglee co-developed with Mylan,",positive,positive,-6.684764166949436,negative,15.369059656218404,positive
2020-03-19 10:05:01.643,240.3,264.95,235.55,252.45,5392025.0,‘India must scale up its testing rates by involving accredited private labs’,"Major companies, whose employees travel, could chip in by testing staff, says Biocon chairperson Kiran Mazumdar-Shaw",neutral,neutral,5.056179775280889,positive,6.564678543764519,positive
2020-03-20 10:00:49.484,258.2,276.95,253.5,275.15,5171044.0,Biocon share price rises 3% on EIR from USFDA,"The inspection was conducted between February 20 to 26, 2020 and EIR has been closed with a “VAI” classification.",positive,neutral,6.564678543764519,positive,0.3937007874015747,neutral
2020-03-20 10:04:31.789,258.2,276.95,253.5,275.15,5171044.0,Biocon gets EIR for Bengaluru API unit by USFDA,"The EIR has been closed with a “VAI” classification for the observations, the pharma company said.",neutral,neutral,6.564678543764519,positive,0.3937007874015747,neutral
2020-03-20 18:01:04.906,258.2,276.95,253.5,275.15,5171044.0,Biocon gets EIR from USFDA for manufacturing facility in Bengaluru,Biocon on Friday said it has received the establishment inspection report (EIR) from US health regulator for the post-approval and good manufacturing practice (GMP) inspection of its small molecules manufacturing facility in Bengaluru.,neutral,neutral,6.564678543764519,positive,0.3937007874015747,neutral
2020-03-20 18:02:43.091,258.2,276.95,253.5,275.15,5171044.0,Biocon receives EIR from USFDA for good manufacturing practice inspection,"""We remain committed to global standards of quality and compliance,"" company spokesperson said",neutral,positive,6.564678543764519,positive,0.3937007874015747,neutral
2020-03-24 23:02:47.624,267.95,286.0,265.05,271.55,4207615.0,Efforts on to develop antibody-based test kits for Covid-19: Biocon CMD,She also emphasises on the need for a Covid-19 database and more R&D investment towards communicable diseases to be future-ready,neutral,neutral,1.343534241462968,positive,2.147016011644824,positive
2020-03-25 18:02:09.464,274.8,284.65,270.6,280.7,4741247.0,Coronavirus pandemic | 21-day lock-down needed from scientific perspective: Kiran Mazumdar-Shaw,"""The government has done the right thing. Scientifically, you need those three weeks,"" the Chairman and Managing Director of Biocon Ltd, told PTI.",neutral,neutral,2.147016011644824,positive,-2.112676056338028,negative
2020-03-25 23:04:35.362,274.8,284.65,270.6,280.7,4741247.0,"21-day lockdown: Mahindra suggests plan to help less-privileged families, and Biocon, Paytm founder call it 'best decision'",India Inc saw this step in a different and more positive light.,neutral,positive,2.147016011644824,positive,-2.112676056338028,negative
2020-03-27 18:03:06.734,284.0,291.2,272.0,278.0,3957999.0,"Biocon will continue to operate essential pharmaceutical manufacturing in full compliance with government requirements, it added.","Biocon will continue to operate essential pharmaceutical manufacturing in full compliance with government requirements, it added.",neutral,neutral,-2.112676056338028,negative,-1.0473094980137152,negative
2020-03-31 13:02:49.107,277.95,285.7,274.4,278.15,4723325.0,Apollo-led group of companies to help govt with Covid care,"The group, which also includes Biocon, Oyo Hotels, Lemon Tree Hotels, Ginger Hotels, Zomato, SBI, HUL and Deutsche Bank, has identified about 80,000 hotel rooms across the country that can be converted into isolation rooms with medical supervision based on need. It is also pooling CSR funds to help patients with financial issues.",neutral,neutral,0.0719553876596469,neutral,4.171161452714838,positive
2020-04-01 10:01:40.325,277.95,285.7,274.4,278.15,4723325.0,Biocon's Malaysia unit gets EIR from USFDA,"Biocon’s Insulin manufacturing facility in Malaysia receives EIR from USFDA with Voluntary Action Indicated (VAI) classification, inspection stands closed.",neutral,neutral,0.0719553876596469,neutral,4.171161452714838,positive
2020-04-01 13:01:43.188,277.95,285.7,274.4,278.15,4723325.0,Biocon gains 5% as manufacturing unit in Malaysia gets EIR from USFDA,"Biocon Sdn Bhd, a subsidiary of Biocon, received the EIR from the USFDA for the pre-approval inspection of its insulin manufacturing facility in Malaysia, for insulin glargine",positive,positive,0.0719553876596469,neutral,4.171161452714838,positive
2020-04-01 13:01:44.016,277.95,285.7,274.4,278.15,4723325.0,Biocon share price rises nearly 5% on EIR for Malaysia facility,Company's subsidiary Biocon Sdn Bhd has received the establishment inspection report (EIR) from the US FDA for the pre-approval inspection of the Malaysia facility.,positive,neutral,0.0719553876596469,neutral,4.171161452714838,positive
2020-04-01 13:02:34.493,277.95,285.7,274.4,278.15,4723325.0,FDA concludes inspection of Biocon's insulin unit in Malaysia,"The inspection, which was carried out between February 10 and February 21, 2020, has been closed with a “VAI” (Voluntary Action Indicated) classification in the EIR",neutral,neutral,0.0719553876596469,neutral,4.171161452714838,positive
2020-04-01 13:02:52.844,277.95,285.7,274.4,278.15,4723325.0,Biocon's insulin manufacturing facility in Malaysia gets EIR with VAI classification From USFDA,"In a regulatory filing the company said, Biocon Sdn Bhd, a subsidiary of Biocon Ltd has received the EIR from the USFDA for the Pre-Approval Inspection (PAI) of its insulin manufacturing facility in Malaysia, for Insulin Glargine.",neutral,positive,0.0719553876596469,neutral,4.171161452714838,positive
2020-04-01 13:03:47.730,277.95,285.7,274.4,278.15,4723325.0,Biocon says probe on Malaysia manufacturing unit ends,"“This is to inform you that Biocon Sdn Bhd, a subsidiary of Biocon, has received the EIR from the USFDA for the pre-approval inspection of its insulins manufacturing facility in Malaysia, for Insulin Glargine. The inspection was conducted between Feb 10 and 21, 2020,” said the company spokesperson in a statement. 
",neutral,neutral,0.0719553876596469,neutral,4.171161452714838,positive
2020-04-01 18:00:17.710,277.95,285.7,274.4,278.15,4723325.0,"Market Movers: YES Bank, Biocon jump; TechM, Kotak Bank bleed; Rs 3.2L cr lost",Here is a lowdown of the movers and shakers of Wednesdays session on Dalal Street.,negative,neutral,0.0719553876596469,neutral,4.171161452714838,positive
2020-04-02 13:03:59.617,278.1,295.85,277.9,289.7,6290405.0,Biocon's US prospects get a boost after company receives EIR from USFDA,"The insulin patent win, clearance of Malaysian unit and oncology biosimilar filing are triggers",positive,positive,4.171161452714838,positive,6.316666666666664,positive
2020-04-07 13:03:58.484,322.4,345.0,315.0,325.9,14302003.0,"D-Street Buzz: Pharma stocks shine; Cadila, Laurus Labs, Biocon shares jump up to 15%","Brokerages do not see a meaningful adverse impact of the lockdown, which is in its second week, on the earnings of pharma players.",positive,negative,1.08560794044665,positive,-0.2994011976047904,neutral
2020-04-07 13:04:00.644,322.4,345.0,315.0,325.9,14302003.0,"Kotak Bank, Biocon, Torrent Pharma to benefit from MSCI index rejig","$1.3-billion FPI inflows expected; RIL, HDFC, Infosys, ITC, Bajaj Auto to see reduction in weight",positive,neutral,1.08560794044665,positive,-0.2994011976047904,neutral
2020-04-07 18:14:04.000,322.4,345.0,315.0,325.9,14302003.0,"RIL, HDFC, Infosys shares may be hit by MSCI index rejig, even as Indian equities get Rs 50,000 crore","MSCI revision could bring windfall gains to shares of certain companies including Kotak Mahindra Bank, IGL and Biocon, but at the same time, may cut the heft of heavyweight stocks such as Reliance Industries and HDFC.",negative,positive,1.08560794044665,positive,-0.2994011976047904,neutral
2020-04-08 18:02:53.077,334.0,342.95,330.3,333.0,6292290.0,"Nifty Pharma index gains led by Cadila, Sun Pharma","Cipla rose 4%, Dr Reddy’s, Piramal, Glenmark and Lupin was up in the range of 2-1% respectively and Biocon was up 1.5%.",positive,positive,-0.2994011976047904,neutral,1.5031998809346665,positive
2020-04-13 11:33:00.000,335.95,355.5,331.6,341.0,13167083.0,Share market update:16 stocks hit 52-week highs on NSE,"Ruchi Soya Inds, Alembic Pharma, Biocon, Dr. Reddy’s Lab and Sun Pharma hit their fresh 52-week high during the day.",positive,positive,1.5031998809346665,positive,-4.560906515580743,negative
2020-04-14 05:30:00.000,353.0,353.0,330.15,336.9,8435176.0,"BRIEF-Biocon, Mylan Launch Fulphila Biosimilar Pegfilgrastim In Australia - Investing.com India","The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-4.560906515580743,negative,3.323529411764709,positive
2020-04-14 10:30:00.000,353.0,353.0,330.15,336.9,8435176.0,"Biocon, Mylan launch cancer drug in Australia","Fulphila, co-developed by Biocon Biologics and Mylan, was the first biosimilar pegfilgrastim to be approved in the US and was launched in July 2018, thus expanding access for patients in need of an affordable alternative.",neutral,positive,-4.560906515580743,negative,3.323529411764709,positive
2020-04-14 10:39:26.000,353.0,353.0,330.15,336.9,8435176.0,"Biocon, Mylan launch Fulphila, biosimilar Pegfilgrastim in Australia","Fulphila is approved by the Therapeutic Goods Administration for the treatment of cancer patients following chemotherapy, to decrease the duration of severe neutropenia and reduce the incidence of infections, as manifested by febrile neutropenia, city-headquartered Biocon said in a statement.…",neutral,positive,-4.560906515580743,negative,3.323529411764709,positive
2020-04-14 11:34:00.000,353.0,353.0,330.15,336.9,8435176.0,"Biocon and Mylan launch Fulphila, a biosimilar to Pegfilgrastim in Australia","Biocon Ltd. and Mylan N V on Tuesday announced the launch of Fulphila, a biosimilar to Neulasta (pegfilgrastim), in Australia.",neutral,positive,-4.560906515580743,negative,3.323529411764709,positive
2020-04-14 12:33:00.000,353.0,353.0,330.15,336.9,8435176.0,"Biocon, Mylan launch Fulphila, a biosimilar Pegfilgrastim in Australia","CEO of Biocon Biologics, Dr Christiane Hamacher said, Fulphila, co-developed by Biocon Biologics and Mylan, is the third biosimilar to be commercialised in Australia",neutral,neutral,-4.560906515580743,negative,3.323529411764709,positive
2020-04-14 16:34:36.000,353.0,353.0,330.15,336.9,8435176.0,"Coronavirus Outbreak: Extension of lockdown right decision amid spiking Covid-19 cases, says Kiran Mazumdar-Shaw - Firstpost","Extension of the nation-wide lockdown is the right decision as India is witnessing a surge in the number of novel coronavirus infections, Biocon Chairperson Kiran Mazumdar-Shaw said",neutral,positive,-4.560906515580743,negative,3.323529411764709,positive
2020-04-15 06:00:00.000,353.0,353.0,330.15,336.9,8435176.0,"Top stocks in focus: Aviation stocks, Hindalco, Maruti, Avenue Supermarts, RIL, Dr Reddy’s, Biocon",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-4.560906515580743,negative,3.323529411764709,positive
2020-04-15 06:00:00.000,353.0,353.0,330.15,336.9,8435176.0,"Biocon, Mylan launch Fulphila biosimilar Pegfilgrastim in Australia; stock up 1%","The approval of Fulphila was based on a comprehensive package of analytical, nonclinical and clinical data, which confirmed that the product is highly similar to Neulasta and no clinically meaningful differences in terms of safety and efficacy exist.",positive,neutral,-4.560906515580743,negative,3.323529411764709,positive
2020-04-15 07:30:00.000,353.0,353.0,330.15,336.9,8435176.0,"Stocks in the news: Wipro, RIL, Hindalco, HDFC, Tata Steel, Welspun Corp and Biocon",IT major Wipro will announce its fourth-quarter and FY20 results today.,neutral,neutral,-4.560906515580743,negative,3.323529411764709,positive
2020-04-15 08:07:00.000,353.0,353.0,330.15,336.9,8435176.0,"Stocks in news: NTPC, DCB Bank, Biocon, Apollo Tyres and more","Stocks to watch today on April 15: NTPC, DCB Bank, Biocon, Apollo Tyres among others are the top stocks to watch out for in Wednesday’s trading session",neutral,neutral,-4.560906515580743,negative,3.323529411764709,positive
2020-04-15 11:08:00.000,353.0,353.0,330.15,336.9,8435176.0,Biocon shares gain 1% in early session,Shares of Biocon Ltd. traded 1.01 per cent up in trade at 11:03AM on Wednesday .,positive,positive,-4.560906515580743,negative,3.323529411764709,positive
2020-04-16 05:30:00.000,340.0,353.5,339.1,351.3,9189240.0,BRIEF-Biocon Says Unit Get EIR From U.S. FDA For Two Manufacturing Facilities - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,3.323529411764709,positive,-0.1125334083555991,neutral
2020-04-16 06:00:00.000,340.0,353.5,339.1,351.3,9189240.0,Biocon Biologics receives EIR from USFDA for 2 facilities; Biocon gains 2.4%,"Biocon’s subsidiary, receives EIR from USFDA for two manufacturing facilities, inspection stands closed.",positive,neutral,3.323529411764709,positive,-0.1125334083555991,neutral
2020-04-16 09:39:00.000,340.0,353.5,339.1,351.3,9189240.0,Biocon gains 5% as two Bengaluru facilities receive EIR from USFDA,"The stock was trading close to its all-time high level of Rs 359, touched in September 2018",positive,positive,3.323529411764709,positive,-0.1125334083555991,neutral
2020-04-16 10:27:00.000,340.0,353.5,339.1,351.3,9189240.0,Biocon Biologics receives EIR from USFDA for 2 manufacturing facilities,"The inspection was conducted between September 10 and September 19, 2019, a company spokesperson said, adding, Biocon Biologics has responded to the regulator on the eight observations from this inspection, in October last year.",neutral,positive,3.323529411764709,positive,-0.1125334083555991,neutral
2020-04-16 11:48:54.000,340.0,353.5,339.1,351.3,9189240.0,Biocon Biologics receives EIR from USFDA for two manufacturing facilities in Bengaluru - Firstpost,"Biocon Biologics India Ltd., a subsidiary of Biocon Ltd., said on Thursday it has received the Establishment Inspection Report (EIR) from the USFDA (the United States Food and Drug Administration) for the pre-approval inspection at two of its biologics manufacturing facilities in Bengaluru",neutral,positive,3.323529411764709,positive,-0.1125334083555991,neutral
2020-04-16 11:59:00.000,340.0,353.5,339.1,351.3,9189240.0,Share market update: Pharma shares advance; Biocon gains 4%,The Nifty Pharma index was trading 1.05 per cent up at 9133.45 .,positive,positive,3.323529411764709,positive,-0.1125334083555991,neutral
2020-04-16 12:33:00.000,355.45,360.9,343.05,355.05,10071946.0,"Biocon gains 5% on EIR from USFDA for 2 units; MFs, LIC raise stake in March quarter","LIC also raised its stake to 1.55 percent at the end of March quarter, from 1.16 percent in previous quarter. However FPIs cut their stake in the company to 14.98 percent during the quarter, from 16.09 percent QoQ.",positive,positive,-0.1125334083555991,neutral,-0.6668519033064677,neutral
2020-04-16 23:43:00.000,355.45,360.9,343.05,355.05,10071946.0,India has capacity to be global hub for manufacturing test kits,"Kiran Mazumdar-Shaw, executive chairperson, Biocon, speaking at a webinar held by the Department of Biotechnology, School of Engineering & Applied Sciences at the Bennett University, on Thursday on the theme “Combating Covid-19: Biotech to the Rescue”.",neutral,neutral,-0.1125334083555991,neutral,-0.6668519033064677,neutral
2020-04-24 19:36:00.000,346.0,360.0,339.0,357.1,11730624.0,MyLab partners with Biocon’s research arm Syngene to produce coronavirus testing kits,"In a bid to scale up production and escalate faster delivery of COVID-19 testing kits, Pune-based molecular diagnostics company Mylab Discovery Solutions has entered into partnered with Syngene International",neutral,positive,3.20809248554914,positive,0.3454470084289069,neutral
2020-04-26 23:38:48.000,361.85,367.65,355.2,363.1,7965836.0,Pharmaceuticals: Outlook for earnings to now drive re-rating,"Covid-19 related gains are largely priced in; Aurobindo, Biocon are top picks; Torrent downgraded to ‘Hold’.",positive,positive,0.3454470084289069,neutral,-3.839322311791232,negative
2020-04-27 18:00:00.000,365.95,365.95,348.4,351.9,6309329.0,Mazumdar-Shaw recognised among world’s top 20 inspirational leaders in Biopharma,"Biocon Executive Chairperson Kiran Mazumdar-Shaw has been recognised for her contribution to the world of medicine as an entrepreneur and innovative business leader, the Bengaluru-headquartered biopharmaceuticals company said in a statement.",positive,positive,-3.839322311791232,negative,-3.7704918032786914,negative
2020-04-27 18:31:30.000,365.95,365.95,348.4,351.9,6309329.0,Biocon’s Kiran Mazumdar Shaw makes it to top 20 in this global power list of biopharma leaders,"The Medicine Maker Power List 20 for 2020 celebrates 60 great minds who have brought the world innovation in small molecules, biopharmaceuticals and advanced medicine, it said.",neutral,positive,-3.839322311791232,negative,-3.7704918032786914,negative
2020-04-27 21:29:46.000,365.95,365.95,348.4,351.9,6309329.0,Mazumdar-Shaw recognised among world s top 20 inspirational leaders in Biopharma,Bengaluru: Biocon Ltd announced on Monday that The Medicine Maker Power List 2020 has ranked its Executive Chairperson Kiran Mazumdar-Shaw as one of the world’s top 20 inspirational leaders in the field of biopharmaceuticals. She has been recognised for her contribution to…,positive,positive,-3.839322311791232,negative,-3.7704918032786914,negative
2020-04-28 05:30:00.000,365.95,365.95,348.4,351.9,6309329.0,"BRIEF-Biocon Says Co, Mylan Launch Fulphila, Biosimilar Pegfilgrastim In Canada - Investing.com India","The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-3.839322311791232,negative,-3.7704918032786914,negative
2020-04-28 08:13:35.000,365.95,365.95,348.4,351.9,6309329.0,Biocon chief Kiran Mazumdar-Shaw recognised among world s top 20 inspirational leaders in Biopharma - Firstpost,Biocon Ltd announced on Monday that The Medicine Maker Power List 2020 has ranked its Executive Chairperson Kiran Mazumdar-Shaw as one of the world’s top 20 inspirational leaders in the field of biopharmaceuticals,positive,positive,-3.839322311791232,negative,-3.7704918032786914,negative
2020-04-28 21:42:00.000,366.0,366.0,350.7,352.2,8827917.0,"Biocon, Mylan launch cancer drug in Canada","Fulphila, co-developed by Biocon Biologics and Mylan, was the first biosimilar pegfilgrastim to be approved in the US and was launched in July 2018.",neutral,positive,-3.7704918032786914,negative,-1.6388888888888824,negative
2020-04-29 02:26:00.000,366.0,366.0,350.7,352.2,8827917.0,"Top stocks in focus: Axis Bank, Biocon, Hexaware, Reliance Industries",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-3.7704918032786914,negative,-1.6388888888888824,negative
2020-04-29 06:31:26.000,366.0,366.0,350.7,352.2,8827917.0,"Stocks To Watch: Axis Bank, Biocon, Hexaware Technologies, Reliance Industries",Here are the stocks to watch in trade today.,neutral,neutral,-3.7704918032786914,negative,-1.6388888888888824,negative
2020-04-29 07:54:00.000,366.0,366.0,350.7,352.2,8827917.0,"In pics | Stocks in the news: L&T, Axis Bank, Biocon, NLC India, Zee Ent, PNB Housing",Gabriel India | Crompton Greaves Consumer Electricals | Ujjivan Small Finance Bank | Sangam (India) | PPAP Automotive are among the stocks in focus today.,neutral,neutral,-3.7704918032786914,negative,-1.6388888888888824,negative
2020-04-29 08:32:00.000,366.0,366.0,350.7,352.2,8827917.0,"Stocks in news: Axis Bank, Atul, JK Paper, NLC India, L&T, PNB Housing, Biocon, Thomas Cook and more","Stocks to watch today on April 29: Axis Bank, Atul, JK Paper, NLC India, L&T, PNB Housing, Biocon, Thomas Cook among others are the top stocks to watch out for in Wednesday’s trading session",neutral,neutral,-3.7704918032786914,negative,-1.6388888888888824,negative
2020-04-29 09:01:43.000,366.0,366.0,350.7,352.2,8827917.0,"Stocks to watch: Axis Bank, L&T, IDFC First Bk, Biocon, NLC India, Hexaware",Heres a look at the top stocks that may remain in focus today,neutral,neutral,-3.7704918032786914,negative,-1.6388888888888824,negative
2020-04-29 11:57:00.000,366.0,366.0,350.7,352.2,8827917.0,Biocon jumps 4% on launch of drug Fulphila in Canada,Biocon has shared or co-exclusive commercialisation rights with Mylan for the product in the rest of the world.,positive,positive,-3.7704918032786914,negative,-1.6388888888888824,negative
2020-04-30 00:07:00.000,360.0,360.0,347.25,354.1,5867294.0,"Biocon developing vaccine, antibody cure and repurposed drugs against COVID-19","Biocon is developing a customised non-replicating measles virus based vaccine for coronavirus, a latest therapy that can be commercialised quickly, along with two new generation repurposed drugs and an antibody diagnostic kit",neutral,positive,-1.6388888888888824,negative,1.9886363636363635,positive
2020-05-03 15:26:00.000,352.0,366.0,349.15,359.0,9021997.0,Old drug brings new hope for critically ill coronavirus patients,BMC-run hospitals have successfully tried an immunomodulatory drug to treat extremely critical Covid-19 cases. Two at Nair Hospital show remarkable recovery. Kiran Mazumdar Shaw’s Biocon agrees to free-of-cost trials at all BMC hospitals.,positive,positive,1.9886363636363635,positive,-4.933224311801572,negative
2020-05-04 19:28:00.000,366.9,366.9,347.0,348.8,8527321.0,Mumbai docs try Biocon and Roche’s biologic drugs on critical Covid cases,Two repurposed drugs for rheumatoid arthritis and psoriasis are being tried on over 100 patients in Mumbai,neutral,neutral,-4.933224311801572,negative,0.8690696680438842,neutral
2020-05-05 09:00:00.000,366.9,366.9,347.0,348.8,8527321.0,"Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term","Sudarshan Sukhani of s2analytics.com suggests buying Biocon with a stop loss of Rs 349, target at Rs 369 and Reliance Industries with a stop loss of Rs 1,400, target at Rs 1,470.",neutral,neutral,-4.933224311801572,negative,0.8690696680438842,neutral
2020-05-05 09:09:00.000,366.9,366.9,347.0,348.8,8527321.0,Coronavirus pandemic | Mumbai doctors try Biocon and Roche’s drugs on critical COVID-19 patients: Report,Two drugs from Biocon and Roche are reportedly being tested on critically ill patients at Mumbai’s Nair Hospital and King Edward Memorial Hospital.,neutral,neutral,-4.933224311801572,negative,0.8690696680438842,neutral
2020-05-08 05:12:00.000,355.0,361.0,349.2,358.5,5542026.0,Biocon gets EIR from USFDA in Bengaluru unit; stock rises 2%,"At the conclusion of the inspection the agency had issued a Form 483, with five observations, which are being addressed by the Company.",positive,neutral,0.9859154929577464,positive,-1.9335095284462345,negative
2020-05-08 05:30:00.000,355.0,361.0,349.2,358.5,5542026.0,BRIEF-Biocon Gets FDA EIR For Bengaluru Small Molecules API Plant - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,0.9859154929577464,positive,-1.9335095284462345,negative
2020-05-08 06:14:00.000,355.0,361.0,349.2,358.5,5542026.0,"Nifty Pharma index gains 2%; Dr Reddy’s, Biocon stocks jump","Glenmark, Aurobindo Pharma and Cadia were also trading in the positive zone.",positive,positive,0.9859154929577464,positive,-1.9335095284462345,negative
2020-05-08 10:06:00.000,355.0,361.0,349.2,358.5,5542026.0,Biocon share price up 2% on receiving EIR from USFDA,"The inspection was conducted between January 20 and January 24, 2020.",positive,neutral,0.9859154929577464,positive,-1.9335095284462345,negative
2020-05-08 13:47:00.000,355.0,361.0,349.2,358.5,5542026.0,Biocon gets establishment inspection report from USFDA for Bengaluru plant,"The EIR has been closed with a voluntary action indicated (VAI) classification for the observations, it added. As per the USFDA, a VAI means that objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.",neutral,neutral,0.9859154929577464,positive,-1.9335095284462345,negative
2020-05-08 19:26:00.000,355.0,361.0,349.2,358.5,5542026.0,Biocon share price rises 3% on receiving EIR from USFDA,Biocon share price closed higher today after the firm said it received Establishment Inspection Report (EIR) from US Food and Drug Administration (FDA). Share price of Biocon rose up to 3.22% to Rs 360.9 against previous close of Rs 349.65 on BSE. Biocon,positive,positive,0.9859154929577464,positive,-1.9335095284462345,negative
2020-05-11 07:40:00.000,359.45,363.8,350.05,352.5,8179772.0,"Market Ahead, May 11: Top factors that could guide markets this week","Around 50 companies including the likes of Maruti Suzuki, Nestle, Dr Reddy’s Labs, Biocon, and Bandhan Bank are scheduled to announce their March quarter results.",neutral,neutral,-1.9335095284462345,negative,-2.9661016949152543,negative
2020-05-11 13:41:00.000,354.0,356.8,337.65,343.5,7689877.0,Karnataka government eyes foreign companies seeking to move out of China,"In recent days, the Minister held consultations with industrialists such as co-founder and Non-Executive Chairman of Infosys Ltd, Nandan M Nilekani, Executive Chairperson of Biocon Ltd, Kiran Mazumdar-Shaw and Chairman of early-stage startup accelerator and venture fund Axilor Ventures Senapathy (Kr…",neutral,neutral,-2.9661016949152543,negative,-4.520334419725108,negative
2020-05-11 14:32:00.000,354.0,356.8,337.65,343.5,7689877.0,"Coronavirus: Elisa kits to solve accuracy issue, ease mass testing; Biocon, Transasia wait for approval",Mumbai-based medical devices company Transasia Biomedical’s German subsidiary Erba Mannheim has already got clearance from the US and Europe to make COVID-19 antibody ELISA kits,neutral,positive,-2.9661016949152543,negative,-4.520334419725108,negative
2020-05-11 17:42:02.000,354.0,356.8,337.65,343.5,7689877.0,All eyes on MSCI index rejig as FTSE defers index rebalancing,"The forthcoming half-yearly review for MSCI India index on May 13 may see the inclusion of Tata Consumer Products, Biocon, Indraprastha Gas, Torrent Pharma and Muthoot Finance into the index. The chan",neutral,neutral,-2.9661016949152543,negative,-4.520334419725108,negative
2020-05-12 05:30:00.000,354.0,356.8,337.65,343.5,7689877.0,BRIEF-Biocon Biologics Drug Substance Facilities In Bengaluru Get EU GMP Certification - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-2.9661016949152543,negative,-4.520334419725108,negative
2020-05-12 09:53:00.000,354.0,356.8,337.65,343.5,7689877.0,Biocon share price rises on GMP compliance,"The inspection was inspected by the regulatory agency between January 20 and 23, 2020.",positive,neutral,-2.9661016949152543,negative,-4.520334419725108,negative
2020-05-12 11:45:00.000,354.0,356.8,337.65,343.5,7689877.0,Biocon gets EU GMP certificate on Biologics Drug facilities; stock down 3%,"The mentioned facilities were inspected by the regulatory agency between January 20 and 23, 2020.",negative,neutral,-2.9661016949152543,negative,-4.520334419725108,negative
2020-05-12 12:22:00.000,352.85,352.85,334.1,336.9,8726183.0,Share market update: Pharma shares slip; Biocon down over 3%,The Nifty Pharma index was trading 1.53 per cent down at 9165.35 .,negative,negative,-4.520334419725108,negative,-0.7709414381023048,neutral
2020-05-12 13:10:00.000,352.85,352.85,334.1,336.9,8726183.0,States with good primary healthcare system managed COVID-19 well: Kiran Mazumdar-Shaw,"The Executive Chairperson of bio-pharmaceuticals company, Biocon Ltd, also hit out at people not wearing face-masks in public places and said they don’t understand the gravity of the disease.",neutral,negative,-4.520334419725108,negative,-0.7709414381023048,neutral
2020-05-12 13:12:27.000,352.85,352.85,334.1,336.9,8726183.0,Biocon’s Kiran Mazumdar-Shaw says states with good primary healthcare system managed COVID-19 well,"Citing Karnataka and Kerala, Mazumdar-Shaw said they have managed the COVID-19 well as they have got a very good primary health care ecosystem.",neutral,positive,-4.520334419725108,negative,-0.7709414381023048,neutral
2020-05-14 06:19:09.000,337.25,343.5,333.0,334.65,8702094.0,"Stocks To Watch: ABB India, Biocon, Escorts, Godrej Consumer Products, Indiabulls Real Estate, Manappuram Finance, PFC, REC, Siemens India",Here are the stocks to watch in trade today.,neutral,neutral,-0.7709414381023048,neutral,1.4615384615384617,positive
2020-05-14 07:30:00.000,337.25,343.5,333.0,334.65,8702094.0,"Market Ahead, May 14: All You Need To Know Before The Opening Bell","A total of 18 companies including Biocon, Escorts, and Manappuram Finance are scheduled to announce their results today",neutral,neutral,-0.7709414381023048,neutral,1.4615384615384617,positive
2020-05-14 07:54:00.000,337.25,343.5,333.0,334.65,8702094.0,"Top stocks in focus: Escorts, Maruti, Biocon, PFC, REC, Siemens India",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-0.7709414381023048,neutral,1.4615384615384617,positive
2020-05-14 08:46:00.000,337.25,343.5,333.0,334.65,8702094.0,"Board Meetings Today: RIL, Indiabulls Real Estate, Escorts, Aavas Financiers, Biocon and Manappuram Finance","Mahindra Lifespace, Oracle Financial and TV Today Network are among companies that are slated to announce their March quarter earnings today.",neutral,neutral,-0.7709414381023048,neutral,1.4615384615384617,positive
2020-05-14 08:47:00.000,337.25,343.5,333.0,334.65,8702094.0,"Stocks in focus: Financials, power, realty shares, Maruti, Infosys, Biocon",Heres a look at the top stocks that may trade actively in todays trading session,neutral,neutral,-0.7709414381023048,neutral,1.4615384615384617,positive
2020-05-14 08:49:00.000,337.25,343.5,333.0,334.65,8702094.0,"Stocks in the news: Biocon, DRL, PFC, Cipla, Indiabulls Realty, Escorts and REC - The Economic Times",Here are a few stocks which may create some buzz in Thursdays trade.,neutral,neutral,-0.7709414381023048,neutral,1.4615384615384617,positive
2020-05-14 08:52:49.000,337.25,343.5,333.0,334.65,8702094.0,"Stocks in focus: Biocon, Indiabulls Real Estate, PFC, REC among stocks to hog limelight today","Aavas Financiers, Biocon, Escorts, Indiabulls Real Estate, Escorts, Manappuram Finance, Mahindra Lifespace and Tata Consumer Products are among 18 companies that are slated to announce their March quarter earnings today.",neutral,neutral,-0.7709414381023048,neutral,1.4615384615384617,positive
2020-05-14 09:53:00.000,337.25,343.5,333.0,334.65,8702094.0,"Stocks in news: Maruti, Godrej Consumer, Siemens, Biocon, Tata Consumer, Escorts, ABB, Kotak Bank and more","Stocks to watch today on May 14: Maruti, Godrej Consumer, Siemens, Biocon, Tata Consumer, Escorts, ABB, Kotak Bank among others are the top stocks to watch out for in Thursday’s trading session",neutral,neutral,-0.7709414381023048,neutral,1.4615384615384617,positive
2020-05-14 11:59:00.000,337.25,343.5,333.0,334.65,8702094.0,Biocon Ltd. shares gain 0.76% as Sensex falls,"Shares of Biocon Ltd. traded 0.76 per cent up at Rs 339.85 at 11:59AM (IST) on Thursday, even as BSE benchmark Sensex dropped 644.92 points to 31363.69. The stock had settled at Rs 337.3 in the previous session. The stock of Biocon Ltd. quoted a 52-week high and 52-week low of Rs 367.8 and Rs 21…",positive,positive,-0.7709414381023048,neutral,1.4615384615384617,positive
2020-05-14 12:32:00.000,325.0,338.65,320.7,329.75,26970567.0,"Important results today: Biocon, Tata Consumer, Escorts","Quarterly results that are expected today include Biocon, Tata Consumer, Escorts, Manappuram Finance, Aavas Financiers.",neutral,neutral,1.4615384615384617,positive,0.911854103343465,positive
2020-05-15 00:05:00.000,325.0,338.65,320.7,329.75,26970567.0,"Biocon’s Q4 revenue hit by Covid-19 crisis, pre-tax profit declines 28%","The net profit for the period declined 42.2 per cent to Rs 123 crore on YoY basis, according to a BSE filing by the company",negative,negative,1.4615384615384617,positive,0.911854103343465,positive
2020-05-15 07:59:00.000,325.0,338.65,320.7,329.75,26970567.0,"Top stocks in focus: Cipla, Unichem Labs, L&T Finance, Aurobindo Pharma, Biocon",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,1.4615384615384617,positive,0.911854103343465,positive
2020-05-15 08:09:00.000,325.0,338.65,320.7,329.75,26970567.0,"Stocks to watch: Biocon, Cipla, Aurobindo Pharma, Tata Group stocks, Nocil",Heres a look at the top stocks that may remain in focus today,neutral,neutral,1.4615384615384617,positive,0.911854103343465,positive
2020-05-15 08:38:00.000,325.0,338.65,320.7,329.75,26970567.0,Biocon’s Q4 PAT dives 42% yoy to Rs123cr; Expect Biologics biz to recover in Q1FY21,"Biocon recorded consolidated net profit to Rs123cr during March 2020 (Q4FY20) period, compared to Rs214cr recorded in the same quarter of the previous year.",positive,positive,1.4615384615384617,positive,0.911854103343465,positive
2020-05-15 08:38:00.000,325.0,338.65,320.7,329.75,26970567.0,Biocon Q4 profit declines 42% to Rs 123 crore,"Revenue was up 3 percent to Rs 1,581 crore versus Rs 1,529 crore.",negative,positive,1.4615384615384617,positive,0.911854103343465,positive
2020-05-15 08:57:31.000,325.0,338.65,320.7,329.75,26970567.0,Biocon profit slumps 42% in Q4 as covid-19 disrupts biologics business,"Revenue of the Kiran Mazumdar Shaw-led firm’s subsidiary, Biocon Biologics, was down by a fifth at ₹357 crore.Biocon said early sales of Fulphila, its biosimilar to pegfilgrastim, in Australia were encouraging",negative,negative,1.4615384615384617,positive,0.911854103343465,positive
2020-05-15 09:31:00.000,325.0,338.65,320.7,329.75,26970567.0,Biocon share price falls 3% post Q4 numbers,"Revenue from operations was up 3 percent at Rs 1,581 crore versus Rs 1,528.8 crore year-on-year.",negative,positive,1.4615384615384617,positive,0.911854103343465,positive
2020-05-15 09:46:00.000,325.0,338.65,320.7,329.75,26970567.0,"Biocon Consolidated March 2020 Net Sales at Rs 1,581.00 crore, up 3.41% Y-o-Y",,positive,neutral,1.4615384615384617,positive,0.911854103343465,positive
2020-05-15 09:48:00.000,325.0,338.65,320.7,329.75,26970567.0,Biocon Q4 results: Profit dips 42% on one-time Covid-19 impact,"For the financial year 2019-20, the biopharma company posted a 15% growth in revenue at Rs 6,529 crore.",neutral,positive,1.4615384615384617,positive,0.911854103343465,positive
2020-05-15 09:50:00.000,325.0,338.65,320.7,329.75,26970567.0,"Stocks in news: Biocon, Tata Consumer, Escorts, Cipla, L&T Tech, M&M Financial, Manappuram Finance and more","Stocks to watch today on May 15: Biocon, Tata Consumer, Escorts, Cipla, L&T Tech, M&M Financial, Manappuram Finance among others are the top stocks to watch out for in Friday’s trading session",neutral,neutral,1.4615384615384617,positive,0.911854103343465,positive
2020-05-15 09:52:00.000,325.0,338.65,320.7,329.75,26970567.0,Biocon shares slump over 4% as profit declines 42% in March quarter,"The companys revenue, however, saw a muted growth of 6 per cent as compared to Q4 of FY19",negative,negative,1.4615384615384617,positive,0.911854103343465,positive
2020-05-15 11:01:53.000,325.0,338.65,320.7,329.75,26970567.0,COVID-19 impact: Biocon Q4 net down 42% at Rs 123 crore,"Biocon Ltd s net profit Declined 42 per cent to Rs 123 crore in the fourth quarter of 2019-20 compared to the same period in the previous fiscal following muted revenue growth due to COVID-19 related impact on its biologics business, the company said.",negative,negative,1.4615384615384617,positive,0.911854103343465,positive
2020-05-15 11:11:00.000,325.0,338.65,320.7,329.75,26970567.0,Investors faith in Biocon bleak; stocks plunges by over 4% post Q4 result,Biocon shares opened lower at Rs325.05 per piece compared to the previous closing of Rs335.30 per piece.,negative,negative,1.4615384615384617,positive,0.911854103343465,positive
2020-05-15 11:55:00.000,325.0,338.65,320.7,329.75,26970567.0,Biocon share price falls over 4% as coronavirus hits Q4 earnings,Share price of Biocon lost up to 4.29% to Rs 320.9 against previous close of Rs 335.30 on BSE. The stock touched an intraday low of Rs 320.9 down 4.29%,negative,negative,1.4615384615384617,positive,0.911854103343465,positive
2020-05-15 12:15:00.000,325.0,338.65,320.7,329.75,26970567.0,Share market update: Pharma shares slip; Biocon down 3%,The Nifty Pharma index was trading 0.45 per cent down at 9131.35.,negative,negative,1.4615384615384617,positive,0.911854103343465,positive
2020-05-15 12:20:44.000,325.0,338.65,320.7,329.75,26970567.0,Trading Call: Biocon Ltd (₹327): Sell,Traders looking to capitalise on short-term movements could consider the Biocon stock as it seems to be heading southwards. It has broken a key support at ₹335 and there are signs of a further decline,neutral,positive,1.4615384615384617,positive,0.911854103343465,positive
2020-05-15 12:57:21.000,325.0,338.65,320.7,329.75,26970567.0,Biocon Q4 net profit falls 42 pc to Rs 123 cr due to one-time COVID-19 impact,"The company had posted a net profit of Rs 214 crore for the corresponding period of the previous fiscal, Biocon said in a statement.",negative,positive,1.4615384615384617,positive,0.911854103343465,positive
2020-05-15 13:10:51.000,325.0,338.65,320.7,329.75,26970567.0,"Biocon Q4 net profit falls 42% to Rs 123 cr due to one-time COVID-19 impact; total income up 6% - Business News , Firstpost","Biotechnology major Biocon has reported a 42 percent decline in its consolidated net profit to Rs 123 crore for the quarter ended March 2020, mainly on account of the one-time coronavirus-related impact on its biologics business",positive,negative,1.4615384615384617,positive,0.911854103343465,positive
2020-05-15 15:43:09.000,325.0,338.65,320.7,329.75,26970567.0,"Biocon share price tanks 9% in one week, falls 3% on Friday alone as profits dip in March quarter","After having jumped as much as 42% till last week from its March lows, pharma major Biocon’s share price has tanked 9% just this week.",negative,positive,1.4615384615384617,positive,0.911854103343465,positive
2020-05-15 17:30:23.000,325.0,338.65,320.7,329.75,26970567.0,Biocon Q4 profit falls 42% to ₹123 crore due to Covid-19 impact,"Biotechnology major Biocon has reported a 42 per cent decline in its consolidated net profit to ₹123 crore for the quarter ended March 2020, mainly on account of one-time coronavirus-related impact on",negative,negative,1.4615384615384617,positive,0.911854103343465,positive
2020-05-15 18:04:58.000,325.0,338.65,320.7,329.75,26970567.0,"After covid-19 disruption, Biocon Biologics sees recovery in Q1, growth in July",Parent Biocon’s net profit declined 42% in Q4 as its flagship operations of biologics were hit by the coronavirus crisis .Revenue from Biocon Biologics was down by a fifth at ₹357 crore due to operational challenges,positive,negative,1.4615384615384617,positive,0.911854103343465,positive
2020-05-15 19:45:00.000,325.0,338.65,320.7,329.75,26970567.0,Will invest Rs 2k cr in small molecules segment in 3-4 yrs: Biocon CEO & MD,"In a Q&A, Biocon CEO and MD Siddharth Mittal explains why he believes his company is on track to achieve the $1 billion revenue target from the segment by 2022",neutral,positive,1.4615384615384617,positive,0.911854103343465,positive
2020-05-15 23:19:06.000,325.0,338.65,320.7,329.75,26970567.0,Biocon Q4 profit drops on COVID-19,"Small molecules, research services post good growth",negative,positive,1.4615384615384617,positive,0.911854103343465,positive
2020-05-18 11:50:00.000,329.0,336.8,325.0,332.0,11944538.0,"Reduce Biocon, target price Rs 250: Edelweiss","The stock is trading at 32 times FY22E EPS, which factors in the benefit from potential launches, but not the risks involved.",neutral,positive,0.911854103343465,positive,0.958083832335326,positive
2020-05-18 17:00:00.000,334.0,338.5,329.3,337.2,8102909.0,Buy Biocon; target of Rs 390: ICICI Direct,"ICICI Direct is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 390 in its research report dated May 18, 2020.",neutral,positive,0.958083832335326,positive,3.5273106116981765,positive
2020-05-18 23:47:46.000,334.0,338.5,329.3,337.2,8102909.0,Covid provides larger opportunity to shape the biosimilar landscape,Biocon Biologics announced its Q4FY20 numbers recently. The ongoing Covid-19 crisis has impacted the business in a significant way.,positive,negative,0.958083832335326,positive,3.5273106116981765,positive
2020-05-19 05:30:00.000,334.0,338.5,329.3,337.2,8102909.0,BRIEF-Biocon Unit Gets EU GMP Certification For Biosimilars Manufacturing Facilities In Bengaluru - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,0.958083832335326,positive,3.5273106116981765,positive
2020-05-19 07:08:00.000,334.0,338.5,329.3,337.2,8102909.0,"Ashamed to have abandoned migrant labourers, cannot prosper at cost of poverty: Biocon’s Kiran Mazumdar Shaw","Talking about the government’s economic stimulus package, Biocon chief Kiran Mazumdar Shaw said that we have lost a big opportunity to create demand.",neutral,negative,0.958083832335326,positive,3.5273106116981765,positive
2020-05-19 09:24:00.000,334.0,338.5,329.3,337.2,8102909.0,Biocon gets GMP certificate for Biologics subsidiary to cater needs of patients in the EU markets,Biocon Biologics aims to impact 5 million patient lives and cross a revenue milestone of $1B in FY22.,neutral,positive,0.958083832335326,positive,3.5273106116981765,positive
2020-05-19 16:36:00.000,335.95,349.75,334.0,347.8,7499183.0,Coronavirus: Experts say $266 billion economic stimulus unlikely to soften blow,"""We are creating all sorts of liquidity for supply, but what about the 
demand,"" said Kiran Mazumdar Shaw, chairperson of Biocon Limited, one of
 the country's top health firms",neutral,neutral,3.5273106116981765,positive,2.1645021645021645,positive
2020-05-20 15:56:00.000,346.5,357.7,344.75,354.0,9871925.0,Biocon Biologics on track to achieve $1 billion FY22 revenue target: CEO Christiane Hamacher,"&quot;We currently have adequate capacity to cater to increased market share or to anticipated regulatory approvals of our biosimilars in various jurisdictions,&quot; said Christiane Hamacher, CEO and Managing Director of Biocon Biologics in an email interview to Moneycontrol",positive,positive,2.1645021645021645,positive,-1.4084507042253522,negative
2020-05-21 09:23:00.000,346.5,357.7,344.75,354.0,9871925.0,"Biocon Consolidated March 2020 Net Sales at Rs 1,581.00 crore, up 3.41% Y-o-Y",,positive,neutral,2.1645021645021645,positive,-1.4084507042253522,negative
2020-05-21 12:14:00.000,355.0,356.85,347.6,350.0,4963056.0,Share market update: Pharma shares rise; Biocon up over 2%,The Nifty Pharma index was trading 0.58 per cent up at 9511.5.,positive,positive,-1.4084507042253522,negative,1.5177304964539071,positive
2020-05-21 16:52:00.000,355.0,356.85,347.6,350.0,4963056.0,"People spitting, urinating in public irk Kiran Mazumdar-Shaw; Biocon boss demands stricter Covid norms - The Economic Times",The biotech boss feels people will be in danger of uncontrollable viral infection without proper measures.,neutral,neutral,-1.4084507042253522,negative,1.5177304964539071,positive
2020-05-22 12:12:00.000,355.0,356.85,347.6,350.0,4963056.0,Share market update: Pharma shares mixed; Biocon dips 1%,The Nifty Pharma index was trading 0.34 per cent down at 9488.2.,negative,negative,-1.4084507042253522,negative,1.5177304964539071,positive
2020-05-27 09:43:33.000,358.0,363.3,347.3,351.0,7295074.0,DCGI permits use of Biocon Biologics’ CytoSorb to treat COVID-19 patients,Biocon’s subsidiary Biocon Biologics has received Drugs Controller General of India’s (DCGI) approval to use CytoSorb to treat critical COVID-19 patients. This is an extracorporeal blood purification (EBP) device which can help reduce pro-inflammatory cytokines levels in confirmed COVID-19 patien…,neutral,positive,-1.9553072625698324,negative,-2.437993235625714,negative
2020-05-27 10:43:00.000,358.0,363.3,347.3,351.0,7295074.0,Biocon gets drug regulator’s nod for CytoSorb device to treat critical COVID-19 patients,"&quot;The goal of CytoSorb therapy is to reduce cytokine storm and the deadly inflammatory response through blood purification so that this injury may be mitigated or prevented,&quot; the company added.",neutral,neutral,-1.9553072625698324,negative,-2.437993235625714,negative
2020-05-27 11:23:00.000,358.0,363.3,347.3,351.0,7295074.0,Biocon gains on DCGI approval for use of CytoSorb to treat critical COVID-19 patients,Biocon Biologics has been granted licence for emergency use of CytoSorb in public interest by the Indian health regulator to treat COVID-19 patients who are 18 years of age or older.,positive,positive,-1.9553072625698324,negative,-2.437993235625714,negative
2020-05-27 12:15:00.000,354.8,354.8,342.55,346.15,6469751.0,Biocon gets DCGI nod for CytoSorb device to treat Covid-19 patients,CytoSorb therapy reduces cytokine storm and the inflammatory response in Covid-19 patients through blood purification so that injury to organs may be mitigated or prevented,neutral,positive,-2.437993235625714,negative,2.585584284269838,positive
2020-05-27 12:39:24.000,354.8,354.8,342.55,346.15,6469751.0,Biocon gets DCGI nod for emergency use of CytoSorb to treat critical COVID-19 patients,"CytoSorb is plug-and-play compatible with the most commonly used blood purification machines or pumps in the ICU used to treat COVID-19 patients, including hemoperfusion, hemodialysis, continuous renal replacement therapy, and extracorporeal membrane oxygenation machines, Biocon said.",neutral,positive,-2.437993235625714,negative,2.585584284269838,positive
2020-05-27 12:40:43.000,354.8,354.8,342.55,346.15,6469751.0,Biocon gets approval for use of CytoSorb to treat critical COVID-19 patients,Biocon Biologics has been granted licence for emergency use of CytoSorb in public interest by the Indian health regulator to treat COVID-19 patients who are 18 years of age or older,positive,positive,-2.437993235625714,negative,2.585584284269838,positive
2020-05-27 12:57:00.000,354.8,354.8,342.55,346.15,6469751.0,Biocon gets DCGI nod for device to treat critical COVID-19 patients,"The company has been granted licence for emergency use of CytoSorb, an extracorporeal blood purification device CytoSorb to reduce pro-inflammatory cytokines levels, to treat COVID-19 patients who are 18 years of age or older.",neutral,positive,-2.437993235625714,negative,2.585584284269838,positive
2020-05-27 22:32:09.000,354.8,354.8,342.55,346.15,6469751.0,Biocon Biologics gets DCGI approval for emergency use of CytoSorb,US FDA recently approved CytoSorb for emergency use in CoVID-19 patients,positive,positive,-2.437993235625714,negative,2.585584284269838,positive
2020-05-28 16:04:19.000,346.15,359.15,345.0,355.1,46789253.0,Lockdown has to end: Kiran Mazumdar-Shaw,"The Executive Chairperson of Bengaluru-headquartered biotech major Biocon Ltd said on Thursday their return without controls would cause infections and the states such as Bihar, Uttar Pradesh and Rajasthan should be prepared to meet the possible surge.",neutral,neutral,2.585584284269838,positive,7.5,positive
2020-05-29 01:54:00.000,346.15,359.15,345.0,355.1,46789253.0,"Nifty Pharma index up 2%; Glenmark, Biocon stocks climb","All the components are trading in the positive zone, except Lupin.",positive,neutral,2.585584284269838,positive,7.5,positive
2020-05-29 09:12:00.000,346.15,359.15,345.0,355.1,46789253.0,"Buy Biocon, target price Rs 390: Geojit","According to the brokerage, new product launches and smooth operation amidst US FDA approval for most of the facilities should support longer-term earning growth prospects.",neutral,positive,2.585584284269838,positive,7.5,positive
2020-05-29 12:08:00.000,346.15,359.15,345.0,355.1,46789253.0,Share market update: Pharma shares rise; Biocon gains 3%,The Nifty Pharma index was trading 1.86 per cent up at 9640.55.,positive,positive,2.585584284269838,positive,7.5,positive
2020-05-29 13:44:00.000,346.15,359.15,345.0,355.1,46789253.0,"Pharma shares in focus: Cipla, Aurobindo Pharma hit 52-week high","Dr Reddys, Divis Labs, Biocon, JB Chemicals, Caplin Point Lab, Aarti Drugs, Indoco Remedies, RPG Lifesciences and Glenmark Pharma were up in the range of 3% to 5%.",neutral,positive,2.585584284269838,positive,7.5,positive
2020-05-31 16:27:00.000,360.0,389.9,357.45,387.0,20544591.0,PM Modi to share his vision on ‘Getting Growth Back’ with India Inc on Tuesday,"The day-long virtual event on the theme ‘Getting Growth Back’ will also witness participation from top corporate honchos like Piramal Group Chairman Ajay Piramal, ITC Ltd CMD Sanjiv Puri, Biocon CMD Kiran Mazumdar-Shaw, SBI Chairman Rajnish Kumar, Kotak Mahindra Bank CEO and CII President-Designate …",neutral,positive,7.5,positive,-1.311053984575841,negative
2020-05-31 20:49:39.000,360.0,389.9,357.45,387.0,20544591.0,"Biocon gets DCGI nod for emergency use of CytoSorb to treat critical COVID-19 patients - Health News , Firstpost",Biotechnology major Biocon on Wednesday said its subsidiary has received approval from the Drugs Controller General of India (DCGI) for a medical device to treat critical COVID-19 patients,neutral,positive,7.5,positive,-1.311053984575841,negative
2020-06-01 00:47:25.000,360.0,389.9,357.45,387.0,20544591.0,Biocon arm conducts trial for drug to treat severe covid complications,"Results of the study on the drug, itolizumab, which treats cytokine storms, are expected by mid-July",neutral,neutral,7.5,positive,-1.311053984575841,negative
2020-06-01 09:48:58.000,360.0,389.9,357.45,387.0,20544591.0,Biocon Share Price Up 2% On Favourable Ruling From US PTAB,The PTAB also found Sanofi’s proposed amended claims for the ’486 and ’844 patents unpatentable.,neutral,positive,7.5,positive,-1.311053984575841,negative
2020-06-01 11:32:21.000,360.0,389.9,357.45,387.0,20544591.0,Biocon’s partner Mylan receives favourable ruling for device in U.S.,Clears hurdle for patenting Biocon’s Insulin Glargine.,positive,neutral,7.5,positive,-1.311053984575841,negative
2020-06-01 12:18:17.000,389.0,396.0,381.2,383.9,11910519.0,Biocon partner Mylan gets favourable ruling in insulin device patent row,Sanofi had challenged that Mylan’s device for insulin glargine product Semglee infringed the company’s patents for Lantus SoloSTAR.Sanofi’s Lantus is a long-acting insulin used to treat adults with type 2 diabetes and adults and pediatric patients with type 1 diabetes,positive,negative,-1.311053984575841,negative,-0.7881136950904422,neutral
2020-06-01 12:47:00.000,389.0,396.0,381.2,383.9,11910519.0,Share market update: Pharma shares mixed; Biocon gains 5%,The Nifty Pharma index was trading 0.1 per cent up at 9778.25.,negative,positive,-1.311053984575841,negative,-0.7881136950904422,neutral
2020-06-01 15:01:00.000,389.0,396.0,381.2,383.9,11910519.0,"Biocon rallies 6%, hits record high on favourable ruling from US PTAB",Biocons partner Mylan received a favourable ruling from U.S. Patent and Trademark Appeal Board (PTAB) on Sanofis four device patents for Lantus SoloSTAR.,positive,positive,-1.311053984575841,negative,-0.7881136950904422,neutral
2020-06-01 15:41:00.000,389.0,396.0,381.2,383.9,11910519.0,Biocon’s partner Mylan gets favourable ruling from US patent authority for 4 devices,"We are extremely pleased with the US PTAB’s ruling in favour of our partner Mylan for four device patents of Sanofi’s Lantus SoloSTAR. This strengthens our resolve to provide a high quality affordable Insulin Glargine to diabetic patients in the US and generate savings for their healthcare system, …",positive,positive,-1.311053984575841,negative,-0.7881136950904422,neutral
2020-06-01 20:23:01.000,389.0,396.0,381.2,383.9,11910519.0,"Itolizumab, Biocon’s Drug With Cuban Link, In Hunt For COVID-19 Breakthrough","It has been found that ‘cytoskine storm’ is the leading cause of deaths of COVID-19. Cytokines stimulate immune system to kill virus. But in COVID-19, the virus tricks our body to produce uncontrollable flood of cytokines, which while helping in fighting virus, also worsens a patient’s condition.",neutral,negative,-1.311053984575841,negative,-0.7881136950904422,neutral
2020-06-02 11:25:00.000,389.0,396.0,381.2,383.9,11910519.0,"Nifty Pharma gains 2.5%, crosses 10K mark for the 1st time since Oct 2018","Aurobindo Pharma, Biocon, Cipla, and JB Chemicals & Pharmaceuticals hit their respective 52-week highs on the NSE on Tuesday.",positive,positive,-1.311053984575841,negative,-0.7881136950904422,neutral
2020-06-02 20:17:22.000,387.0,390.0,381.35,383.95,4092880.0,"Biocon arm Syngene develops ELISA test kits, ties up with HiMedia for production",Syngene claims that the testing kit has a capacity to test multiple samples together in a single run and generate results within 3 hours,neutral,neutral,-0.7881136950904422,neutral,2.9673202614379144,positive
2020-06-03 09:36:00.000,387.0,390.0,381.35,383.95,4092880.0,Covid-19: Biocon’s Syngene partners with HiMedia Labs for Elisa test kits,"These test kits, developed indigenously, test the presence of SARS-COV-2 antibodies and confirm if a patient has been exposed to the coronavirus",neutral,neutral,-0.7881136950904422,neutral,2.9673202614379144,positive
2020-06-03 12:51:20.000,382.5,395.75,382.0,393.85,7531600.0,Healthcare can be India’s next IT sector: Kiran Mazumdar-Shaw,"It cannot be business as usual. This is an opportunity to usher in regulatory reforms, says Kiran Mazumdar-Shaw, MD, Biocon",neutral,neutral,2.9673202614379144,positive,-1.5869017632241842,negative
2020-06-04 11:48:12.000,382.5,395.75,382.0,393.85,7531600.0,"D-Street Buzz: Nifty Pharma Gains Led By Biocon; Lupin; Volumes Of Sun Pharma, Aurobindo Pharma Rise","Among the sectors, Nifty Pharma added over a percent led by Sun Pharma, Biocon, Lupin and Torrent Pharma which gained 2 percent each followed by Aurobindo Pharma, Cipla, Divis Labs and Dr Reddy’s Labs among others.",neutral,positive,2.9673202614379144,positive,-1.5869017632241842,negative
2020-06-05 07:39:32.000,397.0,400.5,388.6,390.7,5321004.0,Kiran Mazumdar Shaw Named EY World Entrepreneur Of The Year 2020,"Shaw, 67, founded Bangalore-based Biocon Limited in 1978 with just two employees and currently leads the company that is now worth close to Rs 50,000 crore by market-cap and employs more than 11,000 people.",neutral,neutral,-1.5869017632241842,negative,-3.0152671755725247,negative
2020-06-05 08:21:00.000,397.0,400.5,388.6,390.7,5321004.0,Biocon MD Kiran Mazumdar-Shaw named EY World Entrepreneur Of The Year,The Biocon MD was picked from among 46 nominations from 41 countries,neutral,positive,-1.5869017632241842,negative,-3.0152671755725247,negative
2020-06-05 10:34:00.000,397.0,400.5,388.6,390.7,5321004.0,"Kiran Mazumdar-Shaw named EY World Entrepreneur Of The Year 2020, Biocon boss says she won it for her colleagues",She became the third Indian and second woman to win the Award.,positive,positive,-1.5869017632241842,negative,-3.0152671755725247,negative
2020-06-05 12:01:03.000,397.0,400.5,388.6,390.7,5321004.0,Biocon’s Kiran Mazumdar is EY world entrepreneur of the year 2020,"In the award’s 20-year history, Ms. Mazumdar-Shaw became the third EY ‘World Entrepreneur Of The Year’ awardee from India",neutral,positive,-1.5869017632241842,negative,-3.0152671755725247,negative
2020-06-05 12:21:00.000,397.0,400.5,388.6,390.7,5321004.0,Biocon’s founder Kiran Mazumdar-Shaw named ‘Entrepreneur Of The Year’,"In 2014, Biocon became India’s first biotech company to go public and only the second Indian company to pass the $1 billion mark on its first day of listing. The company’s market capitalisation is currently over $4 billion.",neutral,neutral,-1.5869017632241842,negative,-3.0152671755725247,negative
2020-06-05 14:32:57.000,397.0,400.5,388.6,390.7,5321004.0,Kiran Mazumdar-Shaw becomes first Indian women to win EY World Entrepreneur Of The Year 2020,"Through an award ceremony, EY announced that Kiran Mazumdar-Shaw, Executive Chairperson of India-based Biocon Limited, was named as the EY World Entrepreneur Of The Year 2020. She was picked from among 46 award winners from 41 countries and territories vying for the world title. While she is the …",positive,positive,-1.5869017632241842,negative,-3.0152671755725247,negative
2020-06-05 22:10:00.000,397.0,400.5,388.6,390.7,5321004.0,Biocon’s Kiran Mazumdar-Shaw named EY World Entrepreneur of 2020,Shaw was picked from among 46 award winners from 41 countries and territories vying for the global title,neutral,positive,-1.5869017632241842,negative,-3.0152671755725247,negative
2020-06-10 11:53:00.000,384.0,393.5,382.5,390.9,5865005.0,Share market update: Pharma shares rise; Biocon gains over 2%,The Nifty Pharma index was trading 0.57 per cent up at 10179.75.,positive,positive,1.796874999999994,positive,-0.8975509680728297,neutral
2020-06-12 08:37:00.000,386.0,396.25,381.2,384.6,7256434.0,"Stocks to watch: SBI, SBI Life, M&M, Lakshmi Vilas Bank, Biocon, IHCL",Heres a look at the top stocks that may remain in focus today,neutral,neutral,-0.3626943005181288,neutral,-0.8589743589743648,neutral
2020-06-12 08:46:48.000,386.0,396.25,381.2,384.6,7256434.0,Biocon boss feels WHO shot themselves in the foot,Biocon boss feels WHO shot themselves in the footBiocon’s Kiran Mazumdar-Shaw believes that poor due diligence has damaged the credibility of the WHO.,neutral,negative,-0.3626943005181288,neutral,-0.8589743589743648,neutral
2020-06-12 09:30:00.000,386.0,396.25,381.2,384.6,7256434.0,Biocon gets a shot in the arm with FDA approval for insulin glargine,"The drug will be major contributor in the firms bid to reach $1 billion revenue target by FY22, says biologics CEO Hamacher",neutral,positive,-0.3626943005181288,neutral,-0.8589743589743648,neutral
2020-06-12 09:54:00.000,386.0,396.25,381.2,384.6,7256434.0,Biocon gets US FDA nod to launch insulin glargine,The product branded as Semglee has an identical amino acid sequence to Sanofis Lantus® and is approved for the same indications. This is the third biologics that Biocon will launch in the US. Semglee was approved as a drug product under the 505(b)(2) NDA pathway and is now deemed a biologic under se…,neutral,positive,-0.3626943005181288,neutral,-0.8589743589743648,neutral
2020-06-12 11:04:58.000,386.0,396.25,381.2,384.6,7256434.0,Biocon Shares Gain 2% On USFDA Nod For Insulin Glargine Injection,Biocon and Mylan N.V. announced that the US Food and Drug Administration has approved the New Drug Application for Semglee (insulin glargine injection) in vial and pre-filled pen presentations,neutral,positive,-0.3626943005181288,neutral,-0.8589743589743648,neutral
2020-06-12 12:54:52.000,386.0,396.25,381.2,384.6,7256434.0,US FDA approves Biocon’s insulin glargine injection Semglee,This is the third product of the Biocon subsidiary and Mylan that has been approved by the US FDA.The approval for Semglee follows a favourable ruling from the US Patent and Trademark Appeal Board in favour of Mylan in its dispute with Sanofi over four patents of their insulin injection pen,neutral,positive,-0.3626943005181288,neutral,-0.8589743589743648,neutral
2020-06-12 14:00:06.000,386.0,396.25,381.2,384.6,7256434.0,"Biocon, Mylan get U.S. FDA approval for insulin glargine injection",It will increase access and affordability of insulin for millions of Americans with diabetes.,positive,positive,-0.3626943005181288,neutral,-0.8589743589743648,neutral
2020-06-12 15:04:56.000,386.0,396.25,381.2,384.6,7256434.0,"Biocon, Mylan receive USFDA approval for the launch of their insulin glargine injection",Biocon Ltd and Mylan NV on Friday announced that they have received approval from the United States Food and Drug Administration (FDA) for the launch of its insulin glargine injection Semglee which is,positive,positive,-0.3626943005181288,neutral,-0.8589743589743648,neutral
2020-06-12 15:50:13.000,386.0,396.25,381.2,384.6,7256434.0,"US Approves Biocon-Mylan’s Version Of Insulin Glargine, Companies Working On Interchangeability",Biocon-Mylan’s Semglee is identical to Sanofi’s Lantus and is approved for the same indications.,neutral,positive,-0.3626943005181288,neutral,-0.8589743589743648,neutral
2020-06-12 17:31:00.000,386.0,396.25,381.2,384.6,7256434.0,Biocon and partner Mylan get USFDA approval for Semglee; stock trades in red,Semglee is formed to control high blood sugar in adults with type 2 diabetes and adult and pediatric patients with type 1 diabetes.,neutral,neutral,-0.3626943005181288,neutral,-0.8589743589743648,neutral
2020-06-16 11:03:00.000,389.9,393.0,378.05,386.0,4885894.0,"Biosimilar drugs can help us reach $1 billion target soon: Christiane Hamacher, CEO, Biocon Biologics","It is all about reaching our $1billion revenue target by FY22 and to reach 5 million patients by end of 2022, says Christiane Hamacher.",positive,positive,-1.0002564760194863,negative,2.7539620680696344,positive
2020-06-16 12:07:00.000,384.9,399.8,383.0,395.5,5767362.0,Share market update: Pharma shares advance; Biocon up 1%,The Nifty Pharma index was trading 0.38 per cent up at 10027.1.,positive,positive,2.7539620680696344,positive,-0.694532137896199,neutral
2020-06-18 05:03:00.000,395.95,404.6,391.2,393.2,7875853.0,Two Stock Picks For Thursday’s Session: Buy LIC Housing Finance And Biocon - Investing.com India,Read Two Stock Picks For Thursday’s Session: Buy LIC Housing Finance And Biocon by CapitalVia Global Research on Investing.com India,neutral,neutral,-0.694532137896199,neutral,-2.780246286657368,negative
2020-06-18 18:10:21.000,393.85,397.25,380.1,382.9,6459082.0,Quant Pick - Biocon; ICICI Direct,"According to ICICI Direct, The pharma space has shown significant resilience in the last couple of weeks amid broader market volatility.",neutral,positive,-2.780246286657368,negative,0.4665025268886754,neutral
2020-06-19 18:26:55.000,393.85,397.25,380.1,382.9,6459082.0,Biocon gets DCGI nod for device to treat critical COVID-19 patients,US FDA recently approved CytoSorb for emergency use in COVID-19 patients,neutral,positive,-2.780246286657368,negative,0.4665025268886754,neutral
2020-06-22 05:30:00.000,385.85,391.55,383.0,387.65,3950207.0,"BRIEF-Biocon Says Unit, DKSH Collaborate To Commercialize Seven Generic Formulations In South East Asia - Investing.com India","The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,0.4665025268886754,neutral,1.4322250639386247,positive
2020-06-22 10:55:05.000,385.85,391.55,383.0,387.65,3950207.0,"Biocon Ties Up With DKSH For Distribution Of Seven Products In Singapore, Thailand","Biocon Pharma Ltd, a subsidiary of the bio-tech firm, and DKSH Business Unit Healthcare, have inked an agreement in this regard, Biocon Ltd said in a statement.",neutral,positive,0.4665025268886754,neutral,1.4322250639386247,positive
2020-06-22 11:09:29.000,385.85,391.55,383.0,387.65,3950207.0,"Biocon ties up with DKSH for distribution of seven products in Singapore, Thailand","Bio-technology major Biocon on Monday said it has inked a pact with market expansion services provider DKSH for distribution of seven generic products in Singapore and Thailand. Biocon Pharma Ltd, a s",neutral,positive,0.4665025268886754,neutral,1.4322250639386247,positive
2020-06-22 12:19:00.000,391.0,398.7,388.0,396.6,5772498.0,"Biocon ties up with DKSH to distribute 7 products in Singapore, Thailand","Under the terms of the pact, DKSH will gain an exclusive license to register and commercialise the seven generic formulations from various therapeutic areas",neutral,positive,1.4322250639386247,positive,-1.7293233082706712,negative
2020-06-22 12:27:57.000,391.0,398.7,388.0,396.6,5772498.0,"Biocon, DKSH collaborate to commercialise seven generic formulations in Singapore, Thailand","DKSH will manage marketing and sales as well as logistics for Biocon Pharma, helping drive sales through its capabilities and strengths in the medical and pharmacy channels.",neutral,neutral,1.4322250639386247,positive,-1.7293233082706712,negative
2020-06-22 12:45:31.000,391.0,398.7,388.0,396.6,5772498.0,"D-Street Buzz: Pharma Stocks Rally; Glenmark Zooms 35%, Cipla, Sun Pharma, Biocon Gain","Cipla jumped over 4 percent after the country’s drug regulator on June 20 gave permission to Hetero and Cipla to manufacture and market antiviral drug remdesivir while Lupin, Sun Pharma, Torrent Pharma, Biocon and Divis Labs were the other gainers.",neutral,positive,1.4322250639386247,positive,-1.7293233082706712,negative
2020-06-22 16:24:00.000,391.0,398.7,388.0,396.6,5772498.0,Biocon Pharma and DKSH collaborate to commercialize 7 generic formulations in South East Asia markets,"DKSH will manage marketing and sales as well as logistics for Biocon Pharma, helping drive sales growth through its capabilities and strengths in the medical and pharmacy channels.",positive,positive,1.4322250639386247,positive,-1.7293233082706712,negative
2020-06-22 17:24:00.000,391.0,398.7,388.0,396.6,5772498.0,Biocon to expand generic drugs business with DKSH,"As a part of the pact, DKSH will gain an exclusive license to register and commercialize these seven generic formulations from various therapeutic areas like diabetology, cardiology, oncology and immunology, which will be sold under Biocons brand in these key Asian markets.",positive,positive,1.4322250639386247,positive,-1.7293233082706712,negative
2020-06-26 14:09:00.000,406.0,410.45,399.3,401.5,6821885.0,Is it a crime to do asymptomatic testing? Biocon chief expresses anguish,"The Executive Chairperson of Bengaluru-headquartered biotech major, Biocon Ltd, said given the size of the country, the rising number of cases is expected when the economy is opened up after COVID-19-induced lockdown.",neutral,positive,-1.1083743842364533,negative,-1.0209163346613603,negative
2020-06-26 14:37:30.000,406.0,410.45,399.3,401.5,6821885.0,Is it a crime to do asymptomatic testing? Biocon chief Kiran Mazumdar-Shaw expresses anguish,"Businesses have now opened up their offices and plants and want to make sure that employees returning to their campuses are negative for the novel coronavirus, according to her.",neutral,neutral,-1.1083743842364533,negative,-1.0209163346613603,negative
2020-07-02 12:03:00.000,392.0,397.9,390.3,397.2,3044155.0,Share market update: Pharma shares advance; Biocon rises 1%,The Nifty Pharma index was trading 0.25 per cent up at 9907.7.,positive,positive,1.3265306122448952,positive,0.6390176669590305,neutral
2020-07-02 18:25:37.000,392.0,397.9,390.3,397.2,3044155.0,"Biocon Lines Up Rs 1,500 Crore Capex For The Current Fiscal","We expect capex (capital expenditure) spends to be $200 million in 2020-21, split equally between small molecules and the biosimilars businesses, Mittal said..",neutral,neutral,1.3265306122448952,positive,0.6390176669590305,neutral
2020-07-02 18:38:00.000,392.0,397.9,390.3,397.2,3044155.0,Biocon lines up $200 million capex for current fiscal,"The company’s capital expenditure during 2019-20 stood at Rs 974.2 crore, Mittal said.",neutral,neutral,1.3265306122448952,positive,0.6390176669590305,neutral
2020-07-02 18:59:28.000,392.0,397.9,390.3,397.2,3044155.0,Biocon lines up $200 million capex for the current fiscal,"The recent launch of Trastuzumab in the US, the upcoming launch of Insulin Glargine in the US and Pegfilgrastim in the EU coupled with the launch of Insulin Aspart and Bevacizumab in the EU and the US markets through Mylan in the next calendar year will be drivers of this growth",neutral,positive,1.3265306122448952,positive,0.6390176669590305,neutral
2020-07-02 19:05:28.000,392.0,397.9,390.3,397.2,3044155.0,Biocon lines up $200 mn capex for FY’20,"Biotechnology major Biocon expects to invest $200 million (around ₹1,500 crore) this fiscal on capital expenditure, according to the company’s Annual Report for 2019-20.Sharing information with the co",neutral,neutral,1.3265306122448952,positive,0.6390176669590305,neutral
2020-07-02 19:17:00.000,392.0,397.9,390.3,397.2,3044155.0,Biocon to invest $200 million on capital expenditure in current fiscal,Biocon CEO and Managing Director Siddharth Mittal said the investment would be split across small molecules and biosimilar verticals,neutral,neutral,1.3265306122448952,positive,0.6390176669590305,neutral
2020-07-03 11:01:00.000,392.0,397.9,390.3,397.2,3044155.0,Trending stocks: Biocon shares rise nearly 1%,"A total of 29,814 shares changed hands on the counter till 10:56AM (IST).",positive,neutral,1.3265306122448952,positive,0.6390176669590305,neutral
2020-07-05 14:45:18.000,399.05,406.35,392.65,401.6,4989025.0,Biocon Aims To List Biocon Biologics In India In Next 2-3 Years: Annual Report,"It is important for Biocon to unlock value of its biosimilars business, CEO Siddharth Mittal says in the annual report for FY20.",neutral,positive,0.6390176669590305,neutral,-0.6934125804853917,neutral
2020-07-05 18:05:00.000,399.05,406.35,392.65,401.6,4989025.0,Biocon aims to list biosimilar arm over the next 2-3 years,"Sharing information with the firm’s shareholders, Biocon CEO and Managing Director Siddharth Mittal said it is important for the company to unlock value of the biosimilars business",neutral,neutral,0.6390176669590305,neutral,-0.6934125804853917,neutral
2020-07-06 07:41:00.000,399.05,406.35,392.65,401.6,4989025.0,"Stocks in the news: Reliance Ind, ICICI Bank, Future Retail, Indiabulls Housing, YES Bank, Biocon and NBCC","Lupin, Marksans Pharma, Aurobindo Pharma and Alembic Pharmaceuticals are recalling products in the US market.",neutral,negative,0.6390176669590305,neutral,-0.6934125804853917,neutral
2020-07-06 11:02:00.000,399.05,406.35,392.65,401.6,4989025.0,Trending stocks: Biocon shares trade flat in early session,"A total of 33,881 shares changed hands on the counter till 11:01AM (IST).",negative,neutral,0.6390176669590305,neutral,-0.6934125804853917,neutral
2020-07-09 13:29:00.000,400.5,420.5,400.5,414.25,9981050.0,"Top stocks to bet on: ICICI Bank, Biocon, Rallis India can return 15-20% in near term","On the upside, the Nifty needs to sustain 10,800 for the uptrend to continue towards 11,100 and then possibly 11,350.",positive,positive,3.4332084893882646,positive,-7.193198344333814,negative
2020-07-10 10:34:00.000,400.5,420.5,400.5,414.25,9981050.0,"Pharma stocks gain led by Sun Pharma, Biocon; Aurobindo Pharma hits new 52-week high","Cipla, Dr Reddy’s Labs, Divis Labs and Torrent Pharma added 1-2 percent each.",positive,neutral,3.4332084893882646,positive,-7.193198344333814,negative
2020-07-10 10:42:00.000,400.5,420.5,400.5,414.25,9981050.0,"Pharma shares gain; Biocon, Granules hit record highs, Sun Pharma up 3%","At 10:27 am, Nifty Pharma index was up 1.5 per cent, as compared to 0.22 per cent decline in the benchmark Nifty50 index",positive,positive,3.4332084893882646,positive,-7.193198344333814,negative
2020-07-10 13:16:17.000,400.5,420.5,400.5,414.25,9981050.0,Biocon Ltd rises for third straight session,"Biocon Ltd is quoting at Rs 411.65, up 1.4% on the day as on 12:54 IST on the NSE. The stock is up 62.93% in last one year as compared to a 7.17% slide in NIFTY and a 24.41% slide in the Nifty Pharma index.",positive,positive,3.4332084893882646,positive,-7.193198344333814,negative
2020-07-12 14:55:00.000,446.95,446.95,412.75,414.8,20172995.0,"Biocon’s biosimilar for treating Covid-19: Patients responded positively, says Kiran Mazumdar-Shaw - The Economic Times",The Drug Controller General of India (DGCI) has permitted the Bengaluru-headquartered drug maker to market Itolizumab (ALZUMab) injection 25 mg/5 mL solution for emergency use in India for treating cytokine release syndrome (CRS) in moderate to severe ARDS (acute respiratory distress syndrome) Covid…,positive,neutral,-7.193198344333814,negative,4.061457837065271,positive
2020-07-12 16:33:05.000,446.95,446.95,412.75,414.8,20172995.0,"Coronavirus: Biocon Itolizumab to save many critically ill patients, says Kiran Mazumdar Shaw","Coronavirus Lockdown, COVID-19 cases State Wise Latest Updates: As many as 28,637 new COVID-19 cases and 551 deaths have been reported in India in the last 24 hours.",positive,negative,-7.193198344333814,negative,4.061457837065271,positive
2020-07-12 22:32:15.000,446.95,446.95,412.75,414.8,20172995.0,"Biocon’s COVID-19 drug: Tested on too few patients to reliably conclude on benefits, say experts","It’s safety is not in doubt. Other criteria also convinced several doctors to use it on patients, says company",neutral,positive,-7.193198344333814,negative,4.061457837065271,positive
2020-07-13 06:20:05.000,446.95,446.95,412.75,414.8,20172995.0,"Stocks To Watch: RIL, Avenue Supermarts, IRCTC, SAIL, Biocon, Vodafone Idea",Here are the stocks to watch out for in today’s session.,neutral,neutral,-7.193198344333814,negative,4.061457837065271,positive
2020-07-13 06:59:00.000,446.95,446.95,412.75,414.8,20172995.0,"In pics | Stocks in the news: Reliance Industries, Infosys, ITC, IRCTC, Indostar Capital Finance, Yes Bank, Future Consumer",Ashapura Minechem | SAIL | Amtek Auto | Gujarat Narmada Valley Fertilizers &amp; Chemicals | Dish TV | IRCON International | Newgen Software Technologies | BASF India | Indo Us Bio-Tech | Havells India | Lakshmi Vilas Bank | Dilip Buildcon | Shalby | Biocon | Shriram EPC | Avenue Supermarts | Galaxy…,neutral,neutral,-7.193198344333814,negative,4.061457837065271,positive
2020-07-13 07:44:00.000,446.95,446.95,412.75,414.8,20172995.0,"Top stocks in focus: RIL, Biocon, Avenue Supermarts, IRCTC, SAIL",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-7.193198344333814,negative,4.061457837065271,positive
2020-07-13 07:58:00.000,446.95,446.95,412.75,414.8,20172995.0,"Stocks in the news: DMart, Vodafone Idea, RIL, Biocon and JSW Steel - The Economic Times",RIL has secured Rs 730 crore from wireless technology leader Qualcomm by selling a small stake in Jio Platforms.,neutral,positive,-7.193198344333814,negative,4.061457837065271,positive
2020-07-13 08:09:00.000,446.95,446.95,412.75,414.8,20172995.0,"RIL, Infosys, Biocon in action","Reliance Industries (RIL) and Jio Platforms announced that Qualcomm Ventures, the investment arm of Qualcomm Incorporated, an industry leader in wireless technologies, has committed to invest upto Rs 730 crore in Jio Platforms at an equity value of",neutral,positive,-7.193198344333814,negative,4.061457837065271,positive
2020-07-13 08:13:46.000,446.95,446.95,412.75,414.8,20172995.0,"Stocks to Watch: RIL, Bharti Airtel, Vodafone Idea, Biocon, HDFC Bank, PVR","Qualcomm Ventures, the investment arm of Qualcomm Inc., will invest ₹730 crore for a 0.15% stake in Jio Platforms Ltd.HDFC Bank has conducted a probe into allegations of improper lending practices and conflicts of interests in its vehicle-financing operation",neutral,neutral,-7.193198344333814,negative,4.061457837065271,positive
2020-07-13 08:23:00.000,446.95,446.95,412.75,414.8,20172995.0,Biocon drug Itolizumab gets DCGI approval,The drug maker announced that it has received the Drugs Controller General of India (DCGI)s approval to market Itolizumab to treat moderate to severe covid-19 patients in India.,positive,positive,-7.193198344333814,negative,4.061457837065271,positive
2020-07-13 08:23:00.000,446.95,446.95,412.75,414.8,20172995.0,Biocon drug receives DCGI nod,Biocon announced that it has received the DCGI approval to market Itolizumab to treat moderate to severe covid-19 patients in India.,neutral,positive,-7.193198344333814,negative,4.061457837065271,positive
2020-07-13 08:42:00.000,446.95,446.95,412.75,414.8,20172995.0,"Stocks to watch: RIL, Avenue Supermarts, Biocon, SAIL, IRCTC, IRCON, Infy",Heres a list of stocks that may remain in focus today,neutral,neutral,-7.193198344333814,negative,4.061457837065271,positive
2020-07-13 08:50:18.000,446.95,446.95,412.75,414.8,20172995.0,"Stocks in focus: RIL, Bharti Airtel, Vodafone Idea, DMart, Biocon, Punjab & Sind Bank",The June quarter earnings season started with TCS reporting numbers below estimates. This earnings season would be of key significance as it faced the maximum brunt of lockdown,neutral,negative,-7.193198344333814,negative,4.061457837065271,positive
2020-07-13 09:02:00.000,446.95,446.95,412.75,414.8,20172995.0,Biocon receives DCGI approval to market Itolizumab for treatment of COVID-19 patients,"Itolizumab is the first novel biologic therapy to be approved anywhere in the world for treating patients with moderate to severe COVID-19 complications. Biocon has repurposed Itolizumab, an anti-CD6 IgG1 monoclonal antibody launched in India in",positive,positive,-7.193198344333814,negative,4.061457837065271,positive
2020-07-13 09:06:00.000,446.95,446.95,412.75,414.8,20172995.0,"Stocks in news: RIL, Yes Bank, Avenue Supermarts, IRCTC, SAIL, Biocon","Stocks to watch today on July 13: RIL, Yes Bank, Avenue Supermarts, IRCTC, SAIL, Biocon among others are the top stocks to watch out for in Monday’s trading session.",neutral,neutral,-7.193198344333814,negative,4.061457837065271,positive
2020-07-13 09:28:00.000,446.95,446.95,412.75,414.8,20172995.0,Biocon hits new high on DGCI nod to market Itolizumab for Covid treatment,"Itolizumab will be manufactured and formulated as an intravenous injection at Biocons bio-manufacturing facility at Biocon Park, Bengaluru",neutral,neutral,-7.193198344333814,negative,4.061457837065271,positive
2020-07-13 11:24:55.000,446.95,446.95,412.75,414.8,20172995.0,Biocon share price hits fresh record high as Itolizumab drug gets DCGI nod for COVID-19 treatment,"Biocon share price touched a 52-week low of Rs 211.30 apiece in August 2019, since then the stock price has zoomed 115.33 per cent, doubling the investors’ wealth in less than a year",positive,negative,-7.193198344333814,negative,4.061457837065271,positive
2020-07-13 11:31:13.000,446.95,446.95,412.75,414.8,20172995.0,Biocon jumps 10% after drug Itolizumab gets DCGI approval for covid treatment,"Itolizumab will be manufactured and formulated as an intravenous injection at the company’s bio-manufacturing facility at Biocon Park, Bengaluru",positive,neutral,-7.193198344333814,negative,4.061457837065271,positive
2020-07-13 11:32:00.000,446.95,446.95,412.75,414.8,20172995.0,"Biocon jumps 10%, hits 52-week high as DCGI approves use of Itolizumab on Covid-19 patients - The Economic Times","The drug, which is also used to cure the skin disease psoriasis, was cleared by the Drug Controller General of India (DCGI) for usage in India.",positive,neutral,-7.193198344333814,negative,4.061457837065271,positive
2020-07-13 12:45:00.000,419.8,441.25,417.0,436.85,26080016.0,Biocon gets DCGI nod to market Itolizumab for treatment of Covid-19 patients,"Itolizumab will be manufactured and formulated as an intravenous injection at Biocon’s bio-manufacturing facility at Biocon Park, Bengaluru, the company said.",neutral,neutral,4.061457837065271,positive,-3.1746031746031744,negative
2020-07-13 13:35:11.000,419.8,441.25,417.0,436.85,26080016.0,Biocon’s COVID drug Itolizumab: 6 things to know about Alzumab,Coronavirus treatment: Kiran Mazumdar-Shaw-led Biocon has received approval from the Drugs Controller General of India for its drug Itolizumab for its use in moderate to severe COVID-19 patients.,neutral,positive,4.061457837065271,positive,-3.1746031746031744,negative
2020-07-13 16:49:00.000,419.8,441.25,417.0,436.85,26080016.0,Biocon eyes international markets to supply Itolizumab for Covid-19 therapy,"Its partner Equillium is planning to carry out a clinical trial in the US, which could lead to huge spike in demand for the product",positive,negative,4.061457837065271,positive,-3.1746031746031744,negative
2020-07-13 17:05:40.000,419.8,441.25,417.0,436.85,26080016.0,"Biocon to Launch Drug For Covid-19 Patients; Priced at Rs 8,000 Per Vial",Biocon had earlier said that Itolizumab is the first novel biologic therapy to be approved anywhere in the world for treating patients with moderate to severe COVID-19 complications.,neutral,positive,4.061457837065271,positive,-3.1746031746031744,negative
2020-07-13 17:17:00.000,419.8,441.25,417.0,436.85,26080016.0,"Biocon to launch drug for COVID-19 patients; priced at Rs 8,000 per vial","Itolizumab is the first novel biologic therapy to be approved anywhere in the world for treating patients with moderate to severe COVID-19 complications, Biocon had earlier said in a regulatory filing.",neutral,positive,4.061457837065271,positive,-3.1746031746031744,negative
2020-07-13 17:42:23.000,419.8,441.25,417.0,436.85,26080016.0,"Biocon to launch drug for COVID-19 patients; priced at Rs 8,000 per vial","Itolizumab is the first novel biologic therapy to be approved anywhere in the world for treating patients with moderate to severe COVID-19 complications, Biocon had earlier said in a regulatory filing.",neutral,positive,4.061457837065271,positive,-3.1746031746031744,negative
2020-07-13 18:16:58.000,419.8,441.25,417.0,436.85,26080016.0,"Itolizumab: New anti-coronavirus drug priced at ₹8,000 per vial","‘Until the vaccine comes, we certainly need life-saving drugs. I think what we are doing across the world is to see how we can either repurpose drugs or develop new drugs to treat this pandemic,’ says Biocon Executive Chairperson Kiran Mazumdar-Shaw",neutral,neutral,4.061457837065271,positive,-3.1746031746031744,negative
2020-07-13 18:41:37.000,419.8,441.25,417.0,436.85,26080016.0,"Biocon To Launch Covid Medicine Itolizumab At Rs 8,000 Per Vial","As most Covid-19 patients need four vials, the cost of the therapy is around Rs 32,000, Biocon’s Kiran Mazumdar-Shaw says.",neutral,neutral,4.061457837065271,positive,-3.1746031746031744,negative
2020-07-13 19:01:45.000,419.8,441.25,417.0,436.85,26080016.0,Biocon arm to ramp-up Itolizumab production after DCGI nod for covid treatment,"‘We do have capacity right now to address the present size of serious patients but we do realise that this is a much bigger challenge, not just in India but for the world. We are going to ramp up capacity as much as possible and as fast as possible,’ Kiran Mazumdar-Shaw said",positive,positive,4.061457837065271,positive,-3.1746031746031744,negative
2020-07-13 19:03:00.000,419.8,441.25,417.0,436.85,26080016.0,Biocon share hits all-time high after drug Itolizumab gets DCGI nod for Covid treatment,Share price of Biocon rose 9.90% to Rs 455 against previous close of Rs 414.30 on BSE,positive,positive,4.061457837065271,positive,-3.1746031746031744,negative
2020-07-13 19:19:00.000,419.8,441.25,417.0,436.85,26080016.0,"Plenty of catalysts for Biocon over the next few months, say analysts","Progress in biologics, including planned launches and pending approvals, are driving prospects",neutral,positive,4.061457837065271,positive,-3.1746031746031744,negative
2020-07-13 20:14:00.000,419.8,441.25,417.0,436.85,26080016.0,"Biocon to launch drug for COVID-19 patients; priced at Rs 8,000 per vial - The Economic Times","New Delhi, Jul 13 () Biotechnology major Biocon on Monday said it will launch biologic drug Itolizumab for the treatment of moderate to severe COVID-19 patients at a price of around 8,000 per vial.",neutral,positive,4.061457837065271,positive,-3.1746031746031744,negative
2020-07-13 20:52:02.000,419.8,441.25,417.0,436.85,26080016.0,"With Itolizumab life-saving drug, Biocon in an Atma Nirbhar Bharath moment","Biocon, which is under criticism from several quarters for fast-tracking its Itolizumab drug to treat coronavirus patients, said that such a step was necessary as the initial response to the drug was",neutral,negative,4.061457837065271,positive,-3.1746031746031744,negative
2020-07-13 21:45:00.000,419.8,441.25,417.0,436.85,26080016.0,Biocon’s partner Equillium plans Itolizumab’s global clinical trial for COVID-19,Biocon has out-licensed Itolizumab to US-based biotech firm Equillium in 2017 for development in the US and Canada. Equillium has been awarded ‘fast track’ and ‘orphan drug’ designations for the molecule in both prevention and treatment of graft-versus-host disease by the USFDA.,neutral,positive,4.061457837065271,positive,-3.1746031746031744,negative
2020-07-13 22:45:53.000,419.8,441.25,417.0,436.85,26080016.0,The new drug approval will not add much to Biocon’s fortunes,"Analysts point out the drug may be used only by a limited number of patients, and this restricts its revenue potential",negative,neutral,4.061457837065271,positive,-3.1746031746031744,negative
2020-07-13 23:46:25.000,419.8,441.25,417.0,436.85,26080016.0,Biocon’s Itolizumab Reducing Covid-19 Mortality in Cuba Gets Approval in India: Kiran Mazumdar Shaw,"The medicine has been in the news for reducing the mortality rate in Cuba. The full course will cost Rs 35,000. It is a drug that is used in India for treating psoriasis and has been repurposed for Covid-19.",neutral,neutral,4.061457837065271,positive,-3.1746031746031744,negative
2020-07-14 07:55:26.000,419.8,441.25,417.0,436.85,26080016.0,Biocon’s Covid-19 Drug Itolizumab Approved for Emergency Use after Trial on Only 30 Patients,Itolizumab is an existing drug used to treat skin ailment Psoriasis. The Drug Controller General of India (DCGI) approved its restricted emergency use on Saturday.,neutral,neutral,4.061457837065271,positive,-3.1746031746031744,negative
2020-07-14 07:59:00.000,419.8,441.25,417.0,436.85,26080016.0,"​Stocks in the news: Wipro, RIL, YES Bank , Vodafone Idea, Biocon, Mindtree and Motherson Sumi - The Economic Times","Vodafone Idea has moved the telecom tribunal Monday, challenging the sector regulators July 11 order blocking its RedX premium tariff plan.",neutral,negative,4.061457837065271,positive,-3.1746031746031744,negative
2020-07-14 08:16:59.000,419.8,441.25,417.0,436.85,26080016.0,"Stocks to Watch: RIL, Bharti Airtel, Biocon, Godrej Industries, Cipla","Biocon will launch biologic drug Itolizumab for the treatment of moderate to severe covid-19 patients at a price of around ₹8,000 per vial.Jio Platforms, a wholly owned subsidiary of Reliance Industries Ltd, has received subscription amount of ₹420.5 billion from five investors",neutral,neutral,4.061457837065271,positive,-3.1746031746031744,negative
2020-07-14 09:22:00.000,419.8,441.25,417.0,436.85,26080016.0,"Stocks in news: Biocon, Wipro, Mindtree, Motherson Sumi, ITC","Stocks to watch today on July 14: Biocon, Wipro, Mindtree, Motherson Sumi, ITC among others are the top stocks to watch out for in Tuesday’s trading session.",neutral,neutral,4.061457837065271,positive,-3.1746031746031744,negative
2020-07-14 11:27:00.000,419.8,441.25,417.0,436.85,26080016.0,Biocon to launch COVID-19 drug; stock jumps 5%,"Biocon said the approval of Itolizumab, from the DCGI, is based on the results from the successful conclusion of a randomized, controlled clinical trial at multiple hospitals in Mumbai and New Delhi.",positive,neutral,4.061457837065271,positive,-3.1746031746031744,negative
2020-07-14 12:03:00.000,441.0,441.0,422.45,427.0,6556780.0,Biocon to take on Roche Pharma with its psoriasis drug to treat moderate to severe Covid patients - The Economic Times,​​The company is marketing the drug as a replacement to Roches tocilizumab (originally approved for rheumatoid arthritis) that is currently in off-label use among Covid-19 patients who suffer from cytokine release syndrome (CRS).,neutral,neutral,-3.1746031746031744,negative,0.3529411764705882,neutral
2020-07-14 12:05:00.000,441.0,441.0,422.45,427.0,6556780.0,"Biocon defends limited trial patients for Itolizumab nod, says followed science of “highest order” - The Economic Times",The company is marketing the drug as a replacement to Roche Pharmas Tocilizumab (originally approved for rheumatoid arthritis) that is currently in off label use (it means use of a drug for an unapproved indication) among Covid-19 patients who suffer from cytokine release syndrome (CRS) or “cytokine…,neutral,neutral,-3.1746031746031744,negative,0.3529411764705882,neutral
2020-07-14 13:16:15.000,441.0,441.0,422.45,427.0,6556780.0,"Biocon Ltd spurts 3.83%, gains for five straight sessions","Biocon Ltd is quoting at Rs 430.75, up 3.83% on the day as on 12:49 IST on the NSE. The stock is up 70.46% in last one year as compared to a 8.44% fall in NIFTY and a 22.9% fall in the Nifty Pharma.",positive,positive,-3.1746031746031744,negative,0.3529411764705882,neutral
2020-07-14 14:24:00.000,441.0,441.0,422.45,427.0,6556780.0,Biocon share climbs 5% as firm to launch COVID-19 drug Itolizumab,"Biocon share has risen 7.78% in the last 5 days of gains. The stock opened with a gain of 2.03% and later touched an intraday high of Rs 435.25, rising 4.98% against yesterday’s close of Rs 414.60 on BSE",positive,positive,-3.1746031746031744,negative,0.3529411764705882,neutral
2020-07-14 23:23:19.000,441.0,441.0,422.45,427.0,6556780.0,ICMR Says More Trials Needed to Demonstrate Mortality Reduction Due to Itolizumab & Tocilizumab,ICMR Director General Dr Balram Bhargava’s statement came just a day after Biocon Ltd touted its Psoriasis drug Itolizumab as a potentially life-saving drug.,neutral,neutral,-3.1746031746031744,negative,0.3529411764705882,neutral
2020-07-17 15:57:00.000,427.2,433.3,423.0,430.65,3693000.0,We are going to do phase-4 trial of psoriasis drug on Covid patients: Kiran Mazumdar Shaw,The Drug Controller gave Biocon an restricted emergency use authorisation to try out and continue to treat Covid-19 patients and then do a phase IV trial to corroborate the findings.,neutral,neutral,0.8075842696629186,neutral,-0.9237875288683602,negative
2020-07-20 11:52:00.000,433.0,434.9,424.35,429.0,3442053.0,"D-Street Buzz: Pharma stocks trade mixed; Glenmark, Sun Pharma slip, Granules India edges higher","Glenmark Pharma was down over 3 percent followed by Sun Pharma, Lupin, Aurobindo Pharma, Cipla and Biocon.",positive,negative,-0.9237875288683602,negative,-0.9160482374768064,negative
2020-07-21 05:30:00.000,431.2,433.5,424.55,427.25,2772348.0,BRIEF-Biocon Biologics Announces Global Collaboration Agreement Between Unit & Voluntis - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.9160482374768064,negative,1.0046728971962644,positive
2020-07-21 10:21:00.000,431.2,433.5,424.55,427.25,2772348.0,Biocon partners with Voluntis to develop digital therapeutics for diabetes patients,"The licensing agreement, signed between Biocon Biologics subsidiary Biocon Sdn. Bhd., Malaysia and Voluntis, would make Biocon Biologics one of the first insulin companies to offer a US Food and Drug Administration-cleared and CE-marked, digital therapeutic product - Insulia - to Type 2 diabetes pat…",positive,positive,-0.9160482374768064,negative,1.0046728971962644,positive
2020-07-21 11:00:00.000,431.2,433.5,424.55,427.25,2772348.0,Biocon Biologics partners with Voluntis on digital therapeutics for Insulins,"The partnership will enable access to Insulia, an USFDA-cleared and CE marked, digital therapeutic, for Insulin-dependent Type 2 diabetes patients.",neutral,positive,-0.9160482374768064,negative,1.0046728971962644,positive
2020-07-21 11:15:14.000,431.2,433.5,424.55,427.25,2772348.0,Biocon Biologics partners with Voluntis for digital therapeutics for diabetics patients,"The licensing agreement between Malaysian subsidiary Biocon Sdn. Bhd. and Voluntis will allow Biocon Biologics to offer therapeutic product ‘Insulia’ to type 2 diabetes patients across several markets in the world, Biocon Biologics said in a statement.",neutral,positive,-0.9160482374768064,negative,1.0046728971962644,positive
2020-07-21 11:24:19.000,431.2,433.5,424.55,427.25,2772348.0,Biocon ties up with Voluntis for digital therapeutics for diabetes patients,The licensing agreement with Voluntis will allow Biocon Biologics to offer therapeutic product ‘Insulia’ to type 2 diabetes patients,neutral,positive,-0.9160482374768064,negative,1.0046728971962644,positive
2020-07-21 12:40:22.000,428.0,441.0,425.7,432.3,9092107.0,"Biocon, Voluntis in tie-up for digital therapeutics to manage diabetes",‘Insulia’ helps people with Type 2 diabetes to self-manage their condition,neutral,neutral,1.0046728971962644,positive,-0.2192729371032864,neutral
2020-07-21 16:15:05.000,428.0,441.0,425.7,432.3,9092107.0,"Biocon Biologics, Voluntis in pact for digital therapeutics for insulins","Once developed, the company said the Insulia digital companion would be offered to people with Type 2 diabetes using Biocon Biologics’ insulins, in key global markets",neutral,positive,1.0046728971962644,positive,-0.2192729371032864,neutral
2020-07-21 17:39:00.000,428.0,441.0,425.7,432.3,9092107.0,Natural Biocon (India) reports standalone nil net profit/loss in the March 2020 quarter,Reported sales nil,negative,neutral,1.0046728971962644,positive,-0.2192729371032864,neutral
2020-07-21 19:12:00.000,428.0,441.0,425.7,432.3,9092107.0,"Biocon diversifies business model, enters digital therapeutic segment",To launch Insulia for at-home management of diabetes in collaboration with Voluntis,neutral,positive,1.0046728971962644,positive,-0.2192729371032864,neutral
2020-07-22 00:09:00.000,428.0,441.0,425.7,432.3,9092107.0,"Biocon Biologics, Voluntis tie up on digital therapeutics for people with diabetes","Insulia provides automated insulin dose recommendations and coaching messages for people with diabetes, while enabling the healthcare team to remotely monitor their progress.",neutral,neutral,1.0046728971962644,positive,-0.2192729371032864,neutral
2020-07-22 10:30:47.000,428.0,441.0,425.7,432.3,9092107.0,"Biocon Biologics, Voluntis in pact for digital therapeutics for diabetics",Insulia provides automated insulin dose recommendations enabling people with diabetes to self-manage their condition and healthcare teams to remotely monitor progress.,neutral,neutral,1.0046728971962644,positive,-0.2192729371032864,neutral
2020-07-23 07:35:00.000,433.25,438.5,423.05,432.3,7093598.0,"Stocks in the news: Rossari Biotech, L&T, Glenmark, Biocon, LIC Housing and HDFC AMC","The specialty chemicals maker will debut on the bourses on Thursday, the first after the SBI Card around four months ago.",neutral,neutral,-0.2192729371032864,neutral,-3.2359813084112203,negative
2020-07-23 07:38:00.000,433.25,438.5,423.05,432.3,7093598.0,"Top stocks in focus: Glenmark Pharma, Biocon, L&T, Vodafone Idea, Rossari Biotech",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-0.2192729371032864,neutral,-3.2359813084112203,negative
2020-07-23 08:02:00.000,433.25,438.5,423.05,432.3,7093598.0,"Board Meetings Today: HDFC AMC, Biocon, AU Small Finance Bank, MphasiS and PNB Housing",It makes sense to have a look at the corporate agendas for the days as announced to the stock exchanges.,neutral,neutral,-0.2192729371032864,neutral,-3.2359813084112203,negative
2020-07-23 08:44:49.000,433.25,438.5,423.05,432.3,7093598.0,"Indian stock markets seen rangebound Thursday ; Glenmark, L&T shares in focus","Biocon, HDFC AMC, Dish TV, AU Small Finance Bank,PNB Housing Finance and Bank of Maharashtra, among others, will announce their earnings today",neutral,neutral,-0.2192729371032864,neutral,-3.2359813084112203,negative
2020-07-23 08:49:00.000,433.25,438.5,423.05,432.3,7093598.0,"Stocks to watch: L&T, Rossari Biotech, Biocon, Voda Idea, Future Retail",Heres a list of stocks that may remain in focus today,neutral,neutral,-0.2192729371032864,neutral,-3.2359813084112203,negative
2020-07-23 08:57:05.000,433.25,438.5,423.05,432.3,7093598.0,"Stocks in focus: Rossari Biotech, Glenmark Pharma, L&T, HDFC AMC, Vodafone Idea, Axis Bank","ABB India, Biocon, HDFC Asset Management Company, AU Small Finance Bank, Dish TV, Mphasis, PNB Housing Finance, Radico Khaitan, Sterlite Technologies and Zensar Technologies, are among 49 companies that are scheduled to announce their quarterly earnings today",neutral,neutral,-0.2192729371032864,neutral,-3.2359813084112203,negative
2020-07-23 09:04:00.000,433.25,438.5,423.05,432.3,7093598.0,"Stocks in news: Vodafone Idea, Larsen & Turbo, Rallis India, ICICI Securities","Stocks to watch today on July 23: AU Small Finance Bank, Biocon, Dish TV, HDFC Asset Management Company, PNB Housing Finance, Radico Khaitanamong others are the top stocks to watch out for in Thursday’s trading session.",neutral,neutral,-0.2192729371032864,neutral,-3.2359813084112203,negative
2020-07-23 09:49:00.000,433.25,438.5,423.05,432.3,7093598.0,"Share Market LIVE: Sensex drops 50 points, Nifty at 11,135; Biocon, PNB Housing, Biocon Q1 results today","Stock Market LIVE Updates on July 23: AU Small Finance Bank, Biocon, Dish TV, HDFC Asset Management Company, PNB Housing Finance, Radico Khaitan are among the top companies that will be reporting their April-June quarterly earnings",neutral,neutral,-0.2192729371032864,neutral,-3.2359813084112203,negative
2020-07-24 02:33:00.000,428.0,435.6,413.55,414.15,10173638.0,"Biocon Q1 pre-tax profit declines 21% to Rs 252.30 crore, revenue up 14%","High R&D spend, low profitability in research services due to Covid-19 pull down net profit",negative,negative,-3.2359813084112203,negative,-3.264812575574365,negative
2020-07-24 04:01:00.000,428.0,435.6,413.55,414.15,10173638.0,Biocon stock ends lower after Q1 results,"The sales of the company rose 14.56% to Rs1,671.30cr in the quarter ended June 2020 as against Rs1,458.90cr during the previous quarter ended June 2019.",negative,positive,-3.2359813084112203,negative,-3.264812575574365,negative
2020-07-24 07:33:00.000,428.0,435.6,413.55,414.15,10173638.0,"Top stocks in focus: ITC, Adani Transmission, Biocon, HPCL, ABB, Future Consumer",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-3.2359813084112203,negative,-3.264812575574365,negative
2020-07-24 08:02:52.000,428.0,435.6,413.55,414.15,10173638.0,"Stocks to Watch: Axis Bank, AU Small Finance, Lupin, Biocon, Sun Pharma","AU Small Finance Bank reported a 6% rise in its net profit at ₹201 crore in the April-June quarter of the current fiscal year.Biocon’s Q1FY21 consolidated revenue grew 14% to ₹1,690 crore from ₹1,483 crore in Q1FY20",neutral,positive,-3.2359813084112203,negative,-3.264812575574365,negative
2020-07-24 08:03:00.000,428.0,435.6,413.55,414.15,10173638.0,Biocon consolidated net profit declines 27.58% in the June 2020 quarter,Sales rise 14.56% to Rs 1671.30 crore,negative,positive,-3.2359813084112203,negative,-3.264812575574365,negative
2020-07-24 08:13:00.000,428.0,435.6,413.55,414.15,10173638.0,Biocon Q1 profit falls 28% to Rs 149 crore on higher R&D spend,"Revenue from operations rose 15 percent to Rs 1,671 crore versus Rs 1,459 crore in year ago period",negative,positive,-3.2359813084112203,negative,-3.264812575574365,negative
2020-07-24 08:41:00.000,428.0,435.6,413.55,414.15,10173638.0,Biocon records a consolidated profit of ~Rs171cr in Q1FY21,The consolidated net profit declined by 27.25% yoy in the June quarter of FY21.,neutral,negative,-3.2359813084112203,negative,-3.264812575574365,negative
2020-07-24 08:50:00.000,428.0,435.6,413.55,414.15,10173638.0,"Stocks to watch: RIL, Asian Paints, ITC, Biocon, Wipro, Mphasis, Lupin",Heres a list of stocks that may trade actively in todays trading session.,neutral,neutral,-3.2359813084112203,negative,-3.264812575574365,negative
2020-07-24 08:57:19.000,428.0,435.6,413.55,414.15,10173638.0,Biocon’s Q1 generics business revenue up 16% to ₹599 crore,Intensified focus on generics business pays off for biopharmaceutical player Biocon,positive,neutral,-3.2359813084112203,negative,-3.264812575574365,negative
2020-07-24 09:03:04.000,428.0,435.6,413.55,414.15,10173638.0,"Market LIVE: Sensex, Nifty largely flat at pre-open","In today’s trade, shares of Axis Bank, AU Small Finance, Lupin, Biocon, Sun Pharma will be in focus.A total of 71 companies including ITC, Asian Paints, and Ambuja Cements will announce their June quarter earnings",neutral,neutral,-3.2359813084112203,negative,-3.264812575574365,negative
2020-07-24 09:27:00.000,428.0,435.6,413.55,414.15,10173638.0,Biocon reports 28% drop in Q1 PAT,The biopharmaceuticals companys consolidated net profit fell 28% to Rs 149 crore on a 15% rise in revenue from operations to Rs 1671 crore in Q1 FY21 over Q1 FY20.,negative,negative,-3.2359813084112203,negative,-3.264812575574365,negative
2020-07-24 09:42:29.000,428.0,435.6,413.55,414.15,10173638.0,Covid-19 impact: Biocon Q1 profits down 26.3 per cent,But topline grew 14 per cent y-o-y; profit share of biosimilars business down,negative,positive,-3.2359813084112203,negative,-3.264812575574365,negative
2020-07-24 10:31:00.000,428.0,435.6,413.55,414.15,10173638.0,Biocon share price falls 2% on June quarter numbers,"The company’s revenue from operations rose 15 percent to Rs 1,671 crore versus Rs 1,459 crore.",negative,positive,-3.2359813084112203,negative,-3.264812575574365,negative
2020-07-24 11:19:00.000,428.0,435.6,413.55,414.15,10173638.0,Biocon Q1 results: Net profit declines 26% to Rs 168 crore,"The company had posted a net profit of Rs 227.7 crore for the corresponding period of the previous fiscal, Biocon said in a late night filing to the BSE.",negative,positive,-3.2359813084112203,negative,-3.264812575574365,negative
2020-07-24 12:46:00.000,428.0,435.6,413.55,414.15,10173638.0,Biocon’s net profit nosedives 28%; reaches Rs 149 crore in Q1,Biocon said it plans to carry out a phase IV trial in 200 Covid-19 patients to know the therapeutic efficacy of Itolizumab across the country in 10-15 hospitals,neutral,neutral,-3.2359813084112203,negative,-3.264812575574365,negative
2020-07-24 13:12:00.000,428.0,435.6,413.55,414.15,10173638.0,"Biocon Consolidated June 2020 Net Sales at Rs 1,671.30 crore, up 14.01% Y-o-Y",,positive,neutral,-3.2359813084112203,negative,-3.264812575574365,negative
2020-07-24 13:12:00.000,428.0,435.6,413.55,414.15,10173638.0,"Biocon Standalone June 2020 Net Sales at Rs 520.70 crore, up 8.3% Y-o-Y",,positive,neutral,-3.2359813084112203,negative,-3.264812575574365,negative
2020-07-24 16:25:00.000,428.0,435.6,413.55,414.15,10173638.0,"We are on a very strong growth trajectory, biosimilar biz jumped 60% QoQ: Biocon",’We would have a very comprehensive portfolio of insulins and we will continue to add to that over the years.,positive,neutral,-3.2359813084112203,negative,-3.264812575574365,negative
2020-07-24 16:34:46.000,428.0,435.6,413.55,414.15,10173638.0,Biocon sees 28% fall in profit,"Biopharma firm Biocon saw its June quarter net profit falling 28% to ₹149 crore. Profitability for the quarter was impacted due to a higher R&amp;D spend, lower profit share in the Biosimilars bus",negative,negative,-3.2359813084112203,negative,-3.264812575574365,negative
2020-07-24 16:49:58.000,428.0,435.6,413.55,414.15,10173638.0,Higher expenses shrink Biocon’s Q1 profits stock’s valuation banks on launches,"Research and development expenses in Q1 jumped about 35% .Material costs too were substantially higher, impacting even gross margins",neutral,positive,-3.2359813084112203,negative,-3.264812575574365,negative
2020-07-24 16:59:11.000,428.0,435.6,413.55,414.15,10173638.0,Biocon Ltd (BCNQY) CEO Siddharth Mittal on Q1 2021 Results - Earnings Call Transcript,"Biocon Ltd (OTC:BCNQY) Q1 2021 Earnings Conference Call July 23, 2020, 11:30 ET Company Participants Saurabh Paliwal - Head, IR Kiran Mazumdar-Shaw - Founder & Executive Chairperson Christiane Hamacher - CEO & MD, Biocon Biologics India Ltd.",neutral,neutral,-3.2359813084112203,negative,-3.264812575574365,negative
2020-07-24 18:07:12.000,428.0,435.6,413.55,414.15,10173638.0,Biocon shares decline nearly 4 pc after Q1 earnings,"New Delhi: Shares of biotechnology major Biocon on Friday dropped nearly 4 per cent after the company reported a 26.30 per cent decline in its consolidated net profit for the quarter ended June 30, 2020. The stock fell 3.52 per cent to close at Rs 415.15 on the BSE. During the day, it dipp…",negative,negative,-3.2359813084112203,negative,-3.264812575574365,negative
2020-07-24 20:19:00.000,428.0,435.6,413.55,414.15,10173638.0,Itolizumab to be a blockbuster opportunity for Biocon: Kiran Mazumdar-Shaw,"We felt that this was the drug that would actually have a role to play in dealing with the cytokine storm that is being seen in Covid-19 patients, says Shaw",positive,neutral,-3.2359813084112203,negative,-3.264812575574365,negative
2020-07-26 13:06:00.000,413.5,416.5,397.45,400.0,5591861.0,Buy Biocon; target of Rs 490: ICICI Direct,"ICICI Direct is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 490 in its research report dated July 24, 2020.",neutral,positive,-3.264812575574365,negative,-0.3241895261845415,neutral
2020-07-26 17:23:58.000,413.5,416.5,397.45,400.0,5591861.0,"Despite DGCI Nod, Health Ministry Decides against Including Itolizumab for Treatment of Covid-19","Considering the unmet medical needs in COVID-19, Itolizumab, an already approved drug of Biocon, was approved for “restricted emergency use” in the treatmen.",positive,positive,-3.264812575574365,negative,-0.3241895261845415,neutral
2020-07-26 21:08:37.000,413.5,416.5,397.45,400.0,5591861.0,Health ministry decides against including Itolizumab in clinical management protocols for COVID-19,"Considering the unmet medical needs in COVID-19, Itolizumab, an already approved drug of Biocon, used for treating psoriasis - a skin condition - was approved for “restricted emergency use” in the treatment of coronavirus by the Drugs Controller General of India (DCGI) recently.",neutral,positive,-3.264812575574365,negative,-0.3241895261845415,neutral
2020-07-27 01:06:00.000,413.5,416.5,397.45,400.0,5591861.0,Biocon sees a setback as Centre doesn’t endorse Itolizumab drug for Covid-19 treatment; stock tumbles,"According to Biocon, reportedly nearly 1,000 patients have already used the Itolizumab drug across India.",negative,neutral,-3.264812575574365,negative,-0.3241895261845415,neutral
2020-07-27 12:46:44.000,401.0,407.5,396.5,399.7,4418318.0,Setback for Biocon as Centre Says its Covid-19 Drug Not Part of National Treatment Protocol,"According to the statement issued by the health ministry, the National Task Force on Covid-19 is of the opinion that there is ‘very less evidence in favour of this medicine.’",neutral,neutral,-0.3241895261845415,neutral,-1.0125000000000028,negative
2020-07-27 13:08:00.000,401.0,407.5,396.5,399.7,4418318.0,Biocon share price falls 3% after Health Ministry gives a pass to its COVID-19 drug,"A majority of the members of the task force opined that there was not enough evidence currently to get the drug included in the clinical management protocols for COVID-19, sources said.",negative,neutral,-0.3241895261845415,neutral,-1.0125000000000028,negative
2020-07-27 19:33:05.000,401.0,407.5,396.5,399.7,4418318.0,Biocon to give more data on itolizumab after use in covid-19 treatment rejected,"Biocon said that the drug has been used on nearly 1,000 patients across the country and generated good outcome data, and the company also announced plans to conduct a 200-patient, pan-India Phase 4 trial across 10-15 hospitals",neutral,positive,-0.3241895261845415,neutral,-1.0125000000000028,negative
2020-07-28 07:54:25.000,401.0,407.5,396.5,399.7,4418318.0,Coronavirus Drug: Biocon to submit more data on Itolizumab to Covid taskforce,"Medicine of Covid-19: The company said that based on the encouraging study results of the pivotal phase 2 conducted by Biocon in India, its US-based partner, Equilllium, is planning to conduct a global randomized controlled clinical trial of Itolizumab in Covid-19 patients for which it will file a U…",neutral,positive,-0.3241895261845415,neutral,-1.0125000000000028,negative
2020-07-28 12:11:00.000,400.0,403.45,393.0,395.95,4786874.0,Neutral Biocon; target of Rs 450: Motilal Oswal,"Motilal Oswal recommended Neutral rating on Biocon with a target price of Rs 450 in its research report dated July 25, 2020.",neutral,positive,-1.0125000000000028,negative,1.893939393939394,positive
2020-07-30 12:22:00.000,408.0,412.8,400.8,410.1,7271720.0,Nifty Pharma index rally nearly 3% led by Dr Reddy’s,"Shares of Divi’s Lab climbed 4.5%, followed by Torrent Pharma, Lupin, Biocon, Aurobindo Pharma and Sun Pharma were up over in the range of 3-2%, respectively.",positive,positive,0.5147058823529467,neutral,-0.1214181641573579,neutral
2020-07-31 01:28:00.000,408.0,412.8,400.8,410.1,7271720.0,Biocon gains 1.5% as Tata Capital PE fund to invest $30 mn in Biocon Biologics,"Post the completion of this transaction, Biocon will hold 95.25% stake in Biocon Biologics, the company said in the filing.",positive,neutral,0.5147058823529467,neutral,-0.1214181641573579,neutral
2020-07-31 05:30:00.000,408.0,412.8,400.8,410.1,7271720.0,BRIEF-Biocon’s Unit Gets $30 Mln Investment From Tata Capital Growth Fund - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,0.5147058823529467,neutral,-0.1214181641573579,neutral
2020-07-31 07:33:17.000,408.0,412.8,400.8,410.1,7271720.0,Antibody drug lowers risk of death in elderly coronavirus patients: Study,"Biocon Ltd received regulatory approval in India for itolizumab for use in coronavirus infected patients.Researchers, which developed itolizumab, said timely use of the drug in combination with standard therapy helped reduce inflammation and prevented COVID-19 from worsening",positive,positive,0.5147058823529467,neutral,-0.1214181641573579,neutral
2020-07-31 09:08:00.000,408.0,412.8,400.8,410.1,7271720.0,Tata Capital Growth Fund to invest Rs 225 cr in Biocon Biologic,"The transaction is subject to standard condition precedents and approvals. Post the completion of this transaction, Biocon will hold 95.25% stake in Biocon Biologics.",neutral,neutral,0.5147058823529467,neutral,-0.1214181641573579,neutral
2020-07-31 09:35:00.000,408.0,412.8,400.8,410.1,7271720.0,Tata Capital picks up 0.85% stake in Biocon Biologics for $30 million,"Post the completion of this transaction, Biocon will hold a 95.25 per cent stake in Biocon Biologics.",neutral,neutral,0.5147058823529467,neutral,-0.1214181641573579,neutral
2020-07-31 09:37:32.000,408.0,412.8,400.8,410.1,7271720.0,"Covid-19 vaccine for health workers, youth first priority: Biocon’s chairperson","Kiran Mazumdar-Shaw says young people, health workers should get first priority for Covid-19 vaccine.Earlier, Biocon had said it will launch biologic drug Itolizumab for the treatment of moderate to severe COVID-19 patients",neutral,positive,0.5147058823529467,neutral,-0.1214181641573579,neutral
2020-07-31 09:47:00.000,408.0,412.8,400.8,410.1,7271720.0,Biocon rises as Tata Capital PE fund to invest $30 mln in Biocon Biologics,Biocon gained 0.78% to Rs 406.55 after the biopharmaceuticals company said on Friday a private equity fund managed by Tata Capital will invest Rs 225 crore ($30 million) in its biosimilar business.,neutral,positive,0.5147058823529467,neutral,-0.1214181641573579,neutral
2020-07-31 10:05:00.000,408.0,412.8,400.8,410.1,7271720.0,Tata Capital to pick minority stake in Biocon Biologics for $30 million,Equity infusion part of a larger $200-300 million round the company plans to raise over the next few months as it eyes an IPO,neutral,neutral,0.5147058823529467,neutral,-0.1214181641573579,neutral
2020-07-31 10:15:25.000,408.0,412.8,400.8,410.1,7271720.0,Antibody drug lowers risk of death in elderly COVID-19 patients: Cuban study,India’s Biocon Ltd said earlier this month it received regulatory approval in India for itolizumab for use in coronavirus infected patients with moderate-to-severe respiratory distress.,positive,positive,0.5147058823529467,neutral,-0.1214181641573579,neutral
2020-07-31 11:19:43.000,408.0,412.8,400.8,410.1,7271720.0,Tata Capital Growth Fund to invest ₹225 Crore in Biocon Biologics,Biocon said the board of its subsidiary Biocon Biologics India has approved a primary equity investment by Tata Capital Growth Fund.,neutral,positive,0.5147058823529467,neutral,-0.1214181641573579,neutral
2020-07-31 12:34:00.000,408.0,412.8,400.8,410.1,7271720.0,Tata Capital Growth Fund to invest $30 million in Biocon Biologics,"Post the completion of this transaction, Biocon will hold 95.25 percent stake in Biocon Biologics, the biotechnology major added.",neutral,neutral,0.5147058823529467,neutral,-0.1214181641573579,neutral
2020-07-31 12:35:04.000,408.0,412.8,400.8,410.1,7271720.0,Tata Capital to invest ₹225 cr. in Biocon Biologics for 0.85% stake,Deal values Biocon Biologics an equity valuation of $3.5 billion.,neutral,neutral,0.5147058823529467,neutral,-0.1214181641573579,neutral
2020-07-31 13:00:20.000,408.0,412.8,400.8,410.1,7271720.0,Tata Capital fund to buy 0.85% in Biocon Biologics at $3.5 billion valuation,"This is part of the $200-300 million round of fund raising the biologics maker plans to raise before its initial public offering.With the latest fund raising worth $30 million, Biocon Biologics has raised $105 million so far",positive,neutral,0.5147058823529467,neutral,-0.1214181641573579,neutral
2020-07-31 15:51:10.000,408.0,412.8,400.8,410.1,7271720.0,Tata Capital Growth Fund to invest ₹225 cr in Biocon Biologics,"Biocon Ltd, a global biopharmaceuticals company, announced on Friday that the board of its subsidiary Biocon Biologics India Limited has approved a primary equity investment by Tata Capital Growth Fun",neutral,positive,0.5147058823529467,neutral,-0.1214181641573579,neutral
2020-07-31 16:26:00.000,408.0,412.8,400.8,410.1,7271720.0,Coronavirus vaccine update: Eyes on India as candidates race towards finish line,Coronavirus vaccine news update: Biocon founder Kiran Mazumdar-Shaw said that the first doses of the vaccine should be administered to young people and health workers,positive,neutral,0.5147058823529467,neutral,-0.1214181641573579,neutral
2020-07-31 17:33:42.000,408.0,412.8,400.8,410.1,7271720.0,Tata Capital Growth to invest Rs 225 cr in Biocon Biologics,"Bengaluru: Tata Capital Growth Fund will invest Rs 225 crore in Biocon Biologics India Ltd for an equity stake of 0.85 per cent. In a regulatory filing on Friday, Biocon Ltd said that the Board of its subsidiary Biocon Biologics has approved a primary equity investment by Tata Capital Grow…",neutral,neutral,0.5147058823529467,neutral,-0.1214181641573579,neutral
2020-07-31 22:31:49.000,408.0,412.8,400.8,410.1,7271720.0,Tata Capital to invests ₹225 cr. in Biocon Biologics stake,"Biocon Ltd., a biopharmaceuticals company, on Friday announced that the board of its subsidiary Biocon Biologics India Limited has approved a primary equity investment by Tata Capital Growth Fund.As p",neutral,positive,0.5147058823529467,neutral,-0.1214181641573579,neutral
2020-08-02 23:53:53.000,411.8,416.75,407.7,411.3,5224790.0,Biocon Biologics intends to list on capital markets in next 2-3 years: CFO Chinappa MB,"Five molecules from Biocon Biologics’ portfolio have been taken from lab to market, of which three have been commercialised in developed markets like EU, Australia, US, Canada and Japan.",neutral,neutral,-0.1214181641573579,neutral,-0.2895403546869317,neutral
2020-08-03 05:30:00.000,411.8,416.75,407.7,411.3,5224790.0,"BRIEF-Biocon Ltd Says Co, Tata Capital Growth Fund II Execute Share Subscription Agreement - Investing.com India","The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.1214181641573579,neutral,-0.2895403546869317,neutral
2020-08-03 12:58:00.000,414.45,416.65,404.0,413.25,4144107.0,Aim to list Biocon Biologics on capital markets by 2023: CFO MB Chinappa,Biocon Biologics has raised $105 million so far this calendar year through two primary equity infusions.,neutral,positive,-0.2895403546869317,neutral,-1.228915662650608,negative
2020-08-03 21:16:17.000,414.45,416.65,404.0,413.25,4144107.0,Covid-19: Biocon to amend phase-4 trial protocol for psoriasis drug Itolizumab,Drug regulator says safety must be main objective; sample size must be increased,neutral,neutral,-0.2895403546869317,neutral,-1.228915662650608,negative
2020-08-04 10:52:25.000,414.45,416.65,404.0,413.25,4144107.0,Biocon update on proposed primary equity investment by Tata Capital Growth Fund II,Powered by Capital Market - Live News,neutral,neutral,-0.2895403546869317,neutral,-1.228915662650608,negative
2020-08-04 12:52:00.000,415.0,418.8,407.2,409.9,4341955.0,Biocon executes a share subscription agreement with Tata Capital Growth Fund II via subsidiary,"Biocon will hold 95.25% of the share capital of BBIL, on a fully diluted basis post completion of this transaction.",neutral,neutral,-1.228915662650608,negative,-0.7543496775763392,neutral
2020-08-07 02:29:00.000,409.0,411.85,396.05,400.4,5634108.0,"Sensex, Nifty trade volatile; Lupin, Biocon stocks dip","Biocon, Torrent Pharma, Sun Pharma, Aurobindo Pharma and Cipla also fell in the pharma index.",neutral,negative,-2.1026894865525727,negative,2.871705619094981,positive
2020-08-10 11:37:00.000,402.2,414.5,400.7,413.75,7026122.0,"D-Street Buzz: Pharma stocks rally led by Divis Labs, Cipla; Lupin, Sun Pharma gain 3% each","Lupin gained over 5 percent followed by Sun Pharma and Dr Reddy’s Labs up 3 percent each while Biocon, Cadila Healthcare and Aurobindo Pharma were the other gainers.",positive,positive,2.871705619094981,positive,-1.8072289156626504,negative
2020-08-12 03:35:00.000,407.55,407.8,392.1,397.4,5533567.0,"Sensex ends flat; PSU Bank, auto stocks shine","On the sectoral front, the Nifty Pharma was down for the second straight day and was also the top sectoral laggard led by Biocon, Cadila, Sun Pharma and Torrent Pharma.",neutral,negative,-2.490491964176183,negative,-1.0651629072681703,negative
2020-08-12 12:15:00.000,399.0,401.1,391.7,394.75,4015831.0,"D-Street Buzz: Pharma stocks under pressure; Lupin, Biocon, Divis Labs, Cipla shed 2% each","Lupin, Cadila Healthcare, Divis Laboratories and Biocon shed over 2 percent each while Sun Pharma and Aurobindo Pharma were down a percent.",negative,neutral,-1.0651629072681703,negative,0.126742712294043,neutral
2020-08-12 13:20:00.000,399.0,401.1,391.7,394.75,4015831.0,Stock market update: BSE MidCap index down; Biocon loses 3%,The index was trading 0.47 per cent down at 14325.27.,negative,negative,-1.0651629072681703,negative,0.126742712294043,neutral
2020-08-14 02:10:00.000,394.5,402.3,391.5,395.0,5375169.0,"Market at day’s low; Lupin, Sun Pharma stocks gain","All the pharma constituents were trading higher except Dr Reddy’s, Biocon and Divis Lab in the afternoon session.",negative,positive,0.126742712294043,neutral,-1.604814443329999,negative
2020-08-14 09:29:00.000,394.5,402.3,391.5,395.0,5375169.0,Russia Vaccine: Russia not world’s first to develop coronavirus vaccine: Kiran Mazumdar-Shaw,"The world has not seen any data on Phase 1 or 2 clinical trials conducted by Moscow-based Gamaleya Research Institute, the Executive Chairperson of Bengaluru-headquartered Biocon Ltd said. But it doesn’t make them the world’s first vaccine as several other vaccine programmes are even more advanced,…",neutral,neutral,0.126742712294043,neutral,-1.604814443329999,negative
2020-08-17 06:41:00.000,398.8,399.65,389.35,392.4,3370301.0,Coronavirus LIVE: Biocon chief Kiran Mazumdar-Shaw tests positive,"Coronavirus latest news: India is increasingly appearing to be the global hub of coronavirus. Maharashtra cases at 595,865, Tamil Nadu 338,055, Karnataka 226,966. Stay tuned for coronavirus updates",positive,neutral,-1.604814443329999,negative,1.1337579617834366,positive
2020-08-17 08:39:27.000,398.8,399.65,389.35,392.4,3370301.0,"Stock calls by Sameet Chavan of Angel Broking: Sell Tata Motors, Biocon",One can see a formation of Bearish Engulfing pattern on Tata Motors daily chart,neutral,neutral,-1.604814443329999,negative,1.1337579617834366,positive
2020-08-17 10:33:00.000,398.8,399.65,389.35,392.4,3370301.0,"Biocon remains untroubled by Covid-19 challenges, stock trades flat","Under essential services the pharma company continued the manufacturing and selling of pharmaceutical products, with fewer challenges in lockdown.",negative,neutral,-1.604814443329999,negative,1.1337579617834366,positive
2020-08-17 23:45:00.000,392.5,397.0,388.0,396.95,3097440.0,Coronavirus Live Updates: Biocon chairman Kiran Mazumdar Shaw tests Covid positive - The Economic Times,"I have added to the Covid count by testing positive. Mild symptoms n I hope it stays that way, she tweeted.",neutral,neutral,1.1337579617834366,positive,-0.1761449421238018,neutral
2020-08-18 00:12:31.000,392.5,397.0,388.0,396.95,3097440.0,Biocon chief Kiran Mazumdar-Shaw tests positive for Covid-19,The 67-year-old biotechnology industry veteran said on Twitter she has mild symptoms and hopes they ‘stay that way’,positive,neutral,1.1337579617834366,positive,-0.1761449421238018,neutral
2020-08-18 00:35:00.000,392.5,397.0,388.0,396.95,3097440.0,Biocon CMD Kiran Mazumdar Shaw tests positive for coronavirus,"“I have added to the Covid count by testing positive. Mild symptoms n I hope it stays that way,” Kiran Mazumdar Shaw said in a tweet",positive,neutral,1.1337579617834366,positive,-0.1761449421238018,neutral
2020-08-18 00:44:36.000,392.5,397.0,388.0,396.95,3097440.0,Biocon executive chairperson Kiran Mazumdar-Shaw tests positive for Covid-19,Kiran Mazumdar-Shaw wrote on Twitter that she has tested positive for the coronavirus disease with mild symptoms.,positive,positive,1.1337579617834366,positive,-0.1761449421238018,neutral
2020-08-18 01:08:00.000,392.5,397.0,388.0,396.95,3097440.0,Biocon chairperson Kiran Mazumdar-Shaw tests positive for Covid-19,"Shaw adds to the list of high-profile people who have been tested positive in Bengaluru in a span of few weeks, including Karnataka chief minister B S Yediyurappa",positive,neutral,1.1337579617834366,positive,-0.1761449421238018,neutral
2020-08-18 02:02:00.000,392.5,397.0,388.0,396.95,3097440.0,"Coronavirus | Biocon chairperson, Kiran Mazumdar-Shaw tests positive for COVID 19","Biocon chairperson, Kiran Mazumdar-Shaw has tested positive for COVID 19.Ms. Shaw took to Twitter late on Monday night to state that she had tested positive. ""I have added to the Covid count by t",positive,positive,1.1337579617834366,positive,-0.1761449421238018,neutral
2020-08-18 06:34:00.000,392.5,397.0,388.0,396.95,3097440.0,Coronavirus LIVE: India tally crosses 2.7-million mark; Biocon CEO infected,"Coronavirus latest news: India cases have crossed the 2.7-million mark. Maharashtra coronavirus tally at 6,04,358. Stay tuned for coronavirus LIVE updates",neutral,positive,1.1337579617834366,positive,-0.1761449421238018,neutral
2020-08-18 07:13:00.000,392.5,397.0,388.0,396.95,3097440.0,Biocon chief Kiran Mazumdar-Shaw tests positive for COVID-19,"Bengaluru: Biocon chairperson Kiran Mazumdar-Shaw on Monday night said she tested COVID-19 positive.“I have added to the COVID count by testing positive. Mild symptoms and I hope it stays that way,” tweeted the 67-year-old city-based biotech queen Shaw.Responding to…",positive,neutral,1.1337579617834366,positive,-0.1761449421238018,neutral
2020-08-18 07:14:21.000,392.5,397.0,388.0,396.95,3097440.0,Biocon chairperson Kiran Mazumdar Shaw tests positive for coronavirus COVID-19,Biocon chairperson Kiran Mazumdar-Shaw on Monday (August 17) said that she has tested positive for coronavirus COVID-19. Mazumdar-Shaw said that she currently has mild symptoms of coronavirus.,positive,positive,1.1337579617834366,positive,-0.1761449421238018,neutral
2020-08-18 08:40:29.000,392.5,397.0,388.0,396.95,3097440.0,"‘Added to Covid Count’: Kiran Mazumdar Shaw, Biocon Chairperson, Tests Positive for Coronavirus","Kiran Mazumdar Shaw’s bio-pharmaceutical company has been working to launch biologic drug Itolizumab for the treatment of moderate to severe Covid-19 patients at a price of around 8,000 per vial.",neutral,positive,1.1337579617834366,positive,-0.1761449421238018,neutral
2020-08-18 09:07:52.000,392.5,397.0,388.0,396.95,3097440.0,Biocon’s Kiran Mazumdar-Shaw tests positive for Covid-19,Executive Chairperson of Bengaluru-headquartered Biocon Ltd. Kiran Mazumdar-Shaw said on Monday night that she has tested positive for Covid-19.“I have added to the covid count by testing positive. Mi,positive,positive,1.1337579617834366,positive,-0.1761449421238018,neutral
2020-08-18 09:12:02.000,392.5,397.0,388.0,396.95,3097440.0,Biocon chief Kiran Mazumdar-Shaw tests positive for COVID-19,The information about her testing positive was shared by Shaw herself on her official twitter account late last night.,positive,neutral,1.1337579617834366,positive,-0.1761449421238018,neutral
2020-08-18 12:08:00.000,397.4,402.2,394.5,396.7,3744435.0,"Biocon chief Kiran Mazumdar-Shaw tests COVID-19 positive; Anand Mahindra, Shashi Tharoor wish speedy recovery",Biocon chief Kiran Mazumdar-Shaw said on Monday that she has tested positive for COVID-19.,positive,positive,-0.1761449421238018,neutral,-0.3282828282828311,neutral
2020-08-19 08:03:00.000,397.4,402.2,394.5,396.7,3744435.0,"Weekly trading ideas by Religare Broking: Buy Grasim Industries, Biocon",Grasim is witnessing a breakout from the range where it has spent the last two months,neutral,neutral,-0.1761449421238018,neutral,-0.3282828282828311,neutral
2020-08-19 10:49:12.000,397.4,402.2,394.5,396.7,3744435.0,"India can use pandemic opportunity to become an innovator, says Biocon’s Shaw","Kiran Mazumdar Shaw, chairperson and managing director of Biocon, said India must leverage its resources to become a key component of the global innovation value chain .Shaw said that the pandemic also brought the focus on India’s roadmap for its presence in the pharmaceutical sector",positive,positive,-0.1761449421238018,neutral,-0.3282828282828311,neutral
2020-08-20 12:18:00.000,397.0,398.15,392.55,395.35,2230823.0,Stock market update: Pharma stocks mixed; Biocon falls 1%,The Nifty Pharma index was trading 0.01 per cent down at 11536.4.,negative,negative,-0.4156171284634703,neutral,-0.7197878520015067,neutral
2020-08-25 15:31:18.000,388.2,394.45,386.55,392.8,3679864.0,Natural Biocon (India) reports standalone nil net profit/loss in the June 2020 quarter,Reported sales nil,negative,neutral,1.18495620814014,positive,-0.9120851279452664,negative
2020-08-31 05:30:00.000,393.8,397.9,372.25,375.0,7022554.0,"BRIEF-Mylan, Biocon Biologics Announce Launch Of Semglee In U.S. - Investing.com India","The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-4.773996952767905,negative,6.000784416263561,positive
2020-08-31 17:03:01.000,382.45,408.0,379.0,405.4,17368092.0,"Biocon Biologics, Mylan launch diabetic drug Semglee in US","Biocon Biologics India, a fully integrated biosimilars company and a subsidiary of Biocon Ltd, and Mylan N.V. on Monday announced the US launch of Semglee (insulin glargine injection).The drug is bein",neutral,positive,6.000784416263561,positive,1.6029593094944512,positive
2020-08-31 17:11:00.000,382.45,408.0,379.0,405.4,17368092.0,"Biocon Biologics launches Semglee, drug to control high blood sugar, in US","To encourage broad patient access to this important medicine, Mylan is offering Semglee at a wholesale acquisition cost (WAC)[1] of $147.98 per package of five (5) 3ml pens and $98.65 per 10ml vial, representing the lowest WAC for any long-acting insulin glargine on the market, said Biocon in a pres…",neutral,positive,6.000784416263561,positive,1.6029593094944512,positive
2020-08-31 17:25:23.000,382.45,408.0,379.0,405.4,17368092.0,"Biocon Biologics, partner Mylan launch insulin glargine in US","Mylan, which is responsible for commercialisation in the US, would offer Semglee at a wholesale cost of $147.98 per package of five 3ml pens and $98.65 per 10ml vial, making it the cheapest brand of insulin glargine in the US market",neutral,neutral,6.000784416263561,positive,1.6029593094944512,positive
2020-08-31 21:12:00.000,382.45,408.0,379.0,405.4,17368092.0,Biocon-Mylan launch insulin Glargine at lowest price in US market,"The commercialisation in the US of the drug, which already has approval in 45 countries, gives a boost to Biocons ambitious target of $1 billion in sales through its biologics division by FY22",negative,positive,6.000784416263561,positive,1.6029593094944512,positive
2020-08-31 23:00:56.000,382.45,408.0,379.0,405.4,17368092.0,Biocon arm introduces Semglee in U.S.,"Insulin to be sold below market price, says firm",neutral,neutral,6.000784416263561,positive,1.6029593094944512,positive
2020-09-01 06:28:48.000,382.45,408.0,379.0,405.4,17368092.0,"Stocks To Watch: Biocon, Grasim, L&T, M&M, ONGC",Here are the stocks to watch in trade today.,neutral,neutral,6.000784416263561,positive,1.6029593094944512,positive
2020-09-01 07:20:00.000,382.45,408.0,379.0,405.4,17368092.0,"Top stocks in focus: ONGC, Biocon, L&T, Grasim, M&M",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,6.000784416263561,positive,1.6029593094944512,positive
2020-09-01 07:32:00.000,382.45,408.0,379.0,405.4,17368092.0,"Stocks in the news | Bharti Airtel, L&T, Biocon, M&M, Aarey Drugs, Jindal Steel & Power, India Grid Trust","Century Textiles, Bharat Dynamics, Jai Corp, Consolidated Construction Consortium, Pricol, JVL Agro Industries, NCL Industries, MRO-Tek Realty, Technocraft Industries, Mukand, Shree Renuka Sugars, Entertainment Network India, Company and TV Today Network, Sadbhav Infrastructure Project, Zensar Techn…",neutral,neutral,6.000784416263561,positive,1.6029593094944512,positive
2020-09-01 09:12:00.000,382.45,408.0,379.0,405.4,17368092.0,"Stocks in news: Biocon, Morepen Labs, Edelweiss, L&T, Bharat Dynamics","Stocks to watch today on September 1: Biocon, Morepen Labs, Edelweiss, L&T, Bharat Dynamics among others are the top stocks to watch out for in Tuesday’s trading session.",neutral,neutral,6.000784416263561,positive,1.6029593094944512,positive
2020-09-01 10:19:00.000,382.45,408.0,379.0,405.4,17368092.0,Glargine launch in US opens up a huge opportunity for Biocon: Kiran Mazumdar Shaw,"Even as a biosimilar, it is estimated to be a $2.2-billion opportunity for Biocon and Mylan.",positive,positive,6.000784416263561,positive,1.6029593094944512,positive
2020-09-01 10:23:00.000,382.45,408.0,379.0,405.4,17368092.0,Biocon shares up 6% after Co launches insulin glargine in US market,Biocon Biologics India and its partner Mylan NV launched insulin glargine injection under the brand Semglee in the US market.,positive,positive,6.000784416263561,positive,1.6029593094944512,positive
2020-09-01 11:13:00.000,382.45,408.0,379.0,405.4,17368092.0,Biocon shares jump 5% on launch of diabetes drug in US,"As per a regulatory filing on BSE, Biocon Biologics India, a subsidiary of Biocon, and Mylan N.V., announced the US launch of Semglee.",positive,neutral,6.000784416263561,positive,1.6029593094944512,positive
2020-09-01 12:16:09.000,405.5,413.4,402.05,412.0,9343078.0,Vakrangee Ltd leads gainers in ‘A’ group,"Biocon Ltd, Essel Propack Ltd, Bharti Airtel Ltd and City Union Bank Ltd are among the other gainers in the BSEs A group today, 01 September 2020.",positive,neutral,1.6029593094944512,positive,3.410194174757284,positive
2020-09-01 12:26:00.000,405.5,413.4,402.05,412.0,9343078.0,Biocon skyrockets 6% as subsidiary Biocon Biologics and Mylan launch Semglee in US market,Semglee is approved to help control high blood sugar in adult and pediatric patients with type 1 diabetes and adults with type 2 diabetes.,neutral,positive,1.6029593094944512,positive,3.410194174757284,positive
2020-09-01 14:54:00.000,405.5,413.4,402.05,412.0,9343078.0,Biocon share price rises 7% on launch of diabetes drug in US,"Following the announcement, Biocon shares opened at Rs 382.05 and jumped 6.97% to its intraday high of Rs 402.65 against the last closing of Rs 376.40 on BSE. The stock trades near its 52-week high of Rs 455, hit on July 13, 2020",positive,positive,1.6029593094944512,positive,3.410194174757284,positive
2020-09-01 17:15:00.000,405.5,413.4,402.05,412.0,9343078.0,"Market Movers: Voda slumps; Airtel, Biocon jump; sell signal in 269 stocks","The recent swing high of Nifty to 11,794 is unlikely to be breached on the upside in the short term. Immediate support is placed at 11,365.",positive,positive,1.6029593094944512,positive,3.410194174757284,positive
2020-09-01 22:05:00.000,405.5,413.4,402.05,412.0,9343078.0,Pick up in biosimilar launches driving Biocon’s prospects; stock gains 7.8%,"As US launch of Insulin addresses a large market, improved visibility for more launches will keep sentiment elevated",positive,positive,1.6029593094944512,positive,3.410194174757284,positive
2020-09-02 09:10:00.000,405.5,413.4,402.05,412.0,9343078.0,"Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term","Ashwani Gujral of ashwanigujral.com suggests buying Biocon with a stop loss of Rs 398, target at Rs 420 and Bharti Airtel with a stop loss of Rs 540, target at Rs 575.",neutral,neutral,1.6029593094944512,positive,3.410194174757284,positive
2020-09-02 11:29:00.000,405.5,413.4,402.05,412.0,9343078.0,‘Trade cautiously until unwinding cools off; Biocon among top 3 trading ideas’,"For the rest of the week the range looks shifted towards 11,700-11,350 as of now.",neutral,neutral,1.6029593094944512,positive,3.410194174757284,positive
2020-09-03 14:11:00.000,421.7,434.4,418.45,420.0,12303988.0,Stock market update: Nifty Pharma index climbs 1%; Biocon rises 3%,The index was trading 1.25 per cent up at 11546.4.,positive,positive,-0.4031301873369667,neutral,0.05938947618482,neutral
2020-09-04 02:53:00.000,421.7,434.4,418.45,420.0,12303988.0,Tata Capital Growth Fund II invests Rs225cr in Biocon’s subsidiary; stock pares early gain,"Biocon said that the board of BBIL has approved allotment of 88,30,456 equity shares having face value of Rs10 each at an issue price of Rs254.80 per share.",positive,neutral,-0.4031301873369667,neutral,0.05938947618482,neutral
2020-09-04 11:11:00.000,421.7,434.4,418.45,420.0,12303988.0,Biocon Biologics India receives Rs 225 crore equity infusion from Tata Capital Growth Fund II,"Consequently, the Board of BBIL has approved the allotment of 88,30,456 equity shares of Rs. 10 each at an issue price of Rs. 254.80/- per equity share (including a premium of Rs. 244.80/- per equity share) to the Investor.",neutral,positive,-0.4031301873369667,neutral,0.05938947618482,neutral
2020-09-04 15:09:00.000,421.7,434.4,418.45,420.0,12303988.0,Biocon Biologics India to allot 88.30 lakh equity shares to Tata Capital Growth Fund II,"Biocon on Thursday announced that the board of its subsidiary, Biocon Biologics India, has approved the allotment of 88,30,456 equity shares for Rs 254.80 each to Tata Capital Growth Fund II.",neutral,positive,-0.4031301873369667,neutral,0.05938947618482,neutral
2020-09-04 21:49:58.000,421.7,434.4,418.45,420.0,12303988.0,Biocon Biologics sees big opportunity in US for its insulin injection,"Biocon Biologics India, a subsidiary of Biocon, is engaged in developing affordable biosimilars. The company along with Mylan recently announced the launch of Semglee™ (insulin glargine injection) in",positive,positive,-0.4031301873369667,neutral,0.05938947618482,neutral
2020-09-06 17:40:00.000,420.95,424.3,415.4,421.2,3955153.0,"Biocon set for bigger insulin play, aims to reach one in five diabetics","Biocon Biologics CEO says portfolio to form a substantial part of $1 bn revenue target, to roll out insulin Aspart by next year",positive,positive,0.05938947618482,neutral,-1.6261127596439224,negative
2020-09-06 18:51:15.000,420.95,424.3,415.4,421.2,3955153.0,Your Stock Portfolio: Biocon in a long-term uptrend,Investors looking for the long haul can buy the stock in declines with a stop-loss at ₹290,positive,neutral,0.05938947618482,neutral,-1.6261127596439224,negative
2020-09-15 12:26:00.000,440.05,453.9,434.55,437.15,10049356.0,"Nifty Pharma stocks outperform; JB Chemicals, Aurobindo Pharma stocks jump","Torrent Pharma, Sun Pharma, Biocon and Cadila gained 2% each, and Divi’s Lab also up 1%, while Alkem Lab slipped on the pharma index.",positive,positive,-0.659016020906723,neutral,0.603644646924824,neutral
2020-09-17 11:01:00.000,439.0,444.85,432.55,441.65,4421157.0,"Dr Reddy’s, Biocon, Torrent Pharma: What charts indicate for these stocks","The next upside for Nifty Pharma is located above the resistance of 12,100 levels.",neutral,positive,0.603644646924824,neutral,2.4280067758328627,positive
2020-09-23 09:07:00.000,424.6,429.0,418.2,424.95,2530362.0,Board of Biocon appoints CFO,At meeting held on 22 September 2020,neutral,neutral,0.0824305228450225,neutral,-3.225806451612909,negative
2020-09-23 13:51:00.000,421.6,423.4,406.1,408.0,2874579.0,Biocon appoints Anupam Jindal as new CFO,He will report to the Chief Executive Officer and Managing Director Siddharth Mittal. Jindal will take over from Indranil Sen who was the interim CFO and he will continue as Vice-President for Finance.,neutral,neutral,-3.225806451612909,negative,3.231641143132771,positive
2020-09-23 13:55:22.000,421.6,423.4,406.1,408.0,2874579.0,Anupam Jindal Biocon’s new CFO,Jindal worked with Vedanta Group for 22 years,neutral,neutral,-3.225806451612909,negative,3.231641143132771,positive
2020-09-29 18:36:23.000,455.5,463.5,444.6,445.1,4752297.0,Biocon to roll out phase-4 post-marketing surveillance for Itolizumab to treat Covid-19 patients,"Biopharmaceuticals major, Biocon Ltd, is set to roll out the phase-4 post-marketing surveillance for its repurpose drug Itolizumab to treat Covid-19 patients.It may be noted that the Drug Controller G",neutral,neutral,-2.283205268935231,negative,0.5881700144268066,neutral
2020-10-01 21:30:00.000,450.55,456.95,444.3,453.2,2790264.0,Exclusive I Goldman Sachs Private Equity in talks to buy minority stake in IPO-bound Biocon Biologics,"If the deal — which may value the firm in excess of $3.5 billion — fructifies, it would mark the third successive investment in 2020 for Kiran Mazumdar Shaw-led Biocon Biologics",positive,positive,0.5881700144268066,neutral,1.0141093474426732,positive
2020-10-05 21:04:51.000,461.1,469.25,455.5,456.95,4412640.0,Sales of Biocon’s itolizumab surge as phase-4 clinical trials begin,"With phase 4 clinical trials now on, the sales may see a further uptick if data supports its use on Covid-19 patients, said experts.",neutral,positive,-0.9000216872695801,negative,-1.0376843255051884,negative
2020-10-08 05:30:00.000,453.0,473.75,451.15,472.2,4290709.0,BRIEF-Biocon Signs MoU With Bangalore Metro To Contribute Towards Building Metro Station - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,4.238410596026487,positive,-4.646251319957761,negative
2020-10-08 19:19:38.000,473.5,478.0,449.5,451.5,8193205.0,Biocon Foundation signs MoU with BMRCL to fund ₹65 crore in building Hebbagodi Metro Station,"Biocon Foundation, the CSR arm of Biocon Ltd, Biocon Biologics India and Syngene International Ltd have signed a Memorandum of Understanding (MoU) with the Bangalore Metro Rail Corporation Limited (BM",neutral,positive,-4.646251319957761,negative,2.2123893805309733,positive
2020-10-08 19:26:00.000,473.5,478.0,449.5,451.5,8193205.0,Biocon Foundation to fund Rs 65 crore for Hebbagodi metro station,"The project is expected to help in easing the traffic on the busy Hosur road, according to a press release from Biocon. In return, Biocon Foundation will request the Karnataka government to name the Hebbagodi metro station as “Biocon Hebbagodi Metro Station.”",neutral,positive,-4.646251319957761,negative,2.2123893805309733,positive
2020-10-08 19:45:00.000,473.5,478.0,449.5,451.5,8193205.0,Biocon Foundation to contribute Rs 65 crore for Metro station construction in Bengaluru,The MoU was inked by Biocon Foundation Founder and Managing Trustee Kiran Mazumdar-Shaw and BMRCL Director Ajay Seth.,positive,neutral,-4.646251319957761,negative,2.2123893805309733,positive
2020-10-09 08:59:00.000,473.5,478.0,449.5,451.5,8193205.0,"Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani for short term","Ashwani Gujral of ashwanigujral.com recommends buying Cadila Healthcare with a stop loss of Rs 430, target at Rs 456 and Biocon with a stop loss of Rs 460, target at Rs 485.",neutral,neutral,-4.646251319957761,negative,2.2123893805309733,positive
2020-10-09 10:29:03.000,473.5,478.0,449.5,451.5,8193205.0,Biocon Foundation to Contribute Rs 65 Crore for Metro Station Construction in Bengaluru,The MoU was inked by Biocon Foundation Founder and Managing Trustee Kiran Mazumdar-Shaw and BMRCL Managing Director Ajay Seth.,neutral,neutral,-4.646251319957761,negative,2.2123893805309733,positive
2020-10-09 12:04:00.000,473.5,478.0,449.5,451.5,8193205.0,Forbes India Rich List 2020: A look at 5 wealthiest women and their net worth,"Biocon’s Kiran Mazumdar-Shaw is the highest percentage gainer, not just in women’s list but also amongst the 100 richest persons listed by Forbes.",neutral,positive,-4.646251319957761,negative,2.2123893805309733,positive
2020-10-15 12:35:00.000,435.0,449.5,434.05,447.85,4495531.0,"Nifty Pharma trades lower; Sun Pharma, Lupin stocks down","On the flip side, Aurobindo Pharma and Biocon trading higher. on the pharma index",negative,positive,2.9540229885057525,positive,-2.363433667781499,negative
2020-10-15 22:05:31.000,435.0,449.5,434.05,447.85,4495531.0,"India Needs to Scale Up Coronavirus Testing to Contain Pandemic, Says Biocon Chairperson","She said some parts of the country are dealing with testing in a better way than other parts of the country but as a whole, it is not at optimal levels and certainly, way below other countries.",neutral,positive,2.9540229885057525,positive,-2.363433667781499,negative
2020-10-16 12:49:00.000,435.0,449.5,434.05,447.85,4495531.0,"Nifty Pharma gains over 1%; Cadila, Lupin, Biocon in the fast lane","Cadila, Lupin and Biocon were among top gainers to drive the index. While Dr Reddy’s, Cipla and Aurobindo Pharma also lifted the performance.",positive,positive,2.9540229885057525,positive,-2.363433667781499,negative
2020-10-22 08:42:00.000,441.25,441.8,427.35,429.5,3236382.0,"Stocks to watch: Asian Paints, Bajaj Auto, Biocon, Vedanta, ZEEL, KPIT Tech",Heres a list of stocks that may trade actively in todays session.,neutral,neutral,-2.6628895184135977,negative,-0.4999404832758059,neutral
2020-10-22 10:35:00.000,441.25,441.8,427.35,429.5,3236382.0,"Important results today: Asian Paints, Bajaj Auto, Infratel, Biocon","Reliance Power, Sterlite Technologies, Subros, Tube Investments of India and UCO Bank will announce their quarterly earnings on October 22.",neutral,neutral,-2.6628895184135977,negative,-0.4999404832758059,neutral
2020-10-22 10:50:00.000,441.25,441.8,427.35,429.5,3236382.0,Nifty Pharma index slumps 2%; Aurobindo Pharma sinks 6%,"Shares of Dr Reddy is ~3% down, Cipla slipped over 2%, while Cadila, Lupin and Biocon are down over 1.5% each. On other hand, Divis Lab is slightly down on the pharma index.",negative,negative,-2.6628895184135977,negative,-0.4999404832758059,neutral
2020-10-23 07:25:00.000,420.05,430.5,415.7,417.95,7416138.0,"Top stocks in focus: Tech Mahindra, Nestle, Biocon, Kirloskar Brothers",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-0.4999404832758059,neutral,-4.045346062052503,negative
2020-10-23 08:39:00.000,420.05,430.5,415.7,417.95,7416138.0,Biocon standalone net profit declines 10.46% in the September 2020 quarter,Sales rise 6.89% to Rs 560.00 crore,negative,positive,-0.4999404832758059,neutral,-4.045346062052503,negative
2020-10-23 09:08:00.000,420.05,430.5,415.7,417.95,7416138.0,Biocon consolidated net profit declines 21.51% in the September 2020 quarter,Sales rise 11.33% to Rs 1744.80 crore,negative,positive,-0.4999404832758059,neutral,-4.045346062052503,negative
2020-10-23 09:24:00.000,420.05,430.5,415.7,417.95,7416138.0,Biocon slips after Q2 PAT slips 23% YoY,Biocon fell 0.79% to Rs 426.10 after the companys consolidated net profit fell 23% to Rs 195.4 crore on 11.33% rise in net sales to Rs 1744.8 crore in Q2 September 2020 over Q2 September 2019.,neutral,negative,-0.4999404832758059,neutral,-4.045346062052503,negative
2020-10-23 09:57:00.000,420.05,430.5,415.7,417.95,7416138.0,Biocon Q2 results: Net profit drops 22% on higher R&D cost; revenue jumps 10%,"Biocon reported a 10% rise in total revenue to Rs 1,760 crore driven by overall growth in generics, biosimilar and research services businesses.",negative,positive,-0.4999404832758059,neutral,-4.045346062052503,negative
2020-10-23 10:12:00.000,420.05,430.5,415.7,417.95,7416138.0,"Biocon posts 22% fall in Q2 net profit on high R&D expenses, staff costs","The Bengaluru-headquartered company posted 10 per cent growth in consolidated revenue on a y-o-y basis to Rs 1,760 crore in Q2",negative,positive,-0.4999404832758059,neutral,-4.045346062052503,negative
2020-10-23 11:45:00.000,420.05,430.5,415.7,417.95,7416138.0,Biocon stock dips ~2% after Q2FY21 profit decline,"""We have introduced ARAFLU (Favipiravir) in addition to Cytosorb and ALZUMAB-L, and Syngene has started manufacturing Remdesivir under a voluntary licensing agreement with Gilead. she added.",negative,positive,-0.4999404832758059,neutral,-4.045346062052503,negative
2020-10-23 12:09:00.000,420.05,430.5,415.7,417.95,7416138.0,Biocon Q2 net profits down 23.8% at Rs200.40cr,Biocon reported an increase of 11.33% in top line sales for the Sep-20 quarter at Rs1744.80cr on a yoy basis.,negative,positive,-0.4999404832758059,neutral,-4.045346062052503,negative
2020-10-23 13:51:00.000,420.05,430.5,415.7,417.95,7416138.0,Biocon Q2 net profit down 23% at Rs 195 crore,"It had posted a net profit of Rs 253.8 crore for the July-September quarter previous fiscal, Biocon said in a late-night BSE filing on Thursday.",negative,positive,-0.4999404832758059,neutral,-4.045346062052503,negative
2020-10-23 18:05:40.000,420.05,430.5,415.7,417.95,7416138.0,"Biocon Q2 profits down 23% on higher R&D expenses, forex losses","Biocon, impacted by higher R&amp;D expenses, staff costs and forex losses, has posted 23.01 per cent lower profits for the period to Rs 195.4 crore on a consolidated basis for the second quarter o",negative,negative,-0.4999404832758059,neutral,-4.045346062052503,negative
2020-10-23 18:25:56.000,420.05,430.5,415.7,417.95,7416138.0,"Biocon initiates global phase-3 trials for Itolizumab, holds meeting with USFDA","In India, it commences enrolment for a 300-patient, phase-4 clinical study across 15 centres",positive,neutral,-0.4999404832758059,neutral,-4.045346062052503,negative
2020-10-23 18:47:55.000,420.05,430.5,415.7,417.95,7416138.0,Sebi levies fine on Biocon employee for violating insider trading norms,"The employee, Vandana Singh (noticee), general manager regulatory affair of Biocon at the time of investigation and also a designated person, is facing a fine of Rs 3 lakh for violating provisions of Prohibition of Insider Trading (PIT) norms.",negative,negative,-0.4999404832758059,neutral,-4.045346062052503,negative
2020-10-23 19:11:00.000,420.05,430.5,415.7,417.95,7416138.0,Sebi levies fine on Biocon employee for violating insider trading norms,"Accordingly, Sebi imposed a consolidated fine of Rs 3 lakh on Singh for both the violations -- not obtaining pre-clearance and making delayed disclosures",negative,negative,-0.4999404832758059,neutral,-4.045346062052503,negative
2020-10-23 19:14:00.000,420.05,430.5,415.7,417.95,7416138.0,SEBI levies fine on Biocon employee for violating insider trading norms,"The employee, Vandana Singh (noticee), general manager regulatory affair of Biocon at the time of investigation and also a designated person, is facing a fine of Rs 3 lakh for violating provisions of Prohibition of Insider Trading (PIT) norms.",negative,negative,-0.4999404832758059,neutral,-4.045346062052503,negative
2020-10-23 19:45:00.000,420.05,430.5,415.7,417.95,7416138.0,Strong prospects of Biologics business keep Street positive on Biocon,"Even though Q2 performance missed estimates, analysts expect a stronger second half",positive,positive,-0.4999404832758059,neutral,-4.045346062052503,negative
2020-10-25 12:57:40.000,419.0,419.75,389.75,402.05,9660894.0,"COVID-19 vaccine may be available in India by June 2021, says Kiran Mazumdar Shaw",Chairperson and managing director of Bengaluru-based Biocon Kiran Mazumdar Shaw said a vaccine for COVID-19 could be available in India by June 2021.,neutral,neutral,-4.045346062052503,negative,2.380062305295953,positive
2020-10-25 18:34:30.000,419.0,419.75,389.75,402.05,9660894.0,"Corona vaccine tracker on Oct 25, 2020","India could have a vaccine for its masses by June considering that the country’s 1.4 billion population will throw a massive challenge before the authorities, according to Kiran Mazumdar-Shaw, the head of Biocon Ltd.",neutral,neutral,-4.045346062052503,negative,2.380062305295953,positive
2020-10-26 14:46:00.000,401.25,415.0,401.25,410.8,6326173.0,Biocon dips 11% in three days on disappointing September quarter results,"The company said profitability was impacted on account of higher R&D expenses, staff costs, other expenses and forex losses",negative,negative,2.380062305295953,positive,-1.446808510638295,negative
2020-10-26 14:53:57.000,401.25,415.0,401.25,410.8,6326173.0,Biocon In Talks With More PE Firms For Investment In Biologics Business: Kiran Mazumdar-Shaw,"This is a very capital-intensive business, says Kiran Mazumdar-Shaw.",neutral,neutral,2.380062305295953,positive,-1.446808510638295,negative
2020-10-26 15:38:00.000,401.25,415.0,401.25,410.8,6326173.0,Biocon Biologics bets on insulin glargine ramp-up as it looks overcome a tepid Q2,"Despite the operational challenges posed by Covid-19, Biocon’s biologics division says it is committed to achieve its $1 billion revenue target by the end of FY22.",positive,positive,2.380062305295953,positive,-1.446808510638295,negative
2020-10-26 16:42:00.000,401.25,415.0,401.25,410.8,6326173.0,Why Biocon shares fall over 11% in three sessions,Shares of Biocon fell nearly 7 per cent in intraday trade on the Bombay Stock Exchange on Monday after the biopharmaceutical company reported disappointing earnings for the September quarter,negative,negative,2.380062305295953,positive,-1.446808510638295,negative
2020-10-26 20:33:00.000,401.25,415.0,401.25,410.8,6326173.0,"Biocon Consolidated September 2020 Net Sales at Rs 1,744.80 crore, up 10.98% Y-o-Y",,positive,neutral,2.380062305295953,positive,-1.446808510638295,negative
2020-10-27 14:11:00.000,411.25,416.5,405.0,405.3,3205701.0,Buy Biocon; target of Rs 500: ICICI Direct,"ICICI Direct is bullish on Biocon recommended buy rating on the stock with a target price of Rs 500 in its research report dated October 23, 2020.",neutral,positive,-1.446808510638295,negative,0.4844118743013261,neutral
2020-10-27 16:02:00.000,411.25,416.5,405.0,405.3,3205701.0,Buy Biocon; target of Rs 495: Sharekhan,"Sharekhan is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 495 in its research report dated October 23, 2020.",neutral,positive,-1.446808510638295,negative,0.4844118743013261,neutral
2020-10-27 18:58:00.000,411.25,416.5,405.0,405.3,3205701.0,Neutral Biocon; target of Rs 400: Motilal Oswal,"Motilal Oswal recommended Neutral rating on Biocon with a target price of Rs 400 in its research report dated October 23, 2020.",neutral,positive,-1.446808510638295,negative,0.4844118743013261,neutral
2020-10-28 10:52:00.000,411.25,416.5,405.0,405.3,3205701.0,"Buy Biocon, target price Rs 498: Centrum Broking","Biocon Ltd., incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 49554.00 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-1.446808510638295,negative,0.4844118743013261,neutral
2020-10-29 17:14:00.000,404.3,408.6,398.1,404.5,3085303.0,Sebi imposes fine on Biocon employee for violating insider trading norms,"The investigation carried out by the regulator found that Ravishankar, who held 19,500 shares of the company, acquired through exercise of employee stock option plan (ESOP), sold 5,000 shares in September 2018 without seeking pre-clearance from the compliance officer.",negative,neutral,0.0494682166707862,neutral,-0.1858275520317145,neutral
2020-10-30 00:38:41.000,404.3,408.6,398.1,404.5,3085303.0,"Invest more in medical, clinical research: Biocon MD","‘Need to find solution to COVID-19, other infectious diseases’",neutral,neutral,0.0494682166707862,neutral,-0.1858275520317145,neutral
2020-10-30 12:52:00.000,404.3,408.6,398.1,404.5,3085303.0,Biocon’s partner Equillium gets USFDA nod to begin phase-3 trial of itolizumab on COVID-19 patients,The Phase 3 trial called as EQUINOX will enroll a total of 800 patients at sites in the United States and abroad and include interim assessments at 20 percent and 50 percent of enrollment.,neutral,neutral,0.0494682166707862,neutral,-0.1858275520317145,neutral
2020-10-30 13:52:48.000,404.3,408.6,398.1,404.5,3085303.0,Biocon ranked among top 5 global biotech employers for 2020,"Biocon Ltd, a global biopharmaceuticals company, has been ranked among the Top 5 Global Biotech Employers for 2020 on the US-based Science magazine’s annual ‘Science Careers Top 20 Employers’ list.The",neutral,positive,0.0494682166707862,neutral,-0.1858275520317145,neutral
2020-10-30 14:16:16.000,404.3,408.6,398.1,404.5,3085303.0,Biocon ranked among top five biotech employers globally in ‘Science Careers Top 20 Employers’ list,"According to the ‘Top Employers Survey’ of approximately 7,600 respondents from across the world this year, Biocon said in a statement its ranking was based on three key attributes",neutral,neutral,0.0494682166707862,neutral,-0.1858275520317145,neutral
2020-10-30 14:36:00.000,404.3,408.6,398.1,404.5,3085303.0,"Biocon among top 5 biotech employers; overtakes Moderna, Novo Nordisk","The company said that it has been listed ahead of global pharma companies such as Roche, Eli Lilly, Abbott, Novartis, and Pfizer in this year’s rankings",neutral,neutral,0.0494682166707862,neutral,-0.1858275520317145,neutral
2020-10-30 20:43:26.000,404.3,408.6,398.1,404.5,3085303.0,Biocon ranked among top five biotech employers globally,"Biocon Ltd, a Bengaluru-headquartered biopharmaceuticals company, has been ranked among the Top 5 Global Biotech Employers for 2020 in the U.S.-based Science magazine’s annual‘Science Careers Top 20 E",neutral,positive,0.0494682166707862,neutral,-0.1858275520317145,neutral
2020-11-03 17:03:00.000,406.95,411.9,402.35,409.25,2697550.0,Natural Biocon (India) reports standalone net profit of Rs 0.03 crore in the September 2020 quarter,Sales reported at Rs 0.04 crore,neutral,neutral,0.5651799975426984,neutral,-0.1210653753026634,neutral
2020-11-05 22:04:21.000,415.0,416.9,409.8,414.0,2837865.0,"Biocon plans ₹2,000-crore capex for generics biz","Biocon has planned a cumulative capex of ₹2,000 crore for the generics business over the next three years.The company’s overall capex in generics is spread across the greenfield plant in Vizag, a pept",neutral,neutral,-0.2409638554216867,neutral,-3.6395348837209247,negative
2020-11-06 19:21:03.000,415.0,416.9,409.8,414.0,2837865.0,GITAM’se-convoctiontoday,"The 11th convocation of GITAM Deemed to be University will be held online this year amidst the COVID-19 situation on Saturday (November 7). Chairperson of Biocon Limited Kiran Majumdar Shaw, who will",neutral,neutral,-0.2409638554216867,neutral,-3.6395348837209247,negative
2020-11-08 00:20:04.000,430.0,430.0,413.3,414.35,6553639.0,"Indian biotech cos. have huge opportunities, says Biocon chief","Startups have found many investors, says Kiran Mazumdar Shaw",positive,neutral,-3.6395348837209247,negative,-2.6463896539336638,negative
2020-11-09 08:22:00.000,430.0,430.0,413.3,414.35,6553639.0,"Stocks in the news: ITC, Biocon, SAIL, United Breweries, BHEL, Maruti, Cipla, BEL, Ashok Leyland","SAIL, Allcargo Logistics, BHEL, Tata Consumer, Maruti Suzuki, Cipla, Union Bank of India, Bharat Electronics and Ashok Leyland are some of the stocks which are in news today.",neutral,neutral,-3.6395348837209247,negative,-2.6463896539336638,negative
2020-11-09 08:32:00.000,430.0,430.0,413.3,414.35,6553639.0,"ITC, Cipla, Biocon in focus","ITC posted a 20% fall in standalone net profit to Rs 3232.40 crore in Q2 September 2020 from Rs 4023 crore reported in Q2 September 2019. Net sales fell 3.81% to Rs 11,098.24 crore in Q2 September 2020 over Q2 September 2019.",neutral,negative,-3.6395348837209247,negative,-2.6463896539336638,negative
2020-11-09 09:21:00.000,430.0,430.0,413.3,414.35,6553639.0,Biocon gains after Goldman Sachs injects $150 mln in subsidiary,"Biocon rose 1.81% to Rs 422.25 after the board of Biocon Biologics, the companys subsidiary, approved a Rs 1,125 crore (approximately $150 million) capital injection from Goldman Sachs.",positive,positive,-3.6395348837209247,negative,-2.6463896539336638,negative
2020-11-09 09:38:00.000,430.0,430.0,413.3,414.35,6553639.0,"Stocks in news: RIL, Biocon, Adani Gas, Maruti Suzuki, ITC, Ashok Leyland","Stocks to watch today on November 9: RIL, Biocon, Adani Gas, Maruti Suzuki, ITC, Ashok Leyland among others are the top stocks to watch out for in Monday’s trading session",neutral,neutral,-3.6395348837209247,negative,-2.6463896539336638,negative
2020-11-09 12:50:00.000,417.55,417.8,398.05,406.5,6212666.0,"Top stocks in focus: Biocon, Dilip Buildcon, Adani Gas, NTPC, Cipla, ITC",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-2.6463896539336638,negative,1.7804878048780517,positive
2020-11-09 16:01:00.000,417.55,417.8,398.05,406.5,6212666.0,Goldman Sachs investment to set valuation benchmark before Biocon Biologics IPO,"Given the kind of growth trajectory that has been set, this investment and IPO to be extremely important, says Kiran Mazumdar Shaw.",neutral,neutral,-2.6463896539336638,negative,1.7804878048780517,positive
2020-11-09 16:31:00.000,417.55,417.8,398.05,406.5,6212666.0,"Biocon’s arm to receive capital infusion of Rs1,125cr from Goldman Sachs",The transaction is subject to customary approvals and conditions.,neutral,neutral,-2.6463896539336638,negative,1.7804878048780517,positive
2020-11-11 12:23:00.000,415.0,427.7,413.1,424.1,4538337.0,"4 Nifty, 3 pharma names among 40 stocks looked set to rally on MACD","The list included pharma names such as Aurobindo Pharma, Biocon and Pfizer.",positive,neutral,2.192771084337355,positive,2.500589761736264,positive
2020-11-13 08:30:00.000,423.9,435.4,423.35,434.5,4914777.0,"Nifty Pharma index soars over 1% after FM’s unveils new stimulus package; Torrent Pharma, Biocon lead gainers","Of the total PLI scheme, an outlay of Rs15,000cr is set for pharmaceuticals and drugs sector.",positive,neutral,2.500589761736264,positive,-0.2293577981651376,neutral
2020-11-13 10:00:00.000,423.9,435.4,423.35,434.5,4914777.0,"Stocks in news: Dr Reddy, Sun Pharma, RIL, Eicher Motors, Biocon, Fortis Healthcare","Stocks to watch today on November 13: Dr Reddy, Sun Pharma, RIL, Eicher Motors, Biocon, Fortis Healthcare among others are the top stocks to watch out for in Friday’s trading session",neutral,neutral,2.500589761736264,positive,-0.2293577981651376,neutral
2020-11-13 16:16:00.000,436.0,438.35,432.2,435.0,413700.0,Bengaluru’s civic workers get surprise gift from Biocon’s Kiran Mazumdar-Shaw,"Biocon founder Kiran Mazumdar-Shaw had decided to send sweet boxes to each one of them as a festival gift. “We take them (poura karmikas) for granted. I thought we should bring some cheer into their life,” Shaw told ET.",neutral,neutral,-0.2293577981651376,neutral,-1.505574071945756,negative
2020-11-14 11:05:00.000,436.0,438.35,432.2,435.0,413700.0,Biocon chief Kiran Mazumdar-Shaw packs a sweet surprise for Bengaluru’s civic workers,"Biocon founder Kiran Mazumdar-Shaw took the help of members of the Bangalore Political Action Committee, a non-partisan citizens grouping, as well as volunteers to distribute the gift in every ward.",positive,neutral,-0.2293577981651376,neutral,-1.505574071945756,negative
2020-11-17 08:39:00.000,435.05,436.35,422.9,428.5,3453901.0,"Nifty Pharma under pressure; Torrent Pharma, Lupin, Biocon drag the performance",Pfizer Inc and its group companies have filed a petition against Aurobindo Pharma Ltd and Dr Reddy’s Laboratories in a US court.,positive,neutral,-1.505574071945756,negative,-1.3494648673801797,negative
2020-11-19 09:05:00.000,422.15,426.8,420.35,422.95,2828469.0,"Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term","Sudarshan Sukhani of s2analytics.com suggests selling Biocon with a stop loss of Rs 434, target at Rs 403 and Dabur India with a stop loss of Rs 520, target at Rs 474.",neutral,neutral,0.1895060997275877,neutral,-0.839045142992203,neutral
2020-11-19 19:04:32.000,423.1,425.95,415.0,419.55,3341540.0,Karnataka set to be half of India’s $100 billion bio-economy by 2025,"Karnataka is well on its path to grow and contribute 50 per cent to the national bio-economy which is expected to cross a $100 billion mark by 2025, said Kiran Mazumdar-Shaw, chairperson of Biocon. Be",neutral,positive,-0.839045142992203,neutral,-0.178147268408551,neutral
2020-11-19 22:07:42.000,423.1,425.95,415.0,419.55,3341540.0,Karnataka may contribute about 50% of India’s $100 bn bio-economy by 2025: Mazumdar-Shaw,"Karnataka is well on its path to grow and contribute 50% to the national bio-economy which is expected to cross a $100 billion mark by 2025, said Kiran Mazumdar-Shaw, chairperson of Biocon.Speaking at",neutral,positive,-0.839045142992203,neutral,-0.178147268408551,neutral
2020-11-20 21:38:00.000,423.1,425.95,415.0,419.55,3341540.0,"Karnataka bioeconomy grows 17%, contributes 10% to state GDP","Kiran Mazumdar-Shaw, Chairperson of Karnataka’s Vision Group on Biotechnology & Biocon group said that even if the current growth trends continue to be impacted by COVID-19 hiccups, Karnataka is estimated to reach $42 billion by 2025",positive,positive,-0.839045142992203,neutral,-0.178147268408551,neutral
2020-11-23 05:30:00.000,421.0,425.3,417.6,420.25,7775442.0,BRIEF-Biocon to Buy 26% Stake in Hinduja Renewables Two - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.178147268408551,neutral,3.113531431277371,positive
2020-11-23 10:18:00.000,421.0,425.3,417.6,420.25,7775442.0,Biocon to acquire a 26% equity stake in Hinduja Renewables on a fully diluted basis,HRTPL is a special purpose vehicle formed for power generation and developing a captive power plant as per Electricity laws.,neutral,neutral,-0.178147268408551,neutral,3.113531431277371,positive
2020-11-23 18:17:33.000,422.35,436.0,418.1,435.5,6931577.0,Biocon to buy 26% stake in Hinduja Renewables Two,"Incorporated recently, Hinduja Renewables Two Private Limited will develop 19.77 MW wind power (captive) in Raichur.",neutral,neutral,3.113531431277371,positive,-4.568181818181824,negative
2020-11-23 19:07:00.000,422.35,436.0,418.1,435.5,6931577.0,Biocon to acquire 26% stake in Hinduja Renewables Two,"The cost of the acquisition is Rs 5,91,61,730 for the acquisition of 26 percent stake on a fully diluted basis in one or more tranches, it added.",neutral,neutral,3.113531431277371,positive,-4.568181818181824,negative
2020-11-24 07:28:00.000,422.35,436.0,418.1,435.5,6931577.0,"Stocks in the news: Coal India, IIFL Finance, Indiabulls Housing, Biocon, JK Tyre and Aavas Financiers",Ircon International said it has received a Rs 723 crore work order from the National Capital Region Transport Corporation (NCRTC).,neutral,positive,3.113531431277371,positive,-4.568181818181824,negative
2020-11-24 08:40:00.000,422.35,436.0,418.1,435.5,6931577.0,"Nifty Pharma picks up pace as investors turn bullish; Aurobindo Pharma, Biocon rallies","Dr Reddy’s Laboratories , Sun Pharma and Lupin were also among the top gainers to trade over 1%.",positive,positive,3.113531431277371,positive,-4.568181818181824,negative
2020-11-24 09:27:00.000,422.35,436.0,418.1,435.5,6931577.0,Biocon gains on picking up 26% stake in renewables firm,Biocon rose 0.80% to Rs 423.25 after the company announced the acquisition of 26% stake in Hinduja Renewables Two (HRTPL).,positive,positive,3.113531431277371,positive,-4.568181818181824,negative
2020-11-24 09:35:00.000,422.35,436.0,418.1,435.5,6931577.0,"Stocks in news: Reliance Industries, GMR Infra, Coal India, Indian Oil Corp, Biocon","Stocks to watch today on November 24: Reliance Industries, GMR Infra, Coal India, Indian Oil Corp, Biocon among others are the top stocks to watch out for in Tuesday’s trading session",neutral,neutral,3.113531431277371,positive,-4.568181818181824,negative
2020-11-24 23:03:00.000,440.0,444.0,418.65,419.9,6126195.0,Hopefully DCGI to give nod for Oxford’s vaccine immediately: Biocon chief,"India saw 37,975 new coronavirus infections in a day taking the countrys Covid-19 caseload to 91.77 lakh",neutral,neutral,-4.568181818181824,negative,1.1480648597467211,positive
2020-11-25 08:24:00.000,440.0,444.0,418.65,419.9,6126195.0,"Nifty Pharma in a huge selloff, nosedives 1.5%; Aurobindo, Biocon, Sun Pharma laggards","On the index, major laggards were - Aurobindo Pharma, Biocon and Sun Pharma tumbling over 2% each.",neutral,negative,-4.568181818181824,negative,1.1480648597467211,positive
2020-11-25 09:04:00.000,440.0,444.0,418.65,419.9,6126195.0,"Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term","Mitessh Thakkar of mitesshthakkar.com recommends buying Biocon with a stop loss of Rs 425, target at Rs 450 and Dr Reddy’s Labs with a stop loss of Rs 4,840, target at Rs 5,130.",neutral,neutral,-4.568181818181824,negative,1.1480648597467211,positive
2020-11-25 13:05:00.000,422.45,427.9,418.25,427.3,3903769.0,Stock market update: Nifty Pharma index falls 1%; Biocon sheds 2%,The index was trading 0.93 per cent down at 11769.9.,neutral,negative,1.1480648597467211,positive,0.3989673785496335,neutral
2020-11-27 08:35:52.000,426.1,435.1,422.3,427.8,14769348.0,Motilal Oswal: Biocon Biologics - Takeaways From The Management Call,Motilal Oswal: Biocon Biologics - Takeaways From The Management Call,neutral,neutral,0.3989673785496335,neutral,-0.6751344547431031,neutral
2020-12-03 15:36:35.000,435.05,444.0,431.45,442.2,6351713.0,Roshni Nadar tops Kotak Wealth and Hurun India’s list of richest women,"Biocon Chairperson Kiran Mazumdar-Shaw is the second-richest woman on the list, with a net worth of 36,600 crore",neutral,neutral,1.6434892541087178,positive,1.1689333483196558,positive
2020-12-03 17:46:17.000,435.05,444.0,431.45,442.2,6351713.0,Kotak Wealth Hurun - Leading Wealthy Women’s 2nd edition | HCL Technologies’ Roshni Nadar is the wealthiest Indian woman; here’s the full list,"With a net worth of Rs 54,850 crore, HCL Technologies Chairperson Roshni Nadar Malhotra is India’s richest women in 2020, according to a study by Kotak Wealth and Hurun India. Biocon Chairperson Kiran Mazumdar-Shaw is the second-richest woman on the list, with a net worth of 36,600 crore, followed b…",neutral,neutral,1.6434892541087178,positive,1.1689333483196558,positive
2020-12-03 18:59:14.000,435.05,444.0,431.45,442.2,6351713.0,"HCL’s Roshni Nadar Tops the List of Richest Women in India, Followed by Biocon’s Kiran Mazumdar-Shaw","A total of 31 women in the list of 100 having a networth of at least Rs 100 crore, prepared by Hurun India and Kotak Wealth, are ‘self-made’.",neutral,neutral,1.6434892541087178,positive,1.1689333483196558,positive
2020-12-03 21:47:44.000,435.05,444.0,431.45,442.2,6351713.0,Covid-19 vaccine: Biocon’s US partner Equillium to withdraw Itolizumab trials,US company says it will not initiate Phase-3 clinical trials after reviewing its efficacy,neutral,neutral,1.6434892541087178,positive,1.1689333483196558,positive
2020-12-04 08:30:55.000,435.05,444.0,431.45,442.2,6351713.0,HCL’s Roshni Nadar richest woman in India; a third of entrants in list self-made,"IT major HCL Technologies’ Roshni Nadar Malhotra has topped a list of the richest women in the country with a networth of Rs 54,850 crore, followed by Biocon’s Kiran Mazumdar-Shaw at Rs 36,600 crore, a report said on Thursday.",neutral,positive,1.6434892541087178,positive,1.1689333483196558,positive
2020-12-04 16:02:17.000,435.05,444.0,431.45,442.2,6351713.0,Biocon may explore govt research initiatives for Itolizumab,The company already had emergency-use approval for the drug from DCGI,neutral,positive,1.6434892541087178,positive,1.1689333483196558,positive
2020-12-07 13:32:21.000,451.0,459.0,440.55,446.0,6237230.0,Biocon Ltd sees good buying,"Biocon Ltd is quoting at Rs 450.7, up 1.82% on the day as on 12:49 IST on the NSE. The stock is up 55.84% in last one year as compared to a 11.67% spurt in NIFTY and a 58.22% spurt in the Nifty Pharma index.",positive,positive,-1.1086474501108647,negative,1.2234818722640002,positive
2020-12-07 18:25:00.000,451.0,459.0,440.55,446.0,6237230.0,"Nifty Pharma rallies by 2% as Covid-19 vaccine progress lifts mood; Sun Pharma, Dr Reddys top gainers","Lupin also advanced 2.49% higher. Biocon (up 1.77%, Auro Pharma (up 1.40%) and Cipla (up 1.02%) also stayed 1% higher.",positive,positive,-1.1086474501108647,negative,1.2234818722640002,positive
2020-12-09 03:55:00.000,445.45,453.55,445.1,450.9,3287618.0,"Biocon’s subsidiary BBL approves allotment of debentures worth Rs1,125cr","The subscription money aggregating to Rs. 1,125 Crores have
been received by BBL from the Investor.",neutral,neutral,1.2234818722640002,positive,0.2873245662504169,neutral
2020-12-09 07:22:00.000,445.45,453.55,445.1,450.9,3287618.0,Nifty Pharma trades higher on positive Covid-19 vaccine news; Dr Reddys drives the performance,"Biocon, Cadila, Divis Lab, Sun Pharma and Lupin were also trading in the green.",positive,neutral,1.2234818722640002,positive,0.2873245662504169,neutral
2020-12-09 11:21:01.000,445.45,453.55,445.1,450.9,3287618.0,"Nirmala Sitharaman, Kiran Mazumdar-Shaw, Roshani Nadar Malhotra in Forbes 2020 list of 100 most powerful women","Union Finance Minister Nirmala Sitharaman, US Vice President-elect Kamala Harris, Biocon Founder Kiran Mazumdar-Shaw and HCL Enterprise CEO Roshni Nadar Malhotra have been named among the world s 100 most powerful women by Forbes.",neutral,neutral,1.2234818722640002,positive,0.2873245662504169,neutral
2020-12-09 15:23:12.000,452.45,457.5,446.85,453.75,2504274.0,"Will Take COVID-19 Vaccine; Safety, Efficacy Not A Concern: Kiran Mazumdar-Shaw",The Executive Chairperson of Bengaluru-headquartered biotech major Biocon supported the unprecedented speed in taking the vaccine from the development stage to approval process.,neutral,positive,0.2873245662504169,neutral,-0.1098901098901098,neutral
2020-12-09 17:04:12.000,452.45,457.5,446.85,453.75,2504274.0,Board of Biocon Biologics allots OCDs aggregating Rs 1125 cr,On 09 December 2020,neutral,neutral,0.2873245662504169,neutral,-0.1098901098901098,neutral
2020-12-09 17:48:47.000,452.45,457.5,446.85,453.75,2504274.0,"Will Take Covid-19 Vaccine, Safety and Efficacy Not a Concern: Kiran Mazumdar-Shaw",The Executive Chairperson of Bengaluru-headquartered biotech major Biocon supported the unprecedented speed in taking the vaccine from the development stage to approval process.,neutral,positive,0.2873245662504169,neutral,-0.1098901098901098,neutral
2020-12-10 10:42:50.000,452.45,457.5,446.85,453.75,2504274.0,"Roshni Nadar Malhotra, first woman to head a listed Indian IT firm, among Forbes most powerful women list 2020","Finance Minister Nirmala Sitharaman, Biocon Founder Kiran Mazumdar-Shaw and HCL Enterprise CEO Roshni Nadar Malhotra have been named among the world s 100 most powerful women by Forbes 2020.",neutral,neutral,0.2873245662504169,neutral,-0.1098901098901098,neutral
2020-12-14 05:30:00.000,459.0,461.2,450.55,454.8,3238496.0,BRIEF-Biocon - Biocon Biologics & Mylan Get CHMP Recommendation For Approval Of Biosimilar Insulin Aspart - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.9150326797385596,negative,0.0109902187053547,neutral
2020-12-14 10:32:00.000,459.0,461.2,450.55,454.8,3238496.0,"Buy Biocon, target price Rs 480: Motilal Oswal","Biocon Ltd., incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 54366.00 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-0.9150326797385596,negative,0.0109902187053547,neutral
2020-12-14 11:09:47.000,459.0,461.2,450.55,454.8,3238496.0,"Biocon, Mylan’s Diabetic Drug Receives Positive Opinion From European Medicines Agency Committee","""Biocon Biologics and Mylan (a subsidiary of Viatris Inc.) have received a positive opinion from the European Medicines Agency’s committee for medicinal products for human use (CHMP) recommending approval of the market authorisation of Kixelle, a biosimilar Insulin Aspart, which is a rapid acti…",neutral,positive,-0.9150326797385596,negative,0.0109902187053547,neutral
2020-12-14 11:18:29.000,459.0,461.2,450.55,454.8,3238496.0,"Biocon, Mylan’s diabetic drug receives positive opinion from EMA panel",Biotechnology firm Biocon on Monday said its subsidiary Biocon Biologics and Mylan had received a positive opinion from the European Medicines Agency’s Committee for medicinal products for human use (,positive,positive,-0.9150326797385596,negative,0.0109902187053547,neutral
2020-12-14 11:29:00.000,459.0,461.2,450.55,454.8,3238496.0,"Biocon, Mylan’s diabetic drug receives positive opinion from European Medicines Agency",Biocon said the CHMP positive opinion will be considered by the European Commission. The European Commission decision on the approval is expected early next year.,positive,positive,-0.9150326797385596,negative,0.0109902187053547,neutral
2020-12-14 16:30:00.000,454.95,459.9,450.0,455.0,3052744.0,Biocon Biologics and Mylan receive CHMP recommendation for approval of Kixelle,The European Commission decision on the approval is expected early next year.,positive,neutral,0.0109902187053547,neutral,0.1089324618736383,neutral
2020-12-14 18:00:25.000,454.95,459.9,450.0,455.0,3052744.0,Biocon Biologics gets CHMP market authorisation for rapid acting insulin,‘European Commission decision on the approval is expected early next year’,neutral,neutral,0.0109902187053547,neutral,0.1089324618736383,neutral
2020-12-15 05:30:00.000,454.95,459.9,450.0,455.0,3052744.0,BRIEF-Biocon Ltd - Biocon Biologics Signs MoU With CSSC In Tanzania For Affordable Access To Insulins - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,0.0109902187053547,neutral,0.1089324618736383,neutral
2020-12-15 08:49:00.000,454.95,459.9,450.0,455.0,3052744.0,"Budget 2021: India Inc seeks competitive import tariffs, I-T rate cut",Sitharaman held two rounds of discussions with the industry on the first day of the 10-day pre-budget consultation exercise. Biocon chairperson Kiran Mazumder Shaw and Bharti Enterprises vice chairman Rakesh Bharti Mittal were among business leaders who attended the meeting.,positive,neutral,0.0109902187053547,neutral,0.1089324618736383,neutral
2020-12-15 08:49:00.000,454.95,459.9,450.0,455.0,3052744.0,"Budget 2021: India Inc seeks competitive import tariffs, I-T rate cut",Sitharaman held two rounds of discussions with the industry on the first day of the 10-day pre-budget consultation exercise. Biocon chairperson Kiran Mazumder Shaw and Bharti Enterprises vice chairman Rakesh Bharti Mittal were among business leaders who attended the meeting.,positive,neutral,0.0109902187053547,neutral,0.1089324618736383,neutral
2020-12-15 18:50:20.000,459.0,462.5,455.4,459.5,3061830.0,Biocon Biologics inks pact with CSSC in Tanzania for its ‘Mission 10 cents’,"Biotechnology major Biocon on Tuesday said its arm Biocon Biologics has signed a pact with the Christian Social Services Commission (CSSC) in Tanzania, in continuation of its ‘Mission 10 cents’, an af",neutral,positive,0.1089324618736383,neutral,-0.0108271979211804,neutral
2020-12-15 19:36:00.000,459.0,462.5,455.4,459.5,3061830.0,Biocon Biologics signs pact with CSSC in Africa to make insulins available for 10 cents,"In Tanzania, there were 897,000 reported cases of diabetes in 2017 and the prevalence of diabetes is 3.6% of the total adult population of 25 million, said the company.",positive,neutral,0.1089324618736383,neutral,-0.0108271979211804,neutral
2020-12-16 07:39:00.000,459.0,462.5,455.4,459.5,3061830.0,"Stocks in news: IDBI Bank, M&M, Embassy REIT, Biocon, and more",Here are the top stocks that are likely to be in focus in today’s trading.,neutral,neutral,0.1089324618736383,neutral,-0.0108271979211804,neutral
2020-12-16 07:48:07.000,459.0,462.5,455.4,459.5,3061830.0,"Stocks In The News | M&M, Shilpa Medicare, PNB, Biocon, IDBI Bank, Majesco, Shree Cement, JSPL, HDFC","Stocks in the news | M&M, Shilpa Medicare, PNB, Biocon, IDBI Bank, Majesco, Shree Cement, JSPL, HDFC and SREI Infra are some of the stocks which are in news today.",neutral,neutral,0.1089324618736383,neutral,-0.0108271979211804,neutral
2020-12-16 08:45:00.000,459.0,462.5,455.4,459.5,3061830.0,Pharma stocks overcome morning lows to trade ~1% higher; Divi’s Lab gains the most,"Lupin, (up 1.64%) Torrent Pharma (up 1.34%) and Biocon (up 1.15%) were also well over 1% to drive the Pharma sector.",positive,positive,0.1089324618736383,neutral,-0.0108271979211804,neutral
2020-12-16 08:45:00.000,459.0,462.5,455.4,459.5,3061830.0,"M&M, Biocon, PVR in focus","Mahindra & Mahindra (M&M) announced that effective 1 January 2021, the company will increase the price of its range of passenger and commercial vehicles, across models. This has been necessitated due to the increase in commodity prices and various",neutral,positive,0.1089324618736383,neutral,-0.0108271979211804,neutral
2020-12-16 09:27:00.000,459.0,462.5,455.4,459.5,3061830.0,Biocon Biologics inks pact with CSSC in Tanzania for its ‘Mission 10 cents’,"Biocon Biologics, a subsidiary of Biocon, signed a Memorandum of Understanding (MoU) with the Christian Social Services Commission (CSSC), a faith-based organization active in Africa, to provide affordable access to quality insulin.",neutral,positive,0.1089324618736383,neutral,-0.0108271979211804,neutral
2020-12-16 09:59:00.000,459.0,462.5,455.4,459.5,3061830.0,Biocon’s biosimilars arm signs MoU with CSSC in Tanzania for Mission 10 cents; stock ends 1% higher,Tanzania will be the first country in Africa that will benefit from this collaboration between Biocon Biologics and CSSC.,positive,positive,0.1089324618736383,neutral,-0.0108271979211804,neutral
2020-12-16 12:55:00.000,461.8,466.0,458.95,461.75,2146337.0,"Top stocks in focus: Biocon, HDFC, Axis Bank, IDBI Bank, Embassy Office Parks REIT, HG Infra",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-0.0108271979211804,neutral,2.080624187256182,positive
2020-12-17 13:16:34.000,461.4,473.15,460.2,471.0,4368409.0,Biocon Ltd soars 1.09%,"Biocon Ltd is quoting at Rs 465, up 1.09% on the day as on 12:49 IST on the NSE. The stock is up 58.14% in last one year as compared to a 12.36% spurt in NIFTY and a 56.7% spurt in the Nifty Pharma index.",neutral,positive,2.080624187256182,positive,-5.12765957446809,negative
2020-12-18 17:28:00.000,461.4,473.15,460.2,471.0,4368409.0,Nifty Pharma index maintains upside on vaccine trials; Dr Reddys leads the gains,"DR Reddys led the gains while Biocon, Lupin, and Cipla also continued the winning streak.",positive,positive,2.080624187256182,positive,-5.12765957446809,negative
2020-12-23 08:19:00.000,462.2,487.75,459.1,482.2,4952781.0,"Nifty Pharma climbs over 1% despite new Covid-19 restrictions; Biocon, Aurobinda Pharma soar 3-5%","The index has climbed to an intraday high of 12,745.70.",positive,positive,4.327131112072696,positive,-1.0796915167095116,negative
2020-12-23 10:59:00.000,462.2,487.75,459.1,482.2,4952781.0,Wistron riots: Karnataka CM BS Yediyurappa urged to fix flaws in labour rules,"“The labour department should play a very different role in dispute redressal. There should be a proper grievance redressal system to address issues raised by workers early and ensure the workforce does not take law into their hands,” Biocon founder Kiran Mazumdar-Shaw told ET.",neutral,neutral,4.327131112072696,positive,-1.0796915167095116,negative
2020-12-24 09:09:06.000,486.25,486.25,472.9,481.0,2493796.0,"Top Buy And Sell Ideas By Sudarshan Sukhani, Mitessh Thakkar For Short Term","Mitessh Thakkar of mitesshthakkar.com suggests buying Biocon with a stop loss of Rs 470, target at Rs 505 and Cipla with a stop loss of Rs 807, target at Rs 860.",neutral,neutral,-1.0796915167095116,negative,-0.789080827468541,neutral
2020-12-24 18:15:00.000,486.25,486.25,472.9,481.0,2493796.0,Pharma stocks rally ahead of the festive season amid fresh Covid-19 restrictions; Divis Lab leads,"Pharma majors Cadila, Biocon and Cipla were trading flat. Torrent Pharma and Dr Reddy were on the downside.",positive,neutral,-1.0796915167095116,negative,-0.789080827468541,neutral
2020-12-28 05:30:00.000,468.9,477.5,463.0,465.2,8757707.0,BRIEF-Biocon- Expands Generic Formulations Portfolio With Launch Of Tacrolimus Capsules In US - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.789080827468541,neutral,-3.609653725078696,negative
2020-12-28 07:15:56.000,468.9,477.5,463.0,465.2,8757707.0,"Hot Stocks | Biocon, IndusInd Bank Two Trading Ideas For The Short Term; Here’s Why","A sustainable move beyond 13,780-13,800 would lead to the continuation of the move towards 14,000-14,200 levels.",neutral,positive,-0.789080827468541,neutral,-3.609653725078696,negative
2020-12-28 07:39:00.000,468.9,477.5,463.0,465.2,8757707.0,"Stocks in the news: DLF, Vodafone Idea, Dish TV, Biocon, BPCL and PNB",Vodafone Idea said that it has started using 3G spectrum for 4G services in Mumbai and claimed that customers in the metro city will get higher data speed with the refarming of spectrum.,neutral,positive,-0.789080827468541,neutral,-3.609653725078696,negative
2020-12-28 08:49:00.000,468.9,477.5,463.0,465.2,8757707.0,Nifty Pharma under pressure despite Covid-19 vaccine rollout progress at full swing; Biocon nosedives 3%,"On the index, Biocon was the top underperformer, tumbling by 3.21%.",negative,negative,-0.789080827468541,neutral,-3.609653725078696,negative
2020-12-28 09:56:00.000,468.9,477.5,463.0,465.2,8757707.0,Biocon tanks 4% as USFDA defers decision on Avastin biosimilar application,"Biocon’s arm Biocon Biologics and Mylan, a subsidiary of Viatris Inc, have been informed by the USFDA of a deferred action on the BLA for MYL-1402O, a proposed biosimilar to Avastin (bevacizumab).",neutral,positive,-0.789080827468541,neutral,-3.609653725078696,negative
2020-12-28 10:14:00.000,468.9,477.5,463.0,465.2,8757707.0,Biocon expands generic formulations portfolio with the launch of Tacrolimus capsules in the US,"The launch of Tacrolimus capsules, following an approval from the US FDA in November 2020, underscores Biocon’s relentless pursuit of its mission to make affordable healthcare accessible.",positive,positive,-0.789080827468541,neutral,-3.609653725078696,negative
2020-12-28 10:19:43.000,468.9,477.5,463.0,465.2,8757707.0,"Biocon Share Price Slips After CLSA Retains ‘sell’ Call, Expects Stock To Dip To Rs 250","Biocon Biologics, and Mylan have been informed by the US health regulator of deferred action on the biologics licence application for a biosimilar to drug Avastin, used to treat various types of cancers, Biocon said.",neutral,positive,-0.789080827468541,neutral,-3.609653725078696,negative
2020-12-28 10:19:55.000,468.9,477.5,463.0,465.2,8757707.0,Top 10 Trading Ideas By Experts For January 2021 Series,"Biocon, IndusInd Bank and HUL among the stocks that experts are betting on for short term",neutral,neutral,-0.789080827468541,neutral,-3.609653725078696,negative
2020-12-28 11:13:00.000,468.9,477.5,463.0,465.2,8757707.0,Biocon dips 3% after USFDA informs arm Biocon Biologics of deferred action on Avastin biosimilar license application,"Biocon Biologics spokesperson said,",neutral,neutral,-0.789080827468541,neutral,-3.609653725078696,negative
2020-12-28 13:10:00.000,476.5,476.5,457.35,459.3,7356462.0,"Top stocks in focus: Reliance Industries, Advanced Enzyme Technology, Biocon, Lupin, Cadila, Central Bank of India",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-3.609653725078696,negative,-1.11471861471861,negative
2020-12-28 14:12:00.000,476.5,476.5,457.35,459.3,7356462.0,Biocon slips after USFDA issues deferred action on Avastin biosimilar license application,Biocon fell 3.06% to Rs 467.05 after the US drug regulator issued deferred action on the biologics license application (BLA) for a proposed biosimilar to Avastin (bevacizumab).,neutral,negative,-3.609653725078696,negative,-1.11471861471861,negative
2020-12-28 15:04:05.000,476.5,476.5,457.35,459.3,7356462.0,Dish TV India Ltd leads losers in ‘A’ group,"India Tourism Development Corporation Ltd, Biocon Ltd, Bliss GVS Pharma Ltd and Kiri Industries Ltd are among the other losers in the BSEs A group today, 28 December 2020.",positive,negative,-3.609653725078696,negative,-1.11471861471861,negative
2020-12-28 18:20:30.000,476.5,476.5,457.35,459.3,7356462.0,Biocon launches Tacrolimus capsules in US,"Biopharmaceuticals company Biocon on Monday announced the launch of Tacrolimus capsules in the US. Tacrolimus, a calcineurin inhibitor, is an immunosuppressant used in the treatment of organ transplan",neutral,neutral,-3.609653725078696,negative,-1.11471861471861,negative
2020-12-28 19:42:00.000,476.5,476.5,457.35,459.3,7356462.0,"Biocon: Street to keep an eye on CY21 launches, market share gains",Launch of a cancer drug was delayed due to Covid-19,positive,negative,-3.609653725078696,negative,-1.11471861471861,negative
2020-12-29 07:41:27.000,476.5,476.5,457.35,459.3,7356462.0,"Stocks To Watch: AU Small Finance, Biocon, Cochin Shipyard, Tube Investments",Here are the stocks to watch in trade today,neutral,neutral,-3.609653725078696,negative,-1.11471861471861,negative
2020-12-29 07:46:00.000,476.5,476.5,457.35,459.3,7356462.0,"Nifty Pharma trades under pressure for 2nd straight day; Torrent Pharma, Cadila, Biocon dampens investors mood","The index has touched an intraday low of Rs12,802.85.",positive,negative,-3.609653725078696,negative,-1.11471861471861,negative
2020-12-29 07:59:00.000,476.5,476.5,457.35,459.3,7356462.0,"Stocks in focus: 3i Infotech, Biocon, AU Bank & more",Here are the top stocks that are likely to be in focus in today’s trading.,neutral,neutral,-3.609653725078696,negative,-1.11471861471861,negative
2020-12-29 08:26:20.000,476.5,476.5,457.35,459.3,7356462.0,"Stocks In The News | Biocon, HDFC Bank, SBI Life, GE Shipping, 3i Infotech, Snowman Logistics, Fineotex Chemical","Biocon, HDFC Bank, SBI Life, GE Shipping, Snowman Logistics, Fineotex Chemical, Sutlej Textiles and 3i Infotech are some of the stocks which are in news today.",neutral,neutral,-3.609653725078696,negative,-1.11471861471861,negative
2020-12-29 08:34:00.000,476.5,476.5,457.35,459.3,7356462.0,"Stocks to watch: Wipro, 3i Infotech, Biocon, SBI Life, AU Small Finance","3i Infotech Ltd has entered into definitive agreements to sell its software products business to the funds advised by Apax Partners for Rs 1,000 crore",neutral,positive,-3.609653725078696,negative,-1.11471861471861,negative
2020-12-29 08:44:49.000,476.5,476.5,457.35,459.3,7356462.0,"Stocks in focus: Wipro, PNB, HDFC Bank, Biocon, AU Small Finance Bank, ICICI Prudential Life Insurance","Nifty futures were trading 35 points or 0.25 per cent up at 14,005, suggesting a record high opening for BSE Sensex and Nifty 50 in today’s session",neutral,positive,-3.609653725078696,negative,-1.11471861471861,negative
2020-12-29 08:57:00.000,476.5,476.5,457.35,459.3,7356462.0,"Biocon, Titan Company, TVS Motor in spotlight","Biocon announced the launch of Tacrolimus capsules in the US. Tacrolimus, a calcineurin inhibitor, is an immunosuppressant used in the treatment of organ transplant patients, which reduces the body’s ability to reject a transplanted organ. It has",neutral,positive,-3.609653725078696,negative,-1.11471861471861,negative
2020-12-29 08:59:00.000,476.5,476.5,457.35,459.3,7356462.0,Biocon launches Tacrolimus capsules in US,Biocon said it has expanded generic formulations portfolio with the launch of Tacrolimus capsules in the US.,neutral,positive,-3.609653725078696,negative,-1.11471861471861,negative
2020-12-29 09:27:00.000,476.5,476.5,457.35,459.3,7356462.0,"Stocks in news: Coal India, NTPC, Lupin, Biocon, HDFC Bank, SBI Life","Stocks to watch today on December 29: Coal India, NTPC, Lupin, Biocon, HDFC Bank, SBI Life among others are the top stocks to watch out for in Tuesday’s trading session",neutral,neutral,-3.609653725078696,negative,-1.11471861471861,negative
2020-12-29 09:47:18.000,476.5,476.5,457.35,459.3,7356462.0,Biocon Share Price Rises 2% On Launch Of Tacrolimus Capsules In US,"The share touched its 52-week high Rs 487.70 and 52-week low Rs 235.80 on 23 December, 2020 and 19 March, 2020, respectively.",neutral,negative,-3.609653725078696,negative,-1.11471861471861,negative
2020-12-29 11:41:26.000,476.5,476.5,457.35,459.3,7356462.0,Stocks that moved on December 29,"Dixon Tech, 3i Infotech, Biocon rally",neutral,neutral,-3.609653725078696,negative,-1.11471861471861,negative
2020-12-29 12:20:34.000,462.0,463.65,453.25,456.85,3504206.0,Buy Biocon: Target Of Rs 520: Sharekhan,"Sharekhan is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 520 in its research report dated December 28, 2020.",neutral,positive,-1.11471861471861,negative,1.30718954248366,positive
2020-12-29 13:01:00.000,462.0,463.65,453.25,456.85,3504206.0,"Top stocks in focus: Biocon, AU Small Finance Bank, HDFC Bank, Titan, GE Shipping",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-1.11471861471861,negative,1.30718954248366,positive
2020-12-29 16:35:00.000,462.0,463.65,453.25,456.85,3504206.0,Biocon share rises over 2% post launch of Tacrolimus capsules in US,"Biocon stock opened higher at Rs 475 today and gained 2.1% to hit the day’s high of Rs 475.75 during the session. Although, later the stock erased gains and hit an intraday low of Rs 459.10, against the last close of Rs 465.80",positive,positive,-1.11471861471861,negative,1.30718954248366,positive
2020-12-31 07:58:00.000,459.0,466.95,456.6,465.0,3575778.0,"Pharma stocks rally on hope for Covid-19 vaccine rollout in 2021; Aurobindo Pharma, Biocon, Sun Pharma shines","The index has gained to an intraday high of 12,986.45.",positive,positive,1.30718954248366,positive,-0.1502145922746756,neutral
2021-01-04 12:24:13.000,471.5,471.75,460.85,467.2,2525252.0,Coronavirus Vaccine: India Inc Starts Drawing Roadmap To Vaccinate Employees,"Several companies, including Biocon, Tata Steel, Whirlpool and Arvind Advanced Materials, are planning for vaccination against the novel coronavirus.",neutral,neutral,-0.9119830328738094,negative,-1.7866695196319722,negative
2021-01-07 05:30:00.000,461.5,464.1,453.85,455.5,3177716.0,BRIEF-Biocon Says Biocon Biologics Gets 5.55 Bln Rupees Capital Injection From ADQ - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-1.3001083423618636,negative,-0.3968679609567663,neutral
2021-01-07 08:35:00.000,461.5,464.1,453.85,455.5,3177716.0,Pharma stocks under pressure; Lupin offsets losses by surging 2%,"Divis Lab leads the laggards to drag the Pharma sector. Biocon, Auro Pharma, Sun Pharma and Dr Reddy were also under extreme selling pressure.",positive,positive,-1.3001083423618636,negative,-0.3968679609567663,neutral
2021-01-07 17:05:17.000,466.15,467.95,461.25,464.3,5476694.0,"Sovereign Wealth Fund ADQ To Invest $75 Million In Biocon Biologics, Deal Values Firm At Around $4 Billion","The current investment has put the post-money valuation of Biocon Biologics at ~$4.17 billion, said Kiran Mazumdar-Shaw, Executive Chairperson of Biocon",neutral,neutral,-0.3968679609567663,neutral,1.3666200365866832,positive
2021-01-07 18:37:00.000,466.15,467.95,461.25,464.3,5476694.0,Abu Dhabi’s ADQ to invest $75 mn in Biocon Biologics for 1.8% stake,"Transaction values firm, which plans to list and is a subsidiary of Biocon, at $4.17 bn",neutral,neutral,-0.3968679609567663,neutral,1.3666200365866832,positive
2021-01-07 18:40:00.000,466.15,467.95,461.25,464.3,5476694.0,Biocon Biologics receives capital infusion of Rs 555 cr from Abu Dhabi based ADQ,"The transaction is subject to customary condition precedents and approvals. Post the completion of this transaction, Biocon will hold 89.89% stake in Biocon Biologics on a fully diluted basis.",neutral,neutral,-0.3968679609567663,neutral,1.3666200365866832,positive
2021-01-07 20:21:00.000,466.15,467.95,461.25,464.3,5476694.0,Biocon Biologics approves primary equity investment by ADQ worth Rs 555 crore,"As per the terms of the proposed agreement, ADQ will invest Rs 555 Crore for a 1.80 per cent minority stake in the biosimilar business, valuing Biocon Biologics at a post money valuation of USD 4.17 billion, Biocon said in a statement.",neutral,neutral,-0.3968679609567663,neutral,1.3666200365866832,positive
2021-01-07 21:52:40.000,466.15,467.95,461.25,464.3,5476694.0,Abu Dhabi-based ADQ to invest Rs 555 crore in Biocon Biologics,"Biocon on Thursday said Abu Dhabi-based ADQ will invest Rs 555 crore in its subsidiary Biocon Biologics.The board of Biocon Biologics has approved a primary equity investment by ADQ, Biocon Ltd said in a statement.As per the terms of the proposed agreement, ADQ will invest Rs 555 cr…",neutral,positive,-0.3968679609567663,neutral,1.3666200365866832,positive
2021-01-07 22:09:25.000,466.15,467.95,461.25,464.3,5476694.0,ADQ to buy 1.8% stake in Biocon arm for ₹555 cr,"Abu Dhabi-based ADQ is to invest ₹555 crore for a 1.8 per cent stake in Biocon Biologics, a subsidiary of Biocon, at a post money valuation of $4.17 billion.From January to November 2020, the company",neutral,neutral,-0.3968679609567663,neutral,1.3666200365866832,positive
2021-01-07 22:41:00.000,466.15,467.95,461.25,464.3,5476694.0,Abu Dhabi-based ADQ picks up minority stake in Biocon Biologics for $75 million,"The transaction values Biocon Biologics at $4.17 billion, said the company in a press release.",neutral,neutral,-0.3968679609567663,neutral,1.3666200365866832,positive
2021-01-08 07:15:58.000,466.15,467.95,461.25,464.3,5476694.0,"Stocks In The News | NHPC, Biocon, Tata Power, IDFC, Sanghvi Brands, AGC Networks","Tata Consultancy Services, Bharat Rasayan, JMT Auto, SE Power, Uttam Sugar Mills, UFO Moviez India, Indo Rama Synthetics, Rane Holdings, are also among the stocks in focus today.",neutral,neutral,-0.3968679609567663,neutral,1.3666200365866832,positive
2021-01-08 07:35:25.000,466.15,467.95,461.25,464.3,5476694.0,"Stocks To Watch: Biocon, HCC, NHPC, ONGC, Tata Power",Here are the stocks to watch in trade today.,neutral,neutral,-0.3968679609567663,neutral,1.3666200365866832,positive
2021-01-08 07:39:00.000,466.15,467.95,461.25,464.3,5476694.0,"Stocks in the news: TCS, Biocon, NTPC, Union Bank, Tata Power and JSW Steel",Power giant NTPC served notices to six states and two Union Territories for non-payment of dues.,neutral,neutral,-0.3968679609567663,neutral,1.3666200365866832,positive
2021-01-08 08:24:00.000,466.15,467.95,461.25,464.3,5476694.0,"Stocks to watch: TCS, Biocon, Bharat Rasayan, Vodafone Idea, Tata Power","Biocon announced that its subsidiary Biocon Biologics has approved a primary equity investment by Abu Dhabi-based ADQ, one of the regions largest holding companies",neutral,positive,-0.3968679609567663,neutral,1.3666200365866832,positive
2021-01-08 08:37:00.000,466.15,467.95,461.25,464.3,5476694.0,"TCS, Biocon, Bharat Rasayan in focus","Tata Consultancy Services (TCS) will declare its December 2020 quarter earnings today, 8 January 2021.",neutral,neutral,-0.3968679609567663,neutral,1.3666200365866832,positive
2021-01-08 08:48:05.000,466.15,467.95,461.25,464.3,5476694.0,"Stocks in focus today: TCS, Vodafone Idea, State Bank of India, Tata Power, Biocon","Nifty futures were trading 32.50 points up at 14,287.50 on Singaporean Exchange, suggesting a gap-up start for BSE Sensex and Nifty 50 on Friday",neutral,positive,-0.3968679609567663,neutral,1.3666200365866832,positive
2021-01-08 08:54:00.000,466.15,467.95,461.25,464.3,5476694.0,Biocon Biologics gets Rs 555 crore capital injection from ADQ,"Biocon announced that the board of its subsidiary Biocon Biologics has approved a primary equity investment by Abu Dhabi based ADQ (ADQ), one of the regions largest holding companies.",neutral,positive,-0.3968679609567663,neutral,1.3666200365866832,positive
2021-01-08 09:06:00.000,466.15,467.95,461.25,464.3,5476694.0,"Stocks in focus: TCS, Biocon Biologics, IndiGo and more","Here are the top stocks that are likely to be in focus in today’s trading. TCS, Biocon Biologics, IndiGo, Tata Power and IDFC.",neutral,neutral,-0.3968679609567663,neutral,1.3666200365866832,positive
2021-01-08 09:29:00.000,466.15,467.95,461.25,464.3,5476694.0,"Stocks in news: TCS, Biocon, Tata Power, Union Bank, Strides Pharma, HCL Tech","Stocks to watch today on January 8: TCS, Biocon, Tata Power, Union Bank, Strides Pharma, HCL Tech among others are the top stocks to watch out for in Friday’s trading session",neutral,neutral,-0.3968679609567663,neutral,1.3666200365866832,positive
2021-01-08 09:38:00.000,466.15,467.95,461.25,464.3,5476694.0,Biocon gains 2% after arm gets Rs 555 crore capital injection from ADQ,"ADQ will invest Rs 555 Crore for a 1.80 per cent minority stake in the biosimilar business, valuing Biocon Biologics at a post money valuation of around $4.17 billion",positive,neutral,-0.3968679609567663,neutral,1.3666200365866832,positive
2021-01-08 09:45:00.000,466.15,467.95,461.25,464.3,5476694.0,Biocon gains 2% as arm receives Rs 555 crore equity investment from ADQ,"Kiran Mazumdar-Shaw, Executive Chairperson at Biocon in a company filing to BSE said, We welcome ADQ as our investment partner as we pursue our shared goal of expanding access to high quality affordable biopharmaceuticals to patients across the globe.",positive,positive,-0.3968679609567663,neutral,1.3666200365866832,positive
2021-01-08 09:51:39.000,466.15,467.95,461.25,464.3,5476694.0,Biocon Shares Up 2% After ADQ Pumps Rs 555 Crore In Subsidiary,"The transaction is subject to customary condition precedents and approvals. Post the completion of this transaction, Biocon Ltd will hold 89.89 percent stake in Biocon Biologics on a fully diluted basis, the company said.",neutral,neutral,-0.3968679609567663,neutral,1.3666200365866832,positive
2021-01-08 10:45:17.000,466.15,467.95,461.25,464.3,5476694.0,From Biocon to Vodafone Idea — Here are All the Top Stocks for Investors,"SGX Nifty which is an indicator of the Nifty50 and Sensex was trading 63.00 points or 0.44 percent higher at 14,273.00 higher at 7 am.",neutral,positive,-0.3968679609567663,neutral,1.3666200365866832,positive
2021-01-08 10:52:47.000,466.15,467.95,461.25,464.3,5476694.0,Biocon Shares Gain On Abu Dhabi’s ADQ Investment In Biosimilar Unit,"This is the fourth equity investment in Biocon Biologics, starting January 2020.",neutral,neutral,-0.3968679609567663,neutral,1.3666200365866832,positive
2021-01-08 11:33:48.000,466.15,467.95,461.25,464.3,5476694.0,"D-Street Buzz: Pharma Stocks Gain Led By Sun Pharma, Biocon; CLSA Picks DRL, Downgrades Aurobindo Pharma","CLSA has a buy on Sun Pharma, Cadila Healthcare and Dr Reddy’s Labs and has a sell on Biocon and Lupin. The research firm has downgraded Aurobindo Pharma to underperform from outperform.",neutral,positive,-0.3968679609567663,neutral,1.3666200365866832,positive
2021-01-08 12:53:00.000,466.15,467.95,461.25,464.3,5476694.0,Covid has been a bit of a deterrent for creating new markets: Kiran Mazumdar Shaw,"Latest funding in Biocon Biologics is a precursor to the IPO. The initial funding of $300 million plus very important to ensure that we remain at a very low debt level, says Kiran Mazumdar Shaw.",neutral,positive,-0.3968679609567663,neutral,1.3666200365866832,positive
2021-01-08 13:00:00.000,466.15,467.95,461.25,464.3,5476694.0,"Top stocks in focus: TCS, Biocon, Tata Power, NHPC",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-0.3968679609567663,neutral,1.3666200365866832,positive
2021-01-08 16:58:00.000,466.15,467.95,461.25,464.3,5476694.0,ADQ to invest Rs555cr in Biocon Biologics for 1.80% stake in biosimilar biz; Biocon zooms 2.5%,"After the completion of the transaction, Biocon’s shareholding in Biocon Biologics will stand at 89.89% on a fully diluted basis.",neutral,neutral,-0.3968679609567663,neutral,1.3666200365866832,positive
2021-01-11 17:59:00.000,472.0,474.35,466.1,469.85,3000666.0,Praises pour as four women pilots fly US-Bengaluru nonstop,"A number of well-known personalities including Odisha chief minister Naveen Patnaik, union minister Dharmendra Pradhan, Congress leaders Rahul Gandhi, Mukul Wasnik, and Shashi Tharoor, TDP president N Chandrababu Naidu, Sadhguru Jaggi Vasudev and Biocon founder Kiran Mazumdar-Shaw, and Air India com…",neutral,neutral,-0.4555084745762663,neutral,-1.9809322033898356,negative
2021-01-13 08:47:00.000,472.0,472.2,460.55,462.65,3430011.0,Pharma stocks under pressure in broad self off,"Torrent Pharma, Biocon, Divi’s Labs and Sun Pharma were among the top drags on the pharma index.",negative,neutral,-1.9809322033898356,negative,0.734182681926145,neutral
2021-01-19 17:13:00.000,451.6,453.9,448.05,448.05,2499619.0,India Inc comes to a standstill to watch India’s historic win over Australia,"The moment the match was over - top corporate heads Sundar Pichai, CEO of Alphabet - Google’s parent firm; Anand Mahindra, chairman of Mahindra Group, Harsh Goenka, chairman of RPG; Kiran Mazumdar Shaw, executive chairperson of Biocon; Rishad Premji- chairman of Wipro, among others, posted their rea…",neutral,neutral,-0.7860938883968138,neutral,-2.72527472527472,negative
2021-01-21 07:57:00.000,455.0,455.0,440.15,442.6,3605162.0,"Stocks in the news: RIL, Future Retail, Axis Bank, Bajaj Finance, Asian Paints & Bajaj Auto","SBI Card, Bandhan Bank, Biocon, Mphasis, Kajaria Ceramics, MCX and Mphasis are some of the companies which will announce their Q3 results today.",neutral,neutral,-2.72527472527472,negative,-6.841856060606055,negative
2021-01-21 11:37:00.000,455.0,455.0,440.15,442.6,3605162.0,Biocon Ltd Q3 PAT down -19.7% yoy at Rs187.4cr on higher operating costs,"Biocon Ltd reported 7.82% growth yoy in Dec-20 quarter consolidated revenues at Rs1,851cr",negative,positive,-2.72527472527472,negative,-6.841856060606055,negative
2021-01-21 13:22:00.000,422.4,423.0,376.3,393.5,28315121.0,"Pharma stocks under pressure as heavyweights Cadila, Sun Pharma drag",Biocon was also struggling ahead of declaring quarterly results on Thursday.,negative,negative,-6.841856060606055,negative,-2.772831340625804,negative
2021-01-21 14:32:00.000,422.4,423.0,376.3,393.5,28315121.0,Biocon Biologics appoints director,With effect from 21 January 2021,neutral,neutral,-6.841856060606055,negative,-2.772831340625804,negative
2021-01-21 14:46:00.000,422.4,423.0,376.3,393.5,28315121.0,Biocon Biologics appoints Peter Piot as independent director,Piot was the founding executive director of UNAIDS.,neutral,neutral,-6.841856060606055,negative,-2.772831340625804,negative
2021-01-22 00:56:00.000,422.4,423.0,376.3,393.5,28315121.0,Biocon posts 19% dip in Q3 net profit as generics biz takes a hit,Biocon’s consolidated revenue for Q3 of FY21 increased by 7.20 per cent at Rs 1878.9 crore as against Rs 1752.6 crore for the said quarter last year,negative,positive,-6.841856060606055,negative,-2.772831340625804,negative
2021-01-22 08:04:09.000,422.4,423.0,376.3,393.5,28315121.0,"Stocks In The News | Wipro, Biocon, JK Tyre, HDFC Bank, Vedanta, HDFC, SBI Cards","Indian Energy Exchange, South Indian Bank, SRF, Saint-Gobain, Rolta India, Cyient, MCX India, Aster DM Healthcare, SBI Cards, HDFC, Kirloskar Electric, Bajaj Holdings, Shalimar Paints, IIFL Securities, are also among the stocks in focus today.",neutral,neutral,-6.841856060606055,negative,-2.772831340625804,negative
2021-01-22 08:07:00.000,422.4,423.0,376.3,393.5,28315121.0,Biocon consolidated net profit declines 16.86% in the December 2020 quarter,Sales rise 5.89% to Rs 1851.00 crore,negative,positive,-6.841856060606055,negative,-2.772831340625804,negative
2021-01-22 08:36:00.000,422.4,423.0,376.3,393.5,28315121.0,"Stocks to watch: RIL, YES Bank, Vedanta, HDFC Bank, SBI Card, Biocon",SBI Cards and Payment Services reported nearly 52 per cent dip in its net profit to Rs 210 crore in the third quarter ended December 2020,neutral,negative,-6.841856060606055,negative,-2.772831340625804,negative
2021-01-22 08:40:00.000,422.4,423.0,376.3,393.5,28315121.0,"Biocon, SBI Cards, Bajaj Holdings to be watched","Biocon reported a 16.86% fall in consolidated net profit to Rs 168.60 crore on a 5.33% rise in total income to Rs 1,878.90 crore in Q3 December 2020 over Q3 December 2019.",neutral,negative,-6.841856060606055,negative,-2.772831340625804,negative
2021-01-22 08:59:00.000,422.4,423.0,376.3,393.5,28315121.0,"Biocon reports 17% drop in net profit, Christiane Hamacher steps down as MD of Biocon Biologics","“2020 has been one of the most challenging years for the world with an unprecedented pandemic impact on the global economy. We continue to face headwinds across operational, regulatory and commercial functions which have been deterrents to our planned market expansion. However, we expect normalizati…",negative,negative,-6.841856060606055,negative,-2.772831340625804,negative
2021-01-22 09:30:00.000,422.4,423.0,376.3,393.5,28315121.0,Biocon slumps after Q3 PAT drops 17% YoY,"Biocon tumbled 8.85% to Rs 402.85 after the company’s consolidated net profit fell 16.9% to Rs 169 crore on 8% rise in revenue from operations to Rs 1,851 crore in Q3 FY21 over Q3 FY20.",neutral,negative,-6.841856060606055,negative,-2.772831340625804,negative
2021-01-22 10:02:13.000,422.4,423.0,376.3,393.5,28315121.0,Biocon Share Price Falls 9% After Q3 Profit Dips 18% YoY To Rs 186 Crore,"The generics business reported a 3 percent dip in the third quarter at Rs 561 crore, as against Rs 576 crore in the corresponding period last year.",neutral,negative,-6.841856060606055,negative,-2.772831340625804,negative
2021-01-22 10:09:00.000,422.4,423.0,376.3,393.5,28315121.0,Biocon tanks 10% on lower-than-expected December quarter results,"Due to professional differences with the chairperson on strategic priorities and the vision for the company, Dr Christiane Hamacher has stepped down as the MD of Biocon Biologics",negative,negative,-6.841856060606055,negative,-2.772831340625804,negative
2021-01-22 10:14:06.000,422.4,423.0,376.3,393.5,28315121.0,Biocon net profit down 18 per cent to ₹169 cr on Covid impact,Kiran Mazumdar-Shaw expects normalisation of operational functions by next fiscal,negative,neutral,-6.841856060606055,negative,-2.772831340625804,negative
2021-01-22 11:03:08.000,422.4,423.0,376.3,393.5,28315121.0,Why Biocon’s Stock Tumbled Most In 10 Months,"Shares of Biocon fell as much as 8% — the biggest single-day drop since March 23, 2020.",neutral,negative,-6.841856060606055,negative,-2.772831340625804,negative
2021-01-22 11:55:00.000,422.4,423.0,376.3,393.5,28315121.0,Biocon Q3 results: Net profit falls 19% to Rs 186.6 crore,"The company’s revenue from operations rose to Rs 1,851 crore for the quarter under consideration, up 7.81 per cent, as against Rs 1,716.8 crore during the same period a year ago.",negative,positive,-6.841856060606055,negative,-2.772831340625804,negative
2021-01-22 11:58:39.000,422.4,423.0,376.3,393.5,28315121.0,Biocon Q3 Net Profit Falls 19 Percent to Rs 186.6 crore,Biotechnology major Biocon has reported an 18.,neutral,neutral,-6.841856060606055,negative,-2.772831340625804,negative
2021-01-22 12:00:18.000,422.4,423.0,376.3,393.5,28315121.0,"Biocon Standalone December 2020 Net Sales At Rs 456.10 Crore, Down 9.02% Y-o-Y",,neutral,neutral,-6.841856060606055,negative,-2.772831340625804,negative
2021-01-22 12:00:24.000,422.4,423.0,376.3,393.5,28315121.0,"Biocon Consolidated December 2020 Net Sales At Rs 1,851.00 Crore, Up 5.89% Y-o-Y",,neutral,neutral,-6.841856060606055,negative,-2.772831340625804,negative
2021-01-22 12:10:00.000,422.4,423.0,376.3,393.5,28315121.0,Biocon nosedives 10% after Q3 PAT falls by 19% yoy to Rs187cr,"Biocon’s revenue increased by 7.81% to Rs1,851cr in the quarter under review, against Rs1,716.8cr last year similar quarter.",neutral,positive,-6.841856060606055,negative,-2.772831340625804,negative
2021-01-22 12:19:49.000,422.4,423.0,376.3,393.5,28315121.0,Biocon Q3 net profit falls 19% to ₹186.6 cr,The company had posted a profit of ₹230.3 crore for the corresponding period of the previous fiscal.,positive,positive,-6.841856060606055,negative,-2.772831340625804,negative
2021-01-22 12:22:28.000,422.4,423.0,376.3,393.5,28315121.0,Biocon shares plunge 9% post Q3 results,"The shares of Biocon Limited were down 9 per cent during the morning trade on Friday after the company posted 18 per cent lower profits at ₹169 crore for the third-quarter of FY 2020-21.At 11:15 am, B",negative,negative,-6.841856060606055,negative,-2.772831340625804,negative
2021-01-22 13:07:00.000,422.4,423.0,376.3,393.5,28315121.0,"Market reacts negatively to Biocon’s weaker results, exit of biologics’ MD",Analysts have raised doubts over the $1 billion guidance for biosimilars by FY22 and Hamacher’s exit due to “professional differences”,negative,negative,-6.841856060606055,negative,-2.772831340625804,negative
2021-01-22 15:03:00.000,422.4,423.0,376.3,393.5,28315121.0,"Nifty Pharma underperforms by 1% as Biocon drags most after Q2 result; Cadila, Torrent Pharma also weighs","On Nifty Pharma, 3 scrips advanced and 7 scrips declined.",neutral,neutral,-6.841856060606055,negative,-2.772831340625804,negative
2021-01-22 15:04:24.000,422.4,423.0,376.3,393.5,28315121.0,Steel Authority of India Ltd leads losers in ‘A’ group,"Biocon Ltd, Bandhan Bank Ltd, Tata Steel Ltd Partly Paid Up and RBL Bank Ltd are among the other losers in the BSE’s ‘A’ group today, 22 January 2021.",negative,negative,-6.841856060606055,negative,-2.772831340625804,negative
2021-01-22 15:15:58.000,422.4,423.0,376.3,393.5,28315121.0,Arun Chandavarkar named Biocon Biologics MD,Prof Peter Piot joins Biocon Biologics board,neutral,neutral,-6.841856060606055,negative,-2.772831340625804,negative
2021-01-22 15:36:52.000,422.4,423.0,376.3,393.5,28315121.0,Biocon Biologics reports topline of ₹769 crore in Q3,"The subsidiary of Biocon Ltd raised raised $330 million in the quarter, says CEO Hamacher",neutral,positive,-6.841856060606055,negative,-2.772831340625804,negative
2021-01-22 17:04:00.000,422.4,423.0,376.3,393.5,28315121.0,Biocon share closes 11% lower post Q3 earnings,Biocon share fell 12.66% to intraday low of Rs 386 on BSE. It opened with a loss of 4.06% at Rs 424 against previous close of Rs 441.95,negative,negative,-6.841856060606055,negative,-2.772831340625804,negative
2021-01-22 17:39:00.000,422.4,423.0,376.3,393.5,28315121.0,"Biocon Q3 net profit falls 17% to Rs 169 crore, revenue up 7%","The biosimilars and research services segment posted 11 per cent and 13 per cent growth, respectively, in their income during the quarter, while the generics business recorded a 3 per cent decline",positive,positive,-6.841856060606055,negative,-2.772831340625804,negative
2021-01-22 17:56:15.000,422.4,423.0,376.3,393.5,28315121.0,"Biocon Q3 Review - Subdued Generics, Higher Costs Impact Financials: ICICI Direct","Biocon Q3 Review - Subdued Generics, Higher Costs Impact Financials: ICICI Direct",neutral,neutral,-6.841856060606055,negative,-2.772831340625804,negative
2021-01-22 18:56:55.000,422.4,423.0,376.3,393.5,28315121.0,Biocon Q3 Net Profit Falls 19% To Rs 186.6 Crore,"Expenses rose to Rs 1,642.6 crore for the December quarter, an increase of 14.52 percent, as against Rs 1,434.3 crore in the year-ago period.",neutral,positive,-6.841856060606055,negative,-2.772831340625804,negative
2021-01-22 22:04:51.000,422.4,423.0,376.3,393.5,28315121.0,Christiane Hamacher quits as CEO of Biocon Biologics,Move follows differences with Mazumdar-Shaw,neutral,neutral,-6.841856060606055,negative,-2.772831340625804,negative
2021-01-22 22:19:04.000,422.4,423.0,376.3,393.5,28315121.0,Biocon Q3 net profit falls 19 pc to Rs 186.6 cr,"Biotechnology major Biocon has reported an 18.97 per cent fall in consolidated profit at Rs 186.6 crore for the quarter ended December 31, 2020 on account of higher expenses.",negative,negative,-6.841856060606055,negative,-2.772831340625804,negative
2021-01-22 22:31:28.000,422.4,423.0,376.3,393.5,28315121.0,Biocon’s net slumps 16.7% to ₹169 crore,"Biocon reported a 16.7% dip in net profit to ₹169 crore for the third quarter ended December 31.Revenue from operations rose 7.8% to ₹1,851 crore. Its generics business took a hit and there were headw",negative,positive,-6.841856060606055,negative,-2.772831340625804,negative
2021-01-25 10:00:39.000,393.1,394.3,377.65,382.2,13581787.0,Biocon Share Price Falls 2% After CLSA Retains Sell On Stock,CLSA has retained sell on the stock and has cut target to Rs 240 from Rs 260 per share,neutral,negative,-2.772831340625804,negative,-0.3947368421052631,neutral
2021-01-25 22:29:21.000,393.1,394.3,377.65,382.2,13581787.0,"Delay in award of tenders, higher entry barriers to new markets restricting growth: Kiran Mazumdar Shaw",The nature of these challenges is not linked to the fundamentals of the business: Biocon chief,neutral,neutral,-2.772831340625804,negative,-0.3947368421052631,neutral
2021-01-27 11:29:00.000,380.0,386.95,368.55,378.5,10395200.0,"Add Biocon, target price Rs 453: Centrum Broking","Biocon Ltd., incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 45078.00 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-0.3947368421052631,neutral,0.7834284955517166,neutral
2021-01-28 14:58:37.000,385.0,386.0,369.0,372.45,6595498.0,Hold Biocon; Target Of Rs 450: ICICI Direct,"ICICI Direct recommended hold rating on Biocon with a target price of Rs 450 in its research report dated January 22, 2021.",neutral,positive,-3.2597402597402625,negative,2.182061579651935,positive
2021-01-28 23:28:00.000,385.0,386.0,369.0,372.45,6595498.0,Women’s economic empowerment vital to tackle gender inequality: Biocon head,"Economic empowerment of women is extremely important to bridge the gap of gender inequality,US-India Business Council Vice Chair and Biocon Executive Chair Kiran Mazumdar-Shaw said on Thursday.",neutral,neutral,-3.2597402597402625,negative,2.182061579651935,positive
2021-02-01 16:47:00.000,384.0,394.0,379.1,393.0,4881501.0,"Proposals for healthcare infra, Covid-19 vaccine allocation promising: Kiran Mazumdar Shaw","Stating that the allocation for Covid-19 vaccination, Kiran Mazumdar-Shaw, executive chairperson, Biocon, said the government should also involve the private sector to speed up distribution.",positive,neutral,2.34375,positive,1.299356629241826,positive
2021-02-01 18:36:49.000,384.0,394.0,379.1,393.0,4881501.0,Buy Biocon; Target Of Rs 470: Sharekhan,"Sharekhan is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 470 in its research report dated January 22, 2021.",neutral,positive,2.34375,positive,1.299356629241826,positive
2021-02-02 10:24:00.000,384.0,394.0,379.1,393.0,4881501.0,"After Covid, we need to use the same Rs 35,000 cr on other diseases: Kiran Mazumdar Shaw","Other than Rs 35,000 crore Covid, Rs 64,000 crore is to be spent over six years on health infra. Together it is about Rs 100,000 crore. This is an indicator of how much extra is now going to be the new normal, says Biocon executive chairperson.",neutral,neutral,2.34375,positive,1.299356629241826,positive
2021-02-02 21:11:37.000,396.35,404.9,391.55,401.5,7233136.0,Neutral Biocon; Target Of Rs 385: Motilal Oswal,"Motilal Oswal recommended Neutral rating on Biocon with a target price of Rs 385 in its research report dated January 22, 2021.",neutral,positive,1.299356629241826,positive,1.7412935323383083,positive
2021-02-04 05:30:00.000,402.0,410.9,399.75,409.0,5655689.0,BRIEF-Biocon Biologics To Offer Its Oncology Biosimilars Through Cancer Access Partnership In Over 30 Countries,BRIEF-Biocon Biologics To Offer Its Oncology Biosimilars Through Cancer Access Partnership In Over 30 Countries,neutral,neutral,1.7412935323383083,positive,-2.5616471151544142,negative
2021-02-04 18:04:00.000,417.7,417.7,398.2,407.0,9775947.0,Biocon Biologics signs agreement with Clinton Health Access Initiative,To deliver advance cancer therapies in Africa and Asia,positive,neutral,-2.5616471151544142,negative,0.1349196614743067,neutral
2021-02-04 19:38:00.000,417.7,417.7,398.2,407.0,9775947.0,Biocon Biologics inks pact to expand access to its cancer biosimilars,Biocon Biologics is an arm of biotechnology major Biocon,positive,neutral,-2.5616471151544142,negative,0.1349196614743067,neutral
2021-02-04 19:50:00.000,417.7,417.7,398.2,407.0,9775947.0,"Biocon Biologics to provide cancer biosimilars to 30 countries in Africa, Asia","Biocon Biologics said it aims to deliver substantial savings to healthcare systems by enhancing access and availability of these high-quality and affordable biosimilar cancer therapies in 25 countries in Africa and five countries in Asia, which are currently covered under CAP.",neutral,positive,-2.5616471151544142,negative,0.1349196614743067,neutral
2021-02-04 23:06:32.000,417.7,417.7,398.2,407.0,9775947.0,"Biocon arm, CHAI in pact on affordable cancer therapies","Biocon Biologics, a pure-play biosimilars firm and subsidiary of Biocon Ltd., has signed an agreement with the Clinton Health Access Initiative (CHAI) to expand access to life-saving cancer biosimilar",neutral,positive,-2.5616471151544142,negative,0.1349196614743067,neutral
2021-02-05 07:31:38.000,417.7,417.7,398.2,407.0,9775947.0,"Stocks In The News | Biocon, Tata Power, Adani Transmission, Vedanta, Godrej Agrovet","Stove Kraft, Bharat Electronics, PSP Projects, Container Corporation of India, Trent, Gillette India, Dollar Industries, are also among the stocks in focus today.",neutral,neutral,-2.5616471151544142,negative,0.1349196614743067,neutral
2021-02-05 08:07:00.000,417.7,417.7,398.2,407.0,9775947.0,"Stocks to watch: Stove Kraft, Hero Moto, Britannia, M&M, Biocon, Tata Power",IRFC has sold $750 million worth of dollar-denominated bonds to overseas investors priced at a coupon of just 2.80 per cent per annum,neutral,neutral,-2.5616471151544142,negative,0.1349196614743067,neutral
2021-02-05 08:38:00.000,417.7,417.7,398.2,407.0,9775947.0,Biocon’s arm ties with Clinton Health Access Initiative to offer Oncology Biosimilars in over 30 countries,Biocon highlighted the partnership is a significant step in ensuring equitable access to high-quality biosimilars in low- and middle-income countries (LMICs).,positive,positive,-2.5616471151544142,negative,0.1349196614743067,neutral
2021-02-05 08:58:00.000,417.7,417.7,398.2,407.0,9775947.0,"Stocks in the news: PNB, M&M, Alkem Labs, Container Corp, Trent and Biocon",Here are a few stocks which may buzz the most in today’s trade.,neutral,neutral,-2.5616471151544142,negative,0.1349196614743067,neutral
2021-02-05 09:17:00.000,417.7,417.7,398.2,407.0,9775947.0,Biocon gains as subsidiary offers its oncology biosimilars in over 30 countries,Biocon rose 1.04% to Rs 413.90 after the company’s subsidiary signed an agreement with the Clinton Health Access Initiative (CHAI) to expand access to lifesaving cancer biosimilars in over 30 countries in Africa and Asia.,positive,positive,-2.5616471151544142,negative,0.1349196614743067,neutral
2021-02-05 09:40:00.000,417.7,417.7,398.2,407.0,9775947.0,"Stocks in news: Stove Kraft, FDC, Bharat Electronics, Trent, Biocon, Adani Transmission","Stocks to watch today on February 5: Stove Kraft, FDC, Bharat Electronics, Trent, Biocon, Adani Transmission among others are the top stocks to watch out for in Friday’s trading session",neutral,neutral,-2.5616471151544142,negative,0.1349196614743067,neutral
2021-02-05 13:00:00.000,417.7,417.7,398.2,407.0,9775947.0,"Top stocks in focus: Hero MotoCorp, Vedanta, Biocon, Tata Power, M&M",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-2.5616471151544142,negative,0.1349196614743067,neutral
2021-02-08 08:20:00.000,407.65,413.25,406.1,408.2,3322375.0,Nifty Pharma index trade higher as heavyweight Dr Reddy’s drive,"Auro Pharma, Cipla, Lupin and Biocon are also over 0.50% higher to support the sector. Alkem Lab, Divis Lab and Cadila drag the sector.",positive,neutral,0.1349196614743067,neutral,-0.9779951100244498,negative
2021-02-12 08:18:00.000,407.0,411.25,403.8,407.1,2992386.0,Biocon: European Commission gives marketing approval to Biocon Biologics-Viatris developed Kixelle insulin,"Kixelle is for treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.",neutral,neutral,0.0245700245700301,neutral,-0.4768309084240099,neutral
2021-02-12 09:06:00.000,407.0,411.25,403.8,407.1,2992386.0,Biocon Biologics receives European Commission approval for Kixelle (biosimilar insulin aspart),"Kixelle, a fast-acting insulin analog indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above, has been approved as a 100 units/ml solution
for injection in vial and pre-filled pen presentations.",positive,positive,0.0245700245700301,neutral,-0.4768309084240099,neutral
2021-02-12 09:22:00.000,407.0,411.25,403.8,407.1,2992386.0,Biocon’s unit Biocon Biologics receives approval for Kixelle,"Biocon Biologics, a subsidiary of Biocon has announced that Kixelle, a biosimilar Insulin Aspart co-developed with Viatris Inc, has received marketing authorization approval from the European Commission.",positive,positive,0.0245700245700301,neutral,-0.4768309084240099,neutral
2021-02-12 10:41:00.000,407.0,411.25,403.8,407.1,2992386.0,"Biocon Biologics, Viatris receive EC approval for biosimilar insulin as part Kixelle","Biocon Biologics Ltd., a subsidiary of Bengaluru-headquartered Biocon Ltd., has announced that Kixelle, a biosimilar insulin as part co-developed with NASDAQ-listed Viatris Inc., has received marketing authorisation approval from the European Commission.",positive,positive,0.0245700245700301,neutral,-0.4768309084240099,neutral
2021-02-12 11:13:25.000,407.0,411.25,403.8,407.1,2992386.0,"Biocon Biologics, Viatris Receive EC Approval For Biosimilar Insulin Aspart Kixelle","This follows the positive recommendation by the Committee for Medicinal Products for Human Use of the European Medicines Agency, a Biocon statement said on Friday.",neutral,positive,0.0245700245700301,neutral,-0.4768309084240099,neutral
2021-02-12 15:59:28.000,407.0,411.25,403.8,407.1,2992386.0,"Biocon Biologics, Viatris gets European Commission nod for co-developed diabetes drug","Biocon Biologics Ltd, a subsidiary of Biocon Ltd, has got marketing authorisation approval from the European Commission for Kixelle - a biosimilar Insulin Aspart co-developed with Viatris Inc.The appr",neutral,positive,0.0245700245700301,neutral,-0.4768309084240099,neutral
2021-02-16 09:37:00.000,407.95,418.6,406.25,417.4,5401365.0,Biocon Biologics partners with The International Diabetes Federation,For enabling affordable access to insulin for Diabetes care,neutral,positive,2.3164603505331507,positive,-0.3461033536221479,neutral
2021-02-16 10:45:32.000,407.95,418.6,406.25,417.4,5401365.0,Centenary Celebrations of insulin: Biocon Biologics to partner with International Diabetes Federation,The partnership with IDF coincides with the start of the centenary celebrations of the discovery of insulin and takes forward Biocon Biologics’ mission of enabling affordable access to insulins to people with diabetes worldwide,neutral,positive,2.3164603505331507,positive,-0.3461033536221479,neutral
2021-02-16 11:14:00.000,407.95,418.6,406.25,417.4,5401365.0,Biocon gains on partering IDF to promote diabetes care,"Biocon rose 1.08% to Rs 412 after the company said its subsidiary, Biocon Biologics, partnered International Diabetes Federation (IDF) to promote diabetes care, prevention and effective management worldwide.",positive,positive,2.3164603505331507,positive,-0.3461033536221479,neutral
2021-02-16 11:23:00.000,407.95,418.6,406.25,417.4,5401365.0,Biocon Biologics to partner with International Diabetes Federation,"Global Head of Market Access & Policy, Biocon Biologics, Alexander Zach, said:“Given our extensive experience in providing affordable insulins globally, we believe we can contribute and support IDF in driving real policy and access actions that will transform lives and diabetes care.”",neutral,positive,2.3164603505331507,positive,-0.3461033536221479,neutral
2021-02-16 11:34:12.000,407.95,418.6,406.25,417.4,5401365.0,"Biocon, Bandhan Bank Among 11 Stocks That Brokerages Are Betting On For Double-digit Return","SBI Life Insurance, South Indian Bank, Mphasis and HDFC Life Insurance also figure on the list",neutral,neutral,2.3164603505331507,positive,-0.3461033536221479,neutral
2021-02-17 09:07:04.000,418.95,422.95,415.2,417.5,7368400.0,"Top Buy And Sell Ideas By Sudarshan Sukhani, Mitessh Thakkar For Short Term","Mitessh Thakkar of mitesshthakkar.com suggests buying Bandhan Bank with a stop loss of Rs 344, target at Rs 370 and Biocon with a stop loss of Rs 412, target at Rs 435.",neutral,neutral,-0.3461033536221479,neutral,0.4896106997850517,neutral
2021-02-19 08:01:00.000,419.8,419.8,401.6,404.2,4820988.0,"Nifty Pharma plummets 200 pts on broad-based selloff; Biocon, Cadila drags most","The index has touched an intraday low of 12,236.15.",negative,negative,-3.7160552644116303,negative,-2.209876543209874,negative
2021-02-23 14:24:00.000,388.8,392.45,385.35,389.6,1469744.0,Stock market update: Pharma stocks down; Biocon sheds 3%,The Nifty Pharma index was trading 0.05 per cent down at 12026.75.,negative,negative,0.2057613168724309,neutral,1.863671176921116,positive
2021-02-28 14:36:55.000,395.0,399.0,387.4,397.8,2680964.0,Companies ‘feel betrayed’ due to capping of Covid-19 vaccine price: Kiran Mazumdar Shaw,"Biocon Chairperson Kiran Mazumdar Shaw on Sunday hit out at the government capping Covid-19 vaccine price at Rs 250 at private hospitals, saying vaccine companies ""feel betrayed"" as it is to",neutral,neutral,0.7088607594936738,neutral,0.0502765208647533,neutral
2021-02-28 21:45:24.000,395.0,399.0,387.4,397.8,2680964.0,Companies ‘feel betrayed’ due to capping of COVID-19 vaccine price: Shaw,"Biocon Chairperson Kiran Mazumdar Shaw on Sunday hit out at the government capping COVID-19 vaccine price at Rs 250 at private hospitals, saying vaccine companies “feel betrayed” as it is too low to sustain.",neutral,neutral,0.7088607594936738,neutral,0.0502765208647533,neutral
2021-03-01 05:30:00.000,395.0,399.0,387.4,397.8,2680964.0,BRIEF-Biocon Biologics Promotes Shreehas Tambe To Deputy CEO,BRIEF-Biocon Biologics Promotes Shreehas Tambe To Deputy CEO,neutral,neutral,0.7088607594936738,neutral,0.0502765208647533,neutral
2021-03-01 08:55:00.000,395.0,399.0,387.4,397.8,2680964.0,Biocon’s biosimilars subsidiary Biocon Biologics promotes Shreehas Tambe to Deputy CEO,"Shreehas joined Biocon in 1997 and has, since then, taken on positions of increasing responsibility.",neutral,neutral,0.7088607594936738,neutral,0.0502765208647533,neutral
2021-03-01 09:23:00.000,395.0,399.0,387.4,397.8,2680964.0,Biocon subsidiary and Viatris secure CHMP nod for Abevmy,"Abevmy is a biosimilar to Roche’s Avastin, prescribed for all indications including metastatic colorectal carcinoma, metastatic breast cancer, non-small-cell lung carcinoma, glioblastoma, ovarian, cervical and renal cancer.",neutral,neutral,0.7088607594936738,neutral,0.0502765208647533,neutral
2021-03-01 10:02:10.000,395.0,399.0,387.4,397.8,2680964.0,"Biocon Biologics, Viatris Inc. get CHMP nod for Abevmy, a biosimilar to Avastin","Abevmy is abiosimilar to Roche’s Avastin, prescribed for all indications including metastatic colorectal carcinoma, metastatic breast cancer, non-small-cell lung carcinoma, glioblastoma, ovarian, cervical and renal cancer as part of a specific regimen",neutral,neutral,0.7088607594936738,neutral,0.0502765208647533,neutral
2021-03-01 11:57:00.000,395.0,399.0,387.4,397.8,2680964.0,Biocon may bag approval for cancer drug in European market,"Once approved, the product can be marketed in the 27 European Union (EU) member countries and European Economic Area (EEA) member states of Norway, Iceland and Liechtenstein",positive,neutral,0.7088607594936738,neutral,0.0502765208647533,neutral
2021-03-01 15:43:47.000,397.8,399.9,392.1,398.0,2765051.0,"Biocon Biologics, Viatris get CHMP nod for Abevmy","Drug is a biologic therapy for metastatic colorectal carcinoma, metastatic breast cancer, non-small-cell lung carcinoma, glioblastoma, ovarian, cervical and renal cancer",neutral,neutral,0.0502765208647533,neutral,0.8771929824561403,neutral
2021-03-01 16:34:00.000,397.8,399.9,392.1,398.0,2765051.0,Biocon Biologics promotes Shreehas Tambe as deputy CEO,"A Biocon veteran, Shreehas Tambe joined the company in 1997 and has more than 20 years of leadership experience in operational and strategic roles.",neutral,neutral,0.0502765208647533,neutral,0.8771929824561403,neutral
2021-03-01 18:01:00.000,397.8,399.9,392.1,398.0,2765051.0,"Biocon Biologics receives CHMP nod for Abevmy, a biosimilar to Avastin",The decision of the European Commission is expected in May 2021.,positive,neutral,0.0502765208647533,neutral,0.8771929824561403,neutral
2021-03-01 18:35:08.000,397.8,399.9,392.1,398.0,2765051.0,Shreehas Tambe promoted as Deputy CEO of Biocon Biologics,"Biocon Biologics Ltd, a subsidiary of Biocon Ltd, has promoted Shreehas Tambe to the position of Deputy Chief Executive Officer of Biocon Biologics Limited effective from March 1. A Biocon veteran,",neutral,neutral,0.0502765208647533,neutral,0.8771929824561403,neutral
2021-03-02 06:57:00.000,397.8,399.9,392.1,398.0,2765051.0,Biocon’s biosimilars subsidiary Biocon Biologics appoints Susheel Umesh as Chief Commercial Officer,"Susheel has over 30 years of experience in the pharmaceuticals industry, having worked in India, France and Sub-Saharan Africa.",neutral,neutral,0.0502765208647533,neutral,0.8771929824561403,neutral
2021-03-02 07:12:00.000,397.8,399.9,392.1,398.0,2765051.0,Private equity fund True North acquires minority stake in Bengaluru-based Anthem Bio,"Set up by ex-Biocon executive Ajay Bharadwaj, Rs.1200-crore Anthem Biosciences competes with Biocon owned Syngene International and Hyderabad based GVK Bio. Outbidding global buyout funds, private equity fund True North is all set to acquire a minority stake in Anthem Biosciences, ET reported in Jan…",neutral,positive,0.0502765208647533,neutral,0.8771929824561403,neutral
2021-03-02 09:47:00.000,397.8,399.9,392.1,398.0,2765051.0,"Infy trio, Biocon chief get inoculated","Though most enlisted hospitals could not give the vaccine due to glitches in the Co-Win portal, several senior citizens got inoculated, setting an example for their fellow citizens to shrug off vaccine hesitancy.",neutral,negative,0.0502765208647533,neutral,0.8771929824561403,neutral
2021-03-02 13:11:22.000,399.0,403.8,396.6,402.5,2970205.0,Biocon Biologics appoints Susheel Umesh as Chief Commercial Officer for emerging markets,His appointment comes at a time when the company is setting up a direct commercial presence in many markets,neutral,neutral,0.8771929824561403,neutral,0.1503759398496297,neutral
2021-03-03 08:30:00.000,399.0,403.8,396.6,402.5,2970205.0,"Nifty Pharma index trade higher; Dr Reddys, Sun Pharma lead the gains","Biocon, Divis Lab and Cadila also gain over 1% to support the sector. Alkem Lab shed over 2.5% to drag the sector.",positive,positive,0.8771929824561403,neutral,0.1503759398496297,neutral
2021-03-08 06:55:00.000,396.0,396.95,391.3,392.7,1919832.0,"Nifty Pharma gain 1%; Lupin surges 2%; Cadila, Cipla, Divis Lab contribute to the gains",Alkem Lab and Biocon were marginally in the negative zone.,positive,negative,-0.8333333333333363,neutral,-2.138364779874214,negative
2021-03-08 18:04:08.000,397.5,397.5,385.6,389.0,2591251.0,Biocon Biologics allots 1.97 cr equity shares to Beta Oryz,Powered by Capital Market - Live News,neutral,neutral,-2.138364779874214,negative,2.7551020408163294,positive
2021-03-09 07:42:36.000,397.5,397.5,385.6,389.0,2591251.0,"Buzzing Stocks | Wipro, Kotak Mahindra Bank, Biocon, VIP Clothing, Gabriel India","Nava Bharat Ventures, Greenpanel Industries, Dhunseri Ventures, Zodiac Clothing, Ankit Metal & Power, Rungta Irrigation, Southern Petrochemicals, are also among the stocks in focus today.",neutral,neutral,-2.138364779874214,negative,2.7551020408163294,positive
2021-03-09 08:34:00.000,397.5,397.5,385.6,389.0,2591251.0,"Stocks to watch: BPCL, CIL, Biocon, Mindspace REIT, Jindal Poly Films",Mindspace Business Parks REIT said its arm Gigaplex Estate has entered into an agreement to sub-lease about 6.3 lakh sq ft space in Mumbai to a data centre operator,neutral,positive,-2.138364779874214,negative,2.7551020408163294,positive
2021-03-09 08:42:00.000,397.5,397.5,385.6,389.0,2591251.0,"Wipro, BPCL, Biocon in spotlight","Wipro announced that Appirio, a Wipro company, is helping National Grid transform its business with an omnichannel customer experience by unifying its engagement with 68 million customers across two continents.",neutral,positive,-2.138364779874214,negative,2.7551020408163294,positive
2021-03-09 13:00:00.000,392.0,404.45,388.7,402.8,7933601.0,"Top stocks in focus: Wipro, Biocon, JSW Energy, BPCL, PSP Projects",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,2.7551020408163294,positive,-0.7576698546764405,neutral
2021-03-09 15:21:00.000,392.0,404.45,388.7,402.8,7933601.0,Biocon subsidiary receives subscription amount of Rs555cr from investor; stock trades flat,The board of Biocon Biologics has approved the allotment of ~1.98cr shares at an issue price of Rs280.3 per share.,neutral,neutral,2.7551020408163294,positive,-0.7576698546764405,neutral
2021-03-09 18:20:00.000,392.0,404.45,388.7,402.8,7933601.0,"Nifty Pharma under pressure, index dives 0.7%; Torrent Pharma, Dr Reddy’s, Biocon drags most","Cadila, Lupin and Sun Pharma also traded in the red to complete all negative trade from the Nifty Pharma sector.",neutral,negative,2.7551020408163294,positive,-0.7576698546764405,neutral
2021-03-09 19:52:24.000,392.0,404.45,388.7,402.8,7933601.0,Biocon Biologics joins Cancer Access Partnership to offer life- saving treatment,"Biocon Biologics Ltd has joined a growing list of companies in the Cancer Access Partnership (CAP), which currently includes Novartis, Pfizer, and Viatris.The Clinton Health Access Initiative (CHAI) a",neutral,neutral,2.7551020408163294,positive,-0.7576698546764405,neutral
2021-03-10 14:15:00.000,392.0,404.45,388.7,402.8,7933601.0,Stock market update: Nifty Pharma index rises over 1%; Biocon climbs 3%,The index was trading 1.2 per cent up at 12279.,positive,positive,2.7551020408163294,positive,-0.7576698546764405,neutral
2021-03-10 16:53:16.000,392.0,404.45,388.7,402.8,7933601.0,Nykaa Founder Falguni Nayar Set to Become India’s Second Richest Woman Entrepreneur,"With fashion and cosmetic retailer Nykaa’s latest funding round expected to close by end of this month, founder Falguni Nayar is likely to become India’s second billionaire woman entrepreneur after Biocon Chairperson Kiran Mazumdar Shaw, according to Forbes.",neutral,neutral,2.7551020408163294,positive,-0.7576698546764405,neutral
2021-03-10 18:10:00.000,392.0,404.45,388.7,402.8,7933601.0,Nifty Pharma index rally 1%; Biocon and Lupin led the pack,Cipla and Sun Pharma were also bullish to push the sector further while Torrent Pharma and Alkem Lab lagged.,positive,positive,2.7551020408163294,positive,-0.7576698546764405,neutral
2021-03-11 12:21:00.000,402.55,404.8,397.7,399.5,3744154.0,Kiran Mazumdar-Shaw on ET Awards for Corporate Excellence 2020,"ET Awards Jury member Kiran Mazumdar-Shaw (Chairperson, Biocon), highlights 3 critical attributes of corporate excellence that are being exemplified most in India Inc. today. Join us at The Economic Times Awards for Corporate Excellence on March 20. Register on www.economictimes.com/etawards #ETAwar…",neutral,neutral,-0.7576698546764405,neutral,-1.5085400822840072,negative
2021-03-16 07:08:00.000,396.0,396.0,389.3,391.1,2739381.0,"Nifty Pharma index under pressure as Cipla, Biocon and Divis Lab drags; DR Reddy’s top gainer","Cipla, Biocon and Divis Lab dragged the pharma index most.",positive,negative,-1.2373737373737317,negative,-0.944600459535356,negative
2021-03-17 21:03:31.000,390.0,392.95,383.25,390.2,2760163.0,Analyst corner: Retain buy on Biocon with revised target price of Rs 480,"We assume US biosimilars market to further evolve in terms of reimbursement mechanism, thus, revalidating growth opportunities for players like Biocon.",positive,positive,0.0512820512820483,neutral,2.1345407503234157,positive
2021-03-18 07:25:00.000,390.0,392.95,383.25,390.2,2760163.0,"Nifty Pharma index underperforms 1.5%; DR Reddys, Divis Lab, Cipla drags",Auro Pharma led the losses while Cadila and Lupin were also bearish. Biocon gained 1% amidst gloomy picture.,neutral,positive,0.0512820512820483,neutral,2.1345407503234157,positive
2021-03-19 07:25:00.000,386.5,398.0,385.85,394.75,4194548.0,"Nifty Pharma index surges 1%; Biocon, Torrent Pharma, Divis Lab and DR Reddys in fast lane","Lupin, Cadila, Auro Pharma and Cipla also gained more than 1%. Sun Pharma also advanced 0.82% higher. Alkem Lab was lone laggard.",positive,positive,2.1345407503234157,positive,1.706268958543984,positive
2021-03-22 08:11:00.000,395.6,403.4,394.05,402.35,3708270.0,"Biocon, VIP Ind: Trading calls by Vaishali Parekh of Prabhudas Lilladher",RSI Indicator has given ‘buy’ signals on Biocon and VIP Industries’ stocks,neutral,positive,1.706268958543984,positive,-0.8312655086848691,neutral
2021-03-22 10:36:00.000,395.6,403.4,394.05,402.35,3708270.0,Share price of Biocon Ltd. jumps as Sensex drops 276.75 points,"A total of 77,840 shares changed hands on the counter till 10:36AM (IST)",positive,neutral,1.706268958543984,positive,-0.8312655086848691,neutral
2021-03-22 13:00:00.000,403.0,405.7,398.05,399.65,3432555.0,"Top stocks in focus: Bharti Airtel, Power Grid, Biocon, Adani Green, JSW Energy",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-0.8312655086848691,neutral,0.5527638190954746,neutral
2021-03-22 13:31:20.000,403.0,405.7,398.05,399.65,3432555.0,Biocon Ltd spurts 1.38%,"Biocon Ltd is quoting at Rs 401.15, up 1.38% on the day as on 12:49 IST on the NSE. The stock is up 56.94% in last one year as compared to a 92.34% spurt in NIFTY and a 84.23% spurt in the Nifty Pharma index.",neutral,positive,-0.8312655086848691,neutral,0.5527638190954746,neutral
2021-03-22 16:42:00.000,403.0,405.7,398.05,399.65,3432555.0,Biocon incorporates wholly-owned subsidiary Biofusion Therapeutics; Stock gains,The business of a wholly-owned subsidiary company would be in the field of Research and Development and allied services.,positive,neutral,-0.8312655086848691,neutral,0.5527638190954746,neutral
2021-03-23 20:43:00.000,398.0,403.4,397.7,400.2,2563444.0,Healthcare players welcome government’s decision to allow vaccine for all above 45 years,"In a tweet, Biocon’s Kiran Mazumdar-Shaw said, “From April 1, vaccine for all those who’re 45 or older - a welcome decision that is gradually progressing towards the rest of the general population. By August 15 we will truly celebrate independence from COVID-19.”",positive,positive,0.5527638190954746,neutral,-0.9457441513190672,negative
2021-03-26 14:13:00.000,396.5,399.0,390.75,395.0,4213364.0,Biocon Ltd. shares decline 0.51% as Sensex climbs,"A total of 125,297 shares changed hands on the counter till 02:13PM (IST)",negative,neutral,-0.3783102143757881,neutral,2.1451733599401406,positive
2021-03-29 05:30:00.000,400.9,409.5,399.05,409.5,4166907.0,BRIEF-Biocon Says Biocon Pharma Partners With Libbs Farmaceutica To Launch Generic Formulations In Brazil,BRIEF-Biocon Says Biocon Pharma Partners With Libbs Farmaceutica To Launch Generic Formulations In Brazil,neutral,neutral,2.1451733599401406,positive,-1.3801452784503605,negative
2021-03-29 11:37:37.000,400.9,409.5,399.05,409.5,4166907.0,Biocon Pharma partners with Libbs Farmaceutica to launch generic formulations in Brazil,"Biocon Ltd, an innovation-led global biopharma company, has announced a partnership between Biocon Pharma Limited, a wholly owned subsidiary of Biocon Limited, and Libbs Farmaceutica, a pharmaceutical",positive,positive,2.1451733599401406,positive,-1.3801452784503605,negative
2021-03-29 11:38:54.000,400.9,409.5,399.05,409.5,4166907.0,Biocon enters Latin American market with its generic drugs,"Global biopharmaceutical company Biocon has launched its generic drugs in the Brazil market. The company is making an entry into Latin America with generic formulations through a partnership between Biocon Pharma Limited, a wholly-owned subsidiary of Biocon Limited, and Libbs Farmaceutica. This …",neutral,positive,2.1451733599401406,positive,-1.3801452784503605,negative
2021-03-29 15:37:00.000,400.9,409.5,399.05,409.5,4166907.0,Biocon partners with Libbs Farmaceutica to launch generic drugs in Brazil,"This partnership, which marks the entry of Biocons generic formulations into Latin America, builds upon a successful association with Libbs, which began in 2017 to launch biosimilar Trastuzumab in Brazil.",neutral,positive,2.1451733599401406,positive,-1.3801452784503605,negative
2021-03-29 19:58:44.000,400.9,409.5,399.05,409.5,4166907.0,Biocon forms tie-up with Libbs Farmaceutica,"Biotechnology major Biocon on Monday said its subsidiary has joined hands with Libbs Farmaceutica to launch generic drugs in Brazil.Biocon Pharma, a unit of the company, has tied up with Brazil-based",neutral,positive,2.1451733599401406,positive,-1.3801452784503605,negative
2021-03-29 23:03:57.000,400.9,409.5,399.05,409.5,4166907.0,Biocon ties with Brazil’s Libbs for generic drugs,"Biopharmaceutical major Biocon on Monday said wholly owned subsidiary Biocon Pharma has formed a partnership with Brazilian firm Libbs Farmaceutica to unveil generic drugs in Brazil, the world’s sixth",neutral,positive,2.1451733599401406,positive,-1.3801452784503605,negative
2021-03-30 07:08:58.000,400.9,409.5,399.05,409.5,4166907.0,"Stocks To Watch: JSW Steel, Adani Transmission, Biocon, HPCL",Here’s are the stocks to watch out for in today’s trading session.,neutral,neutral,2.1451733599401406,positive,-1.3801452784503605,negative
2021-03-30 07:31:07.000,400.9,409.5,399.05,409.5,4166907.0,"Stocks to Watch: Biocon, PSBs, HPCL, Manappuram Finance, Coal India",World’s largest miner Coal India is likely to post marginal contraction of its output for the year 2020-21 by 5-6 million tonne in 2020-21 as its production will remain below the 600 million mark,neutral,negative,2.1451733599401406,positive,-1.3801452784503605,negative
2021-03-30 07:46:00.000,400.9,409.5,399.05,409.5,4166907.0,Biocon surges 2% after partnering with Libbs Farmaceutica to launch generic formulations in Brazil,"As per the deal, Biocon Pharma will be responsible for drug development and manufacturing, while Libbs will leverage its deep expertise and reach in Brazil.",positive,neutral,2.1451733599401406,positive,-1.3801452784503605,negative
2021-03-30 08:29:00.000,400.9,409.5,399.05,409.5,4166907.0,"Stocks to watch: Nazara Tech, DRL, Adani Transmission, JSW Steel, Biocon","Pharma major Dr Reddy’s Laboratories (DRL) expects the Russian coronavirus vaccine Sputnik V to get approval from the Indian regulator in the next few weeks, a company official has said",neutral,positive,2.1451733599401406,positive,-1.3801452784503605,negative
2021-03-30 08:40:00.000,400.9,409.5,399.05,409.5,4166907.0,"Nazara Technologies, BPCL, Biocon in focus","Shares of mobile gaming company Nazara Technologies will be listed on the stock exchanges today, 30 March 2021. The Rs 582.91 crore IPO was open for subscription between March 17 and March 19 and the shares were sold in the price band of Rs",neutral,neutral,2.1451733599401406,positive,-1.3801452784503605,negative
2021-03-30 08:47:00.000,400.9,409.5,399.05,409.5,4166907.0,Biocon’s unit announces partnership with Libbs Farmaceutica,"Biocon announced a partnership between Biocon Pharma, its wholly owned subsidiary and Libbs Farmaceutica, a leading pharmaceuticals company in Brazil.",neutral,positive,2.1451733599401406,positive,-1.3801452784503605,negative
2021-03-30 09:13:12.000,400.9,409.5,399.05,409.5,4166907.0,"Coal India, Biocon, HCL Technologies: Top Stocks for Investors Today","The stock market on Friday, March 26, gained over 1 percent to break the two-day losing streak.",neutral,positive,2.1451733599401406,positive,-1.3801452784503605,negative
2021-03-30 09:43:00.000,400.9,409.5,399.05,409.5,4166907.0,Biocon Pharma partners with Libbs Farmaceutica for launch of generic drugs in Brazil,"This partnership, which marks the entry of Biocon’s generic formulations into Latin America, builds upon a successful association with Libbs, which began in 2017 to launch biosimilar Trastuzumab in Brazil. It reflects
Biocon’s commitment to make",neutral,positive,2.1451733599401406,positive,-1.3801452784503605,negative
2021-03-30 10:35:00.000,400.9,409.5,399.05,409.5,4166907.0,Biocon rises 3% as co enters Brazilian generic formulation market,"Chief Executive Officer and Managing Director, Siddharth Mittal, Biocon Ltd, said the association with Libbs Farmaceutica will help his company establish a firm footing in Latin America, starting with Brazil. He said his company is committed to expanding global presence.",positive,positive,2.1451733599401406,positive,-1.3801452784503605,negative
2021-03-30 12:08:00.000,413.0,413.4,405.8,407.3,5201625.0,"Add Biocon, target price Rs 443: ICICI Securities","Biocon Ltd., incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 48372.00 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-1.3801452784503605,negative,0.1955034213098757,neutral
2021-03-30 13:05:00.000,413.0,413.4,405.8,407.3,5201625.0,"Top stocks in focus: Adani Transmission, HPCL, Biocon, Minda Industries, Vascon Engineers",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-1.3801452784503605,negative,0.1955034213098757,neutral
2021-03-30 14:14:00.000,413.0,413.4,405.8,407.3,5201625.0,Biocon share rises 3% on plan to launch generic formulations in Brazil,Biocon share price rose as much as 2.71 per cent to hit intraday high of Rs 406 on the BSE after the biopharma company signed pact with Libbs Farmaceutica to launch generic formulations in Brazil,positive,positive,-1.3801452784503605,negative,0.1955034213098757,neutral
2021-03-31 08:11:00.000,413.0,413.4,405.8,407.3,5201625.0,"Top trading ideas by Ajit Mishra of Religare Broking: Buy Biocon, TVS Motor",The favorable indication from the pharma index is added positive for Biocon’s stock,neutral,positive,-1.3801452784503605,negative,0.1955034213098757,neutral
2021-04-01 09:41:00.000,409.2,413.2,408.8,410.0,1857454.0,Sputnik V Vaccine | Covid-19: More Indian cos could begin manufacturing Sputnik vaccine,"It is indicative that companies like Serum Institute of India (SII), Panacea Biotec and Biocon may also get into manufacturing Sputnik, not immediately but down the line.",neutral,neutral,0.1955034213098757,neutral,-1.0230179028132964,negative
2021-04-01 11:48:00.000,409.2,413.2,408.8,410.0,1857454.0,Biocon Ltd. shares gain 0.45% as Sensex rises,The stock quoted a 52-week high of Rs 487.7 and a 52-week low of Rs 268.2.,positive,negative,0.1955034213098757,neutral,-1.0230179028132964,negative
2021-04-05 01:45:00.000,410.55,410.55,401.55,406.35,1315861.0,"Nifty Pharma index trades lower amid fragile markets; Alkem Lab, DR Reddys, Biocon drag","Sun Pharma, Lupin and Divis Lab also traded in the red. Auro Pharma was the lone gainer at Rs883.10 per piece, up 0.20%.",negative,positive,-1.0230179028132964,negative,1.9183472700442583,positive
2021-04-05 12:15:00.000,406.6,415.55,405.1,414.4,2103997.0,Shares of Biocon Ltd. fall as Nifty drops,"On the technical charts, the 200-day moving average of the stock stood at Rs 420.32.",negative,neutral,1.9183472700442583,positive,-0.6130544536602984,neutral
2021-04-06 12:20:00.000,415.95,418.5,412.45,413.4,2457168.0,Biocon Ltd. rises 1.24% as Sensex climbs,"The stock traded at a P/E multiple of 80.58, while the price-to-book value ratio stood at 4.84.",positive,neutral,-0.6130544536602984,neutral,-0.2294685990338137,neutral
2021-04-07 13:43:00.000,414.0,416.55,411.15,413.05,2081960.0,Biocon shares fall 0.17 per cent in Wednesday’s trading session,The Relative Strength Index of the stock stood at 58.32 on Wednesday.,negative,neutral,-0.2294685990338137,neutral,2.045757172255172,positive
2021-04-08 13:38:00.000,413.05,424.4,412.2,421.5,3197812.0,Biocon shares fall 0.13% as Nifty gains,"A total of 67,698 shares changed hands on the counter till time (IST).",negative,neutral,2.045757172255172,positive,-3.1764986864103206,negative
2021-04-09 10:58:00.000,413.05,424.4,412.2,421.5,3197812.0,Biocon rises 0.99% as Sensex slides,"The stock traded at a P/E multiple of 81.19, while the price-to-book value ratio stood at 4.84.",neutral,neutral,2.045757172255172,positive,-3.1764986864103206,negative
2021-04-09 12:56:13.000,413.05,424.4,412.2,421.5,3197812.0,PE Fund True North Fund Sells Part Stake In IPO Bound Policybazaar: Buyers Include Serum Institute,"True North has launched six separate investment funds with a combined corpus of ~$3 billion including co-investments and its domestic portfolio includes the likes of Biocon Biologics, Fincare and Home First Housing Finance which recently made a market debut.",neutral,neutral,2.045757172255172,positive,-3.1764986864103206,negative
2021-04-12 05:30:00.000,418.7,420.5,401.0,405.4,3589531.0,"BRIEF-Biocon Ltd - Unit Receives GMP Compliance Certificate From MHRA, UK","BRIEF-Biocon Ltd - Unit Receives GMP Compliance Certificate From MHRA, UK",neutral,neutral,-3.1764986864103206,negative,0.1967051880993389,neutral
2021-04-12 09:22:00.000,418.7,420.5,401.0,405.4,3589531.0,Biocon Pharma’s Bengaluru facility receives GMP certification,From UK’s MHRA,neutral,neutral,-3.1764986864103206,negative,0.1967051880993389,neutral
2021-04-12 10:24:00.000,418.7,420.5,401.0,405.4,3589531.0,"Biocon subsidiary bags GMP compliance certificate from MHRA, UK",Biocon Pharma received the GMP compliance certificate for its manufacturing facility at Biocon Park in Bengaluru (Karnataka).,neutral,positive,-3.1764986864103206,negative,0.1967051880993389,neutral
2021-04-12 10:31:00.000,418.7,420.5,401.0,405.4,3589531.0,Biocon share price down 0.1 per cent,"A total of 147,450 shares changed hands on the counter till 10:31AM (IST).",negative,neutral,-3.1764986864103206,negative,0.1967051880993389,neutral
2021-04-12 10:32:00.000,418.7,420.5,401.0,405.4,3589531.0,"Biocon’s subsidiary receives GMP compliance certificate from MHRA, UK","On Sensex, Biocon closed at Rs404.10 per piece down by 3.85%.",neutral,negative,-3.1764986864103206,negative,0.1967051880993389,neutral
2021-04-12 10:55:00.000,418.7,420.5,401.0,405.4,3589531.0,Biocon’s arm gets GMP compliance certificate from UK’s health regulator MHRA for Bengaluru facility,"The certificate, which includes manufacturing and packaging of tablets and capsules in the non-potent and potent blocks of the facility, was issued based on a remote inspection in the week of March 22, 2021, in the wake of travel restrictions amidst COVID-19, the company added.",neutral,neutral,-3.1764986864103206,negative,0.1967051880993389,neutral
2021-04-12 10:58:43.000,418.7,420.5,401.0,405.4,3589531.0,Biocon’s Arm Gets GMP Compliance Certificate From UK’s Health Regulator MHRA For Bengaluru Facility,"“Biocon Pharma Limited, a wholly owned subsidiary of Biocon Limited, has received a certificate of Good Manufacturing Practice (GMP) compliance from the Medicines and Healthcare products Regulatory Agency (MHRA), the United Kingdom (UK), for its manufacturing facility at Biocon Park in Bengaluru,” B…",neutral,neutral,-3.1764986864103206,negative,0.1967051880993389,neutral
2021-04-12 17:39:31.000,406.7,412.35,401.35,407.5,2064625.0,Biocon Pharma gets GMP compliance certificate from MHRA,"Biocon Pharma Limited, a wholly-owned subsidiary of Biocon Limited, has received GMP compliance certificate from MHRA, UK.The company, in a regulatory filing to exchanges, said Biocon Pharma Limited r",neutral,neutral,0.1967051880993389,neutral,-1.6994416120417577,negative
2021-04-12 20:40:38.000,406.7,412.35,401.35,407.5,2064625.0,Biocon Q4 PAT Seen Up 54.1% YoY To Rs. 203.4 Cr: Sharekhan,"Net Sales are expected to increase by 28.3 percent Y-o-Y (up 8 percent Q-o-Q) to Rs. 1,999.6 crore, according to Sharekhan.",neutral,positive,0.1967051880993389,neutral,-1.6994416120417577,negative
2021-04-12 21:53:13.000,406.7,412.35,401.35,407.5,2064625.0,Biocon opens vaccination centre at Syngene for people in Electronic City,"Biocon Group on Monday opened Covid-19 vaccination centre at its Bengaluru campus of Syngene International Limited, as part of the nationwide drive for mass vaccination of individuals above 45 years o",neutral,neutral,0.1967051880993389,neutral,-1.6994416120417577,negative
2021-04-13 12:51:00.000,406.7,412.35,401.35,407.5,2064625.0,Biocon shares rise 1.61 per cent in Tuesday’s trading session,The Relative Strength Index of the stock stood at 53.16 on Tuesday.,positive,neutral,0.1967051880993389,neutral,-1.6994416120417577,negative
2021-04-15 05:35:06.000,411.9,411.9,400.0,404.9,2733275.0,"Biocon’s prospects look good, but Street eyes better execution",Biocon’s prospects have been improving since it unveiled its biosimilars pipeline along with Mylan,positive,positive,-1.6994416120417577,negative,2.196029776674944,positive
2021-04-15 11:59:00.000,411.9,411.9,400.0,404.9,2733275.0,Biocon shares down 1.04% as Nifty falls,The stock quoted a 52-week high price of Rs 487.7 and low of Rs 320.9.,negative,negative,-1.6994416120417577,negative,2.196029776674944,positive
2021-04-15 17:00:00.000,403.0,418.55,399.35,411.85,5664016.0,"Thusday’s Bull: Nifty Pharma soars 2% despite fragile markets; Cipla, Cadila, Sun Pharma drive the index",Biocon was the top underperformer of the day tumbling by 1.13% at Rs402.35 per piece dragging the index.,positive,negative,2.196029776674944,positive,-2.0225263412861865,negative
2021-04-16 14:15:00.000,403.0,418.55,399.35,411.85,5664016.0,Biocon shares rise 2.92% as Nifty gains,The stock quoted a 52-week high price of Rs 487.7 and a 52-week low of Rs 320.9.,positive,negative,2.196029776674944,positive,-2.0225263412861865,negative
2021-04-16 17:42:00.000,403.0,418.55,399.35,411.85,5664016.0,"Nifty Pharma trade higher; Auro Pharma, Cadila gain momentum",Cipla also advanced 0.83% while DR Reddys was up 0.73%. Biocon gained 0.59% while Lupin and Sun Pharma traded higher 0.38% and 0.32% respectively.,positive,positive,2.196029776674944,positive,-2.0225263412861865,negative
2021-04-19 10:46:00.000,412.85,412.85,399.75,404.5,4433255.0,Biocon declines 1.89% as Sensex slides,"The stock traded at a P/E multiple of 79.55, while the price-to-book value ratio stood at 4.84.",negative,neutral,-2.0225263412861865,negative,-2.1831930723258908,negative
2021-04-19 14:24:09.000,409.95,409.95,397.8,401.0,4423208.0,Country Will Have Abundant Supply of Remdesivir by Second Week of May: Kiran Mazumdar Shaw,"Kiran Mazumdar Shaw chief of Biocon, the company which manufactures Remdesivir, said that the country may have an abundant supply of the crucial drug in the country by the second week of May and attributed the shortage to slowed down production as the first wave was seen to have been subsided.",neutral,negative,-2.1831930723258908,negative,-0.7711442786069709,neutral
2021-04-19 18:10:00.000,409.95,409.95,397.8,401.0,4423208.0,"Nifty Pharma Index edges higher despite fragile markets; DR Reddy’s, Cipla lift the performance","Auro Pharma rose nearly 1% while Divis Lab also rallied to gain 0.58%. Biocon dragged the most, shedding 2.10%.",positive,positive,-2.1831930723258908,negative,-0.7711442786069709,neutral
2021-04-20 13:59:00.000,409.95,409.95,397.8,401.0,4423208.0,"Tata Steel, Asian Paints among 21 stocks sending out weak signals on MACD charts","Data showed 21 stocks are showing bearish trends. They included Tata Steel, Biocon, Asian Paints, Dr Lal Pathlabs, Hindustan Unilever, Britannia Industries, Nestle India and Shree Cement.",neutral,negative,-2.1831930723258908,negative,-0.7711442786069709,neutral
2021-04-20 14:04:00.000,409.95,409.95,397.8,401.0,4423208.0,Biocon share price down 0.82 per cent,"A total of 109,100 shares changed hands on the counter till 02:03PM (IST).",negative,neutral,-2.1831930723258908,negative,-0.7711442786069709,neutral
2021-04-22 07:51:26.000,402.0,404.75,398.65,398.9,3837824.0,Demand spikes for Biocon’s repurposed drug,Itolizumab is undergoing Phase 4 trials,neutral,neutral,-0.7711442786069709,neutral,-0.6260172780768749,neutral
2021-04-22 12:12:00.000,399.35,403.35,396.0,396.85,3378383.0,Biocon shares drop 0.27% as Sensex rises,The stock quoted a 52-week high of Rs 487.7 and a 52-week low of Rs 320.9.,negative,negative,-0.6260172780768749,neutral,-1.470588235294112,negative
2021-04-23 10:52:00.000,399.35,403.35,396.0,396.85,3378383.0,Biocon shares drop 0.25% as Sensex rises,"On the technical charts, the RSI of the stock stood at 44.71.",negative,neutral,-0.6260172780768749,neutral,-1.470588235294112,negative
2021-04-26 05:30:00.000,401.2,401.2,395.0,395.3,2453911.0,"BRIEF-Biocon Says Biocon Biologics, Viatris Get European Commission Nod For Biosimilar Bevacizumab","BRIEF-Biocon Says Biocon Biologics, Viatris Get European Commission Nod For Biosimilar Bevacizumab",neutral,neutral,-1.470588235294112,negative,0.949367088607595,positive
2021-04-26 09:34:00.000,401.2,401.2,395.0,395.3,2453911.0,Biocon Biologics receives European Commission approval for biosimilar Bevacizumab,"Abevmy 100 & 400 mg, a biosimilar Bevacizumab, is approved for the treatment in metastatic colorectal carcinoma, metastatic breast cancer, nonsmall-cell lung carcinoma, glioblastoma, ovarian, cervical and renal cancer as part of a specific",positive,positive,-1.470588235294112,negative,0.949367088607595,positive
2021-04-26 10:31:50.000,401.2,401.2,395.0,395.3,2453911.0,"Biocon Biologics, Viatris Receive EC Nod For Biosimilar Bevacizumab","The nod came following the positive recommendation by the Committee for Medicinal Products for Human Use of the European Medicines Agency, it said.",neutral,positive,-1.470588235294112,negative,0.949367088607595,positive
2021-04-26 11:04:00.000,401.2,401.2,395.0,395.3,2453911.0,"Biocon Biologics, Viatris receive approval for cancer drug","Abevmy is approved for treatment in metastatic colorectal carcinoma, metastatic breast cancer, non small-cell lung carcinoma, glioblastoma, ovarian, cervical and renal cancer as part of a specific regimen.",positive,positive,-1.470588235294112,negative,0.949367088607595,positive
2021-04-26 14:31:55.000,395.0,399.05,392.2,398.75,4357730.0,Biocon Ltd extends losing spree,"Biocon Ltd is quoting at Rs 396.9, down 0.18% on the day as on 13:19 IST on the NSE. The stock jumped 9.29% in last one year as compared to a 56.04% rally in NIFTY and a 37.75% spurt in the Nifty Pharma index.",positive,positive,0.949367088607595,positive,-2.07286432160804,negative
2021-04-26 14:52:00.000,395.0,399.05,392.2,398.75,4357730.0,Biocon Biologics and Viatris receives European Commission approval for Biosimilar Bevacizumab,"Abevmy 100 & 400 mg, a biosimilar Bevacizumab, is approved for the treatment in metastatic colorectal carcinoma, metastatic breast cancer, non-small-cell lung carcinoma, glioblastoma, ovarian, cervical and renal cancer as part of a specific regimen.",positive,positive,0.949367088607595,positive,-2.07286432160804,negative
2021-04-27 13:43:00.000,398.0,399.8,387.5,389.75,11332954.0,Share price of Biocon falls as Nifty strengthens,"A total of 112,634 shares changed hands on the counter till 01:43PM (IST).",positive,neutral,-2.07286432160804,negative,1.5463917525773196,positive
2021-04-28 08:06:00.000,398.0,399.8,387.5,389.75,11332954.0,"Stocks in the news: Axis Bank, Info Edge, Biocon, SBI and Bajaj Finserv","Tata Communications, Carborundum Universal, KPR Mill and UTI Asset Management Company, KPIT Tech are among companies which will disclose their quarterly earnings today.",neutral,neutral,-2.07286432160804,negative,1.5463917525773196,positive
2021-04-28 10:09:00.000,398.0,399.8,387.5,389.75,11332954.0,Biocon Biologics’ Monoclonal Antibodies drug wins ’2021 Facility of the Year Award’ by ISPE,"The company received an Honorable Mention award for its monoclonal antibodies drugs substances manufacturing facility located at Biocon Park, Bengaluru.",neutral,positive,-2.07286432160804,negative,1.5463917525773196,positive
2021-04-28 12:08:34.000,388.0,402.25,385.95,394.0,13477713.0,Biocon’s Kiran Mazumdar first Indian to be appointed on board of Sloan Kettering Cancer Centre,"Kiran Mazumdar Shaw, Executive Chairperson, Biocon Ltd has been appointed to the board of trustees of US-based Memorial Sloan Kettering Cancer Center (MSK), a leader in cancer treatment and research. Shaw has become the first Indian woman to be appointed for the role,",neutral,neutral,1.5463917525773196,positive,-3.139356814701381,negative
2021-04-28 12:55:00.000,388.0,402.25,385.95,394.0,13477713.0,"Top stocks in focus: Axis Bank, Britannia, Bajaj Finance, Bajaj Finserv, Biocon",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,1.5463917525773196,positive,-3.139356814701381,negative
2021-04-28 14:15:00.000,388.0,402.25,385.95,394.0,13477713.0,Biocon shares drop 1.86% as Sensex rises,"A total of 402,739 shares changed hands on the counter till 02:15PM (IST)",negative,neutral,1.5463917525773196,positive,-3.139356814701381,negative
2021-04-28 16:46:57.000,388.0,402.25,385.95,394.0,13477713.0,Biocon Biologics’ new monoclonal antibodies facility bags ISPE’s 2021 award,This is the first time that a biopharma company from India has been awarded an ISPE FOYA mention,positive,positive,1.5463917525773196,positive,-3.139356814701381,negative
2021-04-28 17:51:00.000,388.0,402.25,385.95,394.0,13477713.0,Biocon Biologics wins 2021 Facility of the Year Award,From the International Society for Pharmaceutical Engineering,neutral,neutral,1.5463917525773196,positive,-3.139356814701381,negative
2021-04-28 18:47:30.000,388.0,402.25,385.95,394.0,13477713.0,"Biocon Biologics, Viatris get EC nod for biosimilar drug Bevacizumab",The drug is used in treatment of cancer as part of a specific regimen,neutral,neutral,1.5463917525773196,positive,-3.139356814701381,negative
2021-04-29 00:41:54.000,388.0,402.25,385.95,394.0,13477713.0,"Results: Biocon’s revenue up at Rs 2,044 crore in Q4 of FY21","Bangalore-based Biocon reported a 26 per cent rise in consolidated revenue from Rs 1,621 crore in Q4FY20 to Rs 2,044 crore in Q4FY 2021. Indian biopharmaceutical company registered a net profit of over 100 per cent, at Rs 254 crore in Q4FY20.The consolidated revenue grew 14 per cent to Rs …",neutral,positive,1.5463917525773196,positive,-3.139356814701381,negative
2021-04-29 01:03:22.000,388.0,402.25,385.95,394.0,13477713.0,"Stocks to watch out for today: Reliance Industries, Bajaj Finserv, ONGC, Axis Bank, Varun Beverages, Biocon among others","US Fed’s monetary policy decision along with domestic monthly F&O expiry will drive India’s key equity indices on Thursday. On Wednesday, both the indices rallied higher. Besides, broader markets too gained with the majority of the sectors ending in green with banks and financials clearly leading…",neutral,positive,1.5463917525773196,positive,-3.139356814701381,negative
2021-04-29 01:12:27.000,388.0,402.25,385.95,394.0,13477713.0,Biocon drug itolizumab in demand,"Demand for Biocon Biologics’ itolizumab has jumped three-fold from what it was in the first wave of the covid-19 pandemic, fuelled by a shortage of the imported tocilizumab from Cipla",positive,positive,1.5463917525773196,positive,-3.139356814701381,negative
2021-04-29 08:17:00.000,388.0,402.25,385.95,394.0,13477713.0,Biocon consolidated net profit rises 105.19% in the March 2021 quarter,Sales rise 18.05% to Rs 1838.70 crore,positive,positive,1.5463917525773196,positive,-3.139356814701381,negative
2021-04-29 08:18:00.000,388.0,402.25,385.95,394.0,13477713.0,Biocon Q4 results: Net profit grows 105% on strong biosimilar business growth,"For the fiscal year 2020-21, Biocon reported a 1 per cent decline in net profit to Rs 740 crore; while revenue grew 14 per cent to Rs 7360 crore.",positive,negative,1.5463917525773196,positive,-3.139356814701381,negative
2021-04-29 08:25:00.000,388.0,402.25,385.95,394.0,13477713.0,"Biocon logs a whopping 105% yoy growth in Q4 PAT to Rs254cr, revenue stood at Rs2,044cr","Consolidated revenue grew 26% to Rs2,044cr for the quarter from Rs1,621cr in Q4FY20.",positive,positive,1.5463917525773196,positive,-3.139356814701381,negative
2021-04-29 08:53:00.000,388.0,402.25,385.95,394.0,13477713.0,"Stocks in focus: Biocon, Tata Communications, ONGC and more","Stocks in focus: Biocon, Tata Communications, ONGC and more",neutral,neutral,1.5463917525773196,positive,-3.139356814701381,negative
2021-04-29 09:23:00.000,388.0,402.25,385.95,394.0,13477713.0,Biocon allots 6 lakh equity shares to Trust under ESOP,"Consequent to the aforesaid allotment, the revised paid up equity share capital of the company has increased to 120,06,00,000 equity shares of Rs 5 each aggregating Rs 600.30 crore.",neutral,neutral,1.5463917525773196,positive,-3.139356814701381,negative
2021-04-29 09:31:00.000,388.0,402.25,385.95,394.0,13477713.0,Biocon gains after Q4 PAT rises 105% YoY,Biocon rose 1.32% to Rs 396.10 after the company reported 105% jump in consolidated net profit to Rs 254 crore in Q4 FY21 from Rs 123 crore in Q4 FY20.,positive,positive,1.5463917525773196,positive,-3.139356814701381,negative
2021-04-29 09:32:22.000,388.0,402.25,385.95,394.0,13477713.0,Biocon Biologics posts 53% growth in reveunes at ₹664 crore for Q4FY21,"For the full year, revenues have grown 21 per cent to ₹2,800 crore",positive,positive,1.5463917525773196,positive,-3.139356814701381,negative
2021-04-29 09:52:01.000,388.0,402.25,385.95,394.0,13477713.0,Biocon posts profit of ₹254 crore for Q4,"Performance driven by biosimilars, research services and generics businesses",neutral,neutral,1.5463917525773196,positive,-3.139356814701381,negative
2021-04-29 10:58:00.000,388.0,402.25,385.95,394.0,13477713.0,Biocon shares gain 1.32% as Sensex falls,"A total of 480,590 shares changed hands on the counter till 10:57AM (IST)",positive,neutral,1.5463917525773196,positive,-3.139356814701381,negative
2021-04-29 12:03:44.000,391.8,391.8,378.2,379.5,9685307.0,"Biocon Consolidated March 2021 Net Sales At Rs 1,838.70 Crore, Up 16.3% Y-o-Y",,neutral,neutral,-3.139356814701381,negative,-0.6431290195563693,neutral
2021-04-29 13:00:00.000,391.8,391.8,378.2,379.5,9685307.0,"Top stocks in focus: Biocon, Tata Communications, GHCL, Hindustan Unilever, Bajaj Auto",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-3.139356814701381,negative,-0.6431290195563693,neutral
2021-04-29 13:20:00.000,391.8,391.8,378.2,379.5,9685307.0,Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21,"Biocon’s revenue for the said quarter stood at Rs 2,044 crore, showing a growth of 26 per cent. Its EBITDA grew 68 per cent to Rs 641 crore in Q4 of the financial year",positive,positive,-3.139356814701381,negative,-0.6431290195563693,neutral
2021-04-29 13:20:53.000,391.8,391.8,378.2,379.5,9685307.0,"Biocon’s APIs, generic formulations biz posts ₹578 cr revenues","Company faced pricing pressure in the US, travel restrictions delayed approvals & launch new products",neutral,negative,-3.139356814701381,negative,-0.6431290195563693,neutral
2021-04-29 16:16:27.000,391.8,391.8,378.2,379.5,9685307.0,Biocon Q4 Review - Biosimilars Performance Below Expectations: ICICI Direct,Biocon Q4 Review - Biosimilars Performance Below Expectations: ICICI Direct,neutral,neutral,-3.139356814701381,negative,-0.6431290195563693,neutral
2021-04-29 17:04:00.000,391.8,391.8,378.2,379.5,9685307.0,"Nifty Pharma trades higher; Aurobindo top gainer; Heavyweights Biocon, Cadila, Dr Reddy’s lift the index","Serum Institute of India SII, the manufacturer of the Covidshield vaccine has reduced its per dose price from Rs400 to Rs300 for state governments.",positive,positive,-3.139356814701381,negative,-0.6431290195563693,neutral
2021-04-29 20:33:04.000,391.8,391.8,378.2,379.5,9685307.0,Biocon does not declare dividend for FY21,Powered by Capital Market - Live News,neutral,neutral,-3.139356814701381,negative,-0.6431290195563693,neutral
2021-04-30 00:23:00.000,391.8,391.8,378.2,379.5,9685307.0,Biotechnology major Biocon Q4 net profit surges 86% to Rs 296.4 crore,"Biocon has reported 86.29% jump in consolidated profit to Rs 296.4 crore for the quarter ended March 31, 2021",positive,positive,-3.139356814701381,negative,-0.6431290195563693,neutral
2021-04-30 07:06:00.000,391.8,391.8,378.2,379.5,9685307.0,Biocon board decides not to declare dividend for FY21,Biocon registered a 105% yoy growth in its net profit to Rs254cr for the quarter ending March 2021 (Q4FY21) period.,neutral,positive,-3.139356814701381,negative,-0.6431290195563693,neutral
2021-04-30 10:06:12.000,391.8,391.8,378.2,379.5,9685307.0,"Biocon Q4 Review - Approvals, Faster Traction To Lead To Better Future Growth: Motilal Oswal","Biocon Q4 Review - Approvals, Faster Traction To Lead To Better Future Growth: Motilal Oswal",neutral,neutral,-3.139356814701381,negative,-0.6431290195563693,neutral
2021-04-30 13:00:00.000,391.8,391.8,378.2,379.5,9685307.0,"Top stocks in focus: Dr. Reddy’s, Biocon, Escorts, Reliance Industries, IndusInd Bank",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-3.139356814701381,negative,-0.6431290195563693,neutral
2021-04-30 14:15:00.000,391.8,391.8,378.2,379.5,9685307.0,Biocon shares down 3.16% as Sensex falls,"A total of 449,665 shares changed hands on the counter till 02:15PM (IST)",negative,neutral,-3.139356814701381,negative,-0.6431290195563693,neutral
2021-04-30 16:03:57.000,391.8,391.8,378.2,379.5,9685307.0,Biocon Q4 Review - Subdued Biosimilars Impacted Performance: ICICI Securities,Biocon Q4 Review - Subdued Biosimilars Impacted Performance: ICICI Securities,neutral,neutral,-3.139356814701381,negative,-0.6431290195563693,neutral
2021-04-30 22:25:00.000,391.8,391.8,378.2,379.5,9685307.0,Govt should have built safety stock of essential drugs: Kiran Mazumdar-Shaw,The Biocon founder and Executive Chairperson points out that drugs like Remdesivir should be allowed at home as an emergency step,neutral,neutral,-3.139356814701381,negative,-0.6431290195563693,neutral
2021-05-02 22:15:00.000,380.95,381.85,375.1,378.5,3460792.0,"Biocon Biologics provided 7,000 doses of Itolizumab in April","The company does not look at Covid-19 related drugs as a business opportunity; it expects higher growth this fiscal year on the back of new biosimilar launches in both emerging and developed markets, Arun Chandavarkar, managing director of Biocon Biologics, told ET in an interview.",neutral,positive,-0.6431290195563693,neutral,-2.0341207349081363,negative
2021-05-02 23:19:00.000,380.95,381.85,375.1,378.5,3460792.0,"Amid weak showing by biosimilars and generics, downgrade pressure on Biocon",Analysts expect ramp-up in biosimilars to be gradual,negative,positive,-0.6431290195563693,neutral,-2.0341207349081363,negative
2021-05-03 12:04:00.000,381.0,382.15,372.5,373.25,3478485.0,Share price of Biocon falls as Nifty weakens,"A total of 92,797 shares changed hands on the counter till 12:04PM (IST).",neutral,neutral,-2.0341207349081363,negative,1.919999999999997,positive
2021-05-03 14:46:14.000,381.0,382.15,372.5,373.25,3478485.0,Remdesivir Supply Issues Might Ease By Third Week Of May: Biocon’s Kiran Mazumdar-Shaw,The sharp surge in COVID-19 cases across has created a massive demand and consequent shortage of medical oxygen and essential drugs.,neutral,negative,-2.0341207349081363,negative,1.919999999999997,positive
2021-05-03 21:21:20.000,381.0,382.15,372.5,373.25,3478485.0,Biocon ties up with Belagavi-based manufacturer to make Remdesivir,Bio-technology bellwether Biocon has tied up with a Belagavi-based pharmaceutical industry to manufacture Remdesivir injection whose demand has shot up in COVID care hospitals. Sri Anand Life Sciences,positive,positive,-2.0341207349081363,negative,1.919999999999997,positive
2021-05-04 13:11:00.000,375.0,382.6,370.15,382.2,6244874.0,Biocon shares down 0.44% as Nifty drops,"A total of 136,527 shares changed hands on the counter till 01:11PM (IST).",negative,neutral,1.919999999999997,positive,-0.796448622535582,neutral
2021-05-05 13:27:00.000,382.95,384.4,377.4,379.9,3002939.0,Biocon shares gain 1.71% as Sensex rises,The stock quoted a 52-week high of Rs 487.7 and a 52-week low of Rs 320.9.,positive,negative,-0.796448622535582,neutral,-0.0917310968418353,neutral
2021-05-06 00:05:11.000,382.95,384.4,377.4,379.9,3002939.0,Biocon case: Sebi bans 6 entities for 2 years for manipulative trades,"Sebi on Wednesday barred six entities from the capital markets for two years for indulging in manipulative trading in the shares of Biocon Limited in the cash market.Those banned are -- Gangwal Sunil Kumar, Vihit Investment, Mohd Faisal, AKG Securities and Consultancy, Paramount Incorporat…",neutral,neutral,-0.796448622535582,neutral,-0.0917310968418353,neutral
2021-05-06 06:12:09.000,382.95,384.4,377.4,379.9,3002939.0,Biocon share trading case: Sebi bans 6 entities for 2 yrs for manipulative trade,Sebi has imposed a penalty of ₹10 lakh each on them. The penalty needs to be paid within 45 days,neutral,neutral,-0.796448622535582,neutral,-0.0917310968418353,neutral
2021-05-06 07:25:00.000,382.95,384.4,377.4,379.9,3002939.0,"Rs 50,000 crore support boosts pharma counters, index up 4%","Several pharmaceuticals and healthcare stocks including Shilpa Medicare, Aarti Drugs, Granules, Narayana Hrudayalaya, Astrazeneca Pharma, Biocon, Aster DM, Glaxosmithkline Pharma and Abbott India among others are trading 20-40 per cent below their 52-week highs.",positive,negative,-0.796448622535582,neutral,-0.0917310968418353,neutral
2021-05-06 12:17:00.000,381.55,383.95,379.4,381.2,2231538.0,Covid second wave has hit India ‘like a tsunami’ says Kiran Mazumdar Shaw,Biocon founder Kiran Mazumdar Shaw attributed the unprecedented spike in coronavirus cases to the recent state elections and religious festivals in the country,negative,negative,-0.0917310968418353,neutral,0.5612844276204091,neutral
2021-05-06 12:30:00.000,381.55,383.95,379.4,381.2,2231538.0,Biocon shares drop 0.51% as Sensex rises,The stock quoted a 52-week high of Rs 487.7 and a 52-week low of Rs 320.9.,negative,negative,-0.0917310968418353,neutral,0.5612844276204091,neutral
2021-05-06 23:07:59.000,381.55,383.95,379.4,381.2,2231538.0,Second wave of COVID19 has hit India ‘like a tsunami’ says Kiran Mazumdar Shaw,"The second wave of COVID-19 has hit India “like a tsunami”, Biocon founder Kiran Mazumdar Shaw has said, attributing the unprecedented spike in coronavirus cases to the recent state elections and religious festivals in the country.India is struggling with a second wave of the pandemic with…",negative,negative,-0.0917310968418353,neutral,0.5612844276204091,neutral
2021-05-07 10:52:00.000,381.55,383.95,379.4,381.2,2231538.0,Biocon shares up 0.5% as Nifty gains,"A total of 35,213 shares changed hands on the counter till 10:51AM (IST).",positive,neutral,-0.0917310968418353,neutral,0.5612844276204091,neutral
2021-05-10 12:01:02.000,383.55,391.65,382.35,387.2,4088161.0,"Mumbai: NITI Aayog CEO Amitabh Kant, Biocon founder Kiran Mazumdar Shaw lauds BMC for COVID-19 mitigation efforts","Days after the Supreme Court of India hailed the Mumbai model of COVID-19 mitigation, NITI Aayog CEO Amitabh Kant and Biocon founder Kiran Mazumdar Shaw have also lauded the Brihanmumbai Municipal Corporation (BMC) for its management of the second COVID-19 wave.Kant took to Twitter to appl…",neutral,neutral,0.9516360318081024,positive,-0.4772346188572078,neutral
2021-05-10 12:31:00.000,383.55,391.65,382.35,387.2,4088161.0,Share price of Biocon jumps as Sensex gains 349.26 points,"A total of 74,028 shares changed hands on the counter till 12:31PM (IST)",positive,neutral,0.9516360318081024,positive,-0.4772346188572078,neutral
2021-05-10 18:02:18.000,383.55,391.65,382.35,387.2,4088161.0,COVID-19: Kiran Muzumdar Shaw ‘super impressed’ with ‘Mumbai model’; check out Aaditya Thackeray’s reaction,"Biocon founder Kiran Mazumdar Shaw on Monday lauded the Brihanmumbai Municipal Corporation (BMC) for its management of the second COVID-19 wave. Taking to Twitter, Shaw said that she studied the Maharashtra and BMC model of decentralised COVID-19 management and she is super impressed with …",neutral,positive,0.9516360318081024,positive,-0.4772346188572078,neutral
2021-05-11 10:36:00.000,383.55,391.65,382.35,387.2,4088161.0,Biocon shares rise 1.68% as Sensex slides,"A total of 58,205 shares changed hands on the counter till 10:36AM (IST)",positive,neutral,0.9516360318081024,positive,-0.4772346188572078,neutral
2021-05-11 12:09:21.000,387.65,390.5,384.15,385.8,2208227.0,Biocon chief Kiran Mazumdar-Shaw expresses concern over Covid vaccine shortage,"‘My concern comes from why we hear of declining vaccination numbers and some centres not completing their vaccination quotas,’ Biocon chief said",negative,negative,-0.4772346188572078,neutral,0.516795865633075,neutral
2021-05-11 12:11:00.000,387.65,390.5,384.15,385.8,2208227.0,Biocon chief expresses concern over Covid-19 vaccine shortage,Biocon Executive Chairman Kiran Mazumdar-Shaw has expressed concern over shortage of Covid-19 vaccines and sought better transparency from the government.,negative,positive,-0.4772346188572078,neutral,0.516795865633075,neutral
2021-05-11 12:16:58.000,387.65,390.5,384.15,385.8,2208227.0,Biocon Chief Concerned Over COVID-19 Vaccine Shortage,"Concerned due to the shortage of vaccines, Biocon Executive Chairman Kiran Mazumdar Shaw sought better transparency from the government regarding their availability.",neutral,positive,-0.4772346188572078,neutral,0.516795865633075,neutral
2021-05-11 12:37:00.000,387.65,390.5,384.15,385.8,2208227.0,Biocon chief Kiran Mazumdar-Shaw expresses concern over COVID-19 vaccine shortage,"“Very concerned about why vaccines are in such short supply. Can we please know where the 70 million doses are being deployed every month? @MoHFW_INDIA We need better transparency to avoid the suspense. If a timetable of supplies is made public people can patiently wait their turn,” Mazumdar-Shaw sa…",negative,neutral,-0.4772346188572078,neutral,0.516795865633075,neutral
2021-05-11 19:39:38.000,387.65,390.5,384.15,385.8,2208227.0,Biocon chief fears vaccines remain in warehouses instead of being jabbed into peoples’ arms,Biocon Executive Chairman Kiran Mazumdar-Shaw has expressed concern over the shortage of COVID-19 vaccines. She stated that maybe these vaccines are just lying in the warehouse rather than reaching people. She feels this lacuna can only be addressed by bringing in better transparency.Mazum…,neutral,negative,-0.4772346188572078,neutral,0.516795865633075,neutral
2021-05-12 11:24:00.000,387.65,390.5,384.15,385.8,2208227.0,Biocon shares down 0.55% as Nifty drops,"A total of 84,667 shares changed hands on the counter till 11:24AM (IST).",negative,neutral,-0.4772346188572078,neutral,0.516795865633075,neutral
2021-05-14 11:08:00.000,387.0,392.9,386.25,389.0,3418253.0,Biocon shares up 1.1% as Nifty drops,"A total of 60,926 shares changed hands on the counter till 11:08AM (IST).",positive,neutral,0.516795865633075,neutral,-1.968753969262035,negative
2021-05-16 06:58:34.000,393.65,393.65,384.6,385.9,2211146.0,COVID-19: THIS business tycoon just compared India’s vaccination situation to arranged marriage,"New Delhi, May 15 (PTI) Biocon chief Kiran Mazumdar-Shaw has compared the COVID-19 vaccination situation in the country to an arranged marriage.",neutral,neutral,-1.968753969262035,negative,-0.3746286009559458,neutral
2021-05-16 18:55:04.000,393.65,393.65,384.6,385.9,2211146.0,Biocon chief bats for highly decentralised vaccination policy,‘There is a lot of confusion and mismanagement in the programme now’,neutral,negative,-1.968753969262035,negative,-0.3746286009559458,neutral
2021-05-17 07:35:00.000,393.65,393.65,384.6,385.9,2211146.0,Nifty Pharma index under pressure; Cipla tanks ~3%; Torrent Pharma leads,Sun Pharma declined nearly 1% at Rs685.00 per piece while Biocon was also 0.75% on the downside.,neutral,negative,-1.968753969262035,negative,-0.3746286009559458,neutral
2021-05-18 12:53:53.000,383.0,387.5,382.8,386.7,2106865.0,Biocon ‘perplexed’ about Itolizumab not being in Covid protocol,"But will ramp up production, says Chief Medical Officer Sandeep Athalye",neutral,positive,0.9660574412532608,positive,-0.6077848183111253,neutral
2021-05-19 13:37:00.000,386.65,388.4,382.2,384.3,1317924.0,Biocon shares up 0.17% as Nifty drops,"A total of 35,513 shares changed hands on the counter till 01:37PM (IST).",positive,neutral,-0.6077848183111253,neutral,-0.4031209362808872,neutral
2021-05-19 20:24:04.000,386.65,388.4,382.2,384.3,1317924.0,"Sebi fines Biocon, its designated person for violating market norms","Designated person of the firm, Narendra Chirmule, who was employed with the company as senior vice president-R&D is facing a fine of ₹5 lakh for trading in the company’s securities when the trading window was closed",negative,neutral,-0.6077848183111253,neutral,-0.4031209362808872,neutral
2021-05-19 21:15:00.000,386.65,388.4,382.2,384.3,1317924.0,SEBI fines Biocon for violating market norms,"Designated person of the firm, Narendra Chirmule, who was employed with the company as senior vice president-R&D is facing a fine of Rs 5 lakh for trading in the company’s securities when the trading window was closed",negative,neutral,-0.6077848183111253,neutral,-0.4031209362808872,neutral
2021-05-19 22:23:36.000,386.65,388.4,382.2,384.3,1317924.0,"Violation of market norms: Sebi fines Biocon, its designated person Rs 14 lakh","Markets regulator Sebi on Wednesday imposed a total fine of Rs 14 lakh on Biocon Ltd and its designated person for violation of market norms.Designated person of the firm, Narendra Chirmule, who was employed with the company as senior vice president-R&D is facing a fine of Rs 5 lakh for tr…",neutral,negative,-0.6077848183111253,neutral,-0.4031209362808872,neutral
2021-05-19 23:22:00.000,386.65,388.4,382.2,384.3,1317924.0,"Sebi fines Biocon, its designated person for violating mkt norms","Designated person of the firm, Narendra Chirmule, who was employed with the company as senior vice president-R&D is facing a fine of Rs 5 lakh for trading in the company’s securities when the trading window was closed.",negative,neutral,-0.6077848183111253,neutral,-0.4031209362808872,neutral
2021-05-20 01:18:59.000,386.65,388.4,382.2,384.3,1317924.0,"Stocks to watch on May 20: JK Tyre, Biocon, Coffee Day, IOC, PSBs among others","RBI Governor Shaktikanta Das on Wednesday asked state-owned banks to quickly implement measures announced by the central bank recently in the “right earnest”, and to continue focussing on steps to enhance the resilience of their balance sheets. Das during a meeting with the MDs and CEOs of public…",neutral,neutral,-0.6077848183111253,neutral,-0.4031209362808872,neutral
2021-05-20 08:09:33.000,386.65,388.4,382.2,384.3,1317924.0,"Infosys, Indian Oil, Adani Green, Bosch, HPCL, Biocon, JK Lakshmi Cement, Relaxo stocks in focus",Domestic equity market benchmarks BSE Sensex and Nifty 50 were eyeing a positive start on Thursday after markets took a breather in the previous session,neutral,positive,-0.6077848183111253,neutral,-0.4031209362808872,neutral
2021-05-21 11:24:00.000,384.5,386.4,381.65,382.95,1439820.0,Sebi imposes Rs9 lakh penalty on Biocon for delay in disclosure of insider trading,"Biocon said,",negative,neutral,-0.4031209362808872,neutral,0.1698680256108804,neutral
2021-05-25 15:05:02.000,382.7,386.45,380.55,383.5,2345411.0,Hold Biocon: Target Of Rs 400: ICICI Direct,"ICICI Direct recommended hold rating on Biocon with a target price of Rs 400 in its research report dated April 29, 2021.",neutral,positive,0.209041024301022,neutral,-0.36505867014341,neutral
2021-05-26 10:46:00.000,382.7,386.45,380.55,383.5,2345411.0,Share price of Biocon jumps as Sensex gains 252.64 points,"A total of 29,592 shares changed hands on the counter till 10:46AM (IST)",positive,neutral,0.209041024301022,neutral,-0.36505867014341,neutral
2021-05-27 11:07:00.000,383.5,384.85,380.0,382.1,3261861.0,"Syngene targets supplying 500,000 Remdesivir vials in India amid COVID-19 surge","Syngene, majority owned by biopharmaceutical company Biocon Ltd, is one of the seven Indian companies that have licensed remdesivir from U.S.-based Gilead Sciences Inc",positive,neutral,-0.36505867014341,neutral,-0.1436031331592719,neutral
2021-05-27 12:41:00.000,383.0,386.2,380.1,382.45,2261594.0,Biocon shares down 0.1% as Nifty falls,The stock quoted a 52-week high price of Rs 487.7 and low of Rs 342.8.,negative,negative,-0.1436031331592719,neutral,1.171875,positive
2021-05-31 16:45:00.000,390.7,391.45,385.0,386.0,1731492.0,"Nifty Pharma tracks market bull; Divi’s Labs hits new high post Q4; Biocon, Torrent Pharma lift sentiments",The manufacturing of Sputnik vaccine starts in India.,positive,neutral,-1.2029690299462474,negative,0.4404145077720177,neutral
2021-06-01 12:14:00.000,386.0,389.2,384.5,387.7,2297015.0,Biocon shares drop 0.44% as Sensex falls,"A total of 34,242 shares changed hands on the counter till 12:14PM (IST)",negative,neutral,0.4404145077720177,neutral,-0.6193548387096716,neutral
2021-06-04 12:46:00.000,385.2,387.8,383.85,384.95,1477088.0,Biocon shares up 0.08% as Nifty gains,"A total of 87,548 shares changed hands on the counter till 12:46PM (IST).",positive,neutral,-0.0649013499480789,neutral,1.0403120936280883,positive
2021-06-07 11:23:00.000,384.5,392.0,383.25,388.5,3299914.0,"Nifty Pharma witness volatility post RBI Policy; Heavyweights Cipla, Dr Reddy's drag; Biocon shines","Heavyweight, Alkem Industries was the top loser performing at Rs3,139.05 per piece, 0.82% down.",neutral,negative,1.0403120936280883,positive,2.969790066564251,positive
2021-06-07 12:25:00.000,390.6,403.25,390.0,402.2,6799191.0,Share price of Biocon rises as Nifty strengthens,"A total of 75,536 shares changed hands on the counter till 12:25PM (IST).",positive,neutral,2.969790066564251,positive,-0.5650411497359075,neutral
2021-06-08 16:50:00.000,407.05,415.65,400.65,404.75,9574741.0,"Nifty Pharma under pressure post vaccination drive announcements; Lupin, Dr Reddy’s top bears",Biocon and Torrent Pharma were only gainers to support the index.,neutral,neutral,-0.5650411497359075,neutral,2.241379310344833,positive
2021-06-09 01:29:00.000,407.05,415.65,400.65,404.75,9574741.0,Biocon’s Shaw backs Ignite Science Foundation,"Shaw has committed an initial fund of Rs 5 crore which will go for a pool of funding to carry out scientific projects on “pandemic preparedness,” the foundation said in a press release",neutral,neutral,-0.5650411497359075,neutral,2.241379310344833,positive
2021-06-09 13:17:22.000,406.0,415.5,405.85,415.1,4356798.0,Biocon Ltd sees good buying,"Biocon Ltd is quoting at Rs 409.6, up 1.78% on the day as on 12:49 IST on the NSE. The stock is up 5.04% in last one year as compared to a 56.03% gain in NIFTY and a 40.58% gain in the Nifty Pharma index.",positive,positive,2.241379310344833,positive,-0.6581309082206532,neutral
2021-06-09 13:53:00.000,406.0,415.5,405.85,415.1,4356798.0,"Project to help India fight future pandemics on the anvil, ILSF hopes to fund",ILSF also announced that Biocon founder and Executive Chairperson Kiran Mazumdar-Shaw has contributed Rs 5 crore to the organisation dedicated to funding promising life science research.,neutral,positive,2.241379310344833,positive,-0.6581309082206532,neutral
2021-06-09 16:57:00.000,406.0,415.5,405.85,415.1,4356798.0,"Nifty Pharma rallies after fresh order in Covid vaccine, price revision; Biocon, Torrent Pharma, Cadila, Divis Lab emerge as top bulls",Nifty Pharma recorded a broad-based buying with heavyweight stocks taking lead except for Dr Reddy’s Lab.,positive,positive,2.241379310344833,positive,-0.6581309082206532,neutral
2021-06-10 10:52:00.000,406.0,415.5,405.85,415.1,4356798.0,Biocon stock price up 1.83 per cent as Sensex climbs,"As of 31-Mar-2021, promoters held 39.75 per cent stake in the company, while FIIs held 16.3 per cent and domestic institutional investors had 2.51 per cent.",positive,neutral,2.241379310344833,positive,-0.6581309082206532,neutral
2021-06-11 12:43:00.000,417.85,420.25,413.0,415.1,3359882.0,Biocon shares fall 0.01% as Nifty gains,"A total of 70,343 shares changed hands on the counter till time (IST).",negative,neutral,-0.6581309082206532,neutral,-0.4819277108433735,neutral
2021-06-11 13:51:11.000,417.85,420.25,413.0,415.1,3359882.0,Biocon Ltd stays supported,"Biocon Ltd is quoting at Rs 415.55, up 0.19% on the day as on 12:49 IST on the NSE. The stock is up 7.99% in last one year as compared to a 58.38% gain in NIFTY and a 43.85% gain in the Nifty Pharma.",neutral,positive,-0.6581309082206532,neutral,-0.4819277108433735,neutral
2021-06-14 12:37:00.000,412.0,415.65,409.6,410.15,1340360.0,Biocon shares drop 0.29% as Sensex falls,"On the technical charts, the RSI of the stock stood at 71.04.",negative,neutral,-0.4490291262135977,neutral,-1.6463414634146345,negative
2021-06-15 07:40:00.000,412.0,415.65,409.6,410.15,1340360.0,Covid has created an ecosystem of innovation in India: Kiran Mazumdar-Shaw,"The ongoing Covid-19 public health crisis has resulted in the creation of an “ecosystem” of innovation in India, Biocon chief Kiran Mazumdar-Shaw has said",neutral,negative,-0.4490291262135977,neutral,-1.6463414634146345,negative
2021-06-15 07:57:01.000,412.0,415.65,409.6,410.15,1340360.0,Covid has created an ‘ecosystem’ of innovation in India: Kiran Mazumdar-Shaw,"Biocon chief said that COVID has actually resulted in innovative vaccines being produced, such as Covaxin, Genova mRNA programme",neutral,positive,-0.4490291262135977,neutral,-1.6463414634146345,negative
2021-06-15 13:06:00.000,410.0,411.2,402.5,403.25,1725203.0,Biocon shares decline 0.08% as Sensex climbs,"A total of 42,449 shares changed hands on the counter till 01:06PM (IST)",negative,neutral,-1.6463414634146345,negative,-0.8706467661691543,neutral
2021-06-16 13:22:00.000,402.0,406.75,396.05,398.5,1386830.0,Biocon shares down 1.71% as Nifty drops,"A total of 91,657 shares changed hands on the counter till 01:22PM (IST).",negative,neutral,-0.8706467661691543,neutral,0.1251564455569462,neutral
2021-06-18 14:17:38.000,399.5,401.9,389.05,400.0,4007624.0,Biocon Ltd extends losing streak,"Biocon Ltd is quoting at Rs 396.6, down 0.51% on the day as on 13:19 IST on the NSE. The stock jumped 4.03% in last one year as compared to a 52.16% rally in NIFTY and a 40.99% spurt in the Nifty Pharma index.",negative,positive,0.1251564455569462,neutral,2.6548672566371683,positive
2021-06-21 07:35:00.000,395.5,406.2,393.2,406.0,1544057.0,"Nifty Pharma index steady after bearish start; Cadila, Biocon lift performance",Torrent Pharma also gained nearly 1% while and Divis Lab also traded higher. Alkem Lab and Dr. Reddy were under pressure.,positive,positive,2.6548672566371683,positive,-1.360627604805088,negative
2021-06-22 07:35:00.000,407.9,409.6,400.3,402.35,2005142.0,"Nifty Pharma stocks make subdued gains; Divis Lab, Alkem Lab lift performance","Heavyweights Biocon, Cipla, and Sun Pharma were under pressure.",positive,negative,-1.360627604805088,negative,-1.3651030032266072,negative
2021-06-22 13:21:00.000,402.9,404.95,396.6,397.4,1824215.0,Biocon shares down 0.41% as Sensex rises,"A total of 102,002 shares changed hands on the counter till 01:21PM (IST)",negative,neutral,-1.3651030032266072,negative,-0.5524861878453011,neutral
2021-06-23 16:55:00.000,398.2,400.9,394.0,396.0,1883402.0,"Nifty Pharma holds steady; Heavyweights Sun Pharma, Dr Reddys, Lupin drive sectoral gains; Biocon underperforms",Sun Pharma settles patent litigation Celgene over cancer drug.,positive,neutral,-0.5524861878453011,neutral,0.1388888888888917,neutral
2021-06-24 11:48:00.000,398.2,400.9,394.0,396.0,1883402.0,Biocon share price up 0.14 per cent,"A total of 15,952 shares changed hands on the counter till 11:48AM (IST).",positive,neutral,-0.5524861878453011,neutral,0.1388888888888917,neutral
2021-06-25 12:29:00.000,396.0,399.95,394.4,396.55,637229.0,Share price of Biocon rises as Nifty strengthens,"A total of 37,352 shares changed hands on the counter till 12:29PM (IST).",positive,neutral,0.1388888888888917,neutral,1.5438684573867143,positive
2021-06-28 08:45:00.000,398.35,409.7,397.55,404.5,3014447.0,Markets closed lower; Pharma stocks outperformed,"The Nifty Pharma index was among the top outperformers closing ~1.3% higher with stocks like Dr Reddys, Cipla, Biocon & Lupin adding fresh long positions.",negative,positive,1.5438684573867143,positive,0.1474563774883319,neutral
2021-06-28 11:22:00.000,398.35,409.7,397.55,404.5,3014447.0,Share price of Biocon rises as Nifty weakens,"A total of 29,610 shares changed hands on the counter till 11:22AM (IST).",positive,neutral,1.5438684573867143,positive,0.1474563774883319,neutral
2021-06-29 07:19:00.000,406.9,411.0,402.0,407.5,2233265.0,"Nifty Pharma logs modest gains post FM’s Covid relief package; Alkem Lab, Biocon, Aurobindo, Cadila, Dr Reddy’s drive",Nifty Pharma recorded modest gains with heavyweight stocks lifting the overall performance despite broader markets tone is bearish.,positive,positive,0.1474563774883319,neutral,-1.1498470948012205,negative
2021-06-29 12:19:00.000,408.75,411.0,403.55,404.05,1214268.0,Biocon stock price up 0.66 per cent as Sensex slides,"As of 31-Mar-2021, promoters held 39.75 per cent stake in the company, while FIIs held 16.3 per cent and domestic institutional investors had 2.51 per cent.",positive,neutral,-1.1498470948012205,negative,0.3584672435105039,neutral
2021-06-30 08:54:00.000,408.75,411.0,403.55,404.05,1214268.0,"Buy or Sell: Stock ideas by experts for June 30, 2021",ET Now spoke to various experts and here’s what they have to recommend for today’s trading session. Kunal Bothra has a buy/sell recommendation on Biocon and HDFC while Nooresh Merani has recommended IGL and Dr Reddy’s Labs for today’s trading session. Check out the targets and stoploss.,neutral,neutral,-1.1498470948012205,negative,0.3584672435105039,neutral
2021-07-01 11:39:47.000,404.5,409.9,403.5,405.95,1604776.0,"Insider Trading Case: SEBI Bars Biocon’s Official From Securities Market For 3 Months, Levies Fine","Biocon had announced information relating to its collaboration with Sandoz and the period of unpublished price sensitive information (UPSI) was from December 20, 2017 to January 18, 2018, The Securities and Exchange Board of India (Sebi) noted in an order passed late on Wednesday.",neutral,neutral,0.3584672435105039,neutral,0.3938946331856284,neutral
2021-07-01 12:48:00.000,406.2,410.9,405.7,407.8,1262929.0,"Sebi bars Biocon’s official from securities mkt for 3 months, levies fine",Regulator Sebi has restrained an official of Biocon Ltd from accessing the securities market for three months and also levied monetary penalty for contravening insider trading norms.,neutral,negative,0.3938946331856284,neutral,-1.0291595197255683,negative
2021-07-01 17:30:00.000,406.2,410.9,405.7,407.8,1262929.0,"Sebi bars Biocon official from securities market, slaps penalty worth Rs 2 lakh","Senior vice president of Biocon, Shreehas P Tambe, being an insider traded in the shares of the firm between December 19-27, 2017, in violation of market norms",neutral,neutral,0.3938946331856284,neutral,-1.0291595197255683,negative
2021-07-01 21:33:45.000,406.2,410.9,405.7,407.8,1262929.0,"Insider trading case: SEBI bars Biocon’s official from securities market for 3 months, levies fine",Regulator Sebi has restrained an official of Biocon Ltd from accessing the securities market for three months and also levied monetary penalty for contravening insider trading norms. Biocon had announced information relating to its collaboration with Sandoz and the period of unpublished pr…,neutral,negative,0.3938946331856284,neutral,-1.0291595197255683,negative
2021-07-02 11:08:44.000,406.2,410.9,405.7,407.8,1262929.0,Sebi bars Biocon official for insider trading for 3 months,"Shreehas P Tambe, Biocon’s senior vice president, traded in the shares of the company between December 19-27, 2017, in violation of market norms.",neutral,neutral,0.3938946331856284,neutral,-1.0291595197255683,negative
2021-07-02 13:21:07.000,406.2,410.9,405.7,407.8,1262929.0,"Most Vaccines Durable for at least 1 year, Data Shows 2 Different Shots Better: Kiran Shaw","There is enough data available now to indicate that it is even better to give two different vaccine shots to protect against Covid-19, said Kiran Mazumdar Shaw, founder and executive chairperson of Biocon Limited, on Friday.",neutral,positive,0.3938946331856284,neutral,-1.0291595197255683,negative
2021-07-06 13:38:16.000,386.9,394.1,385.0,392.0,2672657.0,Biocon Shares Underperform Pharma Index In A Year; Global Brokerage Retains Sell,Global research firm CLSA has maintained sell on the stock with target at Rs 260 per share. It is of the view that cash flow remained negative for an eighth consecutive year in FY21 with operating cash flow falling 24 percent YoY and capex intensity remaining high.,neutral,negative,1.3181700697854803,positive,-0.801526717557246,neutral
2021-07-09 15:50:08.000,390.0,390.95,386.85,388.5,1494558.0,"Sebi bars Allegro Capital, individual for insider trading activities in Biocon","On January 18, 2018, Biocon had announced an exclusive global collaboration with Sandoz on next generation biosimilars .Sebi had observed that shares of the company rose 5.6 per cent at close on the day after the announcement",neutral,positive,-0.3846153846153846,neutral,-0.8574353724084889,neutral
2021-07-09 16:49:00.000,390.0,390.95,386.85,388.5,1494558.0,Sebi bars Allegro Capital for insider trading activities in Biocon shares,Sebi has barred Allegro Capital and one of its senior executives from the securities market for one year,neutral,neutral,-0.3846153846153846,neutral,-0.8574353724084889,neutral
2021-07-09 16:50:00.000,390.0,390.95,386.85,388.5,1494558.0,"Nifty Pharma witness buying sentiments; Torrent Pharma, Divis Lab drive sectoral gains; Biocon laggards","The UK Health Ministry has idetintified a newer mutation of the virus after ‘Delta’, called the ‘Lamba variant’.",positive,neutral,-0.3846153846153846,neutral,-0.8574353724084889,neutral
2021-07-09 19:01:06.000,390.0,390.95,386.85,388.5,1494558.0,"SEBI bars Allegro Capital, individual for one year on insider trading activities in Biocon shares","Market regulator SEBI has barred Allegro Capital and one of its senior executives from the securities market for one year in a case related to alleged insider trading activities in the shares of Biocon.Besides, the market watchdog has directed them to disgorge wrongful gains along with int…",neutral,negative,-0.3846153846153846,neutral,-0.8574353724084889,neutral
2021-07-09 21:08:20.000,390.0,390.95,386.85,388.5,1494558.0,Sebi Needs To Act Rationally In Insider Trading Judgements: Kiran Mazumdar-Shaw,Mazumdar-Shaw’s tweet came after Sebi barred Allegro Capital and one of its senior executives from the securities market for one year in a case related to alleged insider trading activities in the shares of Biocon.,neutral,negative,-0.3846153846153846,neutral,-0.8574353724084889,neutral
2021-07-09 22:22:16.000,390.0,390.95,386.85,388.5,1494558.0,"Biocon chief Kiran Mazumdar Shaw hits out at SEBI, says ‘it needs to act rationally in insider trading judgements’","Biocon chief Kiran Mazumdar-Shaw on Friday asked Sebi to act rationally while dealing with insider trading judgements after the markets regulator barred one of its senior executives and Allegro Capital from the securities market for one year. “SEBI bars Allegro Capital, its CEO over inside…",neutral,neutral,-0.3846153846153846,neutral,-0.8574353724084889,neutral
2021-07-12 19:35:15.000,389.0,389.0,386.0,387.95,1206538.0,Biocon Q1 PAT Seen Up 21% YoY To Rs 180.7 Cr: ICICI Direct,"Net Sales are expected to increase by 13.4 percent Y-o-Y (up 3.1 percent Q-o-Q) to Rs 1,895.3 crore, according to ICICI Direct.",neutral,positive,-0.2699228791773808,neutral,3.345820953365195,positive
2021-07-13 15:13:18.000,387.05,400.15,386.15,400.0,3942530.0,Moneycontrol Pro Panorama | Some Light Visible At The End Of The Macro Tunnel,"In today’s edition of Moneycontrol Pro Panorama: Macros turn it on, Wabco’s halo, Finolex’s growth pitch, IT’s ‘green’ stripes, Biocon trouble for SEBI, ECB turns a new chapter, and more",neutral,neutral,3.345820953365195,positive,0.5620082427875608,neutral
2021-07-19 06:10:00.000,408.9,414.4,405.1,412.0,2644793.0,Biocon controversy: Sebi’s insider trading laws may need an overhaul,Sebi regulations define “insider” as a company associate who is trading in the company’s shares based on unpublished price sensitive information (UPSI) to make a quick buck,neutral,neutral,0.7581315725116221,neutral,-2.060606060606061,negative
2021-07-19 13:04:07.000,412.5,414.0,402.5,404.0,1838928.0,"Biocon Ltd spurts 0.53%, rises for fifth straight session","Biocon Ltd is quoting at Rs 411.45, up 0.53% on the day as on 12:49 IST on the NSE. The stock is down 3.87% in last one year as compared to a 43.09% jump in NIFTY and a 42.18% jump in the Nifty Pharma.",positive,positive,-2.060606060606061,negative,-1.0190300798035548,negative
2021-07-19 16:50:00.000,412.5,414.0,402.5,404.0,1838928.0,"Nifty Pharma logs modest gains despite bearish markets; Alkem, Divis Labs, Biocon add to gains","India reports 38,164 new cases and 499 deaths in the last 24 hours.",positive,negative,-2.060606060606061,negative,-1.0190300798035548,negative
2021-07-22 07:35:00.000,407.25,407.9,396.3,403.1,2803526.0,"Nifty Pharma stocks trade higher; Torrent Pharma, Alkem Lab, Sun Pharma stocks lead",Cipla continued to remain under selling pressure. Biocon was also in the red while Cadila was marginally lower.,positive,negative,-1.0190300798035548,negative,1.4158163265306152,positive
2021-07-22 08:05:17.000,407.25,407.9,396.3,403.1,2803526.0,"Stocks to Watch: Bajaj Finance, ICICI Pru Life, IDFC, telecom stocks","HUL, UltraTech cement, Bajaj Auto, Agro Tech Foods, Bajaj Holdings & Investment, Biocon, Hindustan Zinc, ICICI Lombard General Insurance Co., IndiaMART InterMESH, India Pesticides, Bank of Maharashtra, Sterlite Technologies, and Wockhardt, among other companies, will report their Q1 earnings today.",neutral,neutral,-1.0190300798035548,negative,1.4158163265306152,positive
2021-07-22 08:22:43.000,407.25,407.9,396.3,403.1,2803526.0,"Markets likely to be volatile; HUL, Bajaj Auto, Biocon in focus","Among major markets Hindustan Unilever, Ultratech Cement, Bajaj Auto, Hindustan Zinc, ICICI Lombard General Insurance Co., Biocon, Mphasis, Bajaj Holdings, Persistent Systems and Bank of Maharashtra will announce quarterly earnings today.",neutral,neutral,-1.0190300798035548,negative,1.4158163265306152,positive
2021-07-22 08:59:05.000,407.25,407.9,396.3,403.1,2803526.0,Markets to open in green after a gap,"HUL, UltraTech, Bajaj Auto, IEX, ICICI Lombard, Biocon key results",neutral,neutral,-1.0190300798035548,negative,1.4158163265306152,positive
2021-07-22 15:05:00.000,392.0,401.55,387.3,397.55,5773147.0,"Important results today: Hindustan Unilever, UltraTech, Biocon, Bajaj Auto among others","Mphasis, Persistent Systems, Music Broadcast, Shiva Cement, South Indian Bank, Sterlite Technologies are set to release their quarterly earnings today.",neutral,neutral,1.4158163265306152,positive,-2.122315710159485,negative
2021-07-22 15:30:00.000,392.0,401.55,387.3,397.55,5773147.0,"Markets bullish after 2-days selloff; Sensex tops 565 pts, Nifty 50 nears 15,790; Bank, Consumer Durables outperform; Bajaj twins, HUL, Titan, HDFC Bank drive","Hindustan Unilever, Bajaj Auto, Biocon, Hindustan Zinc and Ultratech Cement will be in focus ahead of their June 2021 quarterly results today.",positive,neutral,1.4158163265306152,positive,-2.122315710159485,negative
2021-07-23 02:39:00.000,392.0,401.55,387.3,397.55,5773147.0,Biocon Q1FY22 net profit at Rs84cr; John Shaw retires from the Board of Directors; stock dips ~1%,"Invest in share market and mutual funds and get experts consultation at IndiaInfoline. Get your Demat Account at zero brokerage, trade in intraday, futures and options, currency, commodities etc. at just ₹20/order.",neutral,neutral,1.4158163265306152,positive,-2.122315710159485,negative
2021-07-23 08:20:00.000,392.0,401.55,387.3,397.55,5773147.0,"Stocks to watch: Zomato, RIL, SBI Card, Voda Idea, Airtel, BPCL, Biocon","Forty-one companies, including RIL, JSW Steel, SBI Card, YES Bank and Federal Bank will report their quarterly numbers today",neutral,neutral,1.4158163265306152,positive,-2.122315710159485,negative
2021-07-23 09:24:00.000,392.0,401.55,387.3,397.55,5773147.0,Biocon consolidated net profit declines 43.51% in the June 2021 quarter,Sales rise 3.94% to Rs 1760.60 crore,negative,positive,1.4158163265306152,positive,-2.122315710159485,negative
2021-07-23 09:51:55.000,392.0,401.55,387.3,397.55,5773147.0,"Biocon Profit Drops 44% In Q1FY22 Due To Subdued Generics Business, Exceptional Item","The core biologics segment reported revenue growth of 10 percent YoY at Rs 758 crore in Q1FY22, led by strong growth especially in India and other markets, especially biosimilars associated with Covid- care such as Itolizumab and Bevacizumab.",neutral,positive,1.4158163265306152,positive,-2.122315710159485,negative
2021-07-23 10:00:00.000,392.0,401.55,387.3,397.55,5773147.0,Biocon slips after weak Q1 performance,Biocon fell 1.65% to Rs 396.15 after the company’s consolidated net profit declined 43.5% to Rs 84.4 crore in Q1 FY22 from Rs 149 crore in Q1 FY21.,neutral,negative,1.4158163265306152,positive,-2.122315710159485,negative
2021-07-23 10:50:14.000,392.0,401.55,387.3,397.55,5773147.0,"Biocon Standalone June 2021 Net Sales At Rs 382.70 Crore, Down 26.5% Y-o-Y",,neutral,neutral,1.4158163265306152,positive,-2.122315710159485,negative
2021-07-23 10:52:21.000,392.0,401.55,387.3,397.55,5773147.0,"Biocon Consolidated June 2021 Net Sales At Rs 1,760.60 Crore, Up 5.34% Y-o-Y",,neutral,neutral,1.4158163265306152,positive,-2.122315710159485,negative
2021-07-23 13:30:10.000,392.0,401.55,387.3,397.55,5773147.0,Biocon Q1 net profit declines 35% to Rs 108.4 cr; shares down,"Biotechnology major Biocon has reported a 35.39 per cent decline in its consolidated net profit at Rs 108.4 crore for the quarter ended June 30, 2021 mainly on account of its share of loss in associate startup entity Bicara Therapeutics Inc.The company had posted a net profit of Rs 167.8 c…",negative,negative,1.4158163265306152,positive,-2.122315710159485,negative
2021-07-23 13:55:00.000,392.0,401.55,387.3,397.55,5773147.0,Biocon Q1 net profit declines 35% to Rs 108.4 cr; revenue at Rs 1807.8 cr,"Biotechnology major Biocon has reported a 35.39 per cent decline in its consolidated net profit at Rs 108.4 crore for the quarter ended June 30, 2021",negative,negative,1.4158163265306152,positive,-2.122315710159485,negative
2021-07-23 17:30:00.000,392.0,401.55,387.3,397.55,5773147.0,Biocon net profit falls 35% to Rs 108 crore in Apr-Jun,"Consolidated revenue of the company stood at Rs 1,807.8 crore for the quarter under consideration. It was at Rs 1,712.1 crore for the same period a year ago.",positive,neutral,1.4158163265306152,positive,-2.122315710159485,negative
2021-07-23 18:40:43.000,392.0,401.55,387.3,397.55,5773147.0,Biocon Ltd. ADR (BCNQY) CEO Siddharth Mittal on Q1 2022 Results - Earnings Call Transcript,"Biocon Ltd. ADR (OTC:BCNQY) Q1 2022 Earnings Conference Call July 22, 2021, 11:30 PM ET Company Participants Chirag Dalal - IR Kiran Mazumdar-Shaw - Executive Chairperson Shreehas Tambe -...",neutral,neutral,1.4158163265306152,positive,-2.122315710159485,negative
2021-07-23 20:39:55.000,392.0,401.55,387.3,397.55,5773147.0,Biocon Q1 Review - Covid-19 Related Challenges Drags The Quarter: ICICI Direct,Biocon Q1 Review - Covid-19 Related Challenges Drags The Quarter: ICICI Direct,neutral,neutral,1.4158163265306152,positive,-2.122315710159485,negative
2021-07-23 21:17:00.000,392.0,401.55,387.3,397.55,5773147.0,"Biocon eyes market share expansion in developed, emerging markets: Kiran Mazumdar-Shaw","“Trastuzumab (monoclonal antibody used to treat breast and stomach cancers) is another big opportunity we are looking at, not just in the US and Europe, but it is a very large global opportunity with growth potential for us,” Mazumdar-Shaw said.",positive,positive,1.4158163265306152,positive,-2.122315710159485,negative
2021-07-23 22:55:27.000,392.0,401.55,387.3,397.55,5773147.0,Biocon Q1 net plunges 44% to ₹84 crore,"Biocon reported a 44% decline in net profit to ₹84 crore for the quarter ended June on account of losses at an associate firm. Revenue grew 6% to ₹1,808 crore.Profit was impacted by a share of loss in",negative,negative,1.4158163265306152,positive,-2.122315710159485,negative
2021-07-25 02:11:19.000,398.15,398.15,388.8,389.7,2127100.0,"Biocon Q1 Review - Covid Disruption Impacts Generics Sales, Earnings: Motilal Oswal","Biocon Q1 Review - Covid Disruption Impacts Generics Sales, Earnings: Motilal Oswal",neutral,neutral,-2.122315710159485,negative,-3.570072161033034,negative
2021-07-26 00:45:00.000,398.15,398.15,388.8,389.7,2127100.0,Biocon likely to seek full marketing authorisation for Covid-19 drug,Expects results from phase 4 study of itolizumab by end of this quarter,neutral,neutral,-2.122315710159485,negative,-3.570072161033034,negative
2021-07-26 07:58:37.000,398.15,398.15,388.8,389.7,2127100.0,Biocon Revises Revenue Target Timeline For Biosimilars Arm,Biocon has deferred the revenue target for its biosimilars segment for the ongoing financial year amid slowing business.,neutral,negative,-2.122315710159485,negative,-3.570072161033034,negative
2021-07-26 09:33:52.000,398.15,398.15,388.8,389.7,2127100.0,"Biocon Consolidated June 2021 Net Sales At Rs 1,760.60 Crore, Up 5.34% Y-o-Y",,neutral,neutral,-2.122315710159485,negative,-3.570072161033034,negative
2021-07-26 19:38:00.000,394.95,394.95,378.0,380.85,4470976.0,Biocon Biologics partners with Adagio Therapeutics,To manufacture and commercialize an antibody treatment for Covid-19,neutral,neutral,-3.570072161033034,negative,-0.248203788373609,neutral
2021-07-26 19:58:30.000,394.95,394.95,378.0,380.85,4470976.0,Biocon Biologics Partners with Adagio Therapeutics for Covid-19 treatment,"Initial data indicate that ADG20, Adagio’s lead clinical development candidate, could provide both rapid and durable protection against COVID-19 for up to one year",neutral,positive,-3.570072161033034,negative,-0.248203788373609,neutral
2021-07-26 20:00:51.000,394.95,394.95,378.0,380.85,4470976.0,"Biocon Biologics, Adagio Therapeutics Sign Pact For Potential Antibody Treatment Against COVID-19","Under the terms of the deal, Biocon Biologics will get access to the clinical and non-clinical data from Adagio’s EUA submission to the U.S. Food and Drug Administration to seek approvals in the emerging markets.",neutral,positive,-3.570072161033034,negative,-0.248203788373609,neutral
2021-07-26 21:11:00.000,394.95,394.95,378.0,380.85,4470976.0,Biocon Biologics gets licence from Adagio for antibody Covid treatment,Initial data indicate that ADG20 could provide both rapid and durable protection against Covid-19 for up to one year,positive,positive,-3.570072161033034,negative,-0.248203788373609,neutral
2021-07-26 21:29:00.000,394.95,394.95,378.0,380.85,4470976.0,Biocon Biologics gets licence from Adagio Therapeutics for antibody treatment of COVID-19,"“ADG20, a novel monoclonal antibody targeting the spike protein of SARS-CoV-2 and related coronaviruses, is in global clinical development by Adagio as a single agent for both the treatment and prevention of COVID-19, the disease caused by the SARS-CoV-2 virus, its variants, as well as future varian…",positive,neutral,-3.570072161033034,negative,-0.248203788373609,neutral
2021-07-26 22:19:13.000,394.95,394.95,378.0,380.85,4470976.0,US-based Adagio Therapeutics gives Biocon Biologics licence to make antibody treatment for Covid-19,Data indicates that the antibody could provide rapid and durable protection against Covid-19 for up to one year,positive,positive,-3.570072161033034,negative,-0.248203788373609,neutral
2021-07-26 22:33:56.000,394.95,394.95,378.0,380.85,4470976.0,Biocon Biologics Gets Licence from Adagio Therapeutics for Antibody Treatment of Covid-19,"Biocon Biologics, a subsidiary of Biocon, on Monday said it has got a licence from US-based Adagio Therapeutics for an antibody therapy to treat and prevent COVID-19, for India and select markets.",neutral,positive,-3.570072161033034,negative,-0.248203788373609,neutral
2021-07-26 23:56:00.000,394.95,394.95,378.0,380.85,4470976.0,Biocon partners Adagio for licence to make Covid-19 antibody cocktail,Treatment claims to address the resistant Delta variant as well,neutral,neutral,-3.570072161033034,negative,-0.248203788373609,neutral
2021-07-27 04:18:00.000,394.95,394.95,378.0,380.85,4470976.0,"Biocon Biologics to make new antibody to fight, prevent COVID",Vaccines alone will not protect and make the world safer: Kiran Mazumdar-Shaw,neutral,negative,-3.570072161033034,negative,-0.248203788373609,neutral
2021-07-27 07:23:00.000,394.95,394.95,378.0,380.85,4470976.0,Coronavirus LIVE: Biocon joins Adagio for licence to make antibody cocktail,"The antibody treatment is based on ADG20, a novel monoclonal antibody, which targets the spike protein of SARS-CoV-2 and related coronaviruses",neutral,neutral,-3.570072161033034,negative,-0.248203788373609,neutral
2021-07-27 08:50:00.000,394.95,394.95,378.0,380.85,4470976.0,Biocon’s unit partners with Adagio Therapeutics for antibody treatment of Covid-19,Biocon said that its subsidiary Biocon Biologics has partnered with Adagio Therapeutics to advance antibody for the prevention and treatment of COVID-19.,neutral,positive,-3.570072161033034,negative,-0.248203788373609,neutral
2021-07-27 10:37:00.000,394.95,394.95,378.0,380.85,4470976.0,Biocon Biologics ties with Adagio Therapeutics to advance antibody for preventing and treating Covid-19,"Initial data indicate that ADG20, Adagio’s lead clinical development candidate, could provide both rapid and durable protection against COVID-19 for up to one year.",positive,positive,-3.570072161033034,negative,-0.248203788373609,neutral
2021-07-27 10:52:19.000,394.95,394.95,378.0,380.85,4470976.0,Buy Biocon: Target Of Rs 470: Sharekhan,"Sharekhan is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 470 in its research report dated July 23, 2021.",neutral,positive,-3.570072161033034,negative,-0.248203788373609,neutral
2021-07-27 11:09:52.000,394.95,394.95,378.0,380.85,4470976.0,Yediyurappa leaves a legacy of progressive development: Biocon chief,"Yediyurappa, the 78-year-old BJP veteran, submitted his resignation to Governor Thaawarchand Gehlot at the Raj Bhavan in Bengaluru",neutral,neutral,-3.570072161033034,negative,-0.248203788373609,neutral
2021-07-27 12:38:00.000,382.75,383.8,376.7,381.8,1964511.0,New Covid-19 antibody treatment an interesting opportunity for Biocon: Kiran Mazumdar Shaw,"“I personally believe that unless we have treatments that are effective, we are not in a safe place. That is where we are coming from and we believe this is a very interesting opportunity for Biocon because it really allows us to expand into adjacent areas.”",positive,neutral,-0.248203788373609,neutral,-3.7405541561712905,negative
2021-07-27 12:51:37.000,382.75,383.8,376.7,381.8,1964511.0,"Tata Motors, Larsen & Toubro, Biocon: Top Stocks For Investors on July 27",The Indian bourses may open higher on Tuesday following gains in Asian peers and amid positive global cues.,neutral,positive,-0.248203788373609,neutral,-3.7405541561712905,negative
2021-07-27 16:14:45.000,382.75,383.8,376.7,381.8,1964511.0,Hold Biocon: Target Of Rs 400: ICICI Direct,"ICICI Direct recommended hold rating on Biocon with a target price of Rs 400 in its research report dated July 23, 2021.",neutral,positive,-0.248203788373609,neutral,-3.7405541561712905,negative
2021-07-27 16:47:39.000,382.75,383.8,376.7,381.8,1964511.0,Biocon Biologics partners Adagio Therapeutics for antibody treatment of covid,"Under the terms of the deal, Biocon Biologics will get access to the clinical and non-clinical data from Adagio’s EUA submission to the US Food and Drug Administration to seek approvals in the emerging markets.",neutral,positive,-0.248203788373609,neutral,-3.7405541561712905,negative
2021-07-28 18:22:02.000,397.0,404.9,380.05,382.15,7607781.0,"Biocon Biologics Sees Traction In US Biosimilars Sales, No Immediate Plans For IPO","The company anticipates continued pricing pressure in the US but it is taking steps to mitigate this through increased volumes and market share, Deputy CEO Shreehas Tambe has said.",neutral,positive,-3.7405541561712905,negative,0.7823705828660843,neutral
2021-07-28 23:40:52.000,397.0,404.9,380.05,382.15,7607781.0,Biocon Biologics partners Adagio Therapeutics for Covid-19 treatment,"As a part of the deal with Adagio, the company would get access to the clinical and non-clinical data from Adagio’s EUA submission to the US Food and Drug Administration to seek approvals in the emerging markets.",neutral,neutral,-3.7405541561712905,negative,0.7823705828660843,neutral
2021-07-29 08:00:00.000,397.0,404.9,380.05,382.15,7607781.0,"Biocon Biologics, Viatris gets USFDA nod for first interchangeable biosimilar insulin product",Company is Eligible for 12 Months of First Interchangeable Exclusivity from the Date of Commercial Launch.,neutral,neutral,-3.7405541561712905,negative,0.7823705828660843,neutral
2021-07-29 08:16:11.000,397.0,404.9,380.05,382.15,7607781.0,Diabetes Cure: USFDA Approves Biocon’s Long-acting Insulin Semglee As First Interchangeable Biosimilar Product,Diabetes cure: USFDA’s designation of Semglee (insulin glargine) as interchangeable with Lantus (insulin glargine of Sanofi) means that Semglee may now be substituted for the reference product at the pharmacy without the intervention of the prescriber.,neutral,neutral,-3.7405541561712905,negative,0.7823705828660843,neutral
2021-07-29 10:42:00.000,397.0,404.9,380.05,382.15,7607781.0,Biocon rises after USFDA approves insulin Semglee as first interchangeable biosimilar product,Biocon gained 1.18% to Rs 386.2 after the pharma company announced that the USFDA has approved Semglee as the first interchangeable biosimilar product under the 351(k) regulatory pathway.,neutral,positive,-3.7405541561712905,negative,0.7823705828660843,neutral
2021-07-29 14:21:59.000,383.45,389.25,381.1,386.45,2780740.0,"Biocon Biologics, Viatris get USFDA nod for first interchangeable biosimilar insulin product","Biocon Biologics and Viatris on Thursday said the US health regulator has approved the first interchangeable biosimilar insulin product Semglee for the treatment of diabetes in the US.The approval for the product, which will allow substitution of Semglee for the reference product, Lantus, …",neutral,positive,0.7823705828660843,neutral,0.6454944487477408,neutral
2021-07-29 17:56:00.000,383.45,389.25,381.1,386.45,2780740.0,USFDA okays Biocon insulin Semglee as first interchangeable biosimilar drug,"Analysts expect additional revenues of 8 to 15 per cent for Biocon, with no competition in sight",neutral,neutral,0.7823705828660843,neutral,0.6454944487477408,neutral
2021-07-29 21:09:09.000,383.45,389.25,381.1,386.45,2780740.0,"Biocon, Viatris get USFDA’s nod for interchangeable biosimilar product",‘Will make Semglee affordable to diabetes patients’,neutral,positive,0.7823705828660843,neutral,0.6454944487477408,neutral
2021-07-29 23:06:26.000,383.45,389.25,381.1,386.45,2780740.0,U.S. FDA approves Biocon’s insulin Semglee,"Biocon Biologics and Viatris Inc said the U.S. Food and Drug Administration (FDA) had approved Semglee®, a long-acting insulin injection, as the first interchangeable biosimilar product for the treatm",neutral,positive,0.7823705828660843,neutral,0.6454944487477408,neutral
2021-07-30 11:11:21.000,383.45,389.25,381.1,386.45,2780740.0,Vaccines alone will not protect and make the world safer: Biocon chief,Says antibody therapies that arrest the virus in its path of devastation are a necessity,negative,neutral,0.7823705828660843,neutral,0.6454944487477408,neutral
2021-07-30 11:26:54.000,383.45,389.25,381.1,386.45,2780740.0,"The daily dose: July 30, 2021","# Kerala’s rising cases continue to worry health administrators, as age, density and Delta (the virus variant) contribute to the situation. # Biocon’s chief says, vaccines alone will not protect and m",neutral,negative,0.7823705828660843,neutral,0.6454944487477408,neutral
2021-07-30 18:49:00.000,383.45,389.25,381.1,386.45,2780740.0,Biocon Biologics interchangeable insulin Semglee gets US FDA approval,"Biocon partnered with global healthcare company Viatris Inc to develop Semglee, the first interchangeable biosimilar product approved in the United States to treat diabetic patients.",neutral,positive,0.7823705828660843,neutral,0.6454944487477408,neutral
2021-08-02 18:21:00.000,388.8,392.45,388.0,389.15,1063912.0,"India Inc floored by Indian women’s hockey team: Anand Mahindra gives a standing ovation, Gautam Adani calls it a ‘Chak De! India’ show",Sajjan Jindal & the Biocon boss were among those lauding the win over Australia.,neutral,neutral,0.0900205761316784,neutral,-0.810810810810805,neutral
2021-08-03 07:40:00.000,388.8,392.45,388.0,389.15,1063912.0,Nifty Pharma gains 1% amid bullish markets; Sun Pharma emerges top gainer,"Lupin and Divis Lab also outperformed. Biocon was the lone stock in the red, trading 0.12% lower.",positive,positive,0.0900205761316784,neutral,-0.810810810810805,neutral
2021-08-04 07:04:00.000,388.5,391.4,383.6,385.35,1109922.0,"Nifty Pharma defies bull run, trades lower as Alkem, Sun Pharma, Biocon drag; Dr Reddy’s top gainer",Nifty Pharma was among top laggards on NSE with 7 scrip declining and 3 advancings.,neutral,positive,-0.810810810810805,neutral,-0.6729649281739414,neutral
2021-08-04 17:54:00.000,386.35,387.0,381.7,383.75,1232814.0,Natural Biocon (India) reports standalone net profit of Rs 0.01 crore in the June 2021 quarter,Sales reported at Rs 0.06 crore,neutral,neutral,-0.6729649281739414,neutral,-0.1301405517959396,neutral
2021-08-05 06:45:00.000,386.35,387.0,381.7,383.75,1232814.0,Nifty Pharma edges higher amid market rally; Cipla gains over 1% ahead of quarterly results,Sun Pharma and Dr. Reddy are also trading higher. Biocon and Torrent Pharma dragged the most.,positive,positive,-0.6729649281739414,neutral,-0.1301405517959396,neutral
2021-08-10 16:26:00.000,379.95,379.95,366.05,372.5,2380223.0,SAT stays Biocon insider trading order,Sebi had directed Allegro Capital and its owner Kunal Kashyap to disgorge Rs 25 lakh for allegedly dealing in shares of Biocon while in possession of price sensitive information.,neutral,negative,-1.9607843137254877,negative,0.3753351206434255,neutral
2021-08-12 01:22:50.000,373.0,375.7,371.15,374.4,872612.0,Biocon-Viatris obtain USFDA nod for first interchangeable insulin,"Biocon Biologics, through Viatris, is eligible to have exclusivity for 12 months before the United States Food and Drug Administration (USFDA) can approve another biosimilar interchangeable to Lantus.",neutral,positive,0.3753351206434255,neutral,-1.0666666666666669,negative
2021-08-16 08:25:00.000,371.75,373.25,366.2,367.45,1226773.0,"Nifty Pharma under pressure on broad-based selloff; Cadila, Aurobindo, Biocon drag; Alkem Lab hits new high","The index has touched an intraday high and low of 14,074.50 and 13,900.70 respectively.",negative,negative,-1.156691324815067,negative,0.4370987570004004,neutral
2021-08-23 06:58:00.000,359.3,362.35,327.55,335.7,7245866.0,"Cadila, Aurobindo, Divis Lab and Sun Pharma keep Nifty Pharma on a positive note; Biocon top bear","The index has touched an intraday high and low of 13,911.20 and 13,625.40 respectively.",positive,negative,-6.5683273030893465,negative,3.973214285714292,positive
2021-08-23 12:20:00.000,336.0,351.95,332.0,349.35,6349258.0,"Amara Raja, Biocon, Hero MotoCorp, Ujjivan SFB hit 52-week lows","Ujjivan Small Finance Bank hit a new low of Rs 17.80, down 10% intra-day trade today, falling 27% in two days.",positive,negative,3.973214285714292,positive,-1.0285714285714351,negative
2021-08-23 15:50:30.000,336.0,351.95,332.0,349.35,6349258.0,Ujjivan Financial Services Ltd leads losers in ‘A’ group,"Sadbhav Engineering Ltd, Caplin Point Laboratories Ltd, Aditya Birla Capital Ltd and Biocon Ltd are among the other losers in the BSE’s ‘A’ group today, 23 August 2021.",negative,negative,3.973214285714292,positive,-1.0285714285714351,negative
2021-08-24 07:42:00.000,336.0,351.95,332.0,349.35,6349258.0,"Nifty Pharma rallies 1.2%; Biocon, Cipla, Sun Pharma, Lupin lead the winning streaks","Cipla, Sun Pharma, Lupin, DR Reddy’s also advanced to lift the spirits after a gloomy morning.",positive,positive,3.973214285714292,positive,-1.0285714285714351,negative
2021-08-25 10:04:08.000,350.0,350.0,343.85,346.4,1708107.0,Biocon Ltd Falls 1.36%,Biocon Ltd has lost 11.45% over last one month compared to 2.87% fall in S&P BSE Healthcare index and 6.19% rise in the SENSEX,neutral,negative,-1.0285714285714351,negative,-1.625197756364153,negative
2021-08-30 08:05:00.000,349.0,358.0,347.55,355.45,2897260.0,"Nifty Pharma picks speed to advance 2%; Divis Lab, Biocon, Sun Pharma lift performance",Dr Reddy’s Laboratories (up 1.73%) and Torrent Pharmaceuticals (up 1.564%) were also bullish. Lupin and Cipla advanced over 1.2%.,positive,positive,1.848137535816616,positive,0.2801120448179272,neutral
2021-08-31 17:45:00.000,360.0,360.0,352.85,355.2,2207561.0,"Nifty Healthcare advances; Apollo Hospitals, Ipca Labs emerge top gainers","Fortis and Laurus Labs were also in the fast lane. On the flip side Biocon, Pfizer, and Alkem Lab were struggling.",positive,negative,-1.3333333333333366,negative,0.7427130044842986,neutral
2021-09-07 22:15:00.000,362.0,362.1,353.8,355.55,1621996.0,India to take 9 more months for full vaccination; avoid congregations: Shaw,"India has done a tremendous job on the vaccination drive but it will take at least nine more months to fully vaccinate all adults, Biocon Chairperson Kiran Mazumdar Shaw said on Tuesday.",neutral,positive,-1.781767955801102,negative,-0.2966101694915286,neutral
2021-09-08 10:08:06.000,362.0,362.1,353.8,355.55,1621996.0,Revlimid Drug: Biocon Enters Patent Litigation Settlement With Celgene,Celgene Corporation earlier filed a complaint against Biocon over potential patent infringement by a potential generic drug created by Biocon.,neutral,negative,-1.781767955801102,negative,-0.2966101694915286,neutral
2021-09-08 15:17:29.000,354.0,357.7,350.1,352.95,1093916.0,Biocon inks patent litigation settlement pact with Celgene,Biocon shares were trading 0.45% up on BSE,positive,positive,-0.2966101694915286,neutral,-0.0141242937853139,neutral
2021-09-08 18:11:00.000,354.0,357.7,350.1,352.95,1093916.0,Biocon enters into a settlement agreement with Celgene Corp; stock trades flat,The pharma company has settled the suit through a confidential settlement agreement with Celgene Corporation relating to patents for generic Revlimid drug,neutral,positive,-0.2966101694915286,neutral,-0.0141242937853139,neutral
2021-09-13 13:50:12.000,355.0,356.4,353.0,355.9,1171692.0,Biocon Ltd slips for fifth straight session,"Biocon Ltd is quoting at Rs 352.55, down 0.06% on the day as on 13:24 IST on the NSE. The stock tumbled 18.01% in last one year as compared to a 51.8% rally in NIFTY and a 27.73% spurt in the Nifty Pharma index.",neutral,negative,0.253521126760557,neutral,0.1401738155312587,neutral
2021-09-16 06:47:00.000,357.5,379.0,355.85,378.4,5526350.0,MidCap index at new peak; Vodafone Idea extends rally; Biocon surges,"Among sectoral indices, except Nifty IT index, all the indices were trading in the positive territory. Bank Nifty gained over half a per cent, rising over 37,000.",positive,positive,5.84615384615384,positive,-3.333333333333333,negative
2021-09-16 23:38:00.000,390.0,394.15,370.15,377.0,18292287.0,Biocon Biologics to offer 15% stake to Serum Institute Life Sciences,"Under the alliance, BBL will get committed access to 100 million doses of vaccines annually for 15 years and commercialisation rights of the SILS vaccine portfolio for global markets.",neutral,positive,-3.333333333333333,negative,-4.281914893617027,negative
2021-09-17 07:15:38.000,390.0,394.15,370.15,377.0,18292287.0,"Stocks To Watch: Biocon, Hero MotoCorp, JSW Steel, TVS Motor, Kotak Mahindra Bank, Poonawalla Fincorp",Here are the stocks to watch in trade today...,neutral,neutral,-3.333333333333333,negative,-4.281914893617027,negative
2021-09-17 08:21:56.000,390.0,394.15,370.15,377.0,18292287.0,"Stocks to Watch: Airtel, Biocon, Hero MotoCorp, TVS Motor, Zee",Biocon Biologics said it will offer around 15% stake to Serum Institute Life Sciences (SILS) at a post-money valuation of about $4.9 billion. SILS is a unit of Serum Institute of India.,neutral,neutral,-3.333333333333333,negative,-4.281914893617027,negative
2021-09-17 08:51:00.000,390.0,394.15,370.15,377.0,18292287.0,"Stocks to watch: Biocon, Hero Moto, Poonawalla Fin, TVS Motor, bank stocks","Hero MotoCorp on Thursday said it will increase the price of its entire model range by up to Rs 3,000 from September 20",neutral,positive,-3.333333333333333,negative,-4.281914893617027,negative
2021-09-17 08:51:21.000,390.0,394.15,370.15,377.0,18292287.0,Stocks that will see action today,"Buzzing stocks: TVS Motor, Biocon, Intelect Design, M&M, Kotak Bank, Cosmo Films, Balkrishna Ind",neutral,neutral,-3.333333333333333,negative,-4.281914893617027,negative
2021-09-17 09:14:00.000,390.0,394.15,370.15,377.0,18292287.0,Biocon spurts after announcing strategic alliance with Serum Institute,Biocon jumped 3.58% to Rs 390.40 after the drug company announced that it will sell 15% stake in its subsidiary Biocon Biologics to Serum Institute Life Sciences.,neutral,positive,-3.333333333333333,negative,-4.281914893617027,negative
2021-09-17 09:51:10.000,390.0,394.15,370.15,377.0,18292287.0,"The daily dose: September 17, 2021","# Covid-19 vaccine and more : Biocon Biologics and Serum Institute Life Sciences are coming together on vaccines, including those against Covid-19 and other biological products. More details are expec",neutral,neutral,-3.333333333333333,negative,-4.281914893617027,negative
2021-09-17 11:07:06.000,390.0,394.15,370.15,377.0,18292287.0,Biocon Unit To Offer 15% Stake To Serum Institute’s Arm In A Strategic Alliance,Adar Poonawalla will have a board seat in Biocon Biologics.,neutral,neutral,-3.333333333333333,negative,-4.281914893617027,negative
2021-09-17 11:48:33.000,390.0,394.15,370.15,377.0,18292287.0,Biocon Biologics to offer 15% stake to Serum Institute Life Sciences at valuation of $4.9 bn,"In return, to get committed access to 100 million vaccine doses annually for 15 years with commercialisation rights of the SILS vaccine portfolio.",neutral,positive,-3.333333333333333,negative,-4.281914893617027,negative
2021-09-17 13:00:00.000,390.0,394.15,370.15,377.0,18292287.0,"Top stocks in focus: Asian Granito, Biocon, Indiabulls Housing Finance, Infosys, Hero MotoCorp",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-3.333333333333333,negative,-4.281914893617027,negative
2021-09-17 15:56:00.000,390.0,394.15,370.15,377.0,18292287.0,Biocon unit plans 15% stake sale to Serum Institute for access to vaccines,"The deal with Serum Institute Life Sciences values Biocon Biologics at about $4.9 billion and will solely focus on COVID-19 vaccines in the initial years, the companies said.",neutral,neutral,-3.333333333333333,negative,-4.281914893617027,negative
2021-09-17 16:26:38.000,390.0,394.15,370.15,377.0,18292287.0,Biocon Biologics-SILS alliance to help in fighting infectious diseases: Kiran Mazumdar-Shaw,"On Thursday, Biocon Biologics, a subsidiary of Biocon, had said it will offer around 15 per cent stake to Serum Institute Life Sciences (SILS), at a post-money valuation of about USD 4.9 billion.",neutral,neutral,-3.333333333333333,negative,-4.281914893617027,negative
2021-09-17 16:27:39.000,390.0,394.15,370.15,377.0,18292287.0,Adar Poonawalla commits 100 million doses of vaccines every year to Biocon Biologics,Biocon Biologics will offer 15% stake to Serum Institute Life Sciences,neutral,neutral,-3.333333333333333,negative,-4.281914893617027,negative
2021-09-17 16:40:00.000,390.0,394.15,370.15,377.0,18292287.0,Kiran Mazumdar-Shaw & Adar Poonawalla spell out the road map for Biocon-Serum alliance,"“The Biocon-Serum alliance will initially focus on Covid vaccines, because that is the need of the hour. At a later stage, we will see what makes the most global impact, what has the most value. After that, we’ll jointly decide on what those vaccines should be.”",neutral,neutral,-3.333333333333333,negative,-4.281914893617027,negative
2021-09-17 16:40:00.000,390.0,394.15,370.15,377.0,18292287.0,Kiran Mazumdar-Shaw & Adar Poonawalla give road map for Biocon-Serum alliance,"“The Biocon-Serum alliance will initially focus on Covid vaccines, because that is the need of the hour. At a later stage, we will see what makes the most global impact, what has the most value. After that, we’ll jointly decide on what those vaccines should be.”",neutral,neutral,-3.333333333333333,negative,-4.281914893617027,negative
2021-09-17 17:05:00.000,390.0,394.15,370.15,377.0,18292287.0,"Biocon Biologics, Serum Institute Life Sciences enter strategic alliance","Work on mRNA platform, antibodies for dengue, HIV in the plan",positive,neutral,-3.333333333333333,negative,-4.281914893617027,negative
2021-09-17 17:22:07.000,390.0,394.15,370.15,377.0,18292287.0,Biocon - Maiden Foray Into Vaccines Via Serum Alliance: ICICI Direct,Biocon - Maiden Foray Into Vaccines Via Serum Alliance: ICICI Direct,neutral,neutral,-3.333333333333333,negative,-4.281914893617027,negative
2021-09-17 17:30:00.000,390.0,394.15,370.15,377.0,18292287.0,"Biocon-Serum alliance to build a global biotech powerhouse, say Kiran Mazumdar-Shaw, Adar Poonawalla","Speaking at a press conference today, they said the synergistic future oriented deal will help growth of both companies",neutral,positive,-3.333333333333333,negative,-4.281914893617027,negative
2021-09-17 17:30:00.000,390.0,394.15,370.15,377.0,18292287.0,"Stocks in news: Poonawalla Fincorp, Biocon, JSW Steel, Kotak Mahindra Bank and more","On September 16, Sensex closed above the 59,000 mark for the first time, led by gains in banking stocks. Nifty too ended above 17,600 level, with 28 of 50 components ending in the green.",neutral,positive,-3.333333333333333,negative,-4.281914893617027,negative
2021-09-17 17:30:00.000,390.0,394.15,370.15,377.0,18292287.0,Biocon Biologics offers 15% stake to Serum Institute Life Sciences,"The alliance will also develop antibodies in order to target diseases such as dengue, HIV etc. Both companies will enter Service Level Agreements (SLAs) for manufacturing and distribution of these vaccines and antibodies",neutral,neutral,-3.333333333333333,negative,-4.281914893617027,negative
2021-09-17 17:44:00.000,390.0,394.15,370.15,377.0,18292287.0,Biocon-led subsidiary Biocon Biologics and Serum Institute Life Sciences form a strategic alliance,Both companies believe that this is an alliance that can make a significant impact on global healthcare through vaccines and biologics.,neutral,positive,-3.333333333333333,negative,-4.281914893617027,negative
2021-09-17 19:14:20.000,390.0,394.15,370.15,377.0,18292287.0,"Adar Poonawalla hails partnership with Biocon Biologies, says India will be a global vaccine manufacturing powerhouse","Adar Poonawalla hails partnership with Biocon Biologies, says India will be a global vaccine manufacturing powerhouse",positive,positive,-3.333333333333333,negative,-4.281914893617027,negative
2021-09-17 19:16:56.000,390.0,394.15,370.15,377.0,18292287.0,Biocon Biologics to offer 15% stake to Serum Institute Life Sciences,Biocon Biologics to offer 15% stake to Serum Institute Life Sciences,neutral,neutral,-3.333333333333333,negative,-4.281914893617027,negative
2021-09-17 21:40:16.000,390.0,394.15,370.15,377.0,18292287.0,"Biocon, SII join hands to focus on vaccines, other biotech products",BBL to offload 15% stake to SILS; to get 100 million doses annually for 15 years,neutral,neutral,-3.333333333333333,negative,-4.281914893617027,negative
2021-09-17 21:55:19.000,390.0,394.15,370.15,377.0,18292287.0,Serum Institute Expects Tie-Up With Biocon To Yield ‘Synergistic Benefits’,The companies expect to benefit mutually in the areas of vaccines and antibodies.,neutral,positive,-3.333333333333333,negative,-4.281914893617027,negative
2021-09-19 22:36:28.000,376.0,376.0,359.0,359.9,3148558.0,"Vaccine access, biosimilars growth to boost Biocon’s earnings outlook",Biocon Biologics’ valuation will stand at $4.9 billion after the completion of its deal with Serum Institute Life Sciences,positive,neutral,-4.281914893617027,negative,0.6181318681318682,neutral
2021-09-20 12:00:00.000,376.0,376.0,359.0,359.9,3148558.0,Can Serum deal provide a booster dose to Biocon’s target price?,"The Serum alliance would give Biocon Biologics’ access to 100 million doses of vaccines per annum for 15 years with commercialisation rights, including that of Covid-19 vaccines, for global markets.",positive,positive,-4.281914893617027,negative,0.6181318681318682,neutral
2021-09-20 23:23:15.000,364.0,369.15,356.0,366.25,2708231.0,Biocon Rating: Hold – Vaccines to complement biosimilar portfolio,Deal with SILS could add NPV of `21/share to TP; better biosimilar execution remains key; ‘Hold’ retained,positive,positive,0.6181318681318682,neutral,0.6708652792990112,neutral
2021-09-21 08:30:00.000,364.0,369.15,356.0,366.25,2708231.0,"Nifty Pharma index rallies 1.2%; Biocon, Auro Pharma lead the gains",Torrent Pharma and Lupin were under pressure on the flip side.,positive,neutral,0.6181318681318682,neutral,0.6708652792990112,neutral
2021-09-27 07:50:33.000,355.0,361.85,352.65,358.6,4077514.0,"Stocks to Watch: Indiabulls Housing Finance, United Breweries, Biocon, NBCC and More",Indian market taking mixed cues from global markets is expected to open in the positive territory.,neutral,positive,1.01408450704226,positive,0.7502083912197959,neutral
2021-09-27 08:32:00.000,355.0,361.85,352.65,358.6,4077514.0,"Biocon, NHPC, NBCC (India) in focus",Biocon on Saturday announced that the USFDA has issued six observations after the inspection of the manufacturing facility of its Malaysian subsidiary Biocon Sdn Bhd.,neutral,negative,1.01408450704226,positive,0.7502083912197959,neutral
2021-09-27 08:46:00.000,355.0,361.85,352.65,358.6,4077514.0,"Stocks to watch: ZEEL, Info Edge, NBCC, Biocon, United Breweries, SJVN",State-owned power giant NTPC has bagged 1.9 GW solar projects in CPSU Scheme-II tender,neutral,neutral,1.01408450704226,positive,0.7502083912197959,neutral
2021-09-27 09:36:45.000,355.0,361.85,352.65,358.6,4077514.0,The stocks that will see action today,"Focus is on AsrtraZeneca, Biocon, Shipla Medicare, Hind Copper, ZEEL, IRB Infra, SJVN, NBCC, PG Electroplast, Orient Cement and TVS Srichakra",positive,neutral,1.01408450704226,positive,0.7502083912197959,neutral
2021-09-27 10:53:00.000,355.0,361.85,352.65,358.6,4077514.0,Biocon slips after USFDA issues six observations at Malaysia subsidiary,Biocon fell 1% to Rs 356.60 after the company’s Malaysian subsidiary received six observations from the US drug regulator.,neutral,negative,1.01408450704226,positive,0.7502083912197959,neutral
2021-09-27 12:55:00.000,359.9,366.5,357.05,362.6,2065746.0,"Top stocks in focus: PVR, Inox, Shriram City Union Finance, Indiabulls Housing Finance, Biocon",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,0.7502083912197959,neutral,0.2072682050573442,neutral
2021-09-27 14:19:56.000,359.9,366.5,357.05,362.6,2065746.0,Biocon Gets 6 Observations From USFDA For Its Malaysian Facility In Pre-approval Inspection,"“We are confident of addressing these observations through procedural enhancements and an appropriate Corrective and Preventive Action Plan (CAPA), which will be submitted to the US FDA in the stipulated time,” Biocon spokesperson said.",neutral,positive,0.7502083912197959,neutral,0.2072682050573442,neutral
2021-09-27 14:52:00.000,359.9,366.5,357.05,362.6,2065746.0,Biocon Biologics’ insulin manufacturing facility in Malaysia completes USFDA (PAI) Inspection,"At the conclusion of the inspection, the agency has issued a Form 483 with a total of 6 observations.",neutral,neutral,0.7502083912197959,neutral,0.2072682050573442,neutral
2021-09-27 17:30:00.000,359.9,366.5,357.05,362.6,2065746.0,"Stocks in news: Zee Entertainment, Indiabulls Housing, Axis Bank, United Breweries, NTPC and more","Stocks in news today: Indiabulls Housing, Axis Bank, United Breweries, NTPC, United Breweries, Biocon and more",neutral,neutral,0.7502083912197959,neutral,0.2072682050573442,neutral
2021-09-30 06:30:00.000,363.5,369.05,361.15,362.5,2143289.0,"Nifty Pharma stocks continue winning streak; Abbott India, IPCA Lab stocks outperform",Sun Pharma and Cadila also advanced to push the sectorial gains while Biocon and Lupin were also in the fast lane.,positive,positive,-0.2751031636863824,neutral,0.9944751381215532,positive
2021-09-30 13:12:54.000,362.0,367.6,358.25,365.6,1548173.0,Biocon - Malaysian Facility Gets Six Observations From U.S. FDA In Pre-Approval Inspection: Nirmal Bang,Biocon - Malaysian Facility Gets Six Observations From U.S. FDA In Pre-Approval Inspection: Nirmal Bang,neutral,neutral,0.9944751381215532,positive,-0.544959128065395,neutral
2021-10-04 09:22:00.000,367.0,370.6,364.25,365.0,1729706.0,Biocon launches Everolimus tablets in the US market,Everolimus (Afinitor) is a prescription medication that is used to treat certain types of cancers and tumours.,neutral,neutral,-0.544959128065395,neutral,-0.9983588621444294,negative
2021-10-04 10:25:18.000,367.0,370.6,364.25,365.0,1729706.0,Biocon Share Price Gains On Launch Of Cancers Drug In The US Market,Everolimus (Afinitor) is a prescription medication that is used to treat certain types of cancers and tumours,neutral,neutral,-0.544959128065395,neutral,-0.9983588621444294,negative
2021-10-04 12:54:00.000,365.6,367.45,361.5,361.95,1106124.0,Allegro Capital named in Pandora Papers: What was the Sebi order about?,Kunal Kashyap’s Sebi order was also linked to Biocon. It was related to a 2018 announcement about Biocon’s global collaboration with Sandoz,neutral,neutral,-0.9983588621444294,negative,-1.450276243093923,negative
2021-10-04 13:04:33.000,365.6,367.45,361.5,361.95,1106124.0,"Biocon Ltd soars 0.77%, up for fifth straight session","Biocon Ltd is quoting at Rs 368.1, up 0.77% on the day as on 12:49 IST on the NSE. The stock is down 19.69% in last one year as compared to a 53.64% spurt in NIFTY and a 23.73% spurt in the Nifty Pharma.",positive,positive,-0.9983588621444294,negative,-1.450276243093923,negative
2021-10-04 13:31:14.000,365.6,367.45,361.5,361.95,1106124.0,Biocon Ltd continues to edge higher,"Biocon Ltd is quoting at Rs 368.1, up 0.77% on the day as on 12:49 IST on the NSE. The stock is down 19.69% in last one year as compared to a 53.64% spurt in NIFTY and a 23.73% spurt in the Nifty Pharma.",positive,positive,-0.9983588621444294,negative,-1.450276243093923,negative
2021-10-04 16:34:00.000,365.6,367.45,361.5,361.95,1106124.0,"Biocon gains 1% on launch of Everolimus tablets, a generic version of Afinitor in US",The commercial launch of Everolimus follows an US FDA approval in February 2021.,positive,positive,-0.9983588621444294,negative,-1.450276243093923,negative
2021-10-05 00:54:00.000,365.6,367.45,361.5,361.95,1106124.0,"Decoded: Of ‘Pandora Papers’, insider trading and Biocon link","Kiran Mazumdar-Shaw, executive chairperson of Biocon denied any impropriety",neutral,neutral,-0.9983588621444294,negative,-1.450276243093923,negative
2021-10-05 07:13:51.000,365.6,367.45,361.5,361.95,1106124.0,"Biocon, Cipla and ZEEL are among stocks in the news",Initial indicators from stock markets globally indicate a fall in stocks pushed by surging raw-material prices and fears of inflation,neutral,negative,-0.9983588621444294,negative,-1.450276243093923,negative
2021-10-05 14:45:00.000,362.0,364.2,355.85,356.75,1190718.0,Biocon chief says that certain media reports on Pandora Papers have grossly misrepresented the facts,Kiran Mazumdar-Shaw referred to her husband John Shaw’s Offshore trust.,negative,neutral,-1.450276243093923,negative,0.0695410292072322,neutral
2021-10-05 19:18:51.000,362.0,364.2,355.85,356.75,1190718.0,Anatomy Of Black Money: Will The Pandora Papers Tackle It,"The latest expose under the Pandora list has names of prominent Indians like former cricketer Sachin Tendulkar, chairman and MD of Biocon, Mazumdar Shaw, and industrialist Vinod Adani, others.",neutral,neutral,-1.450276243093923,negative,0.0695410292072322,neutral
2021-10-06 03:25:00.000,362.0,364.2,355.85,356.75,1190718.0,Pandora Papers: ‘Kunal Kashyap has no influence over Biocon-linked trust’,"According to a company statement, the Deanstone Trust, which was mentioned as part of a leak of offshore tax haven files called the ‘Pandora Papers,’ was set up for philanthropic endeavours",neutral,neutral,-1.450276243093923,negative,0.0695410292072322,neutral
2021-10-08 18:14:00.000,361.75,363.5,358.15,358.7,1177584.0,Natural Biocon (India) standalone net profit rises 66.67% in the September 2021 quarter,Sales rise 225.00% to Rs 0.13 crore,positive,positive,-0.8431237042156217,neutral,0.3342618384401082,neutral
2021-10-21 07:00:00.000,346.0,349.8,338.0,349.5,4133828.0,Biocon Biologics insulin biosimilar Glargine gets preference in top US formulary; Biocon in focus ahead of Q2 results,Broad coverage of Semglee by Express Scripts will help ensure that the many patients on its network who need Insulin Glargine may receive the full benefits of and access to treatment with lower or maintained out-of-pocket costs.,neutral,positive,1.0115606936416186,positive,-5.204678362573103,negative
2021-10-21 08:02:43.000,346.0,349.8,338.0,349.5,4133828.0,"Stocks to Watch: Reliance, Future Retail, PNB Housing, Mindtree, Asian Paints","Asian Paints, Biocon, Container Corp, CG Power, IDBI Bank, IndiaMart InterMesh, Indian Hotels, Lemon Tree Hotels, JSW Steel, Macrotech Developers, Mphasis, and TVS Motors are some of the companies that will announce results today",neutral,neutral,1.0115606936416186,positive,-5.204678362573103,negative
2021-10-21 08:36:00.000,346.0,349.8,338.0,349.5,4133828.0,"Stocks to Watch: Asian Paints, Biocon, IDBI, JSW Steel, Lodha, TVS Motors",State-run PSU banks and telecom stocks are likely to be in focus along with a slew of mid- and small-cap companies that shall announce their September earnings today,neutral,neutral,1.0115606936416186,positive,-5.204678362573103,negative
2021-10-21 08:53:00.000,346.0,349.8,338.0,349.5,4133828.0,"Tata Communications, Angel One, Dhani Services in focus","Asian Paints, JSW Steel, Biocon, ICICI Lombard General Insurance Company, IDBI Bank, Indian Energy Exchange among others will release their September 2021 quarter earnings today, 21 October 2021.",neutral,neutral,1.0115606936416186,positive,-5.204678362573103,negative
2021-10-21 09:12:46.000,346.0,349.8,338.0,349.5,4133828.0,Stocks to see action today (October 21),"Buzzing stocks: Asian Paints, Biocon, IEX, JSW Steel, IndiaMart, Jubilant Ind, TVS Motor, BoM, ICICI General, LIC Housing Fin, IDBI, Concor, 63 moons, NBCC, SecureKloud, LemonTree",neutral,neutral,1.0115606936416186,positive,-5.204678362573103,negative
2021-10-21 10:30:00.000,346.0,349.8,338.0,349.5,4133828.0,Biocon’s interchangeable biosimilar Insulin glargine added on Express Scripts’ largest formulary in US,"The listing is expected to boost Biocon’s biosimilar business, as inclusion of Semglee on Express Scripts’ NPF will allow pharmacies to substitute the much cheaper Semglee for Sanofi’s Lantus without having to consult the prescribing healthcare professional.",neutral,positive,1.0115606936416186,positive,-5.204678362573103,negative
2021-10-21 10:46:00.000,346.0,349.8,338.0,349.5,4133828.0,Express Scripts lists Biocon subsidiary’s Semglee as a preferred glargine brand on NPF,"Biocon Biologics (BBL) said that Express Scripts will list BBL interchangeable biosimilar Insulin Glargine, commercialized by Viatris, as a preferred glargine brand on its National Preferred Formulary (NPF), which includes more than 28 million",neutral,neutral,1.0115606936416186,positive,-5.204678362573103,negative
2021-10-21 12:19:00.000,342.0,343.0,322.5,324.2,7189933.0,Biocon’s insulin biosimilar Glargine gets preference in top US formulary,The USFDA had approved biosimilar Insulin Glargine-yfgn injection (Semglee) as the first interchangeable biosimilar product in July this year,positive,positive,-5.204678362573103,negative,-0.9844639286263616,negative
2021-10-21 14:36:00.000,342.0,343.0,322.5,324.2,7189933.0,"Important results today: Asian Paints, Biocon, JSW Steel, TVS Motor, ICICI Lombard, IEX, IDBI Bank among others","These companies are right from banking, metal to pharma and auto sectors.",neutral,neutral,-5.204678362573103,negative,-0.9844639286263616,negative
2021-10-21 17:20:59.000,342.0,343.0,322.5,324.2,7189933.0,Biocon’s insulin Glargine to be listed by Express Scripts in US,Biocon’s insulin Glargine to be listed by Express Scripts in US,neutral,neutral,-5.204678362573103,negative,-0.9844639286263616,negative
2021-10-22 08:34:00.000,342.0,343.0,322.5,324.2,7189933.0,Biocon consolidated net profit declines 18.31% in the September 2021 quarter,Sales rise 5.18% to Rs 1840.40 crore,negative,positive,-5.204678362573103,negative,-0.9844639286263616,negative
2021-10-22 09:41:33.000,342.0,343.0,322.5,324.2,7189933.0,Biocon Q2: Consolidated net profit dips 18% to Rs 138 cr,Biocon Q2: Consolidated net profit dips 18% to Rs 138 cr,negative,negative,-5.204678362573103,negative,-0.9844639286263616,negative
2021-10-22 11:35:31.000,342.0,343.0,322.5,324.2,7189933.0,Biocon Consolidated Net Profit Dips 18% To Rs 138 Crore In Q2,The Bengaluru-based company had reported a net profit of Rs 169 crore in the July-September quarter of the previous fiscal.,neutral,neutral,-5.204678362573103,negative,-0.9844639286263616,negative
2021-10-22 11:52:00.000,342.0,343.0,322.5,324.2,7189933.0,"Biocon net rises 11% in Q2 to Rs 188 cr, revenue up 10% at Rs 1,945 cr",Revenue growth was primarily driven by good performance of its research services and biosimilars business segments,positive,positive,-5.204678362573103,negative,-0.9844639286263616,negative
2021-10-22 11:57:50.000,342.0,343.0,322.5,324.2,7189933.0,"Buzzing Stocks: IEX Shares Zoom After Posting 58 Per Cent YOY Growth, Biocon Declines Over 4 Per Cent",IEX said the growth in volumes was driven by a substantial increase in electricity consumption as well as the preference by the distribution utilities to meet their short-term supply.,neutral,positive,-5.204678362573103,negative,-0.9844639286263616,negative
2021-10-22 12:06:42.000,342.0,343.0,322.5,324.2,7189933.0,Biocon quarterly revenue up by 10%,Shares dip over 4 per cent on Friday,positive,neutral,-5.204678362573103,negative,-0.9844639286263616,negative
2021-10-22 12:51:10.000,342.0,343.0,322.5,324.2,7189933.0,Board of Biocon approves appointment of director,At meeting held on 21 October 2021,neutral,neutral,-5.204678362573103,negative,-0.9844639286263616,negative
2021-10-22 12:52:57.000,342.0,343.0,322.5,324.2,7189933.0,Biocon Share Price Falls 5% After Q2 Profit Dips To Rs 138 Crore,Motilal Oswal has kept neutral rating on the stock with a target price of Rs 400 per share.,neutral,positive,-5.204678362573103,negative,-0.9844639286263616,negative
2021-10-22 14:47:00.000,342.0,343.0,322.5,324.2,7189933.0,"Biocon appoints Dr Eric Vivek Mazumdar as Non-Executive, Non-Independent Director","Dr. Eric Mazumdar is an Assistant Professor of Computing and Mathematical Sciences, and Economics at the California Institute of Technology.",neutral,neutral,-5.204678362573103,negative,-0.9844639286263616,negative
2021-10-22 17:30:00.000,342.0,343.0,322.5,324.2,7189933.0,"Biocon Q2 results: Net profit up 11% at Rs 188 cr; revenue jumps 10% to Rs 1,945 cr","The company’s consolidated revenue jumped 10% to Rs 1,945 crore in Q2FY22 on a year-on-year (YoY) basis, against Rs 1,765 crore in the corresponding quarter in the previous fiscal, Biocon said a regulatory filing.",positive,positive,-5.204678362573103,negative,-0.9844639286263616,negative
2021-10-22 18:00:44.000,342.0,343.0,322.5,324.2,7189933.0,"Biocon Consolidated September 2021 Net Sales At Rs 1,840.40 Crore, Up 5.48% Y-o-Y",,neutral,neutral,-5.204678362573103,negative,-0.9844639286263616,negative
2021-10-24 00:22:14.000,325.05,326.9,314.8,321.85,3466090.0,Biocon Q2 Review - Ramp-Up In Biosimilars Offset Lower Generic Sales: Motilal Oswal,Biocon Q2 Review - Ramp-Up In Biosimilars Offset Lower Generic Sales: Motilal Oswal,neutral,neutral,-0.9844639286263616,negative,3.560371517027864,positive
2021-10-25 08:09:00.000,325.05,326.9,314.8,321.85,3466090.0,Biocon eyes $30b US insulin market via its biosimilars,"With the approval of aspart, Biocon says it will become the first company to receive approvals for two interchangeable insulin drugs in the US, helping it make a strong entry into that market. This also proves that the company has the science and vertical integration required to get to the US market…",neutral,positive,-0.9844639286263616,negative,3.560371517027864,positive
2021-10-25 14:46:37.000,323.0,334.7,320.1,334.5,3109139.0,Buy Biocon: Target Of Rs 470: Sharekhan,"Sharekhan is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 470 in its research report dated October 22, 2021.",neutral,positive,3.560371517027864,positive,0.836570062742758,neutral
2021-10-26 18:02:00.000,334.7,341.45,333.0,337.5,2807478.0,Serum alliance will help margins from H2 of FY23: Biocon Biologics dy CEO,"In a Q&A, Shreehas Tambe talks about the road ahead for the firm’s biosimilars business and how its alliance with Serum is projected to pan out",positive,neutral,0.836570062742758,neutral,-0.3698224852071006,neutral
2021-10-27 07:47:00.000,334.7,341.45,333.0,337.5,2807478.0,"Ashok Leyland, Biocon look good on charts for a rebound: Ajit Mishra",The technical analyst from Religare Broking also recommends to accumulate United Spirits. Check out the range below,positive,positive,0.836570062742758,neutral,-0.3698224852071006,neutral
2021-10-27 08:42:09.000,334.7,341.45,333.0,337.5,2807478.0,"‘Alliance with SILS to help add next-generation vaccines, drive long-term growth’",The alliance with Serum Institute Life Sciences (SILS) provides Biocon Biologics an asset-light and accelerated entry into the vaccines segment.,positive,positive,0.836570062742758,neutral,-0.3698224852071006,neutral
2021-10-31 23:43:00.000,351.5,353.95,346.1,348.0,1935944.0,"View: Corporate culture, world is a CEO oyster for India Inc","For India Inc, with a traditionally poor record of hiring expat CEOs, the stints of people like Paris-based Frenchman Thierry Delaporte (Wipro), Israeli national Erez Israeli (Dr Reddys Laboratories), British national Jonathan Hunt (Syngene, Biocon), American Brian Bade (Reliance Retail Digital) and…",neutral,neutral,-0.995732574679943,negative,-0.8756818834338247,neutral
2021-11-08 08:01:00.000,349.5,350.95,343.55,348.5,1040436.0,Biocon Biologics and Viatris confirms Prime Therapeutics to list Semglee and Insulin Glargine injections as preferred insulin,This decision by Prime Therapeutics follows the U.S. Food and Drug Administration’s (FDA) approval of the first-ever interchangeable biosimilar through the interchangeable pathway.,neutral,positive,-0.2861230329041487,neutral,-0.5437893531768682,neutral
2021-11-09 17:58:00.000,347.0,351.15,346.2,347.5,1171703.0,Covid reinforced global dependence on Indian IT sector: Kris Gopalakrishnan,"Bengaluru Tech Summit 2021 unveiled by Gopalakrishnan, Biocon’s Kiran Mazumdar Shaw, to be held during November 17-19",positive,neutral,0.1440922190201729,neutral,-0.4744105807935693,neutral
2021-11-10 13:01:41.000,347.8,348.65,342.5,346.15,872498.0,Nykaa Drives Falguni Nayar To Be India’s Wealthiest Self-made Female Billionaire,"Nayar, who has pipped Biocon founder Kiran Mazumdar-Shaw in terms of assets, is now the second wealthiest woman in India after Savitri Jindal. She is richer than the Muthoot family, Marico founder Harsh Mariwala, and Asian Paints’ Abhay Vakil.",neutral,neutral,-0.4744105807935693,neutral,-0.2877697841726618,neutral
2021-11-10 14:41:00.000,347.8,348.65,342.5,346.15,872498.0,Dalal Street gets Nykaa-ed: Biocon boss calls it a fantastic debut; Zerodha co-founder says value stock investors must go on a long holiday,Nykaa Fashion CEO Adwaita Nayar and actress Katrina Kaif attended the listing event.,positive,neutral,-0.4744105807935693,neutral,-0.2877697841726618,neutral
2021-11-11 11:12:00.000,347.8,348.65,342.5,346.15,872498.0,Nykaa founder Falguni Nayar among India’s 20 richest people after blockbuster listing,"Falguni Nayar, only the second Indian self-made woman billionaire after Biocon founder Kiran Mazumdar-Shaw, was worth around Rs 55,572 crore ($7.48 billion) as of 3:10 pm on Wednesday, when FSNs stock was trading at Rs 2,206.",neutral,neutral,-0.4744105807935693,neutral,-0.2877697841726618,neutral
2021-11-15 08:05:00.000,347.5,362.4,347.1,361.6,7497495.0,"Nifty Pharma emerges top gainer, index soars 1.5% on broad-based buying; Laurus Labs jumps 9%; Biocon, Gland, NATCO, Glenmark lift too","The index has hovered between an intraday high and low of 13,994.10 and 13,770.90 respectively.",positive,neutral,4.057553956834539,positive,1.8518518518518483,positive
2021-11-15 11:08:00.000,347.5,362.4,347.1,361.6,7497495.0,"Biocon starts campaign to treat diabetic children, train healthcare workers",India has one of the largest populations of children and adolescents living with Type 1 diabetes in the world with an estimated 1 million patients in this age group,neutral,neutral,4.057553956834539,positive,1.8518518518518483,positive
2021-11-15 11:46:43.000,347.5,362.4,347.1,361.6,7497495.0,Biocon Biologics collaborates with RSSDI; to expand access to its insulins for children with Type 1 Diabetes,Biocon Biologics collaborates with RSSDI; to expand access to its insulins for children with Type 1 Diabetes,positive,positive,4.057553956834539,positive,1.8518518518518483,positive
2021-11-16 10:07:00.000,361.8,370.5,360.3,368.5,6767036.0,Biocon-led Biologics arm ties with RSSDI to expand access to its Insulins for Children with Type 1 Diabetes,"Biocon Biologics will
provide, educational and other diabetes awareness materials for these training programs as well as will facilitate organizing of these events.",positive,neutral,1.8518518518518483,positive,0.9693053311793276,positive
2021-11-16 18:18:00.000,371.4,377.6,367.6,375.0,6933222.0,Biocon Biologics and Viatris launch first-ever interchangeable biosimilars in U.S.,Powered by Capital Market - Live News,neutral,neutral,0.9693053311793276,positive,-3.020667726550074,negative
2021-11-16 18:38:00.000,371.4,377.6,367.6,375.0,6933222.0,"Biocon Biologics, Viatris launch interchangeable insulin biosimilar for US",These injections will help control high blood sugar in adult and pediatric patients with type-1 diabetes and adults with type-2,neutral,neutral,0.9693053311793276,positive,-3.020667726550074,negative
2021-11-16 19:43:05.000,371.4,377.6,367.6,375.0,6933222.0,"Biocon Biologics, Viatris Launch Biosimilar Insulin Glargine In US","Biocon Biologics and Viatris Inc have launched Semglee (insulin glargine-yfgn) injection, a branded product, and Insulin Glargine (insulin glargine-yfgn) injection, an unbranded product, to help control high blood sugar in adult and pediatric patients with type 1 diabetes and adults with type 2 diab…",neutral,positive,0.9693053311793276,positive,-3.020667726550074,negative
2021-11-17 05:30:00.000,371.4,377.6,367.6,375.0,6933222.0,"Stock in Focus on Nov 17; Eicher Motors, ONGC, Biocon & More","Stock in Focus on Nov 17; Eicher Motors, ONGC, Biocon & More",neutral,neutral,0.9693053311793276,positive,-3.020667726550074,negative
2021-11-17 08:38:00.000,371.4,377.6,367.6,375.0,6933222.0,"Stocks to Watch: IndiGo, Biocon, Pfizer, IEX, TFCI, SAIL, BHEL, Nalco",Indian Energy Exchange and Apollo Pipes have announced their respective record dates for the issuance of bonus shares for eligible shareholders,neutral,neutral,0.9693053311793276,positive,-3.020667726550074,negative
2021-11-17 08:43:00.000,371.4,377.6,367.6,375.0,6933222.0,"Infosys, Biocon, Home First Finance in spotlight","Infosys and MIT Technology Review, a world-renowned technology media brand and its custom publishing division Insights, announced the launch of ‘The Cloud Hub’, a forum offering insights and learning from successful cloud transformations to help",neutral,neutral,0.9693053311793276,positive,-3.020667726550074,negative
2021-11-17 09:03:58.000,371.4,377.6,367.6,375.0,6933222.0,Stocks that will see action on November 17,"Focus on JSW Steel, Biocon, Coforge, KDDL, Welspun Enterprises, Meghmani Organics, RHI Magnesita, Welspun Enterprises",neutral,neutral,0.9693053311793276,positive,-3.020667726550074,negative
2021-11-17 09:20:58.000,371.4,377.6,367.6,375.0,6933222.0,Biocon launches inter-changeable biosimilar insulin in US,"Biocon Biologics Ltd, a subsidiary of Biocon Ltd and Viatris Inc, has announced the US launch of interchangeable biosimilars Semglee (insulin glargine-yfgn) injection, a branded product, and Insulin G",neutral,positive,0.9693053311793276,positive,-3.020667726550074,negative
2021-11-17 09:23:00.000,371.4,377.6,367.6,375.0,6933222.0,Biocon introduces Semglee & Insulin Glargine injections in the U.S. market,"The subsidiary of Biocon, Biocon Biologics, announced the U.S. launch of interchangeable biosimilars Semglee (insulin glargine- yfgn) injection and Insulin Glargine (insulin glargine-yfgn) injection.",neutral,positive,0.9693053311793276,positive,-3.020667726550074,negative
2021-11-17 12:50:00.000,377.4,377.4,364.0,366.0,3127247.0,"Top stocks in focus: Parag Milk Foods, Biocon, Grindwell Norton, Tourism Finance Corporation of India, PNB",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-3.020667726550074,negative,-2.4559967253376995,negative
2021-11-17 13:31:18.000,377.4,377.4,364.0,366.0,3127247.0,"Biocon Ltd spurts 1.33%, rises for third straight session","Biocon Ltd is quoting at Rs 374.25, up 1.33% on the day as on 12:54 IST on the NSE. The stock is down 11.52% in last one year as compared to a 38.61% gain in NIFTY and a 17.7% gain in the Nifty Pharma index.",positive,positive,-3.020667726550074,negative,-2.4559967253376995,negative
2021-11-17 16:42:00.000,377.4,377.4,364.0,366.0,3127247.0,Nifty Pharma under pressure; Healthcare stocks surge over 1%; Apollo Hospitals hits new high,"Metropolis Healthcare, Torrent Pharma, and Biocon were also in the fast lane. IPCA Labs, Lupin, Glenmark, Star, Auro Pharma, and Divis Lab were under pressure.",positive,neutral,-3.020667726550074,negative,-2.4559967253376995,negative
2021-11-17 17:00:00.000,377.4,377.4,364.0,366.0,3127247.0,Biocon’s biologics arm and Viatris launch Interchangeable SEMGLEE and Insulin Glargine injections; Stock climbs 1%,"Both biosimilar products are available in a vial and prefilled pen presentations and are interchangeable for the reference brand, LANTUS (insulin glargine), allowing for substitution at the pharmacy counter.",positive,neutral,-3.020667726550074,negative,-2.4559967253376995,negative
2021-11-18 13:30:00.000,377.4,377.4,364.0,366.0,3127247.0,Share price of Biocon falls as Nifty weakens,"A total of 234,126 shares changed hands on the counter till 01:30PM (IST).",neutral,neutral,-3.020667726550074,negative,-2.4559967253376995,negative
2021-11-18 17:22:00.000,377.4,377.4,364.0,366.0,3127247.0,Nifty Pharma stocks continue to tumble amid weak markets; Index sheds 1.5%; Healthcare stocks also feel the heat,"Apollo Hospital Enterprises Limited was over 2.5% lower after hitting a new high on Wednesday. Auro Pharma, Glenmark, Biocon, Dr. Reddy dragged the most.",negative,negative,-3.020667726550074,negative,-2.4559967253376995,negative
2021-11-22 00:46:36.000,366.45,366.9,356.15,357.45,2109465.0,"New products will help Biocon, but price pressures loom",The launch of interchangeable Semglee may help shift the prescription share from leader Lantus,positive,positive,-2.4559967253376995,negative,2.791415345770792,positive
2021-11-22 10:05:00.000,366.45,366.9,356.15,357.45,2109465.0,Biocon Biologics and Viatris launch Insulin Glargine Injection,This decision by Walgreens follows the launch of Insulin Glargine (insulin glargine-yfgn) announced on November 16.,neutral,neutral,-2.4559967253376995,negative,2.791415345770792,positive
2021-11-22 12:14:00.000,356.45,372.0,351.4,366.4,3191810.0,Biocon shares fall 1.73% as Nifty drops,The stock quoted a 52-week high price of Rs 487.7 and a 52-week low of Rs 314.9.,negative,negative,2.791415345770792,positive,-1.882417132724058,negative
2021-11-23 13:25:00.000,366.55,368.55,358.7,359.65,1152416.0,Biocon share price up 1.65 per cent,"A total of 365,999 shares changed hands on the counter till 01:25PM (IST).",positive,neutral,-1.882417132724058,negative,1.082882132444824,positive
2021-11-24 13:41:00.000,360.15,365.0,356.3,364.05,1289506.0,Share price of Biocon falls as Sensex gains 202.17 points,"Promoters held 39.73 per cent stake in the company as of 30-Sep-2021, while FII and DII ownership stood at 15.74 per cent and 2.58 per cent, respectively.",positive,neutral,1.082882132444824,positive,0.2624309392265161,neutral
2021-11-25 12:34:00.000,362.0,373.6,358.9,362.95,3524294.0,Share price of Biocon rises as Nifty strengthens,"A total of 43,203 shares changed hands on the counter till 12:34PM (IST).",positive,neutral,0.2624309392265161,neutral,0.4137931034482758,neutral
2021-11-26 10:05:00.000,362.0,373.6,358.9,362.95,3524294.0,Share price of Biocon jumps as Sensex drops 981.62 points,"A total of 121,614 shares changed hands on the counter till 10:05AM (IST)",positive,neutral,0.2624309392265161,neutral,0.4137931034482758,neutral
2021-11-29 13:25:00.000,364.5,370.95,357.55,358.6,4127584.0,Share price of Biocon falls as Sensex gains 410.14 points,"Promoters held 39.73 per cent stake in the company as of 30-Sep-2021, while FII and DII ownership stood at 15.74 per cent and 2.58 per cent, respectively.",positive,neutral,-1.6186556927297604,negative,2.98177802319161,positive
2021-11-30 14:05:00.000,362.2,373.9,358.1,373.0,3490900.0,Share price of Biocon rises as Nifty strengthens,"A total of 169,873 shares changed hands on the counter till 02:05PM (IST).",positive,neutral,2.98177802319161,positive,-1.840490797546006,negative
2021-12-01 03:35:00.000,362.2,373.9,358.1,373.0,3490900.0,Biocon enters in Dow Jones Sustainability Emerging Markets Index,Among Top 15 Companies from India on Premier Global Sustainability Benchmark.,neutral,neutral,2.98177802319161,positive,-1.840490797546006,negative
2021-12-01 10:49:00.000,362.2,373.9,358.1,373.0,3490900.0,"Buy Biocon, target price Rs 425: ICICI Direct","Biocon Ltd., incorporated in the year 1978, is a Large-Cap company (with a market cap of Rs 43209.59 Crore) operating in Pharmaceuticals sector.",neutral,neutral,2.98177802319161,positive,-1.840490797546006,negative
2021-12-01 12:02:00.000,374.9,378.6,363.0,368.0,4987485.0,Biocon shares gain 0.43% as Sensex rises,"A total of 56,313 shares changed hands on the counter till 12:02PM (IST)",positive,neutral,-1.840490797546006,negative,-1.064833535516913,negative
2021-12-01 16:30:00.000,374.9,378.6,363.0,368.0,4987485.0,"Six hours of wait: Even if you are Covid negative, you are likely to acquire it at airport, says Biocon founder","“Day 1 Of Omicron Travel Rules, Upto 6 Hours Wait For Tests: 10 Points - Even if you did not have the infection you are likely to acquire it at the airport!,” Shaw tweeted after new travel regulations, both from the union health ministry and States kicked in on December 1.",neutral,neutral,-1.840490797546006,negative,-1.064833535516913,negative
2021-12-01 16:33:00.000,374.9,378.6,363.0,368.0,4987485.0,Biocon enters Dow Jones Sustainability Index in Emerging Markets category,Pharma major makes it to the DJSI EM Index with a total sustainability score of 45 as against an industry average of 18,neutral,neutral,-1.840490797546006,negative,-1.064833535516913,negative
2021-12-01 17:30:00.000,374.9,378.6,363.0,368.0,4987485.0,Even if you don’t have COVID...: Biocon chief on 6-hr wait at airports amid Omicron threat,"Mazumdar-Shaw had also urged the government to “understand that vaccinations will safeguard people, not travel restrictions” after the Union Health Ministry issued stricter guidelines for international passengers.",neutral,neutral,-1.840490797546006,negative,-1.064833535516913,negative
2021-12-01 18:37:31.000,374.9,378.6,363.0,368.0,4987485.0,Biocon to be listed on DJSI in Emerging Markets category,Biocon had made it to the DJSI EM Index with a Total Sustainability Score of 45 as against an industry average of 18,neutral,positive,-1.840490797546006,negative,-1.064833535516913,negative
2021-12-02 06:47:11.000,374.9,378.6,363.0,368.0,4987485.0,"Even if you are Covid -ve, you can catch it during airport wait: Biocon founder","‘This is a huge infection risk for travellers,’ said Biocon executive chairperson Kiran Mazumdar-Shaw",neutral,neutral,-1.840490797546006,negative,-1.064833535516913,negative
2021-12-02 11:57:00.000,374.9,378.6,363.0,368.0,4987485.0,Biocon shares down 1.95% as Sensex rises,"A total of 191,095 shares changed hands on the counter till 11:57AM (IST)",negative,neutral,-1.840490797546006,negative,-1.064833535516913,negative
2021-12-02 21:40:00.000,370.95,370.95,365.35,367.0,2592469.0,Biotechnology major Biocon gets USFDA approval for generic product,The product is indicated for the prophylaxis of organ rejection in adult patients receiving a kidney transplant,positive,neutral,-1.064833535516913,negative,-2.17983651226158,negative
2021-12-02 22:03:00.000,370.95,370.95,365.35,367.0,2592469.0,Biocon gets USFDA nod for generic product,"Biocon Pharma, a subsidiary of the company, has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Mycophenolic Acid, the company said in a regulatory filing.",neutral,positive,-1.064833535516913,negative,-2.17983651226158,negative
2021-12-03 01:28:00.000,370.95,370.95,365.35,367.0,2592469.0,Biocon subsidiary receives USFDA approval for Mycophenolic Acid product; Stock gains,"Biocon said,",positive,neutral,-1.064833535516913,negative,-2.17983651226158,negative
2021-12-03 05:30:00.000,370.95,370.95,365.35,367.0,2592469.0,"Morning Watch: ONGC Scales Up Energy Footprint, Biocon’s New Drug Approved & More","Morning Watch: ONGC Scales Up Energy Footprint, Biocon’s New Drug Approved & More",neutral,neutral,-1.064833535516913,negative,-2.17983651226158,negative
2021-12-03 08:02:10.000,370.95,370.95,365.35,367.0,2592469.0,"Stocks To Watch: Reliance Capital, Biocon, Airtel, Unichem Laboratories",Here are the stocks to watch in trade today...,neutral,neutral,-1.064833535516913,negative,-2.17983651226158,negative
2021-12-03 08:22:00.000,370.95,370.95,365.35,367.0,2592469.0,"Stocks in the news: ONGC, Tata Power, Biocon, BDL and Canara Bank",The biotechnology major Biocon said its unit has received approval from the US health regulator to market a generic product.,neutral,positive,-1.064833535516913,negative,-2.17983651226158,negative
2021-12-03 08:36:23.000,370.95,370.95,365.35,367.0,2592469.0,"State Bank of India, Adani Group, Reliance Capital, Tata Power, Biocon among stocks in focus today","On the charts, Nifty 50 now sits at a crucial point after yesterday’s up-move that helped bulls garner much-needed strength.",neutral,positive,-1.064833535516913,negative,-2.17983651226158,negative
2021-12-03 11:19:00.000,370.95,370.95,365.35,367.0,2592469.0,Biocon’s subsidiary receives US FDA nod for immunosuppressant medication,Biocon said that its subsidiary Biocon Pharma has received approval of its ANDA for mycophenolic acid from the United States Food and Drug Administration (US FDA).,neutral,positive,-1.064833535516913,negative,-2.17983651226158,negative
2021-12-03 13:20:00.000,370.95,370.95,365.35,367.0,2592469.0,Share price of Biocon jumps as Sensex drops 417.97 points,"Promoters held 39.73 per cent stake in the company as of 30-Sep-2021, while FII and DII ownership stood at 15.74 per cent and 2.58 per cent, respectively.",positive,neutral,-1.064833535516913,negative,-2.17983651226158,negative
2021-12-03 17:30:00.000,370.95,370.95,365.35,367.0,2592469.0,"Stocks in news: Tata Power, SBI, Maruti, Canara Bank and more","Stocks in news: ONGC, Bharat Dynamics, ABB India, Biocon, Canara Bank, Ujjivan Financial and more",neutral,neutral,-1.064833535516913,negative,-2.17983651226158,negative
2021-12-06 14:18:00.000,361.6,364.8,357.55,360.85,1582931.0,"India reports fresh Omicron cases: Mahindra shares ‘profound conclusion’, Marico boss urges people to not panic",The Biocon founder advised people to get fully vaccinated.,neutral,neutral,-0.2074115044247787,neutral,5.8171745152354575,positive
2021-12-06 17:30:00.000,361.6,364.8,357.55,360.85,1582931.0,"‘Pandemonium’: Kiran Mazumdar-Shaw, Harsh Goenka on chaotic scenes at Delhi airport",Biocon Executive Chairperson Kiran Mazumdar-Shaw and RPG Enterprises chairman Harsh Goenka shared the pictures of pandemonium at Delhi International airport due to the compulsory COVID-19 testing on arrival.,neutral,neutral,-0.2074115044247787,neutral,5.8171745152354575,positive
2021-12-07 09:06:00.000,361.6,364.8,357.55,360.85,1582931.0,Biocon enters into an out-licensing deal with Tabuk Pharmaceuticals,For commercialization of select speciality products in Middle East,neutral,neutral,-0.2074115044247787,neutral,5.8171745152354575,positive
2021-12-07 09:13:50.000,361.6,364.8,357.55,360.85,1582931.0,Biocon - On Course To Revive Earnings Growth: Motilal Oswal,Biocon - On Course To Revive Earnings Growth: Motilal Oswal,neutral,neutral,-0.2074115044247787,neutral,5.8171745152354575,positive
2021-12-07 09:24:00.000,361.6,364.8,357.55,360.85,1582931.0,Biocon gains on plans to commercialise select speciality products with Tabuk Pharmaceuticals,"Biocon rose 1.04% to Rs 363 after the company signed a deal with Tabuk Pharmaceuticals, a wholly-owned arm of Astra Industrial Group in the Middle East and North Africa (MENA) region, to commercialise select speciality products in the Middle East.",positive,positive,-0.2074115044247787,neutral,5.8171745152354575,positive
2021-12-07 09:46:51.000,361.6,364.8,357.55,360.85,1582931.0,Biocon partners with Tabuk Pharma to commercialise its speciality generic medicines in Middle East,The partnership enables Biocon’s expansion into Middle East and North Africa region,positive,positive,-0.2074115044247787,neutral,5.8171745152354575,positive
2021-12-07 10:59:30.000,361.6,364.8,357.55,360.85,1582931.0,Why Biocon’s earnings may get a boost after two muted years,Biocon’s foray into the vaccine segment through a strategic tie-up with the Serum Institute of India has added to the cheer,positive,positive,-0.2074115044247787,neutral,5.8171745152354575,positive
2021-12-07 12:12:00.000,361.0,387.9,360.6,382.0,7927142.0,Biocon ties up with Tabuk Pharmaceuticals to commercialise speciality medicines in Middle East,"Under the terms of this agreement, Tabuk Pharmaceuticals will hold the marketing authorisation for select speciality products of Biocon and be responsible to register, importing, and promoting them in Saudi Arabia and other Middle East countries.",neutral,neutral,5.8171745152354575,positive,-2.610966057441253,negative
2021-12-07 12:36:00.000,361.0,387.9,360.6,382.0,7927142.0,Biocon ties up with Tabuk Pharmaceuticals to sell medicines in Middle East,Biocon said it has inked a pact with Saudi Arabia-based drug firm Tabuk Pharmaceutical Manufacturing Company to commercialise select speciality products in Middle East region,positive,positive,5.8171745152354575,positive,-2.610966057441253,negative
2021-12-07 12:39:45.000,361.0,387.9,360.6,382.0,7927142.0,Neutral Biocon; Target Of Rs 360: Motilal Oswal,"Motilal Oswal recommended Neutral rating on Biocon with a target price of Rs 360 in its research report dated December 06, 2021.",neutral,positive,5.8171745152354575,positive,-2.610966057441253,negative
2021-12-07 13:29:00.000,361.0,387.9,360.6,382.0,7927142.0,Biocon shares gain 0.84% as Sensex rises,"A total of 33,845 shares changed hands on the counter till 01:29PM (IST)",positive,neutral,5.8171745152354575,positive,-2.610966057441253,negative
2021-12-07 17:43:00.000,361.0,387.9,360.6,382.0,7927142.0,Biocon ties with Tabuk Pharma to commercialize its speciality generic medicines in Middle East,"As part of the out-licensing deal with Tabuk, Biocon will develop and manufacture the products, and Tabuk will commercialise them.",positive,neutral,5.8171745152354575,positive,-2.610966057441253,negative
2021-12-08 12:48:00.000,383.0,386.0,372.0,373.0,4164772.0,Biocon shares up 2.25% as Nifty gains,"A total of 45,879 shares changed hands on the counter till 12:48PM (IST).",positive,neutral,-2.610966057441253,negative,-0.45582517763775,neutral
2021-12-08 13:58:03.000,383.0,386.0,372.0,373.0,4164772.0,FM Nirmala Sitharaman features on Forbes’ 100 most powerful women list,"Besides Sitharaman, other Indians to feature on the list are the HCL Corporation CEO Roshni Nadar Malhotra, Biocon Executive Chairperson Kiran Mazumdar-Shaw, and Nykaa founder Falguni Nayar",neutral,neutral,-2.610966057441253,negative,-0.45582517763775,neutral
2021-12-08 18:14:00.000,383.0,386.0,372.0,373.0,4164772.0,Biocon Up 6% Today with Potential Upside. Traders Keep Watch,Biocon Up 6% Today with Potential Upside. Traders Keep Watch,neutral,neutral,-2.610966057441253,negative,-0.45582517763775,neutral
2021-12-09 07:05:17.000,383.0,386.0,372.0,373.0,4164772.0,"Trade Spotlight | What Should You Do With MCX India, Bajaj Healthcare, Biocon And Polyplex Corporation?","Here’s what Gaurav Sharma of Globe Capital Markets, recommends investors should do with these stocks when the market resumes trading today.",neutral,neutral,-2.610966057441253,negative,-0.45582517763775,neutral
2021-12-09 09:00:17.000,383.0,386.0,372.0,373.0,4164772.0,"Exclusive | Biocon In Talks With Mylan To Merge Biosimilar Businesses, Plans IPO After Merger: Sources","xxBiocon and Mylan are in advanced talks for combining their biosimilar businesses to create a large company in which Biocon seeks to hold a controlling majority stake, sources told Moneycontrol",neutral,positive,-2.610966057441253,negative,-0.45582517763775,neutral
2021-12-09 12:13:00.000,372.95,378.0,370.4,371.25,1727222.0,Biocon in talks with Mylan to merge biosimilar businesses: Report,"Indian drugmaker Biocon Ltd is in talks with generic drugmaker Mylan for a merger of their biosimilar businesses, a report said",neutral,positive,-0.45582517763775,neutral,1.06951871657754,positive
2021-12-09 13:29:00.000,372.95,378.0,370.4,371.25,1727222.0,Biocon shares drop 2.36% as Sensex rises,"A total of 159,762 shares changed hands on the counter till 01:29PM (IST)",negative,neutral,-0.45582517763775,neutral,1.06951871657754,positive
2021-12-10 10:30:00.000,372.95,378.0,370.4,371.25,1727222.0,Biocon shares gain 0.42% as Sensex falls,"On the technical charts, the RSI of the stock stood at 57.63.",positive,neutral,-0.45582517763775,neutral,1.06951871657754,positive
2021-12-10 23:28:41.000,372.95,378.0,370.4,371.25,1727222.0,Biocon Rating ‘Neutral’; firm in position to revive earnings growth,Earnings CAGR of 36% estimated over FY21-23e; ‘Neutral’ retained with TP of Rs 360 as price factors in upside over medium term,positive,positive,-0.45582517763775,neutral,1.06951871657754,positive
2021-12-13 13:39:00.000,376.5,383.4,374.2,377.3,2415154.0,Biocon shares up 0.48% as Nifty falls,The stock quoted a 52-week high price of Rs 487.7 and low of Rs 314.9.,positive,negative,0.2124833997343987,neutral,-1.2259425257052556,negative
2021-12-14 11:01:00.000,376.5,383.4,374.2,377.3,2415154.0,Biocon shares down 0.24% as Sensex falls,"A total of 78,864 shares changed hands on the counter till 11:01AM (IST)",negative,neutral,0.2124833997343987,neutral,-1.2259425257052556,negative
2021-12-15 13:14:00.000,376.2,377.55,361.65,363.6,2532236.0,Biocon declines 0.54% as Sensex slides,"The stock traded at a P/E multiple of 69.9, while the price-to-book value ratio stood at 6.51.",neutral,neutral,-3.349282296650709,negative,-2.92829775588396,negative
2021-12-15 19:05:00.000,376.2,377.55,361.65,363.6,2532236.0,"Edelweiss MF CEO, Biocon boss proud of Leena Nair; Snapdeal, Parle-G find a special way to honour the next Chanel CEO",Nair joins the list of Indian-origin executives who call the shots at Global Inc.,neutral,neutral,-3.349282296650709,negative,-2.92829775588396,negative
2021-12-16 07:25:35.000,376.2,377.55,361.65,363.6,2532236.0,Hot Stocks | Here’s Why You Should Bet On Tech Mahindra And Biocon For Short Term,"The Nifty is expected to trade in a range of 17,600–16,900 for the next few trading sessions until prices do not give any superior move on the either side of the range",neutral,neutral,-3.349282296650709,negative,-2.92829775588396,negative
2021-12-16 13:46:00.000,365.4,367.25,349.4,354.7,2102508.0,Biocon shares down 3.07% as Nifty gains,"A total of 88,962 shares changed hands on the counter till 01:46PM (IST).",negative,neutral,-2.92829775588396,negative,-0.0284900284900349,neutral
2021-12-16 16:10:00.000,365.4,367.25,349.4,354.7,2102508.0,"Nifty Pharma underperforms amid Omicron concerns; Heavyweights Alembic, Sun Pharma, Biocon weigh down","Stocks like Glenmark Pharma, Gland Pharma, Granules recorded 1.16% drop each.",negative,negative,-2.92829775588396,negative,-0.0284900284900349,neutral
2021-12-17 11:31:00.000,365.4,367.25,349.4,354.7,2102508.0,Biocon stock price down 1.8 per cent as Sensex slides,"As of 30-Sep-2021, promoters held 39.73 per cent stake in the company, while FIIs held 15.74 per cent and domestic institutional investors had 2.58 per cent.",negative,neutral,-2.92829775588396,negative,-0.0284900284900349,neutral
2021-12-20 10:15:00.000,351.0,354.05,343.05,350.9,1855068.0,Biocon shares fall 0.91 per cent in Monday’s trading session,The Relative Strength Index of the stock stood at 41.13 on Monday.,negative,neutral,-0.0284900284900349,neutral,-0.2840909090909091,neutral
2021-12-20 14:05:00.000,352.0,357.65,349.15,351.0,1336747.0,Biocon Ltd continues to fall,"Biocon Ltd is quoting at Rs 347.25, down 1.7% on the day as on 13:24 IST on the NSE. The stock tumbled 22.83% in last one year as compared to a 23.81% rally in NIFTY and a 6.5% spurt in the Nifty Pharma index.",negative,negative,-0.2840909090909091,neutral,2.209631728045329,positive
2021-12-20 17:09:00.000,352.0,357.65,349.15,351.0,1336747.0,Wipro replaces Bajaj Auto on BSE Sensex from today; Bank of Baroda joins Bankex in place of City Union Bank; 2 Adani stocks enter BSE 100,"Stocks like Biocon, Power Finance Corp, Torrent Pharma, and REC has been replaced by Adani Transmission, Adani Total Gas, SRF and Max Financial Services on BSE 100.",neutral,neutral,-0.2840909090909091,neutral,2.209631728045329,positive
2021-12-20 17:30:00.000,352.0,357.65,349.15,351.0,1336747.0,Can booster doses prevent new variants? Here’s what Kiran Mazumdar-Shaw has to say,Biocon executive chairperson Kiran Mazumdar-Shaw has sounded a warning over booster shots being administered against COVID-19 in a recent tweet,neutral,negative,-0.2840909090909091,neutral,2.209631728045329,positive
2021-12-23 19:19:00.000,363.0,366.0,352.5,354.55,7086297.0,Biocon Biologics says clinical study for drug Itolizumab initiated in India after approval from DCGI,"Biocon’s partner US-based Equillium Inc has expanded its ‘EQUALISE’ study in Systemic Lupus Erythematosus (SLE) and Lupus Nephritis for Itolizumab to clinical centers in India, Biocon Ltd said in a regulatory filing.",neutral,positive,-2.3278236914600523,negative,0.2253521126760595,neutral
2021-12-24 06:54:00.000,363.0,366.0,352.5,354.55,7086297.0,"Biocon: Clinical Study for Itolizumab in Lupus Nephritis initiated in India, post DCGI approval",Equillium has initiated this study across several tertiary hospitals specialised to deal with Lupus Nephritis patients in India after obtaining approval from the Drugs Controller General of India (DCGI).,neutral,neutral,-2.3278236914600523,negative,0.2253521126760595,neutral
2021-12-24 15:04:05.000,363.0,366.0,352.5,354.55,7086297.0,L&T Finance Holdings Ltd leads losers in ‘A’ group,"Biocon Ltd, Paisalo Digital Ltd, Cholamandalam Financial Holdings Ltd and Camlin Fine Sciences Ltd are among the other losers in the BSE’s ‘A’ group today, 24 December 2021.",positive,negative,-2.3278236914600523,negative,0.2253521126760595,neutral
2021-12-26 12:10:30.000,355.0,357.85,351.5,355.8,2529737.0,"mRNA boosters prevent omicron infections is incorrect, says Biocon chief",Biocon chief Liran Mazumdar-Shaw said that she knows around 25 people who have been tested Covid-19 positive despite being jabbed with mRNA booster shots,neutral,neutral,0.2253521126760595,neutral,-0.6128133704735345,neutral
2021-12-30 18:36:00.000,363.95,367.0,361.6,363.7,1774533.0,Biocon Biologics partner Viatris wins favourable order from US court,"Biocon Biologics Ltd, said its partner Viatris has won favourable decisions from a US federal court in Sanofi’s challenge over unpatentability of device patents for disposable insulin injection pen",positive,positive,-0.0686907542244813,neutral,-0.3702180172768314,neutral
2021-12-31 07:21:00.000,363.95,367.0,361.6,363.7,1774533.0,Biocon stock gains over 1% as Biocon Biologics partner Viatris wins US court decisions on Sanofi appeals for Lantus Device Patents,The U.S. Court of Appeals for the Federal Circuit (USCAFC) has upheld the U.S. Patent and Trademark Appeal Board’s decisions for unpatentability of five device patents for Sanofi’s Lantus SoloSTAR.,positive,positive,-0.0686907542244813,neutral,-0.3702180172768314,neutral
2021-12-31 07:54:00.000,363.95,367.0,361.6,363.7,1774533.0,"Stocks in the news: CMS Info, SBI, Biocon, RBL Bank, HUL and FSL","CMS Info Systems will make its Dalal Street debut today. The company raised Rs 1,100 crore via primary route offering its shares in the range of Rs 205-216 apiece between December 21-23.",neutral,positive,-0.0686907542244813,neutral,-0.3702180172768314,neutral
2021-12-31 08:00:28.000,363.95,367.0,361.6,363.7,1774533.0,"Stocks To Watch: IDFC, RBL Bank, Power Grid, IndiGo, Biocon, Ashiana Housing, Jindal Steel",Here are the stocks to watch in trade today...,neutral,neutral,-0.0686907542244813,neutral,-0.3702180172768314,neutral
2021-12-31 11:26:00.000,363.95,367.0,361.6,363.7,1774533.0,"Biocon subsiary, Biocon Biologics’ partner Viatris wins favourable order from U.S. court",Biocon Biologics said that the US Court of Appeals for the Federal Circuit upheld the US Patent and Trademark Appeal Board’s decisions for unpatentability of five device patents for Sanofi’s Lantus SoloSTAR and a district court decision on a patent.,positive,positive,-0.0686907542244813,neutral,-0.3702180172768314,neutral
2021-12-31 12:50:00.000,363.95,367.0,361.6,363.7,1774533.0,"Top stocks in focus: CMS Info Systems, PB Fintech, Power Grid, JSW Energy, Biocon",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-0.0686907542244813,neutral,-0.3702180172768314,neutral
2022-01-04 13:41:07.000,366.0,367.9,361.75,363.0,1044514.0,Biocon Biologics Approves Merger With Serum Institute’s Subsidiary,Biocon Biologics’ board approved a merger with a new vaccine subsidiary of the Serum Institute.,neutral,positive,-0.819672131147541,neutral,-0.3185595567866973,neutral
2022-01-04 17:30:00.000,366.0,367.9,361.75,363.0,1044514.0,Biocon announces merger of its arm with Serum Institute subsidiary,"The company stated that there is no cash consideration involved but BBL will issue and allot 15 per cent equity shares to Serum on a fully diluted basis, subject to necessary approvals and sanctions.",neutral,neutral,-0.819672131147541,neutral,-0.3185595567866973,neutral
2022-01-05 02:30:00.000,366.0,367.9,361.75,363.0,1044514.0,Serum’s Covidshield Technologies to merge with Biocon Biologics,"CTPL is in the business of commercialisation of vaccines. BBL is engaged in the business of development, manufacturing, and commercialisation of biosimilars and other biologics. Vaccines were a natural adjacency to BBL’s existing platform.",neutral,neutral,-0.819672131147541,neutral,-0.3185595567866973,neutral
2022-01-06 17:30:00.000,360.0,362.65,356.7,358.15,1174597.0,‘Travel routes must remain uninterrupted ’: Kiran Mazumdar-Shaw on PM security breach,The Biocon chief’s tweet was a reply to a Twitter user who alleged that the central government wanted to cancel the event but put the blame on the Punjab government as a cover.,neutral,neutral,-0.5138888888888953,neutral,0.4204035874439462,neutral
2022-01-18 13:18:00.000,353.3,369.5,353.3,366.1,8439643.0,"L&T, Biocon & other stocks that can be good bets on Budget 2022",Tata Power is well placed to capture the opportunities across the green portfolio where electricity demand is surging and supply is short.,positive,positive,3.622983300311353,positive,-0.4508196721311413,neutral
2022-01-18 17:30:00.000,353.3,369.5,353.3,366.1,8439643.0,"COVID-19: ‘Would like to give booster doses to all employees’, says Kiran Mazumdar-Shaw",Founder and executive chairperson of Biocon Kiran Mazumdar Shaw has said that as an employer she would want to deliver booster doses to all Biocon employees due to the surge in coronavirus cases.,neutral,positive,3.622983300311353,positive,-0.4508196721311413,neutral
2022-01-19 05:30:00.000,353.3,369.5,353.3,366.1,8439643.0,Biocon Surges 5% on Brokerage Upgrading TP at 27% Upside & More,Biocon Surges 5% on Brokerage Upgrading TP at 27% Upside & More,neutral,neutral,3.622983300311353,positive,-0.4508196721311413,neutral
2022-01-19 11:08:59.000,353.3,369.5,353.3,366.1,8439643.0,Biocon Share Price Surges After Morgan Stanley Upgrades Stock To ‘outperform’,"The brokerage raised its price target by 25 percent to Rs 465, saying the pharma company’s earnings may have reached a point of inflection after three years of single-digit profit growth",positive,positive,3.622983300311353,positive,-0.4508196721311413,neutral
2022-01-19 17:53:00.000,366.0,367.9,361.5,364.35,1502283.0,Market movers: Why did Biocon jump 5% in a falling market?,The stock surged about 5 per cent after the foreign broker upgraded Biocon to ‘overweight from ’equalweight with a target price at Rs 465. The stock last traded at Rs 366.,positive,positive,-0.4508196721311413,neutral,3.420329670329667,positive
2022-01-20 07:22:12.000,366.0,367.9,361.5,364.35,1502283.0,"Trade Spotlight | What Should You Do With Bank Of Baroda, Biocon, ONGC, Precision Wires, Tata Elxsi","Trade Spotlight | Here’s what Mehul Kothari of Anand Rathi Shares & Stock Brokers, recommends investors should do with these stocks when the market resumes trading today",neutral,neutral,-0.4508196721311413,neutral,3.420329670329667,positive
2022-01-20 07:49:37.000,366.0,367.9,361.5,364.35,1502283.0,"Stocks To Watch: Asian Paints, HUL, Biocon, Bajaj Auto, L&T Infotech, Havells, Mphasis, PNB Housing",Here are the stocks to watch in today’s trade..,neutral,neutral,-0.4508196721311413,neutral,3.420329670329667,positive
2022-01-20 08:02:51.000,366.0,367.9,361.5,364.35,1502283.0,"Stocks to Watch: HUL, Asian Paints, Bajaj Auto, Tata Communications","Shares of companies like Hindustan Unilever, Biocon, Asian Paints, Bajaj Finserv, Havells India, PNB Housing Finance, Bajaj Holdings & Investment, Lyka Labs, Bank Of Maharashtra, Mphasis, and Reliance Industrial Infrastructure will be in focus as they announce their December quarter earnings today",neutral,neutral,-0.4508196721311413,neutral,3.420329670329667,positive
2022-01-20 08:11:00.000,366.0,367.9,361.5,364.35,1502283.0,"Stocks to Watch: HUL, Bajaj Auto, Mastek, Ceat, OFSS, SBI, M&M, RBL Bank","Asian Paints, Bajaj Finserv, Bajaj Holdings, Biocon, Century Textiles, Havells India, Hindustan Unilever, Bank of Maharashtra, MphasiS, Persistent Systems and Shoppers Stop to announce results today.",neutral,neutral,-0.4508196721311413,neutral,3.420329670329667,positive
2022-01-20 08:21:00.000,366.0,367.9,361.5,364.35,1502283.0,"Stocks in the news: HUL, Bajaj Auto, HCL Tech, PTC India, Vedanta and PFC","HUL, Asian Paints, Bajaj Finserv, Havells, Bajaj Holdings, Mphasis, Biocon, CCI, Persistent Systems, Hatsun Agro and Bank of Maharashtra are among the companies that will announce their December quarter results today.",neutral,neutral,-0.4508196721311413,neutral,3.420329670329667,positive
2022-01-20 08:37:20.000,366.0,367.9,361.5,364.35,1502283.0,Stocks that will see action on January 20,"Buzzing stocks: HUL, Asian Paints, Concor, Bajaj Finserv, Biocon, Havells, PNB Housing South Indian Bank, Vimta Labs, VST Ind, HCL Tech, Palred Tech, Nandan Denim, Warren Tea, Dhunseri Tea",neutral,neutral,-0.4508196721311413,neutral,3.420329670329667,positive
2022-01-20 17:30:00.000,364.0,382.5,356.0,376.45,9923107.0,"Stocks in news: Bajaj Auto, Asian Paints, SBI, Rallis India and more","Stocks in news: Hindustan Unilever, Biocon, Asian Paints, Bajaj Finserv, Havells India, PNB Housing Finance, Bajaj Holdings & Investment, Bajaj Auto, Tata Communications, SBI, L&T Infotech, Rallis India and more",neutral,neutral,3.420329670329667,positive,-1.3126491646778162,negative
2022-01-20 22:53:00.000,364.0,382.5,356.0,376.45,9923107.0,Biocon consolidated net profit rises 18% to Rs 220 crore in Q3,Biosimilars vertical clocked revenue of Rs 981.4 crore as compared to Rs 768.9 crore in the same quarter last fiscal,positive,positive,3.420329670329667,positive,-1.3126491646778162,negative
2022-01-21 08:01:00.000,364.0,382.5,356.0,376.45,9923107.0,"Stocks in the news: RIL, Havells, HUL, Biocon, Voda Idea and Mphasis","RIL, JSW Steel, HDFC Life, Hindustan Zinc, SBI Life,, Gland Pharma, IDBI Bank, Polycab, Vodafone Idea and PVR, are among the companies that will announce their December quarter results today.",neutral,neutral,3.420329670329667,positive,-1.3126491646778162,negative
2022-01-21 08:12:00.000,364.0,382.5,356.0,376.45,9923107.0,"Stocks to Watch: RIL, Asian Paints, HUL, BoM, PNB Housing, VodaIdea, Biocon","Bandhan Bank, HDFC Life, Hindustan Zinc, Voda Idea, Inox Leisure, JSW Steel, Kajaria Ceramics, L&T Fin Holdings, PVR, Reliance Industries, SBI Life and Supriya Lifescience to announce results today",neutral,neutral,3.420329670329667,positive,-1.3126491646778162,negative
2022-01-21 09:19:00.000,364.0,382.5,356.0,376.45,9923107.0,Biocon Q3 PAT spurts 18% to Rs 220 cr,"Biocon’s consolidated net profit jumped 17.68% to Rs 219.60 crore on a 17.05% surge in revenue from operations to Rs 2,174.20 crore in Q3 FY22 over Q3 FY21.",positive,positive,3.420329670329667,positive,-1.3126491646778162,negative
2022-01-21 09:21:18.000,364.0,382.5,356.0,376.45,9923107.0,"Biocon Q3 results: Net profit up 17.68% to Rs 220 cr; income at Rs 2,222.5 cr","Biocon Q3 results: Net profit up 17.68% to Rs 220 cr; income at Rs 2,222.5 cr",positive,positive,3.420329670329667,positive,-1.3126491646778162,negative
2022-01-21 09:43:48.000,364.0,382.5,356.0,376.45,9923107.0,"Biocon Consolidated December 2021 Net Sales At Rs 2,174.20 Crore, Up 17.46% Y-o-Y",,neutral,neutral,3.420329670329667,positive,-1.3126491646778162,negative
2022-01-21 09:50:35.000,364.0,382.5,356.0,376.45,9923107.0,"Biocon Standalone December 2021 Net Sales At Rs 473.00 Crore, Up 3.71% Y-o-Y",,neutral,neutral,3.420329670329667,positive,-1.3126491646778162,negative
2022-01-21 11:16:00.000,364.0,382.5,356.0,376.45,9923107.0,Biocon Q3 Results: Net profit rises 11% YoY to Rs 187 crore,"The earnings before interest, tax depreciation and amortisation (EBITDA) rose 25% YoY to Rs 537 crore. The EBITDA margins for the third quarter stood at 24%. Biocon said had it not been for mark-to-market loss attributed to Biocon Biologics equity investment in Adagio, its core EBITDA stood at Rs 71…",positive,positive,3.420329670329667,positive,-1.3126491646778162,negative
2022-01-21 11:51:49.000,364.0,382.5,356.0,376.45,9923107.0,Biocon Ltd shares surge over 2% after firm reports rise in Q3 net,Biocon Ltd shares surge over 2% after firm reports rise in Q3 net,positive,positive,3.420329670329667,positive,-1.3126491646778162,negative
2022-01-21 17:14:58.000,364.0,382.5,356.0,376.45,9923107.0,"Biocon - Biosimilar Traction Buoys Up Q3, Momentum To Be Key: ICICI Direct","Biocon - Biosimilar Traction Buoys Up Q3, Momentum To Be Key: ICICI Direct",neutral,neutral,3.420329670329667,positive,-1.3126491646778162,negative
2022-01-21 17:30:00.000,364.0,382.5,356.0,376.45,9923107.0,Biocon Q3: Net profit jumps 18% to Rs 220 cr,"The company had posted a consolidated net profit of Rs 186.6 crore in the same quarter of the previous fiscal, Biocon Ltd said in a regulatory filing.",positive,positive,3.420329670329667,positive,-1.3126491646778162,negative
2022-01-21 17:30:00.000,364.0,382.5,356.0,376.45,9923107.0,"Stocks in news: Havells, HUL, Reliance Industries, Mphasis and more","Stocks in news: Mphasis, Biocon, WNS Holdings, Havells, HUL, Reliance Industries, HDFC Life Insurance, SBI Life Insurance and more",neutral,neutral,3.420329670329667,positive,-1.3126491646778162,negative
2022-01-21 17:30:00.000,364.0,382.5,356.0,376.45,9923107.0,Budget 2022 needs to give research incentives to biotech firms: Mazumdar-Shaw,"On the back of a strong quarter, Biocon boss Kiran Mazumdar-Shaw spoke exclusively to Business Today Televison’s Abha Bakaya on the company’s growth drivers among biosimilars and what the Union Budget needs to focus on as far as the healthcare sector is concerned.",neutral,positive,3.420329670329667,positive,-1.3126491646778162,negative
2022-01-21 17:30:00.000,364.0,382.5,356.0,376.45,9923107.0,Budget 2022 needs to give research incentives to biotech firms: Kiran Shaw,"On the back of a strong quarter, Biocon boss Kiran Mazumdar-Shaw spoke exclusively to Business Today Televison’s Abha Bakaya on the company’s growth drivers among biosimilars and what the Union Budget needs to focus on as far as the healthcare sector is concerned.",neutral,positive,3.420329670329667,positive,-1.3126491646778162,negative
2022-01-21 18:58:00.000,364.0,382.5,356.0,376.45,9923107.0,Biocon rises over 3% as biotech major sees strong Dec qtr numbers,"Notwithstanding the muted broader market trend, shares of Biocon Ltd surged over 3 per cent on Friday after the biotechnology major reported strong December quarter earnings.",positive,positive,3.420329670329667,positive,-1.3126491646778162,negative
2022-01-21 19:08:00.000,364.0,382.5,356.0,376.45,9923107.0,R&D expenditure will rise in the coming quarters: Biocon Biologics MD,"In a Q&A, Dr Arun Chandavarkar spoke on how its interchangeable insulin biosimilar has driven the business",positive,neutral,3.420329670329667,positive,-1.3126491646778162,negative
2022-01-24 08:50:00.000,377.1,379.85,367.9,372.15,4390197.0,"Buy Biocon, target price Rs 400: Yes Securities","Biocon Ltd., incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 45274.63 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-1.3126491646778162,negative,0.7837837837837777,neutral
2022-01-24 09:00:53.000,377.1,379.85,367.9,372.15,4390197.0,"Biocon Consolidated December 2021 Net Sales At Rs 2,174.20 Crore, Up 17.46% Y-o-Y",,neutral,neutral,-1.3126491646778162,negative,0.7837837837837777,neutral
2022-01-24 17:30:00.000,370.0,377.3,365.8,372.9,3875032.0,Insulins access program for young expanded in Dec quarter: Biocon Biologics MD,"Arun Chandavarkar, Managing Director, Biocon Biologics, in conversation with Business Today, spoke at length about Q3FY22 earnings and performance of the company’s products.",positive,neutral,0.7837837837837777,neutral,-3.785743052758751,negative
2022-02-01 06:10:00.000,369.1,376.9,366.15,376.5,1560874.0,"Under PLI scheme, Biocon will receive up to Rs 250-crore financial incentives over next six years: Siddharth Mittal",Biocon is today one of the largest manufacturers of statins and immunosuppressants in the world.,neutral,neutral,2.004876727174201,positive,1.978891820580475,positive
2022-02-01 16:19:21.000,379.0,389.9,378.15,386.5,4522731.0,Union Budget 2022 | We were expecting some incentives for Pharma R&D: Kiran Mazumdar Shaw,"Public investment was very low in this critical area of research and innovation, says Biocon chief",positive,negative,1.978891820580475,positive,0.5798969072164949,neutral
2022-02-01 17:30:00.000,379.0,389.9,378.15,386.5,4522731.0,"Budget 2022: ‘Wish FM does not dash our hopes’, says Kiran Mazumdar-Shaw",Executive Chairperson of Biocon Kiran Mazumdar-Shaw tweeted that Budget 2022 is an event wherein everyone is hoping for some good news.,neutral,positive,1.978891820580475,positive,0.5798969072164949,neutral
2022-02-03 13:05:55.000,393.8,395.7,389.65,391.1,2622951.0,"Biocon Ltd spurts 0.27%, rises for fifth straight session","Biocon Ltd is quoting at Rs 388.3, up 0.27% on the day as on 12:49 IST on the NSE. The stock is down 5.27% in last one year as compared to a 18.7% spurt in NIFTY and a 6.78% spurt in the Nifty Pharma.",positive,positive,-0.6856272219400682,neutral,2.035851472471188,positive
2022-02-04 07:19:35.000,393.8,395.7,389.65,391.1,2622951.0,"Hot Stocks | Axis Bank, Maruti Suzuki, Biocon Can Give Double-digit Return In Short Term, Here’s Why?","Hot Stocks | Malay Thakkar of GEPL Capital expects Nifty to trade in a range of 17,000-17,800. For any further upside, it is important that the index breaks and sustains above 17,750-17,800 resistance zone.",neutral,neutral,-0.6856272219400682,neutral,2.035851472471188,positive
2022-02-08 08:48:00.000,403.9,410.7,399.7,403.1,7741912.0,"Adani Wilmar, Biocon, TVS Motor in focus","Adani Wilmar: Shares of Adani Wilmar will debut on the bourses today, 8 February 2022. The issue price is Rs 230 per share.",neutral,neutral,-0.1980688289180377,neutral,0.3830944142362714,neutral
2022-02-08 09:55:00.000,403.9,410.7,399.7,403.1,7741912.0,Biocon spurts after subsidiary bags USFDA nod for Posaconazole Delayed-Release tablets,"Biocon advanced 2% to Rs 407.95 after the company’s subsidiary, Biocon Pharma, received an approval of its Abbreviated New Drug Application (ANDA) for Posaconazole Delayed-Release tablets from the US-based drug regulatory body, USFDA.",neutral,positive,-0.1980688289180377,neutral,0.3830944142362714,neutral
2022-02-08 11:14:00.000,403.9,410.7,399.7,403.1,7741912.0,"Biocon gains 3%, at 6-month high in a weak market; stock up 18% in 3 weeks",Biocon said its subsidiary Biocon Pharma has received approval of its ANDA for Posaconazole Delayed-Release tablets from the US FDA.,positive,positive,-0.1980688289180377,neutral,0.3830944142362714,neutral
2022-02-08 17:30:00.000,404.6,409.2,401.5,406.15,2423025.0,"Stocks in news: Adani Wilmar, TVS Motor, Bharti Airtel, L&T and more","Stocks in news: Adani Wilmar, TVS Motors, Castrol India, Biocon, L&T, Minda Industries and more",neutral,neutral,0.3830944142362714,neutral,-0.8126077320856959,neutral
2022-02-09 21:57:00.000,406.1,408.0,401.25,402.8,1553164.0,Biocon’s Kiran Mazumdar-Shaw calls for incentive scheme for research,"India needs to incentivize industries to invest more in academic research for creating a better ecosystem of research and innovation, Biocon chairperson Kiran Mazumdar-Shaw said on Wednesday.",positive,positive,-0.8126077320856959,neutral,0.9874999999999972,positive
2022-02-09 22:29:59.000,406.1,408.0,401.25,402.8,1553164.0,Biocon chairperson Kiran Mazumdar-Shaw calls for incentive scheme for research,"Mazumdar-Shaw further said as the government has come up with incentives for production, it should also come up with incentives for research.",neutral,positive,-0.8126077320856959,neutral,0.9874999999999972,positive
2022-02-10 10:08:53.000,406.1,408.0,401.25,402.8,1553164.0,Adani Wilmar among top 100 most valuable publicly traded firms in India,"The stock now has 95th rank among all listed firms with a market cap of around Rs50000 crore. Its m-cap is now higher than Bharat Electronics, Biocon Ltd, L&T Technology Services, Bosch, Tata Elxsi, HDFC Asset Management Co, ABB India, Page Industries, Hindustan Aeronautics and Star Health Allied In…",neutral,neutral,-0.8126077320856959,neutral,0.9874999999999972,positive
2022-02-22 14:04:45.000,384.1,397.15,383.45,394.55,2292956.0,Biocon Ltd drops for fifth straight session,"Biocon Ltd is quoting at Rs 379, down 2.19% on the day as on 13:24 IST on the NSE. The stock tumbled 1.65% in last one year as compared to a 15.16% rally in NIFTY and a 6.28% spurt in the Nifty Pharma index.",neutral,negative,2.7206456651913533,positive,-3.650385604113108,negative
2022-02-28 00:55:00.000,394.9,394.9,347.0,349.6,15772673.0,Biocon Biologics acquires Viatris’ biosimilars business in $3.3 bn deal,"BBL will also obtain Viatris’ rights in all biosimilars assets, including its in-licensed portfolio and an option to acquire Viatris’ rights in bAflibercept",neutral,positive,-11.47125854646745,negative,-1.5428571428571365,negative
2022-02-28 07:50:00.000,394.9,394.9,347.0,349.6,15772673.0,Biocon Biologics acquires Viatris’ biosimilar business for $3.34 billion,"BBL said the cash payment of $2 billion to be funded by $800 million raised through equity infusion in BBL and the remainder to be funded by debt, additional equity or a combination.",neutral,neutral,-11.47125854646745,negative,-1.5428571428571365,negative
2022-02-28 08:35:23.000,394.9,394.9,347.0,349.6,15772673.0,Stocks that will see action today (February 28),"Buzzing stocks: Biocon, Sun Pharma, Aurobindo Pharma, Zomato, Reliance Ind, Adani Power, SJVN, Ircon, Muthoot FInance, Star Housing Fin, Vodafone Idea, Bharti Airtel, Hindalco",neutral,neutral,-11.47125854646745,negative,-1.5428571428571365,negative
2022-02-28 09:23:00.000,394.9,394.9,347.0,349.6,15772673.0,Biocon Biologics to acquire Viatris’ biosimilars assets for up to $3.335 bln,"Biocon Biologics (BBL), a subsidiary of Biocon, has entered into a definitive agreement with its partner Viatris Inc.",neutral,positive,-11.47125854646745,negative,-1.5428571428571365,negative
2022-02-28 09:56:55.000,394.9,394.9,347.0,349.6,15772673.0,Biocon Biologics To Acquire Viatris’ Biosimilars Assets For Up To $3.335 Billion,"Viatris will receive a cash payment of up to $2.335 billion and CCPS in Biocon Biologics, valued at $1 billion.",neutral,neutral,-11.47125854646745,negative,-1.5428571428571365,negative
2022-02-28 10:34:25.000,394.9,394.9,347.0,349.6,15772673.0,Biocon Biologics to acquire Viatris Inc’s biosimilars business for $3.33 billion,"The acquisition will help Biocon Biologics to have a comprehensive portfolio, comprising its current range of commercialised insulins, oncology and immunology biosimilars as well as several other biosimilar assets currently under development",neutral,positive,-11.47125854646745,negative,-1.5428571428571365,negative
2022-02-28 10:50:00.000,394.9,394.9,347.0,349.6,15772673.0,Biocon arm plans to acquire Viatris’ biosimilars assets; stock falls 8%,"The companies will also enter into a transition services agreement. Viatris will provide certain transition services, including commercialization services for an expected 2-years",neutral,neutral,-11.47125854646745,negative,-1.5428571428571365,negative
2022-02-28 10:57:36.000,394.9,394.9,347.0,349.6,15772673.0,Biocon Biologics buys Viatris’ biosimilars business in $3.3 bln deal; Mazumdar-Shaw to continue as chairperson,"Kiran Mazumdar-Shaw, founder and executive chairperson of Biocon, said the deal will fast-track the company’s journey to build Biocon into a global brand. Following the deal, Mazumdar-Shaw will continue to be the executive chairperson of BBL and Viatris will designate Rajiv Malik, president of Viatr…",neutral,positive,-11.47125854646745,negative,-1.5428571428571365,negative
2022-02-28 12:37:07.000,394.9,394.9,347.0,349.6,15772673.0,Biocon Biologics to acquire Viatris’ biosimilars business for up to $3.3 billion in stock and cash,"BBL will have a comprehensive portfolio comprising its current range of commercialized insulins, oncology and immunology biosimilars as well as several other biosimilar assets currently under development",neutral,neutral,-11.47125854646745,negative,-1.5428571428571365,negative
2022-02-28 13:40:17.000,394.9,394.9,347.0,349.6,15772673.0,Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw,"“The value of this business post Viatris deal will jump to $8 billion,” Shaw said",neutral,positive,-11.47125854646745,negative,-1.5428571428571365,negative
2022-02-28 14:55:00.000,394.9,394.9,347.0,349.6,15772673.0,Biocon Biologics to go for IPO in 18-24 months: Kiran Mazumdar-Shaw,Biocon arm buys Viatris biosimilars biz for $3.2 billion,neutral,neutral,-11.47125854646745,negative,-1.5428571428571365,negative
2022-02-28 15:31:12.000,394.9,394.9,347.0,349.6,15772673.0,Responsive Industries Ltd leads losers in ‘A’ group,"Biocon Ltd, Carborundum Universal Ltd, Rain Industries Ltd and Edelweiss Financial Services Ltd are among the other losers in the BSE’s ‘A’ group today, 28 February 2022.",negative,negative,-11.47125854646745,negative,-1.5428571428571365,negative
2022-02-28 16:53:15.000,394.9,394.9,347.0,349.6,15772673.0,Biocon – Trapped Traders! Failed to Break the Resistance! | Investing.com India,Market Overview Analysis by Trading Coach covering: Biocon Ltd.. Read Trading Coach’s latest article on Investing.com India.,neutral,neutral,-11.47125854646745,negative,-1.5428571428571365,negative
2022-02-28 17:30:00.000,394.9,394.9,347.0,349.6,15772673.0,Biocon Biologics buys Viatris’ biosimilars assets for up to $3 bn,The deal is expected to expand Biocon’s EBITDA base and strengthen overall financials.,neutral,positive,-11.47125854646745,negative,-1.5428571428571365,negative
2022-02-28 17:30:00.000,394.9,394.9,347.0,349.6,15772673.0,Biocon shares fall over 11% after subsidiary buys Viatris’ biosimilars business for $3 bn,"Biocon stock opened with a loss of 9.36% at Rs 181 against the previous close of Rs 199.70 on BSE. The stock touched an intraday low of Rs 347.9, falling 11.73% on BSE.",negative,negative,-11.47125854646745,negative,-1.5428571428571365,negative
2022-02-28 17:30:00.000,394.9,394.9,347.0,349.6,15772673.0,Biocon Biologics to acquire Viatris’ biosimilars assets for $3.35 bn,"Viatris President Rajiv Malik will serve on the board of Biocon, while Kiran Mazumdar-Shaw will continue as the Executive Chairperson of BBL",neutral,neutral,-11.47125854646745,negative,-1.5428571428571365,negative
2022-02-28 18:11:00.000,394.9,394.9,347.0,349.6,15772673.0,Biocon Biologics to file for IPO within next 2 years: Kiran Mazumdar-Shaw,"“And obviously, we expect the IPO to be at a very, very attractive level. So if you look at it, it’s going to hugely create value for shareholders,” Mazumdar-Shaw said.",neutral,positive,-11.47125854646745,negative,-1.5428571428571365,negative
2022-02-28 18:37:00.000,394.9,394.9,347.0,349.6,15772673.0,"Biocon beefs up biosimilar portfolio with $3.3-bn Viatris deal, shares fall",The company in a statement said that its subsidiary Biocon Biologics has inked a pact to acquire Viatris Inc’s biosimilars business for consideration of up to USD 3.335 billion,negative,positive,-11.47125854646745,negative,-1.5428571428571365,negative
2022-02-28 19:12:30.000,394.9,394.9,347.0,349.6,15772673.0,Why the Biocon stock plunged on acquisition of biosimilar rights of Viatris,"Premium valuation of the deal, the taking on of high debt and potential for margin dilution are key reasons for the fall",negative,negative,-11.47125854646745,negative,-1.5428571428571365,negative
2022-02-28 21:34:25.000,394.9,394.9,347.0,349.6,15772673.0,Biocon Biologic’s Debt-Funded Viatris Deal Spooks Investors,"Shares tumbled after Monday’s announcement and closed more than 11.6% lower, the biggest decline in 13 months.",neutral,negative,-11.47125854646745,negative,-1.5428571428571365,negative
2022-03-01 01:10:00.000,350.0,353.45,343.05,344.6,13063047.0,Biocon arm to buy US company Biosimilar biz for $3.34 billion,"Biocon Biologics (BBL) will get the global biosimilar business of Viatris in developed and emerging markets, with an estimated revenue of $875 million and an operating profit of $200 million for 2022. Biocon Biologics has estimated $1.1 billion in revenue and $250 million in earnings before interest…",positive,positive,-1.5428571428571365,negative,-2.839206734198884,negative
2022-03-01 04:45:00.000,350.0,353.45,343.05,344.6,13063047.0,Cash-and-stock deal: Biocon Biologics acquires Viatris for $3.33 billion,Biocon shares posted their biggest single-day fall since August 2015.,neutral,negative,-1.5428571428571365,negative,-2.839206734198884,negative
2022-03-01 10:00:00.000,350.0,353.45,343.05,344.6,13063047.0,"Biocon to use debt, equity and IPO to buy Viatris biosimilars biz: Kiran Mazumdar Shaw","“It will be a mix of debt, equity and of course IPO. It is going to be a very interesting business opportunity and a very comfortable aspect in terms of financing the deal. Overall, the business itself is going to throw off a lot of cash and that itself will help us to get a faster payback. ”",neutral,neutral,-1.5428571428571365,negative,-2.839206734198884,negative
2022-03-01 12:25:25.000,350.0,353.45,343.05,344.6,13063047.0,Neutral Biocon; target of Rs 385 : Motilal Oswal,"Motilal Oswal recommended Neutral rating on Biocon with a target price of Rs 385 in its research report dated February 28, 2022.",neutral,positive,-1.5428571428571365,negative,-2.839206734198884,negative
2022-03-01 12:31:00.000,350.0,353.45,343.05,344.6,13063047.0,Buy Biocon: target of Rs 420: Sharekhan,"Sharekhan is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 420 in its research report dated February 28, 2022.",neutral,positive,-1.5428571428571365,negative,-2.839206734198884,negative
2022-03-02 01:29:35.000,350.0,353.45,343.05,344.6,13063047.0,Why the Biocon-Viatris deal has pleased no one,"Analysts said if Biocon manages to direct business growth in the right manner, it could be a game changer",neutral,neutral,-1.5428571428571365,negative,-2.839206734198884,negative
2022-03-02 09:22:14.000,350.0,353.45,343.05,344.6,13063047.0,Biocon Biologics’ Viatris Deal To Aid Value Chain But Risks Persist: Analysts,Here’s what analysts have to say about Biocon Biologics-Viatris deal.,neutral,neutral,-1.5428571428571365,negative,-2.839206734198884,negative
2022-03-04 11:51:50.000,340.0,340.95,327.0,327.5,4501315.0,Hold Biocon; target of Rs 390: ICICI Direct,"ICICI Direct recommended hold rating on Biocon with a target price of Rs 390 in its research report dated March 04, 2022.",neutral,positive,-3.6764705882352944,negative,1.119631901840484,positive
2022-03-04 17:30:00.000,340.0,340.95,327.0,327.5,4501315.0,"Kiran Mazumdar, Falguni Nayar are most talked-about women business leaders in India","As per a survey by communications firm Wizikey, Kiran Mazumdar-Shaw, the chairperson of Biocon, has taken the first spot in the latest News Score ranking of ten most-talked about women leaders in India. Nayar is second.",neutral,neutral,-3.6764705882352944,negative,1.119631901840484,positive
2022-03-07 00:42:00.000,326.0,332.0,319.1,329.65,3328894.0,"Dr Reddy’s, Biocon among 6 drug companies in race for Curatio","The second round of bids are expected by March-end, the sources said. Investment banks Edelweiss and Mape Advisory are running the sale process. Leading investors ChrysCapital, Sequoia and the promoters plan to sell Curatio Healthcare, at a valuation of ₹2,000-2,300 crore ($300 million), ET first re…",neutral,neutral,1.119631901840484,positive,1.2121212121212122,positive
2022-03-09 13:31:25.000,344.0,344.0,331.5,332.0,5117083.0,Biocon Ltd gains for third straight session,"Biocon Ltd is quoting at Rs 338, up 1.06% on the day as on 12:54 IST on the NSE. The stock is down 16.04% in last one year as compared to a 7.32% jump in NIFTY and a 6.35% jump in the Nifty Pharma index.",positive,positive,-3.488372093023256,negative,-0.4804804804804873,neutral
2022-03-09 18:17:00.000,344.0,344.0,331.5,332.0,5117083.0,Biocon receives ratings action from CRISIL,"The above rating was placed under watch with developing implications, pursuant to the announcement made by the Company vide its letter dated 27 February 2022, on the acquisition of the biosimilar assets of US-based Viatris Inc. by Biocon Biologics",neutral,positive,-3.488372093023256,negative,-0.4804804804804873,neutral
2022-03-10 09:26:44.000,344.0,344.0,331.5,332.0,5117083.0,"Assembly Election Results 2022: Bharti Airtel, NTPC, Biocon, and Other Stocks to Watch Today","Election results: Do Elections affect the Stock Market? Here is how you can stocks to watch on election result day, Should I invest before or after the elections Result Day at news18.com",neutral,neutral,-3.488372093023256,negative,-0.4804804804804873,neutral
2022-03-10 13:08:00.000,333.0,335.25,328.0,331.4,4943261.0,"Top stocks in focus: PNB Housing Finance, Biocon, Gufic Biosciences, NTPC, Bharti Airtel",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-0.4804804804804873,neutral,-1.174875734297327,negative
2022-03-14 17:10:00.000,331.25,336.95,325.7,327.0,4757970.0,ICRA places Biocon’s credit ratings on watch; Stock sheds ~2%,ICRA has placed its ICRA AA+ and ICRA A1+ ratings on the long term and short-term banking facilities of the Company on ‘Watch with Developing Implications’.,neutral,neutral,-1.2830188679245282,negative,-0.529340592861464,neutral
2022-03-17 17:30:00.000,332.0,332.7,330.0,330.9,3555430.0,Nykaa founder Falguni Nayar amongst world’s new billionaires: Hurun Rich List,"Falguni Nayar, founder of the beauty e-commerce platform Nykaa, entered the Hurun Global Rich List 2022 as India’s most successful self-made woman with a net worth of $7.6 billion, becoming the first woman to overtake Kiran Mazumdar-Shaw of Biocon.",neutral,positive,-0.3313253012048261,neutral,-0.9036144578313252,negative
2022-03-23 17:30:00.000,337.0,343.25,335.2,342.0,1776326.0,Kiran Mazumdar-Shaw elected as fellow of Royal Society of Edinburgh,"Mazumdar-Shaw, who is also the Executive Chairperson of Biocon Biologics, will be joining RSE’s current fellowship of around 1,700 fellows.",neutral,neutral,1.483679525222552,positive,1.5863775287439934,positive
2022-03-23 19:23:00.000,337.0,343.25,335.2,342.0,1776326.0,A birthday treat: Kiran Mazumdar-Shaw joins fellowship at Royal Society of Edinburgh in Scotland,The Biocon boss is one among the 80 luminaries to be appointed for this year’s fellowship.,neutral,neutral,1.483679525222552,positive,1.5863775287439934,positive
2022-03-23 20:08:07.000,337.0,343.25,335.2,342.0,1776326.0,Biocon Executive Chairperson Kiran Mazumdar-Shaw elected as RSE fellow,"RSE is one of the world’s oldest and most respected academic societies. Fellows are elected to join the RSE from across the fields of science, arts, education, business and public life in recognition of their impact in improving the world around them.",neutral,neutral,1.483679525222552,positive,1.5863775287439934,positive
2022-03-24 03:50:00.000,337.0,343.25,335.2,342.0,1776326.0,Expect Biocon to become fully integrated biosimilars firm post Viatris buy: Kiran Mazumdar-Shaw | The Financial Express,"Post the closure of the Viatris’ deal, Biocon Biologics will realise the full revenue and profits from its products, which will be a jump from the existing arrangement where we get only a fraction of the pie.",positive,positive,1.483679525222552,positive,1.5863775287439934,positive
2022-03-29 17:30:00.000,345.85,347.6,340.0,340.05,2469251.0,Glasgow Uni names research centre after John Shaw and Kiran Mazumdar-Shaw,"The £116 million building will officially open in June 2022 and will have over 500 researchers from a range of disciplines, facilitating collaborative research, Biocon said in a statement.",neutral,neutral,-1.6770276131270814,negative,-2.142857142857149,negative
2022-03-31 16:12:00.000,339.0,343.0,335.4,342.45,2386845.0,"BJP accuses Biocon chief of imposing personal, politically coloured opinion",The BJP accused her of imposing personal and ‘politically coloured’ opinion and conflating it with India’s leadership in Information technology and biotechnology sectors,neutral,neutral,1.0176991150442445,positive,0.4648460197559625,neutral
2022-04-01 10:03:00.000,339.0,343.0,335.4,342.45,2386845.0,Biocon Biologics’ biosimilar human insulin gets backing from EMA expert panel,"The EMA’s Committee for Medicinal Products for Human Use (CHMP) opinion will be considered by the European Commission. “The European Commission decision on the approval is expected later this year,” Biocon Biologics said. Once approved by EMA, the company said it commercialise Inpremzia in the EU by…",positive,neutral,1.0176991150442445,positive,0.4648460197559625,neutral
2022-04-01 13:08:00.000,339.0,343.0,335.4,342.45,2386845.0,3 Indians in list of women self-made billionaires - ​3 Indian women in Hurun list,"Three Indian women - Falguni Nayar of Nykaa, Kiran Mazumdar-Shaw of Biocon and Radha Vembu of Zoho - feature in the latest Hurun list of women self-made billionaires (Hurun Richest Self-Made Women in the World 2022). ​3 Indian women in Hurun list",neutral,neutral,1.0176991150442445,positive,0.4648460197559625,neutral
2022-04-12 23:50:00.000,349.95,354.8,348.5,350.15,854998.0,Nykaa CEO Falguni Nayar wins EY Entrepreneur of the Year award,"Nayar, a former investment banker, will now represent India at the EY World Entrepreneur of the Year Award (WEOY) to be held on June 9 this year. Last years winner Kiran Mazumdar-Shaw, Chairperson, Biocon, Neeraj Bharadwaj, Managing Director, had won the WEOY.",positive,positive,0.0571510215745073,neutral,-1.3657274295572168,negative
2022-04-19 06:20:00.000,344.0,348.45,333.0,335.0,2434527.0,Biocon Biologics to raise $1.2 billion overseas loan for Viatris deal,"Biocon Biologics, a unit of Biocon, is raising $1.2 billion via an offshore loan with the pharmaceutical company likely appointing HSBC, MUFG and Standard Chartered Bank to underwrite the proposed five-year overseas loan, two sources familiar with the matter told ET.",positive,positive,-2.616279069767442,negative,3.0994152046783694,positive
2022-04-20 13:16:29.000,352.6,375.0,348.6,373.4,8961697.0,Pharma and healthcare stocks that top mutual fund houses bet on in March,"Biocon, Laurus Labs, Max Healthcare were among the top healthcare and pharma stocks that mutual funds bought in March",neutral,neutral,5.899035734543379,positive,0.2674511901577962,neutral
2022-04-22 14:17:42.000,373.9,384.85,368.15,374.9,7465258.0,Biocon Ltd up for third straight session,"Biocon Ltd is quoting at Rs 381.7, up 2.07% on the day as on 12:54 IST on the NSE. The stock is down 4% in last one year as compared to a 20.57% jump in NIFTY and a 2.74% jump in the Nifty Pharma index.",positive,positive,0.2674511901577962,neutral,2.474448628294779,positive
2022-04-26 09:11:00.000,384.9,388.0,376.75,380.0,4942300.0,"Biocon Biologics secures 3-year contract from Ministry of Health, Malaysia",For supply of its range of insulin ‘Insugen’,neutral,neutral,-1.2730579371265205,negative,0.3553566728086398,neutral
2022-04-26 10:37:00.000,384.9,388.0,376.75,380.0,4942300.0,Biocon Biologics’ arm gets USD 90 mn contract from Malaysian government for supply of insulins,"Biocon Biologics, a part of Biocon Ltd, has created a Centre of Excellence (CoE) for insulins in Malaysia with end-to-end capabilities to manufacture a broad portfolio of regular, basal and rapid insulins.",neutral,neutral,-1.2730579371265205,negative,0.3553566728086398,neutral
2022-04-26 10:38:55.000,384.9,388.0,376.75,380.0,4942300.0,Biocon Biologics’ arm gets $90 million contract from Malaysian government for supply of insulins,"Biocon Sdn Bhd has been awarded the three-year contract by Ministry of Health (MoH), Malaysia.",neutral,positive,-1.2730579371265205,negative,0.3553566728086398,neutral
2022-04-26 13:00:43.000,379.9,383.9,372.0,381.25,2718144.0,Biocon arm signs $90 million contract with Malaysia for human insulin brand Insugen,"“This will enable us to serve over 400,000 people with diabetes using recombinant human insulin, helping the government on its journey towards equitable access to diabetes care,” said Susheel Umesh, chief commercial officer, emerging markets, Biocon Biologics.",positive,positive,0.3553566728086398,neutral,-2.4805194805194835,negative
2022-04-26 13:05:58.000,379.9,383.9,372.0,381.25,2718144.0,"Biocon Ltd soars 0.59%, rises for fifth straight session","Biocon Ltd is quoting at Rs 383.1, up 0.59% on the day as on 12:49 IST on the NSE. The stock is down 3.77% in last one year as compared to a 16.72% spurt in NIFTY and a 0.99% spurt in the Nifty Pharma.",positive,positive,0.3553566728086398,neutral,-2.4805194805194835,negative
2022-04-26 19:06:03.000,379.9,383.9,372.0,381.25,2718144.0,Biocon Biologics bags $90 million contract from Malaysia govt,"Their Insugen formulations will be available at govt hospitals, district health offices, health clinics in Malaysia",neutral,neutral,0.3553566728086398,neutral,-2.4805194805194835,negative
2022-04-26 22:18:00.000,379.9,383.9,372.0,381.25,2718144.0,Biocon Biologics bags $90-mn contract from Malaysian government to supply human insulin,"Biocon Biologics’ Insugen formulations will be available to patients at all Ministry of Health hospitals, district health offices, and health clinics",neutral,neutral,0.3553566728086398,neutral,-2.4805194805194835,negative
2022-04-28 08:14:00.000,385.0,385.0,375.25,375.45,1697184.0,"Stocks to Watch: HUL, RIL, Bajaj Auto, Axis Bank, Vedanta, Ambuja Cements","Stock to Watch: Shares of Axis Bank, Bajaj Finserv, Vedanta, Biocon, Ambuja Cements and SBI Life will be in focus ahead of their Q4 results today.",neutral,neutral,-2.4805194805194835,negative,-1.7506631299734807,negative
2022-04-28 22:48:00.000,377.0,381.7,367.0,370.4,3410585.0,Biocon Q4 consolidated net profit declines by 4% to Rs 283 crore,"Biocon’s consolidated revenue from operations in the fourth quarter stood at Rs 2,408.8 crore as against Rs 1,842.1 crore in the year-ago period",negative,negative,-1.7506631299734807,negative,2.137279079325938,positive
2022-04-28 23:11:00.000,377.0,381.7,367.0,370.4,3410585.0,Biocon Q4 Results: Profit declines 4% to Rs 283 cr,"Consolidated revenue from operations in the fourth quarter stood at Rs 2,408.8 crore as against Rs 1,842.1 crore in the year-ago period, it added.",negative,negative,-1.7506631299734807,negative,2.137279079325938,positive
2022-04-29 05:30:00.000,377.0,381.7,367.0,370.4,3410585.0,"Biocon Q4 results: Consolidated revenue growth recorded at Rs 2,476 Cr, up by 21%","Biocon Q4 results: Consolidated revenue growth recorded at Rs 2,476 Cr, up by 21%",positive,positive,-1.7506631299734807,negative,2.137279079325938,positive
2022-04-29 07:59:00.000,377.0,381.7,367.0,370.4,3410585.0,Biocon standalone net profit declines 43.72% in the March 2022 quarter,Sales rise 5.31% to Rs 517.70 crore,negative,positive,-1.7506631299734807,negative,2.137279079325938,positive
2022-04-29 07:59:00.000,377.0,381.7,367.0,370.4,3410585.0,Biocon consolidated net profit declines 5.77% in the March 2022 quarter,Sales rise 30.76% to Rs 2408.80 crore,negative,positive,-1.7506631299734807,negative,2.137279079325938,positive
2022-04-29 09:53:00.000,377.0,381.7,367.0,370.4,3410585.0,Board of Biocon appoints director,At meeting held on 28 April 2022,neutral,neutral,-1.7506631299734807,negative,2.137279079325938,positive
2022-04-29 10:12:00.000,377.0,381.7,367.0,370.4,3410585.0,Biocon records PAT of Rs 239 crore in Q4 FY22,"Biocon reported 6% fall in consolidated net profit to Rs 239 crore on a 31% rise in revenue from operations to Rs 2,409 crore in Q4 FY22 over Q4 FY21.",neutral,negative,-1.7506631299734807,negative,2.137279079325938,positive
2022-04-29 11:33:50.000,377.0,381.7,367.0,370.4,3410585.0,"Biocon Consolidated March 2022 Net Sales at Rs 2,408.80 crore, up 31.01% Y-o-Y",,positive,neutral,-1.7506631299734807,negative,2.137279079325938,positive
2022-04-29 17:30:00.000,377.0,381.7,367.0,370.4,3410585.0,"‘Encouraged by strong performance’, says Kiran Mazumdar-Shaw on Biocon Q4 results","Biocon reported a 4 per cent decline in consolidated net profit to Rs 283.9 crore in the quarter ending March 31, 2022.",positive,negative,-1.7506631299734807,negative,2.137279079325938,positive
2022-04-29 17:30:00.000,377.0,381.7,367.0,370.4,3410585.0,Biocon Biologics expects R&D expenses to hover between 10-15% in the next financial year,"The company said that this will be a significant jump from the R&D spending of Rs 310 crore it reported for FY22, which represented 9 per cent of its revenue for the year.",positive,positive,-1.7506631299734807,negative,2.137279079325938,positive
2022-05-02 00:26:00.000,364.95,377.55,363.3,372.75,3151730.0,Biocon Biologics may close $3.34 billion Viatris deal in Q1,"Out of $2 billion, $800 million will come through equity infusion from existing investors including parent Biocon and others such as Serum Institute of India, Abu Dhabi-based ADQ.",neutral,neutral,2.137279079325938,positive,-1.3404825737265416,negative
2022-05-03 22:58:54.000,373.0,376.9,364.5,368.0,2136050.0,Ireland regulator reports manufacturing deficiency at Biocon’s Bengaluru plant,"“The inspection report contains no ‘critical’ observations and only one of the deficiencies is categorised as ‘major’ which is being addressed expeditiously in consultation with the regulatory agency,” the spokesperson added.",negative,neutral,-1.3404825737265416,negative,-2.0135135135135105,negative
2022-05-04 01:59:00.000,373.0,376.9,364.5,368.0,2136050.0,Ireland regulator reports manufacturing deficiency at Biocon’s plant,Biocon Biologics is a subsidiary of Biocon Ltd,negative,neutral,-1.3404825737265416,negative,-2.0135135135135105,negative
2022-05-04 06:00:00.000,373.0,376.9,364.5,368.0,2136050.0,"Expect regulatory nods for deal with Serum and Viatris to come by H2: Kiran Mazumdar-Shaw, chairperson, Biocon and Biocon Biologics | The Financial Express","The vaccines alliance with Serum and our continued investment in R&D, adding products to our portfolio, opens up new growth avenues for Biocon Biologics in the coming years.",neutral,positive,-1.3404825737265416,negative,-2.0135135135135105,negative
2022-05-04 08:33:00.000,373.0,376.9,364.5,368.0,2136050.0,Biocon Biologics’ new mAbs drug substance facility undergoes HPRA’s GMP inspection,The inspection report contains no ‘critical’ observations and only one of the deficiencies is categorized as ‘major’ which is being addressed expeditiously in consultation with the regulatory agency,neutral,neutral,-1.3404825737265416,negative,-2.0135135135135105,negative
2022-05-04 16:03:00.000,370.0,370.0,360.8,362.55,836295.0,HPRA completes inspection of Biocon Biologics new mAbs drug substance facility in Bengaluru,The inspection report contains no ‘critical’ observations and only one of the deficiencies is categorized as ‘major’.,neutral,neutral,-2.0135135135135105,negative,-2.8204412175370077,negative
2022-05-08 11:57:54.000,340.2,349.9,337.0,339.0,1309789.0,‘Our vaccines have protected us better than vaccines in the West’: Biocon chief,"Omicron neither overwhelmed our hospitals nor did we have much mortality, the Biocon chief said",positive,neutral,-0.3527336860670161,neutral,-2.2744055530940743,negative
2022-05-10 14:16:55.000,332.8,336.2,327.05,334.85,1134478.0,Biocon Ltd down for fifth straight session,"Biocon Ltd is quoting at Rs 331.1, down 2.2% on the day as on 13:19 IST on the NSE. The stock tumbled 14.59% in last one year as compared to a 9.98% rally in NIFTY and a 10.19% fall in the Nifty Pharma index.",negative,negative,0.6159855769230803,neutral,-1.6346730653869193,negative
2022-05-18 20:55:00.000,334.0,337.8,321.55,323.45,1338887.0,CCI approves Serum Institute Life Sciences-Biocon Biologics deal,"The Competition Commission of India (CCI) has approved a proposed deal involving Serum Institute Life Sciences, Covidshield Technologies and Biocon Biologics.",neutral,positive,-3.1586826347305426,negative,3.776181012077653,positive
2022-05-18 23:07:00.000,334.0,337.8,321.55,323.45,1338887.0,CCI clears Serum Institute Life Sciences-Biocon Biologics deal,"Once the deal is complete, Serum Institute Life Sciences Pvt Ltd will have about 15 per cent stake in Biocon Biologics Ltd, according to the notice filed with the regulator.",neutral,neutral,-3.1586826347305426,negative,3.776181012077653,positive
2022-05-19 08:09:00.000,334.0,337.8,321.55,323.45,1338887.0,"Stocks to Watch: ITC, Lupin, Ruchi Soya, Manappuram Finance, JSW, Biocon","Stocks to Watch today: Ashok Leyland, Bosch, Chambal Fertilisers & Chemicals, Container Corp, Dr Reddy’s will be in focus ahead of their Q4 results today.",neutral,neutral,-3.1586826347305426,negative,3.776181012077653,positive
2022-05-19 08:51:58.000,334.0,337.8,321.55,323.45,1338887.0,stocks that will see action today may 19,"Buzzing stocks: Ashok Leyland, Bosch, HPCL, KIMS, Concor, Ujjivan, Biocon, Future Enterprises, IRB Infra, Adani Enterprises and Endurance Tech",positive,neutral,-3.1586826347305426,negative,3.776181012077653,positive
2022-05-19 14:44:17.000,327.05,340.85,325.75,339.4,3679749.0,CCI approves Serum Institute Life Sciences-Biocon Biologics deal,OFB Tech’s majority stake buy in SMW Ispat also cleared,neutral,positive,3.776181012077653,positive,-1.184037421429619,negative
2022-05-19 17:30:00.000,327.05,340.85,325.75,339.4,3679749.0,CCI approves merger by absorption of Covidshield Technologies into Biocon Biologics,The Competition Commission of India (CCI) on Thursday approved merger by absorption of Covidshield Technologies into Biocon Biologics in consideration for acquisition of approximately 15 per cent equity shareholding of Biocon Biologics by Serum Institute Life Sciences.,neutral,neutral,3.776181012077653,positive,-1.184037421429619,negative
2022-05-19 17:30:00.000,327.05,340.85,325.75,339.4,3679749.0,Biocon Biologics and Viatris launch their third oncology biosimilar in Canada,"Abevmy, co-developed by Biocon Biologics and Viatris, is a biosimilar to Roche’s Avastin (Bevacizumab) and has been approved by Health Canada across four oncology indications.",neutral,positive,3.776181012077653,positive,-1.184037421429619,negative
2022-05-19 18:59:19.000,327.05,340.85,325.75,339.4,3679749.0,"Biocon Biologics, Viatris, launch Abevmy in Canada",Abevmy is a biosimilar to Roche’s Avastin,neutral,neutral,3.776181012077653,positive,-1.184037421429619,negative
2022-05-20 07:55:27.000,327.05,340.85,325.75,339.4,3679749.0,"Stocks to Watch: Godrej Consumer, HPCL, Ashok Leyland, Biocon","Indian indices on Thursday tanked massively, tracking extremely weak trends, with heavy losses recorded in market heavyweights Reliance, SBI, TCS, Infosys, among others.",neutral,negative,3.776181012077653,positive,-1.184037421429619,negative
2022-05-20 08:59:58.000,327.05,340.85,325.75,339.4,3679749.0,stocks that will see action today may 20,"Buzzing stocks: NTPC, Paytm, Biocon, Asahi Songwon, Eros, HAL, Amara Raja Batteries, CE Infosystems, Indiabulls HF, Paras Defence, Pfizer and Dr Reddy’s Lab",positive,neutral,3.776181012077653,positive,-1.184037421429619,negative
2022-05-23 17:30:00.000,339.0,341.0,328.0,329.8,1140827.0,Biocon’s Kiran Mazumdar-Shaw suggests reforms at Bengaluru airport; here’s why,"She addressed the issue raised by music composer Ricky Kej who on Sunday said he was stuck with over 1000 people waiting on Bengaluru International Airport, as very few immigration counters were functioning.",neutral,negative,-2.7138643067846573,negative,-1.2727272727272694,negative
2022-06-07 15:30:21.000,318.4,321.2,311.9,321.0,1969650.0,Biocon chief Kiran Majumdar-Shaw slams poor condition of Bengaluru roads,"The arterial roads which are dug for various civic works are not being repaired. The potholes have resulted in several deaths in Bengaluru, triggering public outrage.",neutral,negative,0.8165829145728715,neutral,3.896103896103904,positive
2022-06-07 17:48:50.000,318.4,321.2,311.9,321.0,1969650.0,"‘Shame on all local politicians…,’ Kiran Mazumdar Shaw’s emotional outburst","Biocon founder, Kiran Mazumdar Shaw expresses frustration & angry over Bengaluru roads",neutral,negative,0.8165829145728715,neutral,3.896103896103904,positive
2022-06-08 11:55:56.000,318.4,321.2,311.9,321.0,1969650.0,Biocon hits over two-year low; slips 18% in six weeks post weak Q4 results,"In the past one year, the stock has slipped 22 per cent, as against a 39 per cent rally in the S&P BSE Sensex.",negative,negative,0.8165829145728715,neutral,3.896103896103904,positive
2022-06-08 13:04:14.000,323.4,338.55,321.55,336.0,8189446.0,Biocon Management Meet Update - Multiple Growth Opportunities In The Near To Medium Term: Nirmal Bang,Biocon Management Meet Update - Multiple Growth Opportunities In The Near To Medium Term: Nirmal Bang,neutral,neutral,3.896103896103904,positive,2.40872595061354,positive
2022-06-09 00:36:00.000,323.4,338.55,321.55,336.0,8189446.0,"Biocon Biologics expects big gains from integration of Viatris business, SII deal","Biocon Biologics in March entered into a definitive agreement to acquire Viatris’ biosimilars assets for $3.34 billion. It will pay Viatris $2 billion in cash at the closing of the deal, and another $335 million in 2024. Out of $2 billion, $800 million will come through equity infusion from existing…",positive,positive,3.896103896103904,positive,2.40872595061354,positive
2022-06-09 05:30:00.000,323.4,338.55,321.55,336.0,8189446.0,BofA Sees 24% Upside in Biocon: Key Factors; Top Gainer on Nifty Pharma,BofA Sees 24% Upside in Biocon: Key Factors; Top Gainer on Nifty Pharma,neutral,neutral,3.896103896103904,positive,2.40872595061354,positive
2022-06-09 11:17:01.000,323.4,338.55,321.55,336.0,8189446.0,Biocon rises for second consecutive session,"Biocon advanced 3.74% to Rs 332.55, extending gains for second day.",positive,positive,3.896103896103904,positive,2.40872595061354,positive
2022-06-14 19:26:28.000,331.8,331.8,323.3,325.0,1746629.0,"CCI Clears BC Asia-IIFL, Viatris-Biocon Biologics Deals, Acquisition of GSK Restructuring","In a series of decisions on Tuesday, the Competition Commission of India (CCI) has given its approvals to the BC Asia Investments X-IIFL Wealth Management deal, Viatris-Biocon Biologics deal and to the acquisition of corporate restructuring of GlaxoSmithKline Consumer Healthcare Holdings Ltd",neutral,neutral,-2.0494273658830653,negative,-2.241878908037219,negative
2022-06-15 08:11:48.000,331.8,331.8,323.3,325.0,1746629.0,"Stocks To Watch Today: Asian Paints, Bajaj Auto, Biocon, GR Infraprojects, IIFL Wealth",Here are the stocks to watch going into trade today...,neutral,neutral,-2.0494273658830653,negative,-2.241878908037219,negative
2022-06-17 15:04:05.000,320.5,321.0,312.0,314.85,1352817.0,Biocon Ltd down for fifth straight session,"Biocon Ltd is quoting at Rs 313, down 2.72% on the day as on 13:19 IST on the NSE. The stock tumbled 21.54% in last one year as compared to a 2.53% slide in NIFTY and a 15.41% fall in the Nifty Metal index.",negative,negative,-1.762870514820586,negative,0.9872611464968224,positive
2022-06-20 17:19:18.000,317.0,326.5,313.5,325.6,1457996.0,Agnipath has job potential in corporate sector for youths: Industry leaders,"Mahindra Group Chairman Anand Mahindra, RPG Enterprises Chairman Harsh Goenka and Biocon Ltd Chairperson Kiran Mazumdar-Shaw came out in support of Agnipath, saying it has potential for employment",neutral,neutral,2.712933753943225,positive,-0.851466414380336,neutral
2022-06-20 22:58:55.000,317.0,326.5,313.5,325.6,1457996.0,Joint drugs controller nabbed taking bribe to clear Biocon unit’s injection,"The CBI registered a case of criminal conspiracy and corruption against Reddy, posted at CDSCO headquarters, and Dinesh Dua, Director at Synergy Network India Private Limited, among others.",neutral,neutral,2.712933753943225,positive,-0.851466414380336,neutral
2022-06-20 23:04:00.000,317.0,326.5,313.5,325.6,1457996.0,CBI apprehends joint drugs controller taking Rs 4 lakh bribe to clear Biocon subsidiary product,"It is alleged that Reddy had demanded a bribe of Rs 9 lakh to send a favourable report about a diabetes injection, they said. Biocon spokesperson did not immediately reply to messages and phone calls made for comments.",neutral,neutral,2.712933753943225,positive,-0.851466414380336,neutral
2022-06-20 23:59:18.000,317.0,326.5,313.5,325.6,1457996.0,"CBI nabs joint drugs controller taking Rs 4 lakh bribe to clear Biocon subsidiary’s product, company denies charges | The Financial Express","The CBI, which was working on the input for over a month, carried out a raid and Dua was caught giving Rs 4-lakh bribe to Reddy of the total promised amount of Rs 9 lakh on behalf of Biocon Biologics",neutral,negative,2.712933753943225,positive,-0.851466414380336,neutral
2022-06-20 23:59:22.000,317.0,326.5,313.5,325.6,1457996.0,CBI Apprehends Joint Drugs Controller Taking Rs 4-lakh Bribe to Clear Biocon Product; Company Denies Charge,"After getting inputs about an exchange of bribe, a CBI team carried out a trap operation in which a middleman, who was giving bribe on behalf of Biocon Biologicals,was apprehended along with Reddy",neutral,neutral,2.712933753943225,positive,-0.851466414380336,neutral
2022-06-21 00:16:45.000,317.0,326.5,313.5,325.6,1457996.0,"India Inc bullish on Agnipath scheme, vows to hire soldiers in 4 years","Bullish on the prospects, Kiran Mazumdar Shaw, founder chairman of pharma major Biocon, said Agniveers will have a distinct advantage in recruitment in the industrial job market",positive,positive,2.712933753943225,positive,-0.851466414380336,neutral
2022-06-21 09:29:04.000,317.0,326.5,313.5,325.6,1457996.0,"Tata Sons Chairman N Chandrasekaran backs Centre’s Agnipath scheme, says THIS","He joined other industry leaders like Mahindra Group Chairman Anand Mahindra, RPG Enterprises Chairman Harsh Goenka, Biocon Ltd Chairperson Kiran Mazumdar-Shaw and Apollo Hospitals Group Joint Managing Director Sangita Reddy who have come out in support of the Agnipath recruitment scheme.",neutral,neutral,2.712933753943225,positive,-0.851466414380336,neutral
2022-06-21 10:41:22.000,317.0,326.5,313.5,325.6,1457996.0,Biocon subsidiary caught offering bribe to waive off trial of new drug,"The CBI apprehended Joint Drugs Controller S. Eswara Reddy for allegedly receiving a ₹4-lakh bribe to waive phase-three clinical trial of Insulin Aspart injection, an underdevelopment product of Biocon Biologics, officials said",neutral,neutral,2.712933753943225,positive,-0.851466414380336,neutral
2022-06-21 12:29:00.000,317.1,324.1,311.5,314.4,2782525.0,CBI arrests joint drugs controller in bribery case to clear Biocon Biologics injection,"After completing the necessary paperwork, the CBI has arrested Reddy and Dua, nabbed during a trap operation on Monday while the alleged bribe exchange was going on, the officials said.",neutral,negative,-0.851466414380336,neutral,3.4865293185419968,positive
2022-06-21 12:34:20.000,317.1,324.1,311.5,314.4,2782525.0,CBI arrests jt drugs controller in bribery case to clear Biocon Biologics injection,Biocon Biologics is a subsidiary of the Kiran Mazumdar Shaw-led Biocon and the company has denied allegations,neutral,neutral,-0.851466414380336,neutral,3.4865293185419968,positive
2022-06-21 12:50:28.000,317.1,324.1,311.5,314.4,2782525.0,Joint drugs controller arrested by CBI in bribery case,Biocon Biologics is a subsidiary of the Kiran Mazumdar Shaw-led Biocon. The company has denied allegations.,negative,neutral,-0.851466414380336,neutral,3.4865293185419968,positive
2022-06-21 12:51:07.000,317.1,324.1,311.5,314.4,2782525.0,Jt Drugs Controller arrested in bribery case to clear Biocon Biologics injection,CBI has arrested Joint Drugs Controller for allegedly taking a ₹4 lakh bribe to clear injections made by Kiran Mazumdar Shaw owned Biocon Biologics,negative,negative,-0.851466414380336,neutral,3.4865293185419968,positive
2022-06-21 16:08:42.000,317.1,324.1,311.5,314.4,2782525.0,Biocon Shares Gain Amid Bribery Allegations Against Subsidiary,Biocon shares swung before rising in early trade after the company denied allegations of bribery against its subsidiary.,neutral,positive,-0.851466414380336,neutral,3.4865293185419968,positive
2022-06-21 17:30:00.000,317.1,324.1,311.5,314.4,2782525.0,Joint drugs controller nabbed taking bribe to clear Biocon Biologics’ diabetes injection,"The CBI, which was working on the input for over a month, carried out a raid and Dua was caught giving Rs 4-lakh bribe to Reddy of the total promised amount of Rs 9 lakh on behalf of Biocon Biologics, a subsidiary of Kiran Majumder Shaw-led Biocon, officials said.",neutral,negative,-0.851466414380336,neutral,3.4865293185419968,positive
2022-06-21 17:30:00.000,317.1,324.1,311.5,314.4,2782525.0,Biocon Biologics denies bribery charge; says it follows ‘a strong code of conduct’,"“We strongly deny the allegations of bribery against the company and its officials associated with the approval process of one of our products in India,” Biocon Biologics said.",neutral,neutral,-0.851466414380336,neutral,3.4865293185419968,positive
2022-06-21 17:30:00.000,317.1,324.1,311.5,314.4,2782525.0,NSE seeks clarification from Biocon in relation to Joint Drugs Controller bribery case,The CBI has arrested Joint Drugs Controller S Eswara Reddy for allegedly receiving a Rs 4 lakh bribe to waive the phase three clinical trial of the Insulin Aspart injection which is a product of Biocon Biologics.,neutral,neutral,-0.851466414380336,neutral,3.4865293185419968,positive
2022-06-21 17:30:00.000,317.1,324.1,311.5,314.4,2782525.0,‘Product approvals legitimate’: Kiran Mazumdar-Shaw on bribe allegations against Biocon,Biocon Executive Chairperson Kiran Mazumdar-Shaw denied these allegations and said product approvals are legitimate and backed by science and clinical data.,neutral,neutral,-0.851466414380336,neutral,3.4865293185419968,positive
2022-06-21 18:58:02.000,317.1,324.1,311.5,314.4,2782525.0,CBI arrests Joint Drugs Controller for accepting bribe to waive off 3rd phase trial of Biocon’s Insulin Aspart Injection,CBI investigators recover “incriminating documents and articles” during search operation,negative,neutral,-0.851466414380336,neutral,3.4865293185419968,positive
2022-06-22 01:15:37.000,317.1,324.1,311.5,314.4,2782525.0,SEC recommendation in accordance with guidelines: Biocon Biologics,The company said its product approvals are backed by science and clinical data,neutral,neutral,-0.851466414380336,neutral,3.4865293185419968,positive
2022-06-22 01:18:00.000,317.1,324.1,311.5,314.4,2782525.0,"Biocon arm denies bribery charges, says cos follows code of conduct","The guidelines provide a framework for waiver of phase III clinical trials in India based on a commitment to undertake a phase IV trial, the design of which should be approved by the central licensing authority. In line with this, Biocon presented a proposal for import and marketing of insulin aspar…",neutral,positive,-0.851466414380336,neutral,3.4865293185419968,positive
2022-06-22 02:31:07.000,317.1,324.1,311.5,314.4,2782525.0,"CBI arrests Jt Drug Controller, Biocon Biologics execs over fishy approvals","All five apprehended will be presented in court on Tuesday afternoon, agency to seek police custody",neutral,neutral,-0.851466414380336,neutral,3.4865293185419968,positive
2022-06-22 04:55:00.000,317.1,324.1,311.5,314.4,2782525.0,Role of pharma firms in allegedly bribing CDSCO officials under CBI scanner,"CBI has arrested five people including S Eswara Reddy, joint drug controller at CDSCO, L Praveen Kumar, associate vice president and head of national regulatory affairs (NRA) at Biocon Biologics, and Dinesh Dua, an alleged middleman and a business partner of Sethi, in connection with the case.",negative,negative,-0.851466414380336,neutral,3.4865293185419968,positive
2022-06-22 06:00:00.000,317.1,324.1,311.5,314.4,2782525.0,"CBI Probe: Biocon denies bribery charges, says it followed due process of law","The Bengaluru-headquartered company, in a statement, said it is governed by a strong code of conduct and condemns any acts of corruption and violation of rules by way of offering or paying bribes or undue favours, either directly or indirectly.",neutral,neutral,-0.851466414380336,neutral,3.4865293185419968,positive
2022-06-22 09:04:04.000,317.1,324.1,311.5,314.4,2782525.0,"Hero MotoCorp, Biocon, Jain Irrigation in spotlight",Hero MotoCorp: The company has further strengthened its commitment and operations in Turkiye with the introduction of Euro-5 compliant variants of its three globally popular products. The range of Hero MotoCorp products in the Turkiye include the,neutral,positive,-0.851466414380336,neutral,3.4865293185419968,positive
2022-06-22 09:12:03.000,317.1,324.1,311.5,314.4,2782525.0,"Stocks To Watch Today: Biocon, Coal India, Hero MotoCorp, Jain Irrigation, SAIL",Here are the stocks to watch going into trade today.,neutral,neutral,-0.851466414380336,neutral,3.4865293185419968,positive
2022-06-22 11:07:40.000,317.1,324.1,311.5,314.4,2782525.0,Biocon slips 4% despite arm denying bribery charges,"At 10:26 AM, the stock of Biocon was down 3 per cent at Rs 316.10, as compared to 1 per cent decline in the S&P BSE Sensex",neutral,negative,-0.851466414380336,neutral,3.4865293185419968,positive
2022-06-22 11:42:30.000,317.1,324.1,311.5,314.4,2782525.0,"How Biocon’s Insulin Aspart, at Centre of ‘Bribery Controversy’, is Different from Its Peers",It is alleged that a bribe was given to Central Drugs Standard Control Organisation (CDSCO)’s official to waive off the Phase 3 clinical trial of the medicine in India,neutral,neutral,-0.851466414380336,neutral,3.4865293185419968,positive
2022-06-23 17:30:00.000,327.0,340.0,325.9,326.4,4594729.0,Will bribery case impact Biocon’s business? Expert weighs in,"“Industry insiders and investors will probably not be rattled by the news as was evidenced by Biocon share price being largely unaffected by the charge, ” said analyst Salil Kallianpur.",neutral,negative,-0.183486238532117,neutral,-3.1212121212121247,negative
2022-06-27 00:49:00.000,330.0,332.25,319.4,319.7,2457765.0,"Regulatory checks on pharmaceutical products stringent, say former CDSCO members","The comments came after the Central Bureau of Investigation (CBI) recently arrested five people, including a senior CDSCO official, for allegedly accepting a bribe to clear an application from Bengaluru-based Biocon Biologics seeking waiver of phase-3 clinical trials for its product, Insulin Aspart.",neutral,negative,-3.1212121212121247,negative,-0.8160703075957385,neutral
2022-06-27 00:56:00.000,330.0,332.25,319.4,319.7,2457765.0,Biocon engages external law firm to review governance of consultants,"“The company already has a strong code of conduct and an anti-bribery and anti-corruption clause in its contracts with all its vendors. The management now plans to step up its vigilance and with help from an external law firm it has appointed, it aims to plug the gaps and strengthen its governance s…",neutral,positive,-3.1212121212121247,negative,-0.8160703075957385,neutral
2022-06-27 09:11:00.000,330.0,332.25,319.4,319.7,2457765.0,Biocon News : Biocon signs up with external law firm to review governance process at vendor firms,"“The company already has a strong code of conduct and an anti-bribery and anti-corruption clause in its contracts with all its vendors. The management now plans to step up its vigilance and with help from an external law firm it has appointed, it aims to plug the gaps and strengthen its governance s…",neutral,positive,-3.1212121212121247,negative,-0.8160703075957385,neutral
2022-06-27 12:45:10.000,318.6,319.25,314.5,316.0,2243776.0,"Zomato, Dish TV, Biocon: Trading strategies for buzzing stocks of the day","Shares of Zomato face stiff resistance at Rs 78, while the downside support stays at Rs 60",neutral,neutral,-0.8160703075957385,neutral,-1.429025087329311,negative
2022-06-27 17:30:00.000,318.6,319.25,314.5,316.0,2243776.0,"CBI yet to question Jt Drug Controller, other accused in Biocon Biologics bribery scandal",Sources said CBI officials are disappointed that the court rejected their application twice for custody as immediate questioning after arrest in a trap case is of extreme importance for the agency so the accused do not get a chance to develop an alibi in their defence.,neutral,negative,-0.8160703075957385,neutral,-1.429025087329311,negative
2022-06-28 17:30:00.000,314.9,315.15,308.05,310.4,2921347.0,Biocon bribery case: CBI moves HC challenging lower court order denying it custody of accused,The Delhi High Court has issued notices to the parties concerned and has scheduled the case for hearing on July 2.,neutral,neutral,-1.429025087329311,negative,-0.948858153747182,negative
2022-06-28 19:55:35.000,314.9,315.15,308.05,310.4,2921347.0,Biocon Biologics bribery case: CBI moves HC challenging lower court verdict,The Delhi High Court has issued notices to the parties concerned and will hear the case on July 2,neutral,neutral,-1.429025087329311,negative,-0.948858153747182,negative
2022-06-28 21:03:11.000,314.9,315.15,308.05,310.4,2921347.0,Biocon Biologics Bribery Case: CBI Moves HC Challenging Lower Court Verdict Denying it Custody of Arrested Accused,"The Delhi High Court has issued notices to the parties concerned and will hear the case on July 2, they said",neutral,neutral,-1.429025087329311,negative,-0.948858153747182,negative
2022-06-29 07:24:41.000,314.9,315.15,308.05,310.4,2921347.0,Biocon bribery case: CBI moves Delhi HC for custody of accused officials,CBI on Tuesday moved the Delhi High Court seeking the custody of officials accused of allegedly demanding bribes to waive the Phase-3 trial of “Insulin Aspart Injection”,neutral,neutral,-1.429025087329311,negative,-0.948858153747182,negative
2022-06-29 07:53:30.000,314.9,315.15,308.05,310.4,2921347.0,"Stocks to watch: Reliance, Tata Motors, Biocon, Tata Steel, J&K Bank, BoB",Stocks to watch today: Akash M Ambani will take over as non-executive director and chairman of the board of directors of Reliance Jio; Tata Motors will hike prices of CVs by 1.5 to 2.5 per cent.,neutral,neutral,-1.429025087329311,negative,-0.948858153747182,negative
2022-06-29 16:52:09.000,310.9,313.0,307.0,307.95,2212240.0,Why does digital India need drug firms to engage intermediaries for regulatory nod? | The Financial Express,"On June 20th, CBI apprehended the joint drug controller of India and the director of a consulting firm acting as an intermediary in regulatory affairs for Biocon Biologics, the subsidiary of the leading biopharmaceutical company Biocon.",neutral,neutral,-0.948858153747182,negative,0.8259109311740928,neutral
2022-06-29 21:04:31.000,310.9,313.0,307.0,307.95,2212240.0,Biocon To Buy 26% Stake In AMPYR Renewable Energy Resources Eleven,Biocon Ltd. on Wednesday said it will acquire 26% stake in AMPYR Renewable Energy Resources Eleven Pvt. Ltd. for Rs 7.5 crore.,neutral,neutral,-0.948858153747182,negative,0.8259109311740928,neutral
2022-06-29 21:37:46.000,310.9,313.0,307.0,307.95,2212240.0,Biocon to buy 26% stake in AMPYR Renewable Energy Resources Eleven,"The company has entered into an agreement for the purpose of “acquisition of solar power by acquiring equity stake up to 26 per cent in AREREPL”, it said.",neutral,positive,-0.948858153747182,negative,0.8259109311740928,neutral
2022-06-30 07:31:57.000,310.9,313.0,307.0,307.95,2212240.0,"Stocks to Watch: Minda Industries, Infosys, TVS Motors, Biocon",Indian indices snapped their four-day gain on Wednesday amid weak global market trends and inflation concerns.,neutral,positive,-0.948858153747182,negative,0.8259109311740928,neutral
2022-06-30 07:49:41.000,310.9,313.0,307.0,307.95,2212240.0,"Stocks to Watch Today: Indian Oil, TVS Motors, Infosys, Biocon, and Others","Stocks to watch today: Shares of firms like Indian Oil, TVS Motors, Infosys, Biocon, and others will be in focus in Thursday’s trade",neutral,neutral,-0.948858153747182,negative,0.8259109311740928,neutral
2022-06-30 08:17:31.000,310.9,313.0,307.0,307.95,2212240.0,"Stocks to watch: Tata Steel, HDFC, Jet Airways, JSW Steel, Biocon, PVR","Stocks to watch today: HDFC, slated to merge with HDFC Bank, raised Rs 4,000 crore through a paper with a maturity of 21 months; Jet Airways plans to lease 6 to 8 planes as part of re-launch.",neutral,positive,-0.948858153747182,negative,0.8259109311740928,neutral
2022-06-30 08:55:13.000,310.9,313.0,307.0,307.95,2212240.0,Stocks that will see action on June 30,"Buzzing stocks: Biocon Ltd, Electrotherm (India) Ltd, Veranda Learning Solutions Ltd, Minda Industries, Wonderla Holidays, Pritika Engineering Components Ltd",neutral,neutral,-0.948858153747182,negative,0.8259109311740928,neutral
2022-06-30 17:30:00.000,308.75,312.0,305.0,311.3,1134735.0,"Stocks in news: Infosys, Indian Oil, Biocon, Hikal and more","Stocks in news: Indian Oil, Sterlite Technologies, Wonderla Holidays, Biocon, Hikal, Infosys and more",neutral,neutral,0.8259109311740928,neutral,-0.3044871794871758,neutral
2022-06-30 19:34:57.000,308.75,312.0,305.0,311.3,1134735.0,Biocon Hires Law Firm For Governance Review After CBI Arrests,The review is part of the management’s reiteration of its commitment to strengthening compliance and governance practices.,neutral,neutral,0.8259109311740928,neutral,-0.3044871794871758,neutral
2022-06-30 20:09:23.000,308.75,312.0,305.0,311.3,1134735.0,Biocon hires law firm for governance review after CBI arrests,"Bid to strengthen compliance, governance practices across Biocon group entities",neutral,positive,0.8259109311740928,neutral,-0.3044871794871758,neutral
2022-07-05 17:24:13.000,316.8,321.5,314.0,320.75,1827352.0,"Biocon Biologics Bribery Case: HC Rejects CBI’s Plea for Custody of Four Accused, Allows for One",The high court directed the jail superintendent to hand over the custody of associate vice president of Biocon Biologics L Praveen Kumar to the CBI investigating officer (IO) till July 6,neutral,neutral,1.2468434343434307,positive,-0.3105590062111801,neutral
2022-07-05 17:30:00.000,316.8,321.5,314.0,320.75,1827352.0,Biocon Biologics gets EU GMP certification for new facility in Bengaluru,The EU Good Manufacturing Practices (GMP) accreditation is offered to pharmaceutical manufacturers who adhere to a minimal standard in their production practices.,neutral,neutral,1.2468434343434307,positive,-0.3105590062111801,neutral
2022-07-05 19:53:00.000,316.8,321.5,314.0,320.75,1827352.0,Biocon Biologics gets EU GMP certification from Ireland’s HPRA,"The company’s new monoclonal antibodies (mAbs) drug substance manufacturing facility (B3) at Biocon Park, Bengaluru has received the certification following a GMP inspection in April 2022, a Biocon Biologics spokesperson said in a statement.",neutral,positive,1.2468434343434307,positive,-0.3105590062111801,neutral
2022-07-05 20:52:45.000,316.8,321.5,314.0,320.75,1827352.0,Biocon Biologics new facility receives EU certification,The monoclonal antibodies drug substance facility received certification for its manufacturing practice,neutral,positive,1.2468434343434307,positive,-0.3105590062111801,neutral
2022-07-06 02:14:17.000,316.8,321.5,314.0,320.75,1827352.0,Delhi HC rejects CBI plea for custody of four accused in Biocon case,"The high court, however, directed the jail superintendent to hand over the custody of associate vice president of Biocon Biologics L Praveen Kumar",neutral,neutral,1.2468434343434307,positive,-0.3105590062111801,neutral
2022-07-06 07:31:36.000,316.8,321.5,314.0,320.75,1827352.0,"Stocks to Watch Today: Adani Power, Biocon, Tata Steel, NTPC, PSU Banks","Stocks to Watch Today: Among airline shares, SpiceJet has reported seven aircraft related incidents in the last two months; while IndiGo said has hired over 1,500 cabin crew staff to counter likely at",neutral,neutral,1.2468434343434307,positive,-0.3105590062111801,neutral
2022-07-06 07:45:56.000,316.8,321.5,314.0,320.75,1827352.0,"Stocks to Watch: Adani Power, Tata Motors, Biocon, Marico, NTPC","Even as volatility rocked debt and equity markets over the past year, infrastructure investment trusts (InvITs) and real estate investment trusts (Reits) became an oasis of stability, with many analysts expecting returns from these instruments to rise further",neutral,positive,1.2468434343434307,positive,-0.3105590062111801,neutral
2022-07-06 07:59:49.000,316.8,321.5,314.0,320.75,1827352.0,"Stocks to Watch Today: TCS, Tata Steel, Biocon, Marico, LIC, and Others","Stocks to watch today: Shares of firms like TCS, Tata Steel, Biocon, Marico, LIC, and others will be in focus in Wednesday’s trade",neutral,neutral,1.2468434343434307,positive,-0.3105590062111801,neutral
2022-07-06 08:31:21.000,316.8,321.5,314.0,320.75,1827352.0,"Stocks that will see action on July 6, 2022","Buzzing stocks: Britannia, Biocon, Coffee Day, Equitas Holdings, Dabur, Control Print, J Kumar Infraprojects",neutral,neutral,1.2468434343434307,positive,-0.3105590062111801,neutral
2022-07-06 10:04:17.000,316.8,321.5,314.0,320.75,1827352.0,Biocon subsidiary gets EU GMP certification for Bengaluru facility,"Biocon Biologics has received the EU GMP certificate from the Health Products Regulatory Authority (HPRA), Ireland, for its new monoclonal antibodies (mAbs) drug substance manufacturing facility (B3) at Biocon Park, Bengaluru.",neutral,neutral,1.2468434343434307,positive,-0.3105590062111801,neutral
2022-07-06 14:15:00.000,322.0,324.1,318.5,321.0,837397.0,Biocon Biologics’ antibody drug unit in Bengaluru gets EU GMP certificate,"Approval comes from Irish health regulator, which had flagged some deficiencies in the manufacturing process iin May",neutral,neutral,-0.3105590062111801,neutral,-0.1702259362426528,neutral
2022-07-06 14:29:04.000,322.0,324.1,318.5,321.0,837397.0,Biocon arm Syngene ends contract with Bioinnovat Research over graft case,Guljit Sethi of Bioinnovat was named in CBI FIR on a bribery case involving CDSCO official and Biocon Biologics executive,neutral,neutral,-0.3105590062111801,neutral,-0.1702259362426528,neutral
2022-07-11 13:17:27.000,328.2,331.9,323.9,323.95,1241258.0,"Biocon Ltd spurts 1.61%, up for five straight sessions","Biocon Ltd is quoting at Rs 328, up 1.61% on the day as on 12:44 IST on the NSE. The stock is down 15.32% in last one year as compared to a 2.83% jump in NIFTY and a 13.05% jump in the Nifty Metal.",positive,positive,-1.2949421084704449,negative,0.9049079754601193,positive
2022-07-17 19:21:33.000,332.85,335.2,329.25,332.3,693539.0,Deal with Zoetis could be worth $500 mn in 10 yrs: Syngene In’l chief,"In a Q&A, Jonathan Hunt, MD & CEO of the Biocon arm, dwells on his firm’s initiatives to overcome supply chain bottlenecks and other issues",neutral,neutral,-0.1652395974162569,neutral,-1.2940114354498982,negative
2022-07-20 01:07:00.000,331.0,331.75,324.5,325.9,1822314.0,Biocon Biologics bribery case: Bail pleas of five accused rejected,"The CBI last month arrested Central Drugs Standard Control Organisation (CDSCO) joint drug controller S Eswara Reddy and Biocon Biologics head of national regulatory affairs L Praveen Kumar among the five accused in the case. Currently, they are in judicial custody.",neutral,negative,-1.5407854984894327,negative,1.391437308868505,positive
2022-07-21 19:59:23.000,330.25,331.85,326.1,326.65,2362840.0,Biocon receives three US FDA observations on its Telangana plant,Biotechnology major Biocon on Thursday said the US health regulator has issued three observations after inspecting its Telangana-based manufacturing plant.,neutral,neutral,-1.0900832702498178,negative,-1.4220183486238462,negative
2022-07-21 20:27:14.000,330.25,331.85,326.1,326.65,2362840.0,"Biocon gets US FDA observations, says it’s committed to quality",Biocon ha received three US FDA observations on its Telangana plant.,positive,neutral,-1.0900832702498178,negative,-1.4220183486238462,negative
2022-07-21 21:22:05.000,330.25,331.85,326.1,326.65,2362840.0,Biocon’s Hyderabad Facility Receives Three U.S. FDA Observations,Biocon said it will be addressing the U.S. FDA observations within the stipulated time.,neutral,neutral,-1.0900832702498178,negative,-1.4220183486238462,negative
2022-07-22 07:32:23.000,330.25,331.85,326.1,326.65,2362840.0,"Stocks to Watch Today: RIL, Biocon, UltraTech, JSW Steel, RBL Bank, and Others","Stocks to watch today: Shares of firms like RIL, Biocon, UltraTech, JSW Steel, RBL Bank, and others will be in focus in Friday’s trade",neutral,neutral,-1.0900832702498178,negative,-1.4220183486238462,negative
2022-07-22 07:32:28.000,330.25,331.85,326.1,326.65,2362840.0,"Stocks to Watch: JSW Energy, ICICI Securities, Biocon, RBL Bank, NLC","Reliance Industries, JSW Steel, Bandhan Bank, Ultratech, and Coforge will be in focus as they declare their June quarter earnings today.",neutral,neutral,-1.0900832702498178,negative,-1.4220183486238462,negative
2022-07-22 08:50:06.000,330.25,331.85,326.1,326.65,2362840.0,Biocon’s Hyderabad facility gets 3 USFDA observations,The biotechnology major said the US health regulator has issued three observations after inspecting its Telangana-based manufacturing plant.,neutral,neutral,-1.0900832702498178,negative,-1.4220183486238462,negative
2022-07-22 09:01:16.000,330.25,331.85,326.1,326.65,2362840.0,"Stocks To Watch Today: Biocon, Emami, PVR, RBL Bank, Reliance Industries",Here are the stocks to watch in today’s trade.,neutral,neutral,-1.0900832702498178,negative,-1.4220183486238462,negative
2022-07-22 17:30:00.000,330.25,331.85,326.1,326.65,2362840.0,"Stocks in news: Reliance Industries, JSW Energy, Biocon, RBL Bank and more","Stocks in news: Reliance Industries, JSW Energy, Biocon, RBL Bank, IDBI Bank, ICICI Securities and more",neutral,neutral,-1.0900832702498178,negative,-1.4220183486238462,negative
2022-07-27 16:46:00.000,316.0,316.0,305.05,307.0,8437240.0,"Hurun power-list: Roshni Nadar Malhotra of HCL wealthiest woman with Rs 84K cr net worth, Nykaa’s Falguni Nayar beats Biocon boss for richest self-made billionaire",Indra Nooyi is the richest professional manager with Rs 5K cr wealth.,positive,positive,-2.848101265822785,negative,-0.4370346390417501,neutral
2022-07-27 17:14:22.000,316.0,316.0,305.05,307.0,8437240.0,Roshni Nadar remains richest Indian woman; Nykaa’s Falguni Nayar top among self-made rich women: Report,"Biocon’s Kiran Mazumdar-Shaw has moved down one rank to be the third richest woman in the country with a wealth of Rs 29,030 crore, as per the Kotak Private Banking-Hurun list",neutral,negative,-2.848101265822785,negative,-0.4370346390417501,neutral
2022-07-27 17:30:00.000,316.0,316.0,305.05,307.0,8437240.0,Biocon net profit rises 71% to Rs 144 crore in June quarter,Biocon Executive Chairperson Kiran Mazumdar-Shaw said revenues grew as a result of robust growth in both biosimilar and generics verticals.,positive,positive,-2.848101265822785,negative,-0.4370346390417501,neutral
2022-07-27 20:15:34.000,316.0,316.0,305.05,307.0,8437240.0,"Biocon Q1 Results: Profit Rises 71%, But Misses Estimates","Biocon’s first-quarter profit rose on higher sales and lower taxes. Still, its earnings missed forecasts.",neutral,positive,-2.848101265822785,negative,-0.4370346390417501,neutral
2022-07-27 21:10:00.000,316.0,316.0,305.05,307.0,8437240.0,"Nykaa’s Falguni Nayar is India’s richest self-made woman, wealth surges 963%","Falguni Nayar, founder and CEO of Nykaa, has moved ahead of Biocon founder and CEO Kiran Mazumdar-Shaw to become the richest self-made woman in India, according to Kotak Private Banking Hurun Leading Wealthy Women List 2021.",positive,positive,-2.848101265822785,negative,-0.4370346390417501,neutral
2022-07-27 21:29:36.000,316.0,316.0,305.05,307.0,8437240.0,Biocon’s Q1 net profit up by 71 per cent to ₹144 crore,Biocon’s biosimilars segment contributed the most revenue at ₹977 crore,positive,positive,-2.848101265822785,negative,-0.4370346390417501,neutral
2022-07-27 22:05:36.000,316.0,316.0,305.05,307.0,8437240.0,Biocon net profit rises 71% to Rs 144 cr in June quarter; revenue rises 23%,Biotechnology major Biocon on Wednesday reported a 71 per cent increase in consolidated net profit at Rs 144 crore for the June quarter on the back of robust growth across business verticals.,positive,positive,-2.848101265822785,negative,-0.4370346390417501,neutral
2022-07-27 23:22:11.000,316.0,316.0,305.05,307.0,8437240.0,"Biocon Consolidated June 2022 Net Sales at Rs 2,139.50 crore, up 21.52% Y-o-Y",,positive,neutral,-2.848101265822785,negative,-0.4370346390417501,neutral
2022-07-28 06:35:37.000,316.0,316.0,305.05,307.0,8437240.0,"Stocks to Watch Today | Tata Motors, Dr Reddy’s Labs, Biocon and others in news today",Stocks to Watch: Check out the companies making headlines before the opening bell.,neutral,neutral,-2.848101265822785,negative,-0.4370346390417501,neutral
2022-07-28 08:38:50.000,316.0,316.0,305.05,307.0,8437240.0,"Stocks To Watch Today: Biocon, Jubilant FoodWorks, Tata Motors, SpiceJet, Vedanta",Here’s a look at the stocks to watch before going into trade today.,neutral,neutral,-2.848101265822785,negative,-0.4370346390417501,neutral
2022-07-28 09:04:06.000,316.0,316.0,305.05,307.0,8437240.0,"Tata Motors, Biocon, Hindustan Aeronautics in focus","Tata Motors: The auto major reported consolidated net loss of Rs 5,006.60 crore in Q1 FY23 as against a net loss of Rs 4,450.92 crore in Q1 FY22. Revenue from operations increased 8.3% YoY to Rs 71,935 crore during the quarter ended 30 June 2022.",neutral,positive,-2.848101265822785,negative,-0.4370346390417501,neutral
2022-07-28 10:16:28.000,316.0,316.0,305.05,307.0,8437240.0,Biocon Q1 PAT climbs 71% YoY to Rs 144 cr,"The biotech company’s consolidated net profit surged 71.1% to Rs 144.40 crore on 21.5% jump in revenue from operations to Rs 2,139.50 crore in Q1 FY23 over Q1 FY22.",positive,positive,-2.848101265822785,negative,-0.4370346390417501,neutral
2022-07-28 10:25:46.000,316.0,316.0,305.05,307.0,8437240.0,HCL’s Roshni Nadar Malhotra is richest woman in India | List of top 10,Top 10 Richest women in India: The position of the second richest woman in India is secured by Nykaa founder and chief executive office (CEO) Falguni Nayar. Biocon’s founder and CEO Kiran Mazumdar Shaw is the country’s third richest woman.,neutral,neutral,-2.848101265822785,negative,-0.4370346390417501,neutral
2022-07-28 14:58:09.000,308.9,309.6,305.2,307.55,4741775.0,"Q1 Review | What Worked, What Didn’t For Biocon","Q1 Review | What Worked, What Didn’t For Biocon #Q1WithBQ | Biocon’s profit jumps 71% but fails to meet estimates. Margins contract sequentially too. MD & CEO Siddharth Mittal shares key highlights from the quarter. #BQLive #Q1WithBQ | Biocon’s profit jumps 71% but fails to meet estimates.",neutral,positive,-0.4370346390417501,neutral,-0.3226326826907565,neutral
2022-07-28 15:04:04.000,308.9,309.6,305.2,307.55,4741775.0,Mahindra Lifespace Developers Ltd leads losers in ‘A’ group,"Biocon Ltd, Brightcom Group Ltd, V I P Industries Ltd and SpiceJet Ltd are among the other losers in the BSE’s ‘A’ group today, 28 July 2022.",positive,negative,-0.4370346390417501,neutral,-0.3226326826907565,neutral
2022-07-28 15:31:00.000,308.9,309.6,305.2,307.55,4741775.0,View Biocon in terms of core EBITDA as R&D is an integral part of our biz growth: Kiran Mazumdar Shaw,"“I just want to emphasise that Biocon Biologics or Biocon as a business must be viewed in terms of core EBITDA and not just on EBITDA because as you know R&D is a very integral part of our business growth which needs to future proof us and therefore, we cannot afford to decrease R&D spending to sust…",neutral,neutral,-0.4370346390417501,neutral,-0.3226326826907565,neutral
2022-07-29 09:49:16.000,308.9,309.6,305.2,307.55,4741775.0,Biocon Q1 Review - Multiple Headwinds Affect Earnings: Motilal Oswal,Biocon Q1 Review - Multiple Headwinds Affect Earnings: Motilal Oswal,neutral,neutral,-0.4370346390417501,neutral,-0.3226326826907565,neutral
2022-07-29 20:22:00.000,308.9,309.6,305.2,307.55,4741775.0,How Bengaluru’s road can be fixed? Biocon boss gives fruitful advice to BBMP,"Biocon chairperson Kiran Mazumdar-Shaw has shared a video on Twitter tagging Rakesh Singh, administrator BBMP on how advanced technology can repair the Bengaluru’s roads",neutral,neutral,-0.4370346390417501,neutral,-0.3226326826907565,neutral
2022-08-01 06:21:19.000,309.95,310.55,307.0,308.95,1763438.0,Biocon exploring treatment to curb monkeypox spread,Biocon reported 71% increase in its net profit from the year ago to ₹144 crore for the June quarter of the fiscal year,neutral,positive,-0.3226326826907565,neutral,0.5658852061438965,neutral
2022-08-04 13:36:13.000,315.0,316.35,311.75,312.0,1406600.0,"U.S. FDA Flags Quality, Procedural Lapses At Biocon’s Hyderabad Facility",The US FDA has flagged quality control and procedural lapses at Biocon’s Hyderabad facility in a pre-approval inspection.,neutral,negative,-0.9523809523809524,negative,0.5595523581135092,neutral
2022-08-04 17:30:00.000,315.0,316.35,311.75,312.0,1406600.0,SAT quashes insider trading charges against Biocon official Shreehas Tambe,"In addition, the appellate tribunal has also set aside the capital markets regulator Sebi’s order that had restrained Tambe from accessing the securities market and prohibited him from being associated with any listed company for three months.",neutral,neutral,-0.9523809523809524,negative,0.5595523581135092,neutral
2022-08-05 07:50:00.000,315.0,316.35,311.75,312.0,1406600.0,Biocon Biologic’s Malaysian arm recognized as largest integrated insulin manufacturer by MBR,"MBR has recognised the company’s 562,000 sq. ft. facility as the first and largest integrated insulin manufacturer in Malaysia.",positive,positive,-0.9523809523809524,negative,0.5595523581135092,neutral
2022-08-05 19:46:00.000,315.0,316.35,311.75,312.0,1406600.0,Eris Lifesciences enters licensing deal with Biocon for insulin glargine,"The launch of long acting insulin glargine will help Eris to fill the gap in its insulin portfolio. Eris derives more than half of its revenues from cardio-metabolic therapeutic segment, and has adopted a “Full Service” approach to diabetes management with a comprehensive range of oral anti-diabetic…",positive,positive,-0.9523809523809524,negative,0.5595523581135092,neutral
2022-08-24 23:57:00.000,307.0,308.9,306.0,306.2,1183123.0,Biocon case: CBI files charge sheet against 5,"The agency in its charge sheet filed last week has annexed alleged incriminating WhatsApp texts exchanged between alleged conduit (a woman) in the case and the accused official of Biocon Biologics to buttress its charges, people aware of the matter told ET.",neutral,positive,-0.2605863192182447,neutral,-0.0814332247557003,neutral
2022-08-25 09:59:59.000,307.0,308.9,306.0,306.2,1183123.0,CBI files charge sheet in Biocon case against five persons,"The agency in its charge sheet filed on August 18 has alleged that the bribe payment was being paid to Joint Drug Controller S Eswara Reddy after clearance from associate vice president of Biocon Biologics L Praveen Kumar, they said.",neutral,neutral,-0.2605863192182447,neutral,-0.0814332247557003,neutral
2022-08-25 10:33:45.000,307.0,308.9,306.0,306.2,1183123.0,CBI files charge sheet in Rs 9 lakh Biocon Biologics bribery case,The CBI has filed a charge sheet in a bribery case in which a senior official of the Central Drugs Standard Control Organisation and a Biocon Biologics executive were arrested in June this year,neutral,negative,-0.2605863192182447,neutral,-0.0814332247557003,neutral
2022-08-25 10:40:20.000,307.0,308.9,306.0,306.2,1183123.0,"Biocon case: CBI files charge sheet against 5, including executive",The agency in its charge sheet filed on August 18 has alleged that the bribe payment was being paid to Joint Drug Controller S Eswara Reddy after clearance from associate vice president of Biocon Biologics L Praveen Kumar,neutral,neutral,-0.2605863192182447,neutral,-0.0814332247557003,neutral
2022-08-30 10:17:10.000,306.5,310.5,305.3,309.0,1603753.0,‘Happily Married’ is an oxymoron: Kiran Mazumdar-Shaw shares hilarious post,Kiran Mazumdar-Shaw is a billionaire entrepreneur who founded ‘India’s largest biopharmaceutical company’ Biocon.,neutral,neutral,0.8156606851549755,neutral,0.3156146179401955,neutral
2022-08-30 17:30:00.000,306.5,310.5,305.3,309.0,1603753.0,‘Happily Married’: Kiran Mazumdar-Shaw posts hilarious tongue-in-cheek take on marriage,"Biocon boss Kiran Mazumdar-Shaw, known for her open views, recently took to the microblogging site to post a pun on the phrase ‘happily married,’ and leaves Twitter in splits.",neutral,neutral,0.8156606851549755,neutral,0.3156146179401955,neutral
2022-08-31 22:01:00.000,301.0,304.9,297.55,301.95,3207874.0,Biocon Biologics receives observations from USFDA: Biocon,"The USFDA conducted three on-site inspections of Biocon Biologics’ seven manufacturing facilities spanning two sites in Bengaluru, India and one at Johor, Malaysia, Biocon said in a regulatory filing.",neutral,neutral,0.3156146179401955,neutral,-2.3471074380165367,negative
2022-08-31 22:10:16.000,301.0,304.9,297.55,301.95,3207874.0,US FDA issues 11 observations each for two sites in Bengaluru: Biocon,Biocon Ltd said the US health regulator has issued Form 483s with 11 observations each for two sites in Bengaluru and six observations for a plant in Malaysia,neutral,neutral,0.3156146179401955,neutral,-2.3471074380165367,negative
2022-09-01 08:42:16.000,301.0,304.9,297.55,301.95,3207874.0,"Stocks to watch: Biocon, SpiceJet, PNB, NTPC, Ashok Leyland, Coffee Day","Stocks to watch today: Biocon received 11 observations in Form 483 for their Bengaluru and Mayalsia facilities from the USFDA; Ashok Leyland won orders from major fleets for 1,400 school buses in UAE.",neutral,positive,0.3156146179401955,neutral,-2.3471074380165367,negative
2022-09-01 09:51:40.000,301.0,304.9,297.55,301.95,3207874.0,"Biocon sheds 4%, hits 52-week low as US FDA issues form 483 for 3 sites",The US health regulator has issued Form 483s with 11 observations each for two sites in Bengaluru and six observations for a plant in Malaysia site.,neutral,neutral,0.3156146179401955,neutral,-2.3471074380165367,negative
2022-09-01 11:40:18.000,301.0,304.9,297.55,301.95,3207874.0,Biocon Biologics May See Delay In Key Launches On U.S. FDA Observations,The U.S. FDA issued 11 observations each for Biocon Biologics’ two sites in Bengaluru and six observations for the Malaysia site.,neutral,neutral,0.3156146179401955,neutral,-2.3471074380165367,negative
2022-09-06 15:02:57.000,292.7,303.2,291.7,301.8,2680106.0,Delhi HC grants bail to Eswara Reddy in Biocon bribery case,"It cannot be overlooked that the alleged recovery in the instant case is not pursuant to any usual trap proceedings, the court said",neutral,neutral,3.108985309190305,positive,-1.4604529044962222,negative
2022-09-06 17:41:34.000,292.7,303.2,291.7,301.8,2680106.0,​‘No Trial Waiver Yet; Not Flight Risk’: HC Grants Bail to Suspended Joint Drug Controller in Biocon Biologics’ Insulin Bribery Case,Reddy was arrested on June 21 after the Central Bureau of Investigation (CBI) caught him with a middleman while allegedly receiving Rs 4 lakh of the total promised bribe of Rs 9 lakh for waiving clinical trials of Biocon Biologics’ Insulin Aspart,neutral,negative,3.108985309190305,positive,-1.4604529044962222,negative
2022-09-06 20:14:42.000,292.7,303.2,291.7,301.8,2680106.0,Biocon sells 5.4% stake in its research arm Syngene International,"According to bulk deal data available with the BSE, Biocon, the promoter of Syngene International, sold a total of 21,789,164 shares, amounting to a 5.4 per cent stake, in the company.",neutral,neutral,3.108985309190305,positive,-1.4604529044962222,negative
2022-09-06 21:11:03.000,292.7,303.2,291.7,301.8,2680106.0,"Biocon divests over ₹1,220 crore stake in Syngene International in bulk deal","While the promoter offloaded a portion of its shares in Syngene, ICICI Prudential Mutual Fund, on the other hand, bought shares worth over ₹158 crore.",neutral,neutral,3.108985309190305,positive,-1.4604529044962222,negative
2022-09-06 23:38:30.000,292.7,303.2,291.7,301.8,2680106.0,"Biocon sells 5.4% stake in arm Syngene International for Rs 1,220 cr","Drugmaker Biocon divested a 5.4% stake in its research arm Syngene International for a little over Rs 1,220 crore through an open market transaction",neutral,neutral,3.108985309190305,positive,-1.4604529044962222,negative
2022-09-15 17:31:53.000,300.4,300.85,290.0,292.9,2746884.0,"Bengaluru encroachment: Kiran Shaw calls for penalty on BBMP, BDA & builders","In the wake of the devastation in Bengaluru due to floods and encroachment, the Executive Chairperson of Biocon, Kiran Mazumdar Shaw, suggested penalising builders, BBMP, and BDA. Here’s why",neutral,negative,-2.496671105193076,negative,-0.8881298035866857,neutral
2022-09-19 18:43:32.000,291.95,301.1,290.3,297.25,2477392.0,Broker’s Call: Biocon (Buy),JM Financial,neutral,neutral,1.8153793457783909,positive,-2.790384938645154,negative
2022-09-26 08:29:54.000,283.8,283.8,275.35,276.9,1345101.0,"U.S. FDA Flags Quality, Procedural Lapses At Biocon Biologics’ Facilities",The U.S. FDA issued Form 483s with 11 observations each for the two sites in Bengaluru and six for the Malaysia site.,neutral,neutral,-2.431289640591978,negative,1.081275905568571,positive
2022-09-30 17:30:00.000,286.85,292.35,285.85,290.3,1856655.0,Biocon’s subsidiary Syngene’s shares drop 12% in 2022; here’s what management and analysts have to say,Kiran Mazumdar’s contract research and manufacturing firm Syngene International has been on a roller coaster ride on Dalal Street in the ongoing calendar year.,negative,neutral,1.2027191912149169,positive,0.378071833648401,neutral
2022-10-03 06:30:00.000,290.95,296.3,286.0,292.05,1651599.0,Biocon’s growth drivers are in place: 5 reasons it is this week’s stock pick,"Improving prospects of the pharma industry, growth in the global generics market, expanded product portfolio and cost reduction initiatives will boost Biocon’s future performance.",neutral,positive,0.378071833648401,neutral,2.04778156996587,positive
2022-10-07 05:00:00.000,290.0,290.0,281.8,282.75,4794994.0,"Stocks To Watch: Dabur, Titan, Nykaa, RIL, Lupin, Yes Bank, Biocon, Quess Corp",Stocks to watch before going into trade today.,neutral,neutral,-2.5,negative,-0.6261180679785331,neutral
2022-10-07 11:16:11.000,290.0,290.0,281.8,282.75,4794994.0,Biocon declines as EDQM finds one major deficiency at API plant,Biocon declined 2.47% to Rs 284.10 after the company said that the European Directorate for the Quality of Medicines and Healthcare (EDQM) found one major ‘deficiency’ at its Bengaluru active pharmaceutical ingredient (API) plant.,neutral,negative,-2.5,negative,-0.6261180679785331,neutral
2022-10-12 11:38:05.000,269.5,269.5,262.25,267.55,4140152.0,Biocon falls 12% in 5 days on one major deficiency alert for API unit,The pharma company said it will respond to the European medical regulator with appropriate corrective and preventive actions within the stipulated time.,neutral,neutral,-0.7235621521335764,neutral,-2.197392923649898,negative
2022-10-17 11:00:00.000,261.9,265.6,258.25,264.4,2627426.0,Biocon Biologics inks out-licensing agreement with Yoshindo Inc,"​​​Under the terms of this deal, Japan-based Yoshindo gets exclusive commercialisation rights in Japan for Ustekinumab and Denosumab -- developed and manufactured by Biocon Biologics -- for an addressable market opportunity of USD 700 million, Biocon Biologics said in a statement.",positive,positive,0.9545628102329132,positive,0.7357102433503069,neutral
2022-10-17 12:16:04.000,265.05,267.6,264.45,267.0,1144456.0,Biocon Biologics out-licenses two biosimilar assets to Yoshindo,Biocon said that its subsidiary Biocon Biologics has entered into a strategic out-licensing agreement with Japanese pharmaceuticals company Yoshindo Inc. for commercializing two of its pipeline biosimilar assets in the Japanese market.,neutral,positive,0.7357102433503069,neutral,0.7281553398058209,neutral
2022-10-17 13:36:22.000,265.05,267.6,264.45,267.0,1144456.0,Biocon Biologics Inks Out-Licensing Agreement With Yoshindo Inc.,"Under the terms of this deal, Japan-based Yoshindo gets exclusive commercialisation rights in Japan for Ustekinumab and Denosumab.",neutral,positive,0.7357102433503069,neutral,0.7281553398058209,neutral
2022-10-17 14:26:35.000,265.05,267.6,264.45,267.0,1144456.0,Biocon Biologics enters licensing agreement with Yoshindo of Japan,To commercialise two of its biosimilar assets in Japan,positive,neutral,0.7357102433503069,neutral,0.7281553398058209,neutral
2022-10-19 16:26:47.000,268.2,272.8,267.35,270.2,2416090.0,Syngene International gains over 6% on September quarter earnings,"Syngene International, the research subsidiary of Biocon, has reported a 53 percent year-on-year growth in consolidated profit at Rs 102 crore in the September quarter",positive,positive,0.7457121551081283,neutral,-1.2707182320441943,negative
2022-10-20 08:30:46.000,268.2,272.8,267.35,270.2,2416090.0,"Exclusive | Biocon Bribery Business: Top Officer Asks Health Ministry to ‘Render Justice’, Revoke Suspension","In a long note explaining the role of each department and expert panel including the subject expert committee, Dr Reddy added that the final responsibility of approving or rejecting any drug is of the DCGI",neutral,neutral,0.7457121551081283,neutral,-1.2707182320441943,negative
2022-10-24 15:07:54.000,270.4,273.8,267.15,272.15,1940214.0,"John Shaw, Biocon chairperson Kiran Mazumdar Shaw’s husband, passes away","According to Biocon’s official website, John Shaw was a member of the board of directors.",neutral,neutral,0.6471893491124261,neutral,0.748175182481756,neutral
2022-10-24 15:36:47.000,270.4,273.8,267.15,272.15,1940214.0,"John Shaw, husband of Kiran Mazumdar dies",John Shaw was a foreign promoter and on the advisory Board of various Biocon Group Companies,neutral,neutral,0.6471893491124261,neutral,0.748175182481756,neutral
2022-10-24 15:47:21.000,270.4,273.8,267.15,272.15,1940214.0,"John Shaw, husband of Biocon chief Kiran Mazumdar Shaw, passes away",Shaw passed away in a hospital where he was undergoing treatment,neutral,neutral,0.6471893491124261,neutral,0.748175182481756,neutral
2022-10-24 15:50:45.000,270.4,273.8,267.15,272.15,1940214.0,"John Shaw, Husband Of Biocon Chief Kiran Mazumdar Shaw, Dies At 73",The exact reason for the death was not known.,neutral,neutral,0.6471893491124261,neutral,0.748175182481756,neutral
2022-10-24 16:54:11.000,270.4,273.8,267.15,272.15,1940214.0,"John Shaw, Biocon’s ex-VC and Kiran Mazumdar-Shaw’s husband, passes away",His cremation will be held at Wilson Gardens Crematorium on Monday.,neutral,neutral,0.6471893491124261,neutral,0.748175182481756,neutral
2022-10-24 17:14:12.000,270.4,273.8,267.15,272.15,1940214.0,Biocon founder Kiran Mazumdar-Shaw’s husband John Shaw dead,"According to the official website of Biocon, John Shaw served Biocon as the Vice Chairman and non executive director of the company.",negative,neutral,0.6471893491124261,neutral,0.748175182481756,neutral
2022-10-24 17:30:00.000,270.4,273.8,267.15,272.15,1940214.0,"John Shaw, former Biocon VC and Kiran Mazumdar-Shaw’s husband, passes away","He was a foreign promoter and member of the advisory board of several Biocon Group companies, according to the company website. Since 1999, he has served on the Board of Directors.",neutral,neutral,0.6471893491124261,neutral,0.748175182481756,neutral
2022-10-24 17:30:37.000,270.4,273.8,267.15,272.15,1940214.0,"John Shaw, Husband of Biocon Chief Kiran Mazumdar Shaw, Passes Away",John Shaw was the former vice chairman of the Bengaluru-headquartered Biocon Limited,neutral,neutral,0.6471893491124261,neutral,0.748175182481756,neutral
2022-10-24 17:57:00.000,270.4,273.8,267.15,272.15,1940214.0,"Biocon founder Kiran Mazumdar-Shaw’s husband, John Shaw, passes away","Born in 1949, Shaw served as the Vice Chairman and non-executive director of Biocon and has been on the board since 1999. He was the foreign promoter and on the advisory board of various Biocon group of companies.",neutral,neutral,0.6471893491124261,neutral,0.748175182481756,neutral
2022-10-25 09:26:33.000,270.4,273.8,267.15,272.15,1940214.0,"Stocks that will see action on October 25, 2022","Infosys, Reliance, RPower, BMW Industries, Zydus Lifesciences, Biocon, DLF, HAL, Welspun Corp, Borosil Renewables, Garden Reach, Arihant Capital, Electronics Mart,Chennai Petroleum Corporation",neutral,neutral,0.6471893491124261,neutral,0.748175182481756,neutral
2022-10-25 10:38:00.000,270.4,273.8,267.15,272.15,1940214.0,‘I will miss you profoundly.’ Biocon’s Kiran Mazumdar-Shaw pens emotional note for late husband,The former VC of Biocon passed away on Monday at the age of 73.,neutral,neutral,0.6471893491124261,neutral,0.748175182481756,neutral
2022-10-25 11:01:11.000,270.4,273.8,267.15,272.15,1940214.0,"John Shaw, husband of Biocon founder Kiran Mazumdar Shaw, dies aged 73",John Shaw had served as a foreign promoter of the company and was a member of the board of directors of Biocon since 1999,neutral,neutral,0.6471893491124261,neutral,0.748175182481756,neutral
2022-10-25 13:34:04.000,270.4,273.8,267.15,272.15,1940214.0,Devastated to lose my husband: Biocon founder Kiran Mazumdar-Shaw,Biocon founder Kiran Mazumdar-Shaw said she was devastated to lose her husband and will miss him profoundly.,neutral,negative,0.6471893491124261,neutral,0.748175182481756,neutral
2022-10-25 17:36:00.000,270.4,273.8,267.15,272.15,1940214.0,USFDA issues Complete Response Letter for Insulin Aspart application of Biocon,"Biocon Biologics remains committed to the global standards of Quality and Compliance, said Company Spokesperson.",neutral,neutral,0.6471893491124261,neutral,0.748175182481756,neutral
2022-10-25 18:04:00.000,270.4,273.8,267.15,272.15,1940214.0,Biocon Biologics’ insulins facility in Malaysia receives EU GMP certification,"Biocon Biologics remains committed to the global standards of Quality and Compliance, said Company’s Spokesperson.",neutral,neutral,0.6471893491124261,neutral,0.748175182481756,neutral
2022-10-25 19:34:17.000,270.4,273.8,267.15,272.15,1940214.0,"I am devastated, will always be guided by John: Biocon chief Kiran Majumdar","Biocon Chief Kiran Majumdar-Shaw, who lost her husband, stated that she is devastated. Sharing her thoughts on social media, she maintained that she will always be guided by her husband John Shaw",neutral,negative,0.6471893491124261,neutral,0.748175182481756,neutral
2022-11-14 05:00:00.000,281.0,287.8,278.7,286.5,2654811.0,"ONGC, Biocon, Apollo Tyres, IRCTC, SpiceJet, Bharat Forge, NMDC Q2 Results Today — Earning Estimates","Earning estimates for ONGC, Biocon, Apollo Tyres, IRCTC and others scheduled to declare their September quarter results today.",neutral,neutral,1.9572953736654803,positive,-0.7167832167832208,neutral
2022-11-14 07:08:00.000,281.0,287.8,278.7,286.5,2654811.0,"Stocks in the news: LIC, Godrej Properties, ONGC, Fortis, Bharat Dynamics and ZEEL","ONGC, Grasim, IRCTC, Bharat Forge, Biocon, Abbott India, Balkrishna Industries, NMDC, Aarti Industries, AIA Engineering, GMR Infra, Godrej Industries and Radico Khaitan are among the companies that will announce their results for September 2022 quarter today.",neutral,neutral,1.9572953736654803,positive,-0.7167832167832208,neutral
2022-11-14 17:30:00.000,286.0,286.95,278.0,283.95,4122931.0,"Q2 result previews: NMDC, IRCTC, ONGC, Grasim, Bharat Forge & Biocon","NMDC may report a 50.3 per cent YoY plunge in net profit at Rs 1,163 crore for September quarter compared with Rs 2,341 crore in the year-ago quarter, said Elara Securities",neutral,negative,-0.7167832167832208,neutral,-0.0351617440224915,neutral
2022-11-14 17:30:00.000,286.0,286.95,278.0,283.95,4122931.0,"Kiran Mazumdar-Shaw, Rohini Nilekani, Kris Gopalakrishnan jointly pledge Rs 51 crore to Science Gallery Bengaluru","Mazumdar-Shaw - Founder, Mazumdar Shaw Philanthropy and Chairperson of Biocon & Biocon Biologics; Rohini Nilekani - Chairperson of Rohini Nilekani Philanthropies and Co-founder and Director of EkStep Foundation; and Gopalakrishnan- Chairman of Axilor Ventures and co-founder of Infosys, are all also …",positive,neutral,-0.7167832167832208,neutral,-0.0351617440224915,neutral
2022-11-14 17:30:00.000,286.0,286.95,278.0,283.95,4122931.0,"Key factors that may influence Dalal Street this week, new IPO and key results to watch out for","Investors will also keep an eye on some important quarterly results including are Biocon, HUDCO, IRCTC, NBCC (India), NMDC, ONGC, SpiceJet, Grasim Industries on November 14, and Rajesh Exports on November 15",neutral,neutral,-0.7167832167832208,neutral,-0.0351617440224915,neutral
2022-11-14 22:05:37.000,286.0,286.95,278.0,283.95,4122931.0,"Biocon Q2 results: Consolidated net profit falls 66% to Rs 47 crore, revenue rises 26%",Biocon Biologics Limited saw 34 percent year-on-year increase in revenue at Rs 997 crore.,positive,positive,-0.7167832167832208,neutral,-0.0351617440224915,neutral
2022-11-14 22:13:47.000,286.0,286.95,278.0,283.95,4122931.0,"Biocon Q2 results: Net profit declines 10% to Rs 168 crore, revenue up 26%","Biocon’s core Ebitda came in at Rs 816 crore, up 34 per cent",negative,positive,-0.7167832167832208,neutral,-0.0351617440224915,neutral
2022-11-15 05:00:00.000,286.0,286.95,278.0,283.95,4122931.0,"Stocks To Watch: L&T, L&T Infotech, Mindtree, Thomas Cook (India), Biocon, Zomato",Stocks to watch before going into trade today.,neutral,neutral,-0.7167832167832208,neutral,-0.0351617440224915,neutral
2022-11-15 07:03:00.000,286.0,286.95,278.0,283.95,4122931.0,"Stocks in the news: Biocon, NMDC, Brigade Enterprises, PB Fintech, SpiceJet and NDTV","Rajesh Exports, AVG Logistics, Shahlon Silk Industries, MRC Agrotech, Lee & Nee Softwares, Milton Industries and Destiny Logistics & Infra are among the companies that will announce their results for September 2022 quarter today.",neutral,neutral,-0.7167832167832208,neutral,-0.0351617440224915,neutral
2022-11-15 07:42:28.000,286.0,286.95,278.0,283.95,4122931.0,"Stocks to Watch: Fusion Microfinance, IRCTC, Biocon, LTI, Mindtree, NDTV","Milton Industries, AVG Logistics, and Rajesh Exports will be the stocks in focus as they declare their September quarter earnings today.",neutral,neutral,-0.7167832167832208,neutral,-0.0351617440224915,neutral
2022-11-15 08:16:00.000,286.0,286.95,278.0,283.95,4122931.0,"Stocks to Watch Today: Biocon, PB Fintech, SpiceJet, NDTV, IRCTC, and Others","Stocks to watch today: Shares of firms like Biocon, PB Fintech, SpiceJet, NDTV, IRCTC, and others will be in focus in Tuesday’s trade",neutral,neutral,-0.7167832167832208,neutral,-0.0351617440224915,neutral
2022-11-15 09:33:52.000,286.0,286.95,278.0,283.95,4122931.0,"Biocon Consolidated September 2022 Net Sales at Rs 2,319.70 crore, up 26.04% Y-o-Y",,positive,neutral,-0.7167832167832208,neutral,-0.0351617440224915,neutral
2022-11-15 09:55:56.000,286.0,286.95,278.0,283.95,4122931.0,Biocon’s net profits slip 66% to ₹47 crore in Q2,Profit decrease as a result of Biocon’s recent decision to adopt a new tax system and an increase in R&D spending of 65 per cent to ₹242,positive,negative,-0.7167832167832208,neutral,-0.0351617440224915,neutral
2022-11-15 13:26:55.000,284.4,287.5,280.5,284.3,2682207.0,"Q2 Review: After Weak Q2, Can Biocon Bounce Back In Q3? | BQPrime","Q2 Review: After Weak Q2, Can Biocon Bounce Back In Q3? | BQPrime #Q2WithBQ | Biocon’s second-quarter profit falls due to a tax write-off; margins come under pressure as well. MD & CEO Siddharth Mittal shares growth strategy and plans for FY23.",neutral,negative,-0.0351617440224915,neutral,0.4929577464788652,neutral
2022-11-15 17:30:00.000,284.4,287.5,280.5,284.3,2682207.0,"Stocks in news: NMDC, Biocon, PB Fintech, SpiceJet and more","Stocks to watch out for today: NMDC, Biocon, PB Fintech, SpiceJet, NDTV, Apollo Tyres, Gammon India and more",neutral,neutral,-0.0351617440224915,neutral,0.4929577464788652,neutral
2022-11-15 22:20:25.000,284.4,287.5,280.5,284.3,2682207.0,Trying to lock in vendors who don’t want to buy from China: Biocon CEO & MD,"Siddharth Mittal, CEO & MD, Biocon, elaborates on his plans to grow this business further",neutral,neutral,-0.0351617440224915,neutral,0.4929577464788652,neutral
2022-11-16 07:49:28.000,284.4,287.5,280.5,284.3,2682207.0,Biocon Seeks To List Biocon Biologics Ltd. By December 2023,Biocon seeks to raise funds over the next one year from its stake in Biocon Biologics to de-leverage balance sheet.,neutral,positive,-0.0351617440224915,neutral,0.4929577464788652,neutral
2022-11-16 07:57:03.000,284.4,287.5,280.5,284.3,2682207.0,Biocon Q2 Results Review - Steady Performance; Focus On Viatris Integration: ICICI Direct,Decision to acquire Viatris’ front end business in the U.S. and the leverage on BS is likely to have more influence on sentiments.,neutral,neutral,-0.0351617440224915,neutral,0.4929577464788652,neutral
2022-11-16 11:04:00.000,284.4,287.5,280.5,284.3,2682207.0,Biocon Biologics secures regulatory approvals for acquisition of Viatris’ biosimilar business,"The transaction with US-based Viatris required regulatory approvals from the Reserve Bank of India, Competition Commission of India and the US Federal Trade Commission, among others.",neutral,neutral,-0.0351617440224915,neutral,0.4929577464788652,neutral
2022-11-16 12:16:15.000,284.0,286.45,282.25,285.4,1317750.0,Biocon resumes uptrend after a day’s pause; up over 9% in one month,"Biocon advanced 1.04% to Rs 286.80, after the scrip resumed its uptrend after a day’s breather.",positive,positive,0.4929577464788652,neutral,-0.1218238774799939,neutral
2022-11-17 06:37:00.000,284.0,286.45,282.25,285.4,1317750.0,Ind Ra assigns Biocon credit rating of ‘IND AA+’ with Stable outlook,"Further, the proposed commercial paper ratings assigned at IND A1+.",neutral,neutral,0.4929577464788652,neutral,-0.1218238774799939,neutral
2022-11-18 16:18:38.000,287.3,289.75,283.0,286.95,1715755.0,Buy Biocon; target of Rs 340: Sharekhan,"Sharekhan is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 340 in its research report dated November 16, 2022.",neutral,positive,-0.1218238774799939,neutral,-3.728813559322034,negative
2022-11-21 15:09:21.000,284.55,285.0,280.0,282.0,1453582.0,Buy Biocon; target of Rs 340: Sharekhan,"Sharekhan is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 340 in its research report dated November 15, 2022.",neutral,positive,-0.8961518186610476,neutral,-0.8480565371024654,neutral
2022-11-23 01:03:38.000,283.0,283.2,279.6,280.6,1407195.0,"Biocon investors await smooth integration, execution of Viatris deal","The Q2 results are not too exciting. While revenue performance was decent, profitability was weaker",positive,negative,-0.8480565371024654,neutral,-2.627374400852114,negative
2022-11-23 10:14:23.000,283.0,283.2,279.6,280.6,1407195.0,Biocon arm raises $1.2 bln debt to fund Viatris’ biosimilars buy,"According to the company’s exchange filing, Biocon Biologics Ltd. and its subsidiaries have completed a debt deal to raise $1.2 billion for the financing of the acquisition of Viatris Inc.’s biosimilars business and other acquisition-related expenses. Biocon spent 18.65 billion rupees in its subsid…",positive,positive,-0.8480565371024654,neutral,-2.627374400852114,negative
2022-11-24 05:00:00.000,281.65,284.1,274.05,274.25,2384839.0,"Stocks To Watch: Biocon, Tamilnad Mercantile Bank, SBI Cards, Neuland Labs",Stocks to watch before going into trade today.,neutral,neutral,-2.627374400852114,negative,2.2101449275362404,positive
2022-11-24 07:51:00.000,281.65,284.1,274.05,274.25,2384839.0,"Biocon issues commercial paper worth Rs2,250 crore on private placement basis",The CPs are valid for 91 days and are issued at an interest rate of 7.75% p.a.,neutral,neutral,-2.627374400852114,negative,2.2101449275362404,positive
2022-11-24 08:39:44.000,281.65,284.1,274.05,274.25,2384839.0,"Stocks to Watch Today: Keystone Realtors, ACC, Tata Power, Biocon, Adani, and Others","Stocks to watch today: Shares of firms like Keystone Realtors, ACC, Tata Power, Biocon, Adani, and others will be in focus in Thursday’s trade, Stock Market Latest News Update at news18.com",neutral,neutral,-2.627374400852114,negative,2.2101449275362404,positive
2022-11-24 15:46:47.000,276.0,282.75,275.1,282.1,1959665.0,Hold Biocon; target of Rs 290: ICICI Direct,"ICICI Direct recommended hold rating on Biocon with a target price of Rs 290 in its research report dated November 15, 2022.",neutral,positive,2.2101449275362404,positive,-0.124047492468533,neutral
2022-11-24 22:06:19.000,276.0,282.75,275.1,282.1,1959665.0,"Biocon Biologics Allots Equity Shares Worth Rs 2,205.6 Crore To Parent","New Delhi, Nov 24 (PTI) Biotechnology major Biocon on Thursday said its subsidiary Biocon Biologics has allotted equity shares worth Rs 2,205.63 crore to it as part of an equity infusion to fund the latter’s acquisition of Viatris Inc’s biosimilars business.",neutral,neutral,2.2101449275362404,positive,-0.124047492468533,neutral
2022-11-25 05:00:00.000,276.0,282.75,275.1,282.1,1959665.0,"Stocks To Watch: Indian Oil, PNB, Bharti Airtel, SBI, Biocon, Lupin",Stocks to watch before going into trade today.,neutral,neutral,2.2101449275362404,positive,-0.124047492468533,neutral
2022-11-25 07:04:28.000,276.0,282.75,275.1,282.1,1959665.0,"Buzzing Stocks | PNB, Biocon, Tube Investments, and others in news today",Stocks to Watch: Check out the companies making headlines before the opening bell.,neutral,neutral,2.2101449275362404,positive,-0.124047492468533,neutral
2022-11-25 07:43:48.000,276.0,282.75,275.1,282.1,1959665.0,"Stocks to Watch: SBI, Biocon, PNB, NDTV, PTC India, ZIM Lab","Sensex set a new high on Thursday driven by a rally in IT companies after minutes from Fed’s latest meeting suggested that the US central bank may slow the pace of interest rate hikes. The Sensex had its first close above 62,000. The broader Nifty50 index soared 1.2% higher.",neutral,positive,2.2101449275362404,positive,-0.124047492468533,neutral
2022-11-25 08:40:02.000,276.0,282.75,275.1,282.1,1959665.0,"Stocks to Watch Today: Lupin, Biocon, PNB, SBI, HDFC Bank, and Others","Stocks to watch today: Shares of firms like Lupin, Biocon, PNB, SBI, HDFC Bank, and others will be in focus in Friday’s trade, Stock Market Latest News Update at news18.com",neutral,neutral,2.2101449275362404,positive,-0.124047492468533,neutral
2022-11-25 17:30:00.000,276.0,282.75,275.1,282.1,1959665.0,"Stocks in news: Lupin, Biocon, Policybazaar, Cummins India and more","Stocks to watch out for today: Lupin, Biocon, Veranda Learning Solutions, Fino Payments Bank, PB Fintech, Hariom Pipe Industries, Cummins India, Tube Investments, PNB and more",neutral,neutral,2.2101449275362404,positive,-0.124047492468533,neutral
2022-11-29 19:24:00.000,284.9,287.0,280.5,282.8,6534578.0,Biocon completes $3.34 billion acquisition of Viatris’s biosimilar business,"To fund the upfront payment, Biocon Biologics has secured $1.2 billion of Sustainability Linked Loan (SLL). The balance has been funded through an equity infusion of $650 million by Biocon and $150 million by Serum Institute Life Sciences (SILS). Biocon Limiteds funding comprises $230 million from e…",positive,neutral,-0.7371007371007252,neutral,0.1755617977528089,neutral
2022-11-29 19:31:04.000,284.9,287.0,280.5,282.8,6534578.0,Biocon Biologics completes acquisition of Viatris’ global biosimilars business,"Biocon Biologics and Viatris have obtained all applicable approvals from key global regulators including the U.S. Federal Trade Commission, the Competition Commission of India and the Reserve Bank of India, and its investors.",positive,positive,-0.7371007371007252,neutral,0.1755617977528089,neutral
2022-11-29 20:31:00.000,284.9,287.0,280.5,282.8,6534578.0,Biocon raises $1.2 billion green loan to fund purchase of Viatris unit,"Biocon agreed to meet certain sustainability targets that helped reduce the cost of the loan. According to sources, the loan came at a cost of 175 basis points above the secured overnight financing rate or SOFR. The loan has a tenure of five years.",positive,positive,-0.7371007371007252,neutral,0.1755617977528089,neutral
2022-11-29 20:47:12.000,284.9,287.0,280.5,282.8,6534578.0,Biocon Biologics completes acquisition of Viatris for over $3 billion,"As part of completing the transaction, Biocon issued compulsorily convertible preference shares in the company for $1 billion",neutral,neutral,-0.7371007371007252,neutral,0.1755617977528089,neutral
2022-11-29 23:30:15.000,284.9,287.0,280.5,282.8,6534578.0,Biocon Biologics completes acquisition of Viatris’ global biosimilars biz,Biocon on Tuesday said its unit Biocon Biologics has completed the multi-billion dollar acquisition of the global biosimilars business of its partner Viatris Inc,positive,positive,-0.7371007371007252,neutral,0.1755617977528089,neutral
2022-11-30 05:00:00.000,284.9,287.0,280.5,282.8,6534578.0,"Stocks To Watch: NDTV, Gland Pharma, Biocon, IDFC, Inox Wind, Inox Green Energy Services",Stocks to watch before going into trade today.,neutral,neutral,-0.7371007371007252,neutral,0.1755617977528089,neutral
2022-11-30 07:13:25.000,284.9,287.0,280.5,282.8,6534578.0,"Buzzing Stocks | Biocon, Inox Green Energy, IDFC and others in news today",Stocks to Watch: Check out the companies making headlines before the opening bell.,neutral,neutral,-0.7371007371007252,neutral,0.1755617977528089,neutral
2022-11-30 07:25:00.000,284.9,287.0,280.5,282.8,6534578.0,"Stocks in the news: Wipro, Britannia, Cipla, IDFC, Biocon and Gland Pharma","BNP Paribas Arbitrage offloaded over 18,00,164 lakh shares at an average price of Rs 405 apiece of IT major Wipro for Rs 72.9 crore through an open market transaction.",neutral,neutral,-0.7371007371007252,neutral,0.1755617977528089,neutral
2022-11-30 07:37:56.000,284.9,287.0,280.5,282.8,6534578.0,"Stocks to Watch: Zomato, NDTV, ONGC, SBI, Gland Pharma, Biocon","NSE has put Bhel, Delta Corp, Punjab National Bank, and Indiabulls Housing Finance stocks on the list of banned securities under the F&O segment for Wednesday trading as they have crossed 95% of the market-wide position limit.",neutral,neutral,-0.7371007371007252,neutral,0.1755617977528089,neutral
2022-11-30 08:47:00.000,284.9,287.0,280.5,282.8,6534578.0,"‘Devastated.’ Vikram Kirloskar, the man behind Toyoto, dies at 64; Twitter pays tribute","​Kiran Mazumdar, the executive chairperson of Biocon, expressed her shock over the news and shared her grief.",neutral,negative,-0.7371007371007252,neutral,0.1755617977528089,neutral
2022-11-30 09:04:29.000,284.9,287.0,280.5,282.8,6534578.0,"Wipro, Biocon, Zomato, Gland Pharma in focus","Wipro: Wipro announced that it is an official launch partner for Amazon Security Lake from Amazon Web Service (AWS), which provides the modern enterprise with intelligent security data to solve more security use cases, increase security visibility",neutral,positive,-0.7371007371007252,neutral,0.1755617977528089,neutral
2022-11-30 09:08:25.000,284.9,287.0,280.5,282.8,6534578.0,"Stocks that will see action on November 30, 2022","Stocks to watch: Zomato, NDTV, Gland Pharma, Biocon, Bandhan Bank, IDFC, Bandhan Bank, Inox Wind, Aditya Sun Life AMC, Klipest and RattanIndia",neutral,neutral,-0.7371007371007252,neutral,0.1755617977528089,neutral
2022-11-30 12:04:06.000,284.8,286.5,283.0,285.3,1123294.0,Biocon’s biologics arm concludes multi-billion-dollar acquisition of Viatris’ biosimilars business,Biocon said that its subsidiary Biocon Biologics has successfully completed its multi-billion-dollar acquisition of the global biosimilars business of its partner Viatris Inc.,neutral,positive,0.1755617977528089,neutral,-0.8056042031523682,neutral
2022-11-30 17:30:00.000,284.8,286.5,283.0,285.3,1123294.0,"Stocks in news: Wipro, Britannia Industries, Cipla, Biocon and more","Stocks to watch out for today: Wipro, Britannia Industries, Cipla, Biocon, Gland Pharma, Kilpest India and more",neutral,neutral,0.1755617977528089,neutral,-0.8056042031523682,neutral
2022-12-01 15:31:20.000,285.5,285.55,282.0,283.2,983421.0,Biocon receives affirmation in credit ratings for bank facilities,"Total bank facilities rated - Rs 250 crore Long term rating - CRISIL AA+/ Stable (Removed from ‘Rating watch with developing implications’, rating reaffirmed) Short term rating - CRISIL A1+ (reaffirmed)",positive,positive,-0.8056042031523682,neutral,-1.7945109078113883,negative
2022-12-05 14:42:21.000,279.4,280.4,272.25,273.5,2373043.0,Shreehas Tambe elevated as MD & CEO of Biocon Biologics effective Monday,He was earlier the firm’s deputy CEO; Outgoing MD Arun Chandavarkar to remain on co Board,neutral,neutral,-2.111667859699348,negative,0.4742794600510596,neutral
2022-12-05 14:50:32.000,279.4,280.4,272.25,273.5,2373043.0,Biocon Biologics elevates Shreehas Tambe as MD and CEO,"Tambe takes over from Dr Arun Chandavarkar, who will continue to serve as a non-Executive, non-Independent Director on the Board of Biocon Biologics.",neutral,neutral,-2.111667859699348,negative,0.4742794600510596,neutral
2022-12-05 15:50:04.000,279.4,280.4,272.25,273.5,2373043.0,"Biocon Biologics appoints Shreehas Tambe as MD, CEO","Tambe will lead Biocon Biologics (BBL), a subsidiary of Biocon, in realizing its goal of being a global biosimilars leader.",neutral,positive,-2.111667859699348,negative,0.4742794600510596,neutral
2022-12-05 16:03:16.000,279.4,280.4,272.25,273.5,2373043.0,Biocon Biologics promotes Shreehas Tambe to MD and CEO,December 5,neutral,neutral,-2.111667859699348,negative,0.4742794600510596,neutral
2022-12-05 17:30:00.000,279.4,280.4,272.25,273.5,2373043.0,Shreehas Tambe appointed as MD & CEO of Biocon Biologics,"Tambe has taken over from Arun Chandavarkar, who continues to serve as a non-Executive, non-Independent Director on the Board of Biocon Biologics",neutral,neutral,-2.111667859699348,negative,0.4742794600510596,neutral
2022-12-05 19:36:00.000,279.4,280.4,272.25,273.5,2373043.0,Biocon Biologics appoints Shreehas Tambe as MD & CEO,"Tambe has been with Biocon since 1997 and has held diverse leadership and operational roles. Over the past 25 years, he has helped build and shape Biocons biosimilars business and spearheaded the Groups strategic capital investments, including its first overseas facility in Malaysia. He has also bee…",neutral,neutral,-2.111667859699348,negative,0.4742794600510596,neutral
2022-12-05 19:49:43.000,279.4,280.4,272.25,273.5,2373043.0,Shreehas Tambe is new MD & CEO of Biocon Biologics,"Shreehas Tambe, the deputy CEO of Biocon Biologics Ltd. (BBL), has been appointed as the MD and CEO",neutral,neutral,-2.111667859699348,negative,0.4742794600510596,neutral
2022-12-05 23:27:17.000,279.4,280.4,272.25,273.5,2373043.0,"Biocon Biologics elevates Shreehas Tambe as managing director, CEO",Biocon Biologics says it has elevated Shreehas Tambe as managing director and CEO of the company with immediate effect,neutral,neutral,-2.111667859699348,negative,0.4742794600510596,neutral
2022-12-06 18:10:06.000,274.1,276.65,272.75,275.4,1239336.0,Viatris deal gives Biocon Biologics entry in 100 countries: Shreehas Tambe,"In a Q&A, the recently named MD & CEO of Biocon Biologics dwells on the scope for an IPO or stake sale to PE investors to retire the debt taken to fund the acquisition",neutral,neutral,0.4742794600510596,neutral,-0.1268115942029067,neutral
2022-12-06 19:57:13.000,274.1,276.65,272.75,275.4,1239336.0,"Adani Power, Varun Beverages, ABB ripe for Nifty Next50 inclusion","Biocon, Gland Pharma, Mphasis and Bandhan Bank may move out, says note by Nuvama Alternative & Quantitative Research",neutral,neutral,0.4742794600510596,neutral,-0.1268115942029067,neutral
2022-12-09 08:30:00.000,276.2,277.35,270.6,272.5,864265.0,Podcast: Will Viatris deal inject fresh momentum into Biocon biz?,Sohini Das caught up with Biocon Biologics CEO Shreehas Tambe to know more about the deal and the company’s future plans,positive,neutral,-1.33960897900072,negative,-0.7878343715646675,neutral
2022-12-14 17:30:00.000,272.45,273.8,269.0,270.0,1784347.0,Biocon starts clinical trial of drug meant to treat Ulcerative Colitis in India,"This is a phase two randomised, double-blind study to evaluate the safety and efficacy of Itolizumab in patients with moderate to severely active UC.",neutral,neutral,-0.899247568361163,neutral,-1.849112426035503,negative
2022-12-14 19:50:04.000,272.45,273.8,269.0,270.0,1784347.0,Biocon initiates clinical study of Itolizumab for Ulcerative Colitis in India,"Having obtained approval from the Drugs Controller General of India (DCGI), the study will cover several tertiary hospitals specialized in handling UC cases. The first patient who intended to participate in the study was screened on 01 December",neutral,neutral,-0.899247568361163,neutral,-1.849112426035503,negative
2022-12-15 09:04:20.000,272.45,273.8,269.0,270.0,1784347.0,"Stocks that will see action on December 15, 2022","IRCTC, SBI, Poonawalla Fincorp, JB Pharma, Glenmark Pharma, AstraZeneca, VRL Logistics, Power Grid, PTC India, Thermax, Wipro, Tata Motors, Biocon, IDBI Bank, ZEE, NTPC, Kamat Hotels, Indian Metals & Ferro Alloys, Shriram Properties",neutral,neutral,-0.899247568361163,neutral,-1.849112426035503,negative
2022-12-15 12:01:22.000,270.4,270.4,265.0,265.4,1185988.0,Biocon starts clinical study to evaluate efficacy of Itolizumab,The study to evaluate the safety and efficacy of Itolizumab for the induction of remission in biologics naive patients with Ulcerative Colitis,neutral,neutral,-1.849112426035503,negative,-1.5329968218358443,negative
2022-12-15 16:21:00.000,270.4,270.4,265.0,265.4,1185988.0,Biocon commences clinical study of Itolizumab for Ulcerative Colitis in India,"This is a two-treatment period, phase two, randomised, double-blind, parallel-group, placebo, and active-controlled (adalimumab) study.",neutral,neutral,-1.849112426035503,negative,-1.5329968218358443,negative
2022-12-15 18:46:36.000,270.4,270.4,265.0,265.4,1185988.0,Biocon starts new clinical study to evaluate efficacy of Itolizumab,"Having obtained approval from the Drugs Controller General of India (DCGI), the study will cover several tertiary hospitals specialised in handling UC cases",neutral,positive,-1.849112426035503,negative,-1.5329968218358443,negative
2022-12-16 08:13:35.000,270.4,270.4,265.0,265.4,1185988.0,"Stocks to watch: Wipro, Vedanta, HPCL, RIL, Kalpataru Power, Biocon","Stocks to watch today: Wipro inked multi-year digital transformation partnership with fintech firm Finastra; HPCL aims to raise around Rs 10,000 crore in debt to fund oil refining operations",neutral,positive,-1.849112426035503,negative,-1.5329968218358443,negative
2022-12-22 06:49:45.000,274.0,275.4,265.05,270.65,2369827.0,"Trade Spotlight | What should you do with Glenmark Pharma, Biocon, LTIMindtree on Thursday?","Biocon shares gained 3.5 percent at Rs 271 and formed long bullish candle on the daily charts with robust volumes. Also there was Morning Star kind of pattern formation, which is generally called as a bullish reversal pattern formed in an downtrend.",neutral,positive,-1.2226277372262857,negative,-1.2145748987854292,negative
2022-12-23 05:00:00.000,271.7,277.0,266.1,268.4,6371801.0,"Stocks To Watch: Reliance Industries, Biocon, IDFC First Bank, Lupin, Yes Bank, NTPC, Granules India",Stocks to watch before going into trade today.,neutral,neutral,-1.2145748987854292,negative,-1.3015991074748978,negative
2022-12-23 08:11:36.000,271.7,277.0,266.1,268.4,6371801.0,"Mehul Kothari recommends Biocon, Aurobindo Pharma for trading gains","According to the technical analyst from Anand Rathi, Aurobindo Pharma can rally to Rs 490; while Biocon can jump to Rs 295.",positive,positive,-1.2145748987854292,negative,-1.3015991074748978,negative
2022-12-23 09:50:09.000,271.7,277.0,266.1,268.4,6371801.0,Biocon’s Bangalore-based API facility gets GMP certificate from EDQM,"The biopharmaceutical company said that following the inspection conducted in September this year, the EDQM has issued a GMP certificate to its Bangalore-based API manufacturing facility.",neutral,neutral,-1.2145748987854292,negative,-1.3015991074748978,negative
2022-12-27 16:45:42.000,265.35,267.05,263.0,263.6,1359847.0,From Paytm to Biocon: 12 Nifty100 stocks are biggest wealth destroyers in 2022,"Shares of One 97 communications, Paytm’s parent company stood at the top of the list. The stock lost 62.6% of its value in 2022",neutral,negative,-0.6595063124175616,neutral,-1.0606060606060648,negative
2022-12-28 17:02:19.000,264.0,266.85,260.2,261.2,2877930.0,Biocon Bribery Case: Health Ministry Revokes Suspension of Eswara Reddy | Exclusive,"The order document accessed by News18 stated: “To prevent tampering of the witness..., the drug controller general may be requested to post Shri Eswara Reddy to a non-sensitive position...”",neutral,neutral,-1.0606060606060648,negative,0.1720841300191161,neutral
2023-01-04 17:30:00.000,262.0,262.15,259.45,260.35,1259332.0,M&A activity with an India angle hit a record $171 billion in 2022,"Domestic M&A activity saw record levels of activity in 2022 at $119.2 billion, up 156.3 per cent from 2021, as per report by Refinitiv; companies like HDFC Bank, HDFC, Ambuja Cements, ACC, Adani Group Biocon, Mindtree, L&T Infotech, AM/NS, Essar Ports were involved in M&A deals in 2022",positive,positive,-0.6297709923664035,neutral,-1.7638036809816036,negative
2023-01-05 08:00:11.000,262.0,262.15,259.45,260.35,1259332.0,"Biocon Bribery Case: Suspension Revoked, Eswara Reddy to Train Officers at Modi Govt-run Institute",The health ministry said the idea is to place Reddy at a “non-sensitive position” to prevent witness tampering in the case,neutral,neutral,-0.6297709923664035,neutral,-1.7638036809816036,negative
2023-01-09 09:07:23.000,257.5,259.0,255.1,257.0,1330674.0,"Stocks that will see action on January 09, 2023","TCS, Paytm, Asian Paints, HCL Technologies, Hi-Tech Pipes, Gland Pharma, Bharat Wire Ropes, Ashoka Buildcon, R&B Denims, NR Agarwal, Keystone Realtors, Aditya Birla Fashions, Girnar Spintex Industries, Biocon, Gensol Engineering",neutral,neutral,-0.1941747572815534,neutral,0.3696498054474664,neutral
2023-01-19 12:49:00.000,249.15,250.4,244.45,245.1,1223115.0,All diseases are cellular diseases: Dr Siddhartha Mukherjee,"Renowned oncologist, cancer researcher and Pulitzer Prize-winning author Dr Siddhartha Mukherjees latest book The Song of The Cell: An Exploration of Medicine and the New Human was unveiled by Kiran Mazumdar-Shaw, Executive Chairperson, Biocon and Biocon Biologics Ltd, at an event at the Museum of A…",neutral,neutral,-1.625526791089709,negative,1.1011419249592238,positive
2023-01-23 23:43:05.000,249.75,250.4,245.5,245.8,852859.0,"Bank of Baroda, CG Power may get added to MSCI global standard index",Biocon is expected to get excluded from the index,positive,neutral,-1.581581581581577,negative,-4.1471843870705385,negative
2023-01-26 17:30:00.000,237.0,240.0,232.65,235.95,6725034.0,"Sudha Murthy awarded with Padma Bhushan, Biocon chief Kiran Mazumdar-Shaw calls her an ‘inspiration’","The Padma Awards are one of the highest civilian honours of India announced annually on the eve of Republic Day. The Awards are given in three categories: Padma Vibhushan, Padma Bhushan, and Padma Shri.",positive,neutral,-0.4430379746835491,neutral,-0.5520169851380091,neutral
2023-02-01 09:00:24.000,237.0,243.95,236.35,239.2,3806125.0,"Stocks that will see action on February 1, 2023","Buzzing stocks: Automobile companies Reliance Industries, Tata Motors, Biocon, Syngene International, VOdafone Idea, Ajanta Pharma, Alembic Pharma, Ashok Leyland, Britannia, Gillette, Hindustan Copper, IDFC, Jubilant Foodworks, Kaya, LMW, Mahindra Logistics, Ramco Systems, Raymond, Redington, RPG L…",neutral,neutral,0.928270042194088,positive,0.3773584905660401,neutral
2023-02-01 09:39:22.000,237.0,243.95,236.35,239.2,3806125.0,"Syngene International sees 4 crore shares sold in block deal, Biocon likely seller","As of December end, Biocon held 64.5 percent promoter stake in Syngene International. After the block deal, this will go down to 54.5 percent.",neutral,neutral,0.928270042194088,positive,0.3773584905660401,neutral
2023-02-01 19:33:39.000,238.5,241.7,236.8,239.4,1590591.0,Biocon sells 9.96% stake in contract research firm Syngene via open market,"Bengaluru-based Biocon had in September 2022 sold a 5.4% stake in the open market, as per an exchange filing",neutral,neutral,0.3773584905660401,neutral,-2.7714107105646915,negative
2023-02-08 19:31:13.000,241.65,244.95,240.95,243.1,1736188.0,Biocon receives credit ratings from India Ratings and Research,Long term issuer rating - IND AA+/ Stable (affirmed)Proposed non convertible debentures - IND AA+/ Stable (assigned) Term loans external commercial borrowings - IND AA+/ Stable (affirmed) Proposed term loans - IND AA+/ Stable (affirmed),neutral,neutral,0.6000413821642825,neutral,0.1237623762376167,neutral
2023-02-09 06:36:00.000,241.65,244.95,240.95,243.1,1736188.0,"BoB, CG Power likely to enter MSCI India Index","The inclusions are expected to result in inflows of $148 million in Bank of Baroda and $150 million in CG Power, while the exclusion of Biocon could lead to an outflow of $66 million, said the brokerage.",neutral,positive,0.6000413821642825,neutral,0.1237623762376167,neutral
2023-02-10 09:48:28.000,242.4,244.5,239.55,242.7,2890688.0,Adani Group stocks tumble after MSCI cuts free float,"MSCI has also announced that Bank of Baroda and CG Power & Industrial Solutions have been added to the MSCI India index, while Biocon has been removed from the index.",negative,neutral,0.1237623762376167,neutral,-2.222679563696224,negative
2023-02-10 10:03:00.000,242.4,244.5,239.55,242.7,2890688.0,"PSU bank stock to enter MSCI India Global Standard Index, Biocon out","Bank of Baroda shares were up 1.5% in the morning hours on Friday following the announcement. CG Power, on the other hand, could witness an inflow of $89 million as a result of the inclusion. “The stock has gained 27% since November 2022 and 90% in the last 8 months. It made a new 52-week high this …",neutral,positive,0.1237623762376167,neutral,-2.222679563696224,negative
2023-02-10 18:19:44.000,242.4,244.5,239.55,242.7,2890688.0,"Stocks In Focus: Biocon, CG Power and Industrials, LIC & More","Stocks In Focus: Biocon, CG Power and Industrials, LIC & More While Biocon was excluded from the MSCI India index, CG Power was included. LIC jumps in trade after Q3 net profit zooms. Fundamental expert Sharmila Joshi shares her insights on stocks you can bet on.",neutral,neutral,0.1237623762376167,neutral,-2.222679563696224,negative
2023-02-12 20:01:00.000,242.95,244.85,237.05,237.55,1673784.0,USFDA issues CRL for Bevacizumab license application moved by Viatris: Biocon,"“The USFDA has issued a CRL for the Biologics License Application (BLA) for Bevacizumab filed by our partner Viatris (Mylan),” a company spokesperson said in a regulatory filing.",neutral,positive,-2.222679563696224,negative,-1.6162888329135157,negative
2023-02-13 08:50:10.000,242.95,244.85,237.05,237.55,1673784.0,Biocon says USFDA issues CRL for biologics license application for Bevacizumab,The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) for Bevacizumab filed by partner Viatris (Mylan).,neutral,neutral,-2.222679563696224,negative,-1.6162888329135157,negative
2023-02-14 05:00:00.000,238.2,238.65,233.65,234.35,3844723.0,"Adani Enterprises, Apollo Hospitals, Eicher Motors, Biocon Q3 Results Today — Earnings Estimates","Adani Enterprises, Apollo Hospitals, Eicher Motors, and Biocon will announce their quarterly results today.",neutral,neutral,-1.6162888329135157,negative,1.8399657680787385,positive
2023-02-14 07:02:24.000,238.2,238.65,233.65,234.35,3844723.0,"Stocks to Watch: Adani Group, Nykaa, Kotak Bank, SAIL, Zee Ent, IRB Infra","Adani Enterprises, Apollo Hospitals, Bharat Forge, Biocon, Eicher Motors, and Vodafone Idea will be among the stocks in focus as they declare their December quarter earnings today.",neutral,neutral,-1.6162888329135157,negative,1.8399657680787385,positive
2023-02-14 19:51:53.000,233.7,239.45,230.6,238.0,5770004.0,Biocon Q3 consolidated net loss at Rs 21 crore,"Total income increased to Rs 3,020 crore in the period under review as against Rs 2,222 crore in the year-ago period",negative,positive,1.8399657680787385,positive,1.6115529510255313,positive
2023-02-14 21:11:01.000,233.7,239.45,230.6,238.0,5770004.0,"Biocon posts net loss of ₹42 cr, even as net revenue grows 36% in Q3",Revenue grew on the back of robust performances across all three of its businesses,negative,positive,1.8399657680787385,positive,1.6115529510255313,positive
2023-02-14 21:35:30.000,233.7,239.45,230.6,238.0,5770004.0,Viatris deal-related expenses drag Biocon’s Q3 net into Rs 42 cr loss,"Biocon Q3 Results: This, even as revenues rise 36% and Ebitda is up 35%",neutral,positive,1.8399657680787385,positive,1.6115529510255313,positive
2023-02-14 22:01:51.000,233.7,239.45,230.6,238.0,5770004.0,"Biocon Q3 net profit falls 25%, revenue jumps 36%","We expect to end FY23 on a strong note with healthy growth across businesses. Biocon Biologics is tracking towards exiting the year at a $1 billion trajectory, excluding vaccines, says Kiran Mazumdar-Shaw",positive,positive,1.8399657680787385,positive,1.6115529510255313,positive
2023-02-15 07:28:54.000,233.7,239.45,230.6,238.0,5770004.0,"Stocks to Watch: Adani Group, ONGC, Biocon, Kotak Bank, Grasim, Paytm",Vesuvius India and JB Industries will be among the stocks in focus as they declare their December quarter earnings today.,neutral,neutral,1.8399657680787385,positive,1.6115529510255313,positive
2023-02-15 08:26:04.000,233.7,239.45,230.6,238.0,5770004.0,"Stocks to Watch: Voda Idea, Biocon, ONGC, Eicher Motors, Siemens, Bharat Forge, and Others","Stocks to watch: Shares of firms like Voda Idea, Biocon, ONGC, Eicher Motors, Siemens, Bharat Forge, and others will be in focus in Wednesday’s trade.",neutral,neutral,1.8399657680787385,positive,1.6115529510255313,positive
2023-02-15 17:30:00.000,238.9,245.5,237.2,242.75,4457747.0,"Stocks in news: Vodafone Idea, Biocon, NMDC, Torrent Power and more","Stocks to watch out for today: Vodafone Idea, Biocon, Grasim Industries, NMDC, Torrent Power and more",neutral,neutral,1.6115529510255313,positive,-4.285125669550877,negative
2023-02-15 21:03:35.000,238.9,245.5,237.2,242.75,4457747.0,Have to keep R&D spends at 12% of revenue: Biocon’s Kiran Mazumdar-Shaw,"Indian pharma R&D: It’s a high growth phase for us in Biocon Biologics: We crossed the Rs 1,500-crore mark in revenue for the first time this quarter. We will exit this year (FY23) at Rs 2,000-crore level",neutral,positive,1.6115529510255313,positive,-4.285125669550877,negative
2023-02-16 00:47:00.000,238.9,245.5,237.2,242.75,4457747.0,"Biocon Biologics has comprehensive plan to integrate Viatris business: Shreehas Tambe, Biocon Biologics","“There are several other discussions that we have been having with private equity investors who are interested in making an investment in Biocon Biologics and that will help us bring down the $1.2 billion debt ... help us reduce the interest component that we see in the P&L,” Shreehas Tambe, chief e…",positive,neutral,1.6115529510255313,positive,-4.285125669550877,negative
2023-02-16 11:44:15.000,238.9,245.5,237.2,242.75,4457747.0,Biocon reports a consolidated net loss of Rs 42 crore in Q3. Here’s what analysts say,"A one-time loss of Rs 271 crore during the quarter, mainly owing to professional fees paid for the acquisition of the global biosimilars business of American company Viatris, triggered the loss",neutral,negative,1.6115529510255313,positive,-4.285125669550877,negative
2023-02-19 12:33:02.000,232.5,233.7,226.5,227.35,5274694.0,"Biocon recalls 3,665 bottles of antifungal drug in U.S. for failed degradation specifications",The lot has been manufactured by Biocon Pharma and distributed in the U.S. by Iselin-based Biocon Pharma Inc.,negative,neutral,-2.2150537634408627,negative,-0.2631578947368396,neutral
2023-02-19 18:24:48.000,232.5,233.7,226.5,227.35,5274694.0,Trade setup for today: Top 15 things to know before the opening bell,"Based on the OI percentage, 98 stocks, including AU Small Finance Bank, L&T Technology Services, Biocon, LIC Housing Finance, and Metropolis Healthcare, saw a short build-up.",neutral,positive,-2.2150537634408627,negative,-0.2631578947368396,neutral
2023-02-21 16:38:43.000,227.3,228.0,221.45,222.05,2499861.0,Pharma sector gets first tranche of payment under under PLI scheme,"Dr Reddy’s Laboratories Limited, Biocon Limited, Strides Pharma Science Limited and Premier Medical Corporation Private Limited have been granted the incentives in the first phase",neutral,neutral,-2.309722833260009,negative,-1.2981199641897967,negative
2023-02-22 05:00:00.000,227.3,228.0,221.45,222.05,2499861.0,"Stocks To Watch: LIC Housing Finance, Mahindra & Mahindra, Biocon, Mahindra CIE Automotive",Stocks to watch before going into trade today.,neutral,neutral,-2.309722833260009,negative,-1.2981199641897967,negative
2023-02-22 07:16:35.000,227.3,228.0,221.45,222.05,2499861.0,"Buzzing Stocks: Bharat Electronics, LIC Housing Finance, Biocon and others in news today",Stocks to Watch: Check out the companies making headlines before the opening bell today.,neutral,neutral,-2.309722833260009,negative,-1.2981199641897967,negative
2023-02-22 09:07:12.000,227.3,228.0,221.45,222.05,2499861.0,"BEL, Biocon, Aurionpro Solutions, Bajaj Steel in focus","Bharat Electronics Ltd (BEL): BEL has signed an MoU with Aeronautical Development Agency (ADA), DRDO, for the Advanced Medium Combat Aircraft (AMCA) programme.",neutral,positive,-2.309722833260009,negative,-1.2981199641897967,negative
2023-02-22 10:04:48.000,227.3,228.0,221.45,222.05,2499861.0,Biocon raises 107 cr via NCDs,Biocon announced that the company has issued and allotted non-convertible debentures (NCDs) aggregating to Rs 107 crore on private placement basis in three series.,neutral,neutral,-2.309722833260009,negative,-1.2981199641897967,negative
2023-02-22 10:51:00.000,227.3,228.0,221.45,222.05,2499861.0,"Biocon raises 1,070 cr via NCDs","Biocon announced that the company has issued and allotted non-convertible debentures (NCDs) aggregating to Rs 1,070 crore on private placement basis in three series.",neutral,neutral,-2.309722833260009,negative,-1.2981199641897967,negative
2023-02-22 16:32:29.000,223.4,223.95,219.0,220.5,4151484.0,"Kotak Special Situations Fund invests ₹1,070 crore in Biocon","Mumbai, Feb 22 MUMBAI - Kotak Special Situations Fund, managed by Kotak Investment Advisors, has inv",neutral,neutral,-1.2981199641897967,negative,2.5815217391304297,positive
2023-02-22 17:30:00.000,223.4,223.95,219.0,220.5,4151484.0,"Stocks in news: SBI, Biocon, Zensar Tech, IRCTC, Hindustan Zinc and more","Stocks to watch out for today: Biocon, Zensar Technologies, Sapphire Foods, BEL, Hindustan Zinc, LIC Housing Finance and more",neutral,neutral,-1.2981199641897967,negative,2.5815217391304297,positive
2023-02-22 17:49:00.000,223.4,223.95,219.0,220.5,4151484.0,Biocon raises $129 million from Kotak to fund biosimilars deal,India’s Kotak Mahindra Group asset management arm said on Wednesday it will invest 10.70 billion rupees ($129 million) in Biocon Ltd to help it fund its acquisition of Viatris Inc’s biosimilars business. Biocon Biologics completed the $3.34-billion acquisition of U.S.-based Viatris’s biosimilars bus…,positive,positive,-1.2981199641897967,negative,2.5815217391304297,positive
2023-02-23 07:02:41.000,223.4,223.95,219.0,220.5,4151484.0,"Stocks To Watch: Biocon, Tata Steel, Orient Cement, Mahindra CIE, Sanofi India, Wipro",Stocks to watch before going into trade today.,neutral,neutral,-1.2981199641897967,negative,2.5815217391304297,positive
2023-02-23 07:21:54.000,223.4,223.95,219.0,220.5,4151484.0,"Stocks to Watch: Adani Group, Orient Cement, Delhivery, Biocon, Zee, HG Infra","Sanofi India, KSB, and Mideast Integrated Steels will be among the stocks in focus as they will declare their December quarter earnings today.",neutral,neutral,-1.2981199641897967,negative,2.5815217391304297,positive
2023-02-23 07:27:32.000,223.4,223.95,219.0,220.5,4151484.0,"Buzzing Stocks: Mahindra CIE, Biocon, Barbeque Nation, and others in news today",Stocks to Watch: Check out the companies making headlines before the opening bell today.,neutral,neutral,-1.2981199641897967,negative,2.5815217391304297,positive
2023-02-23 09:04:14.000,223.4,223.95,219.0,220.5,4151484.0,"Hero MotoCorp, Wipro, Biocon to be watched","Hero MotoCorp: VIDA, Powered by Hero, the mobility brand of Hero MotoCorp has initiated operations of its public charging infrastructure in Bengaluru, Delhi and Jaipur. The brand has set up nearly 300 charging points at 50 locations across the",neutral,neutral,-1.2981199641897967,negative,2.5815217391304297,positive
2023-02-23 12:04:08.000,220.8,228.1,217.35,226.5,4739864.0,"Biocon redeems commercial papers worth Rs 2,250 crore","Biocon said that the company has fulfilled its payment obligation and has fully redeemed the Commercial Papers (CPs) of Rs 2,250 crore.",neutral,positive,2.5815217391304297,positive,1.6349977905435211,positive
2023-02-23 14:16:34.000,220.8,228.1,217.35,226.5,4739864.0,Biocon Ltd drops for fifth straight session,"Biocon Ltd is quoting at Rs 219.75, down 1.12% on the day as on 13:19 IST on the NSE. The stock tumbled 41.27% in last one year as compared to a 8.17% rally in NIFTY and a 4.33% fall in the Nifty Metal index.",neutral,negative,2.5815217391304297,positive,1.6349977905435211,positive
2023-02-23 17:30:00.000,220.8,228.1,217.35,226.5,4739864.0,"Stocks in news: Gujarat Gas, Lemon Tree, Hero MotoCorp, Biocon, HG Infra and more","Stocks to watch out for today: Gujarat Gas, Lemon Tree, Hero MotoCorp, Biocon, Barbeque-Nation Hospitality, HG Infra and more",neutral,neutral,2.5815217391304297,positive,1.6349977905435211,positive
2023-02-27 13:28:45.000,225.0,232.05,223.3,229.5,51559008.0,Buy Biocon; target of Rs 266: Sharekhan,"Sharekhan is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 266 in its research report dated February 21, 2023.",neutral,positive,2.0,positive,-1.364818024263434,negative
2023-02-28 11:16:12.000,225.0,232.05,223.3,229.5,51559008.0,Volumes jump at Biocon Ltd counter,"Biocon Ltd saw volume of 25.52 lakh shares by 10:46 IST on BSE, a 10.5 fold spurt over two-week average daily volume of 2.43 lakh shares",neutral,positive,2.0,positive,-1.364818024263434,negative
2023-02-28 22:06:19.000,230.8,232.7,226.85,227.65,3559054.0,Integrated Core Strategies (Asia) buys Biocon shares worth Rs 185 crore,Integrated Core Strategies (Asia) Pte on Tuesday bought shares of biopharmaceutical company Biocon for Rs 185 crore through an open market transaction.,positive,neutral,-1.364818024263434,negative,-0.9329187027987536,negative
2023-03-01 09:19:33.000,230.8,232.7,226.85,227.65,3559054.0,"Stocks that will see action on March 1, 2023","Adani Enterprises, Reliance Ind, Tata Power, automible companies’s shares, NTPC, Tech Mahindra, Biocon, Powergrid, Zydus Life, Bharat Electronics, Samvardhana Motherson International, Seamec, Vodafone Idea",neutral,neutral,-1.364818024263434,negative,-0.9329187027987536,negative
2023-03-08 17:30:00.000,223.5,226.3,223.3,224.3,3932689.0,"Nykaa, Westlife Foodworld, Biocon: Should you invest in stocks of these 7 women-led companies","From Nykaa’s Falguni Nayar to Biocon’s Kiran Mazumdar-Shaw, a brigade of companies today are being helmed by a group of powerful Indian women.",neutral,neutral,0.3579418344519066,neutral,0.1118067978533094,neutral
2023-03-17 08:10:00.000,223.0,223.4,200.0,207.95,43599658.0,"Flipkart gets Rs 1,700 crore relief from the Bengaluru bench of tax tribunal",​​The ITAT followed a ruling by the Karnataka High Court with regard to a similar case involving pharmaceutical company Biocon as well as ruling in a case involving Novo Nordisk.,positive,positive,-6.748878923766821,negative,-2.281553398058247,negative
2023-03-20 05:00:00.000,206.0,209.95,198.8,201.3,12758863.0,"Stocks To Watch: Tata Consumer, Patanjali Foods, NTPC, Biocon, HDFC, Rail Vikas Nigam",These are the stocks you should watch out for during trade today.,neutral,neutral,-2.281553398058247,negative,-1.1051080550098231,negative
2023-03-21 17:30:00.000,201.15,204.2,200.0,203.8,4964254.0,"Sensex, Nifty open higher; UTI AMC rises 8%; Biocon drops 5%","BSE Sensex was trading 218.57 points, or 0.38 per cent, higher at 57,847.52, whereas NSE’s Nifty50 gained 64.05 points, or 0.38 per cent, to 17,052.45 at 9.25 am.",positive,positive,1.317424807357696,positive,1.6691212567501257,positive
2023-03-31 08:44:00.000,202.6,208.2,202.3,206.0,3873209.0,"Statkraft, first MNC to buy bankrupt Indian power firm","Oslo-headquartered Statkraft was pitted against Biocon-backed Ampyr Energy, ReNew Power, an arm of state-owned NTPC and European renewable energy major Statec, that had also submitted expressions of interest to acquire the Lanco unit.",neutral,neutral,1.678183613030605,positive,-0.0478240076518385,neutral
2023-04-21 11:34:50.000,229.5,230.95,227.2,228.6,2451340.0,"Bernstein Research removes IEX short, adds RIL, Biocon, M&M to portfolio","Bernstein Research has added Reliance Industries Ltd, Biocon Ltd, and Mahindra and Mahindra Ltd to its portfolio and has eliminated its cash allocation and covered its short positions from IEX as it expects a market rebound in 2QCY23.",neutral,negative,-0.3921568627451005,neutral,-1.5730828053310004,negative
2023-04-25 09:53:00.000,230.7,233.9,226.1,230.1,8724177.0,Serum to double investment in Biocon’s unit to $300 mn; aim to generate higher EBITDA going ahead: Kiran Mazumdar-Shaw,"The Serum Institute of Life Sciences will double its investment in one of Biocon Ltd’s units, giving it access to 100 million doses of vaccines annually along with the distribution rights to Serum’s vaccine portfolio, the Indian biopharma firm said on Tuesday. “Serum will not have an operational inv…",positive,positive,-0.2600780234070196,neutral,-0.6688241639697999,neutral
2023-04-25 09:55:00.000,230.7,233.9,226.1,230.1,8724177.0,India’s Serum to double investment in Biocon’s unit to $300 mln,"Serum Institute of Life Sciences is a unit of Serum Institute of India, the world’s biggest vaccine maker. Under new terms of the alliance, it would pump in $150 million after converting a loan to Biocon Pharma Ltd into equity in Biocon Biologics Ltd, the company said.",positive,neutral,-0.2600780234070196,neutral,-0.6688241639697999,neutral
2023-04-25 10:40:00.000,230.7,233.9,226.1,230.1,8724177.0,Serum Life Sciences to double investments in Biocon Biologics to $300 million under new arrangement,"Under the fresh terms of their strategic alliance, Serum Life Sciences will make an additional equity investment of $150 million through the conversion of the $150 million loan provided to Biocon Pharma, a wholly-owned subsidiary of Biocon, into equity in BBL.",positive,neutral,-0.2600780234070196,neutral,-0.6688241639697999,neutral
2023-04-25 10:48:00.000,230.7,233.9,226.1,230.1,8724177.0,"Looking at additional fundraisers to further reduce acquisition debt: Kiran Mazumdar Shaw, Biocon","No, there was no understanding to have operational involvement, but we had offered a board seat and that will remain and it is for Serum to exercise that offer.",neutral,neutral,-0.2600780234070196,neutral,-0.6688241639697999,neutral
2023-04-25 12:23:54.000,231.75,234.15,229.6,230.2,3580382.0,Serum Institute to double its investment in Biocon’s unit to $300 million,SILS equity investment in Biocon: SILS will now make an additional equity investment of $150 million through the conversion of an earlier loan provided to Biocon Pharma into equity in BBL,positive,positive,-0.6688241639697999,neutral,0.6709956709956759,neutral
2023-04-25 15:15:11.000,231.75,234.15,229.6,230.2,3580382.0,Serum Life Sciences to pump in additional $150 million in Biocon Biologics,"Serum Institute of Life Sciences will invest an additional $150 million in Biocon Biologics as the partners decided to restructure the deal which was inked in 2021, Biocon said on Tuesday.",neutral,positive,-0.6688241639697999,neutral,0.6709956709956759,neutral
2023-04-25 16:12:38.000,231.75,234.15,229.6,230.2,3580382.0,Serum Institute to pump in additional $150 mn in Biocon Biologics,"Serum Institute of Life Sciences will invest an additional USD 150 million in Biocon Biologics as the partners decided to restructure the deal which was inked in 2021, Biocon said on Tuesday.",neutral,positive,-0.6688241639697999,neutral,0.6709956709956759,neutral
2023-04-25 17:30:00.000,231.75,234.15,229.6,230.2,3580382.0,Serum Institute to double its investment in Biocon unit to $300 million,Serum Institute Life Sciences will now double its investment in Biocon Biologics from $150 million that was announced earlier in 2021 to $300 million.,positive,positive,-0.6688241639697999,neutral,0.6709956709956759,neutral
2023-04-25 17:40:34.000,231.75,234.15,229.6,230.2,3580382.0,Serum Institute of India doubles Biocon investment to $300 million,"Serum Institute, Biocon: The earlier investment by SILS in BBL was at a valuation of $4.9 billion, and the fresh $150-million investment pushes it up at $6 billion",positive,positive,-0.6688241639697999,neutral,0.6709956709956759,neutral
2023-04-25 19:14:36.000,231.75,234.15,229.6,230.2,3580382.0,Biocon and Serum Institute recast agreement involving biological products,iocon Biologics and Serum Institute of India have recast an agreement they inked 18 months ago involving vaccines and other biological products.,positive,positive,-0.6688241639697999,neutral,0.6709956709956759,neutral
2023-04-25 20:27:00.000,231.75,234.15,229.6,230.2,3580382.0,Serum Institute to double investment in Biocon Biologics to $300 million,"Serum Institute of Life Sciences (SILS) has converted a $150 million loan into equity, increasing its investment in Biocon Biologics. This latest investment adds to the $150 million SILS invested in the firm in November 2022, taking its total equity investment in BBL to $300m.",positive,positive,-0.6688241639697999,neutral,0.6709956709956759,neutral
2023-04-25 21:37:50.000,231.75,234.15,229.6,230.2,3580382.0,Vaccine maker Serum Institute arm to invest $150 mn more in Biocon subsidiary,"Biocon subsidiary Biocon Biologics Limited (BBL) and Serum Institute of Life Sciences (SILS), which is a subsidiary of vaccine maker Serum Institute of India, have reached an agreement to withdraw from the original equity structure contemplated under their September 2021 strategic alliance.",neutral,neutral,-0.6688241639697999,neutral,0.6709956709956759,neutral
2023-04-28 17:30:00.000,233.8,234.0,229.4,232.0,3846467.0,Biocon Biologics facility receives EU GMP certification for Bevacizumab,"Biocon Biologics’ facility has received a certificate of GMP compliance for Bevacizumab from the representative European inspection authority -- Health Products Regulatory Authority (HPRA), Ireland.",neutral,neutral,-0.7698887938408945,neutral,2.1585808933532857,positive
2023-04-28 18:20:05.000,233.8,234.0,229.4,232.0,3846467.0,Biocon Biologics facility gets EU GMP certification for Bevacizumab,Biotechnology major Biocon on Friday said the Bengaluru-based plant of Biocon Biologics has received EU GMP approval for a biosimilar product.,neutral,positive,-0.7698887938408945,neutral,2.1585808933532857,positive
2023-05-02 08:57:38.000,233.95,239.9,232.55,239.0,5089874.0,"Stocks to watch on May 2, 2023","Buzzing stocks of Tata Steel, Central Bank, Spandana Sphoorty, Brookfield REIT, IDBI Bank, Patanjali Foods, Gujarat Containers, Prince Pipes, Angel One, Varun Beverages, Ambuja Cements, Fino Payments Bank, Cigniti, Axis Bank, Blue Star, Biocon",neutral,neutral,2.1585808933532857,positive,-0.376018383120955,neutral
2023-05-10 09:03:46.000,247.7,249.2,243.85,246.35,2313064.0,"Stocks to watch today — May 10, 2023","Buzzing stocks L&T, Dr Reddy’s Lab, Vedanta, Biocon, JP Associates, PTC India, Indiabulls Real Estate, HPCL, Kesar India, Pricol, BASF, Bosch, Escorts, Venky’s India, SRF, Greaves Cotton, Raymond",neutral,neutral,-0.5450141299959607,neutral,-0.4647403515861698,neutral
2023-05-18 12:34:00.000,245.0,246.65,240.55,241.4,2385288.0,"‘Loss to Indian industrial diaspora.’ Biocon boss, Akhilesh Yadav, Maha minister mourn SP Hinduja, billionaire patriarch of Britain’s richest family",India’s business and political class mourned the loss of Srichand Parmanand Hinduja.,neutral,negative,-1.4693877551020385,negative,-0.4554865424430618,neutral
2023-05-23 07:14:12.000,240.5,244.4,240.05,242.9,2127906.0,"NMDC, Biocon, Dixon, Amara Raja Batteries, JSW Energy Q4 Results Today: Here’s What To Expect",Here are the estimates for corporate earnings by major companies scheduled to be announced today:,neutral,neutral,0.9979209979210002,positive,-6.576923076923075,negative
2023-05-23 07:16:12.000,240.5,244.4,240.05,242.9,2127906.0,"Stocks To Watch: Ashok Leyland, Vedanta, Biocon, NMDC, BPCL, Max Healthcare, ITI, JSW Energy",Here are the stocks to watch out for before going to trade today.,neutral,neutral,0.9979209979210002,positive,-6.576923076923075,negative
2023-05-23 07:27:00.000,240.5,244.4,240.05,242.9,2127906.0,"Stocks in news: BPCL, Gland Pharma, PB Fintech, Ashok Leyland, Biocon","Refining major BPCL Ltd posted 168% growth in its consolidated net profit at Rs 6,780 crore for the three months ended March. Revenue from operations during the reporting quarter rose 8% to Rs 1.33 lakh crore.",neutral,positive,0.9979209979210002,positive,-6.576923076923075,negative
2023-05-23 08:11:53.000,240.5,244.4,240.05,242.9,2127906.0,"Stocks to Watch today |Business Standard | May 23, 2023: PolicyBazaar, BPCL, Vedanta, NMDC, JSW Steel","Stocks to Watch today |Business Standard | May 23, 2023: Amara Raja Batteries, Ashok Leyland, Biocon and NMDC among prominent companies to announce Q4 results on Tuesday",neutral,neutral,0.9979209979210002,positive,-6.576923076923075,negative
2023-05-23 20:54:48.000,260.0,260.6,242.5,242.9,17537490.0,"Biocon Q4 Results: Profit Rises, Beats Estimates","Biocon’s Q4 net profit rose 31% year-on-year to Rs 313 crore, while revenue was up 57% at Rs 3,773 crore.",neutral,positive,-6.576923076923075,negative,-1.4171287738755345,negative
2023-05-23 21:16:14.000,260.0,260.6,242.5,242.9,17537490.0,Biocon Q4 net profit rises 31% to Rs 313 crore; declares dividend,"Revenue from operations climbed by 56.7 percent to Rs 3,773.9 crore in the quarter under review, as against Rs 2,409 crore last fiscal.",positive,positive,-6.576923076923075,negative,-1.4171287738755345,negative
2023-05-23 21:37:12.000,260.0,260.6,242.5,242.9,17537490.0,"Biocon Q4 results: Net profit rises 31% to Rs 313 cr, revenue up 57%","For the entire financial year, the company’s net profit saw a decline of 29 per cent to Rs 462.7 crore, as compared to Rs 648.4 crore in 2021-22",positive,negative,-6.576923076923075,negative,-1.4171287738755345,negative
2023-05-24 05:30:00.000,260.0,260.6,242.5,242.9,17537490.0,"Biocon Surges 8% As Net Profit, Revenue Exceed Estimates, EBITDA Jumps 75%","Biocon Surges 8% As Net Profit, Revenue Exceed Estimates, EBITDA Jumps 75%",neutral,neutral,-6.576923076923075,negative,-1.4171287738755345,negative
2023-05-24 06:57:11.000,260.0,260.6,242.5,242.9,17537490.0,"Stocks To Watch: Wipro, Infosys, Adani Green, Ashok Leyland, Biocon, Bajaj Electricals, NMDC, IPCA Labs | The Financial Express",Buzzing stocks: The SGX Nifty hinted at a start in the red for domestic indices NSE Nifty and BSE Sensex. Here’s a look at the stocks to watch in trade today.,neutral,neutral,-6.576923076923075,negative,-1.4171287738755345,negative
2023-05-24 08:06:30.000,260.0,260.6,242.5,242.9,17537490.0,"Top Stocks to Watch today | May 24, 2023 | Business Standard: Adani Group, Max Health, Biocon, Manyavar","Top Stocks to watch on May 24, 2023 | Business Standard: Cummins, Hindalco, India Cements, LIC, National Aluminium, Nykaa and Oil India among prominent companies scheduled to announce Q4 results on Wednesday.",neutral,neutral,-6.576923076923075,negative,-1.4171287738755345,negative
2023-05-24 09:04:55.000,260.0,260.6,242.5,242.9,17537490.0,"Stocks to Watch: LIC, Nykaa, Vedant Fashions, Biocon, Amara Raja, Glenmark, and Others","Stocks to watch: Shares of firms like LIC, Nykaa, Vedant Fashions, Biocon, Amara Raja, Glenmark, and others will be in focus on Wednesday’s trade.",neutral,neutral,-6.576923076923075,negative,-1.4171287738755345,negative
2023-05-24 09:57:31.000,260.0,260.6,242.5,242.9,17537490.0,Biocon’s Q4 PAT up 31 % to ₹313 cr,"Biopharmaceutical major, Biocon’s PAT for the fourth quarter grew by 31 per cent to ₹313 crore against ₹239 crore in the same quarter last year, beating the analyst forecasts on the company’s performance for Q4FY23, which predicted a drop of 58 per cent.",positive,positive,-6.576923076923075,negative,-1.4171287738755345,negative
2023-05-24 10:29:33.000,260.0,260.6,242.5,242.9,17537490.0,Biocon shares surge 8% on 31% growth in Q4 net profit,Biocon’s net profit as well as revenue for the quarter topped the Street’s estimates.,positive,positive,-6.576923076923075,negative,-1.4171287738755345,negative
2023-05-24 13:22:49.000,243.45,249.2,238.85,240.0,6679803.0,"Biocon Q4FY23 profit up 31.3% at Rs 313.20 crore on robust sales, beats estimates | The Financial Express","Biocon posted revenue from operations at Rs 3773.90 crore, up 56.7 per cent in comparison to Rs 2408.80 crore in the fourth quarter of FY22.",positive,positive,-1.4171287738755345,negative,-0.6237006237006237,neutral
2023-05-24 13:55:00.000,243.45,249.2,238.85,240.0,6679803.0,"Trying to raise an additional $300 million to further reduce debt: Kiran Mazumdar Shaw, Biocon",​We are progressing well with various interested investors and we will obviously share it with you as and when we conclude these investment transactions.,positive,positive,-1.4171287738755345,negative,-0.6237006237006237,neutral
2023-05-24 14:38:00.000,243.45,249.2,238.85,240.0,6679803.0,Biocon shares jump 8% post Q4 results. Is the Street happy?,"Biocon’s shares surged by 8% on Tuesday due to strong Q4 earnings growth. Net profit grew by 31% to INR 313 crore with 57% YoY growth in consolidated revenue from operations totaling INR 3,774 crore. Operating profit EBITDA surged 75% while gross spending on R&D rose by 53% to INR 356 crore. The bio…",positive,positive,-1.4171287738755345,negative,-0.6237006237006237,neutral
2023-05-24 18:35:54.000,243.45,249.2,238.85,240.0,6679803.0,"Biocon shares trim most of early gains, end flat amid profit-taking",Shares of Biocon trimmed most of their early gains and ended flat on Wednesday amid profit-taking.,positive,negative,-1.4171287738755345,negative,-0.6237006237006237,neutral
2023-05-24 21:48:42.000,243.45,249.2,238.85,240.0,6679803.0,Biocon IPO after integration of Viatris market: MD & CEO Shreehas Tambe,"‘From our perspective, we have operated with a high band and a lower band model’",neutral,neutral,-1.4171287738755345,negative,-0.6237006237006237,neutral
2023-05-25 14:57:00.000,240.5,241.8,236.7,239.0,3422715.0,Biocon Biologics may raise additional equity of $300 million in FY24 to pare debt,"Biocon Biologics plans to raise a further $300m by the end of FY24 in order to reduce its net debt, which peaked at $1.9bn in December 2022. The additional funds will give the Indian pharmaceutical firm the freedom to develop licence assets and engage in mergers and acquisitions. The company has alr…",positive,positive,-0.6237006237006237,neutral,0.8114856429463123,neutral
2023-06-05 09:51:26.000,242.7,244.4,240.5,241.0,2945186.0,Biocon share price gains as USFDA issues ‘no observations’ on Bengaluru facility,"The share touched a 52-week high of Rs 344 and a 52-week low of Rs 191.60 on 10 June, 2022 and 21 March, 2023, respectively.",positive,negative,-0.7004532344458132,neutral,0.7438016528925667,neutral
2023-06-08 16:54:22.000,244.0,244.5,240.1,240.85,2141704.0,API manufacturing facility in Bangalore receives GMP certificate: Biocon,"Biocon Q4 Results: Shares of Biocon, on Thursday, fell nearly 1% at Rs 241.40 on BSE",neutral,negative,-1.2909836065573794,negative,-1.055900621118017,negative
2023-06-09 07:14:05.000,244.0,244.5,240.1,240.85,2141704.0,"Buzzing Stocks: Biocon, Aether Industries, Kotak Bank, Tata Power, HAL, others in focus today",Stocks to Watch: Check out the companies making headlines before the opening bell today.,neutral,neutral,-1.2909836065573794,negative,-1.055900621118017,negative
2023-06-09 08:44:28.000,244.0,244.5,240.1,240.85,2141704.0,"Stocks to Watch: Tata Power, Tata Steel, Asian Paints, HAL, Biocon, Aether, and Others","Stocks to watch: Shares of firms like Tata Power, Tata Steel, Asian Paints, HAL, Biocon, Aether, and others will be in focus on Friday’s trade.",neutral,neutral,-1.2909836065573794,negative,-1.055900621118017,negative
2023-06-09 08:50:28.000,244.0,244.5,240.1,240.85,2141704.0,"Stocks that will see action today: June 9, 2023","Buzzing stocks: Kotak Mahindra Bank, HAL India, GAIL India, Biocon, Ceat, Tata Power, CCL Products, Indian Hoels, Zydus Lifesciences, Aether Industries, NHPC, Capacite Infraprojects, TCM",neutral,neutral,-1.2909836065573794,negative,-1.055900621118017,negative
2023-06-16 07:48:30.000,244.0,247.95,243.5,244.5,3705726.0,F&O Strategy for Biocon: HDFC Securities recommends a Bull Spread,"The stock price of Biocon has broken out on the daily chart with higher volumes where it closed at highest level since June 7, 2023",neutral,neutral,0.2049180327868852,neutral,-0.2240325865580494,neutral
2023-07-03 07:36:07.000,268.05,270.25,262.6,264.2,5125172.0,"Trade Spotlight | Your game plan for HDFC AMC, Indiabulls Housing Finance, Biocon today","Indiabulls Housing Finance has given a nice consolidation breakout and jumped over 6 percent to Rs 123.4, the highest closing level since January 25 this year, with healthy volumes. The stock has formed long bullish candlestick pattern on the daily scale and closed above 200-day EMA.",neutral,positive,-1.436299197910846,negative,-1.49812734082397,negative
2023-07-03 11:27:10.000,268.05,270.25,262.6,264.2,5125172.0,Biocon Group concludes month-long sustainability initiatives with ‘Nature Positive’ campaign,"Biocon Group, a leading global biopharmaceutical organization, kicked off an extensive month-long ‘Nature Positive’ campaign on June 30, Friday, at Yarandahalli Lake.",neutral,positive,-1.436299197910846,negative,-1.49812734082397,negative
2023-07-03 11:45:00.000,268.05,270.25,262.6,264.2,5125172.0,What to buy in pharma stocks? Rahul Shah answers,"“Pre-Covid most of the pharma stocks rallied and the same was the case with Biocon and then it has done nothing in the last two years. So if I have to look at in terms of market cap, the stocks look cheap but in terms of valuation, it looks fully valued at current levels as well. I do not see any ma…",positive,positive,-1.436299197910846,negative,-1.49812734082397,negative
2023-07-03 23:09:02.000,267.0,270.5,259.8,263.0,6288262.0,"Biocon Biologics biosimilar available in US, to treat inflammatory diseases","Biocon Biologics, a subsidiary of Biocon, on Monday said its biosimilar to treat certain inflammatory diseases is now available in the US market.",neutral,positive,-1.49812734082397,negative,-1.900418091980236,negative
2023-07-04 08:23:24.000,267.0,270.5,259.8,263.0,6288262.0,"Stocks to Watch: RIL, IDFC First, IndusInd Bank, Biocon, Avenue Supermarts, and Others - News18","Stocks to watch: Shares of firms like RIL, IDFC First, IndusInd Bank, Biocon, Avenue Supermarts, and others will be in focus on Tuesday’s trade.",neutral,neutral,-1.49812734082397,negative,-1.900418091980236,negative
2023-07-04 08:57:00.000,267.0,270.5,259.8,263.0,6288262.0,Stocks that will see action today (July 4),"Stocks to watch on July 4 include Reliance Industries, Tube Investments, IDFC First Bank, IDFC, Biocon, Anupam Rasayan, Lupin, IndusInd Bank, Eris Lifesciences, Genus Power, SRG Housing, Waaree Renewables",neutral,neutral,-1.49812734082397,negative,-1.900418091980236,negative
2023-07-04 10:03:20.000,267.0,270.5,259.8,263.0,6288262.0,"Biocon Biologics introduces Hulio, a Humira biosimilar for rheumatoid arthritis, in US","The drug has been made available to patients in the United States after five years of experience in Europe and two years in Canada, the release said.",neutral,neutral,-1.49812734082397,negative,-1.900418091980236,negative
2023-07-04 10:18:00.000,267.0,270.5,259.8,263.0,6288262.0,Biocon Biologics launches biosimilar adalimumab in US,"Adalimumab is used to treat certain inflammatory diseases like rheumatoid arthritis. Humira contributed $21.2 billion in sales to AbbVie for 2022, making it the worlds top-selling non-COVID prescription drug until recently. HULIO is available at a list price (Wholesale Acquisition Cost) of 5% below…",positive,positive,-1.49812734082397,negative,-1.900418091980236,negative
2023-07-04 10:27:44.000,267.0,270.5,259.8,263.0,6288262.0,Biocon Biologics introduces drug to treat autoimmune diseases in the US,"Biocon Biologics, a subsidiary of Biocon, announced that an injection to treat several kinds of autoimmune diseases called Hulio, which is also a biosimilar to Humira, is now available to patients in the United States after five years of experience in Europe and two years in Canada.",neutral,neutral,-1.49812734082397,negative,-1.900418091980236,negative
2023-07-04 10:32:18.000,267.0,270.5,259.8,263.0,6288262.0,Biocon shares rise after launch of inflammatory disease injection in US,HULIO is citrate-free and is made without natural rubber latex to help reduce hypersensitivity reactions.,positive,neutral,-1.49812734082397,negative,-1.900418091980236,negative
2023-07-04 20:28:01.000,263.1,264.55,256.45,258.1,3777986.0,Biocon in talks to acquire 37% stake in Stelis Biopharma for Rs 800 crore,Strides’s 37 per cent stake in Stelis is valued at Rs 800 cr,neutral,neutral,-1.900418091980236,negative,-0.1156069364161893,neutral
2023-07-04 20:59:21.000,263.1,264.55,256.45,258.1,3777986.0,Hulio: Biosimilar Humira likely to boost US revenues for Biocon Biologics,"Analysts, however, feel that together with upcoming Aspart (insulin) and vaccines, Hulio will help drive BBL’s revenues from the current $1 billion to around $1.65 billion by FY25",positive,positive,-1.900418091980236,negative,-0.1156069364161893,neutral
2023-07-05 17:30:00.000,259.5,264.5,257.65,259.2,3784611.0,Biocon Biologics takes over biosimilars business from Viatris in over 70 countries,"Firm will now lead commercial operations in these markets, expanding access to patients, says CEO and MD Shreehas Tambe",neutral,positive,-0.1156069364161893,neutral,-1.721803056684074,negative
2023-07-05 18:56:06.000,259.5,264.5,257.65,259.2,3784611.0,"Biocon Biologics expands to over 70 countries, enters emerging markets",Biocon Biologics Expansion: Completes integration of the acquired biosimilars business from Viatris,positive,neutral,-0.1156069364161893,neutral,-1.721803056684074,negative
2023-07-05 20:07:00.000,259.5,264.5,257.65,259.2,3784611.0,Biocon Biologics takes over Viatris’ biosimilar biz in over 70 countries,"Biocon Biologics on Wednesday said it has completed the integration of the acquired biosimilars business from Viatris Inc in over 70 countries in emerging markets effective July 1, 2023, increasing the scale and scope of its business. Following the deal closure in November 2022, this marks the first…",neutral,positive,-0.1156069364161893,neutral,-1.721803056684074,negative
2023-07-05 20:31:43.000,259.5,264.5,257.65,259.2,3784611.0,Syngene acquires facility from Stelis Biopharma for ₹ 702 cr,"Syngene International, a subsidiary of Biocon Ltd., has decided to acquire a Unit 3 biologics manufacturing facility in Bengaluru from Stelis Biopharma Limited (SBL) on a slump sale basis for a gross value of ₹702 crore.",neutral,neutral,-0.1156069364161893,neutral,-1.721803056684074,negative
2023-07-05 21:45:25.000,259.5,264.5,257.65,259.2,3784611.0,Biocon Biologics completes integration of biosimilars business in 70+ emerging markets,"Biocon Biologics, a subsidiary of Biocon, has successfully integrated the acquired biosimilars business in over 70 countries in emerging markets. The company aims to enhance patient access to high-quality biosimilars, strengthen partnerships, and leverage its R&D capabilities to meet the diverse he…",positive,positive,-0.1156069364161893,neutral,-1.721803056684074,negative
2023-07-06 09:50:59.000,259.5,264.5,257.65,259.2,3784611.0,Biocon gains as arm takes over commercialization of biosimilars business,Biocon Biologics had signed a deal to acquire Viatris Inc’s biosimilars business for $3.33 billion in February 2022,positive,neutral,-0.1156069364161893,neutral,-1.721803056684074,negative
2023-07-06 20:36:46.000,258.45,259.95,253.0,254.0,2981535.0,Biocon Biologics eyes third of FY24 revenue from emerging markets,"Biocon Biologics: BBL, which launched Hulio, a biosimilars version of Abbvie’s blockbuster drug Humira, in the US earlier this week, is planning to launch this drug in other countries in the near term",neutral,positive,-1.721803056684074,negative,-0.0196078431372593,neutral
2023-07-21 22:40:00.000,266.0,267.25,262.75,264.15,2512766.0,Biocon Biologics gets eight observations from USFDA for Malaysia insulin facility,"The US drug regulator issued 6 observations for drug substance, drug product units and quality Control laboratories and 2 observations for the delivery devices unit of Biocon Sdn Bhd, Malaysia, a subsidiary of Biocon Biologics.",neutral,neutral,-0.6954887218045198,neutral,-4.230769230769231,negative
2023-07-23 16:15:00.000,260.0,260.4,248.5,249.0,8214252.0,Govt grants sanction to prosecute joint drugs controller S Eswara Reddy in Biocon Biologics bribery case,"Eswara Reddy along with Animesh Kumar (Assistant Drugs Inspector), Biocon Biologics’ Associate Vice President L Praveen Kumar, and Synergy Network India Private Limited director Dinesh Dua, were arrested last year in the bribery case allegedly to waive the Phase 3 clinical trial of ‘Insulin Aspart’ …",neutral,negative,-4.230769230769231,negative,-2.4428997020854046,negative
2023-07-24 06:50:42.000,260.0,260.4,248.5,249.0,8214252.0,"Buzzing Stocks: RIL, ICICI Bank, RBL Bank, Paytm, Biocon, Kotak Mahindra, others in news",Stocks to Watch: Check out the companies making headlines before the opening bell today.,neutral,neutral,-4.230769230769231,negative,-2.4428997020854046,negative
2023-07-24 09:40:44.000,260.0,260.4,248.5,249.0,8214252.0,Biocon shares fall 2% after Malaysia unit receives 6 observations from USFDA,"The company to announce results for the quarter ended June on August 10, 2023.",negative,neutral,-4.230769230769231,negative,-2.4428997020854046,negative
2023-07-24 12:24:14.000,251.75,251.75,243.4,245.6,4683566.0,"Stocks that will see action: July 24, 2024","Deccan Gold Mines Ltd, Brightcom Group, Naukri Internet Services, SoftTech Engineers, Hikal Ltd, SJVN Ltd, Lupin, Power Finance Corp, Aurobindo Pharma, Biocon, Arunachal Pradesh, Aarti Drugs, Trident, GNA Axles, Jaykay Enterprises, Equipp Social Impact Tech & SenecaGlobal form JV, & Results Calendar…",neutral,neutral,-2.4428997020854046,negative,1.052631578947366,positive
2023-07-26 18:28:14.000,252.0,258.0,250.6,256.9,4519420.0,Syngene’s Q1 net profits up 26% to ₹93 crore,"Syngene, Biocon’s contract research unit, reported 26% increase in net profits to ₹93 crore for Q1, with revenue from operations at ₹808 crore. EBITDA margin stood at 28.3%. Syngene made investments to grow biologics manufacturing and discovery services, while maintaining strong balance sheet and lo…",positive,positive,1.9444444444444355,positive,-0.0778361548939438,neutral
2023-07-27 22:40:31.000,256.95,261.2,254.5,256.75,3312884.0,Cyber frauds misuse BIOCON CEO’s photo to create WhatsApp group,"Unknown person misused BIOCON CEO’s profile to create WhatsApp group, sent messages to staff to buy gift cards. Srikant Patil received email from person posing as Shreehas Tambe, suspected something fishy and informed higher ups. Police registered case against unknown person under IT Act, cheating a…",negative,neutral,-0.0778361548939438,neutral,-0.3100775193798494,neutral
2023-08-01 12:47:00.000,256.7,256.7,250.65,252.95,1569800.0,Lessons to learn from Vijay Mallya’s story: Biocon boss Kiran Mazumdar-Shaw shares cardinal sin that entrepreneurs (usually) make,"Indian entrepreneur Vijay Mallyas downfall began with his decision to diversify beyond his beer business and into regional low-cost airline Air Deccan, according to Biocon Limiteds Executive Chairperson Kiran Mazumdar-Shaw.",neutral,neutral,-1.460849240358395,negative,0.6325360743229977,neutral
2023-08-04 05:30:00.000,255.9,258.2,253.05,254.0,1985430.0,"Biocon Biologics announces key leadership appointments, Rhonda Duffy to be COO","Biocon Biologics announces key leadership appointments, Rhonda Duffy to be COO",neutral,neutral,-0.74247753028527,neutral,3.0871434153966417,positive
2023-08-04 18:29:47.000,255.9,258.2,253.05,254.0,1985430.0,Biocon Biologics announces key leadership appointments,Biocon Biologics Ltd has announced a series of significant leadership appointments aimed at transforming the organisation and realising the company’s ambition of building a global biosimilars leader,neutral,positive,-0.74247753028527,neutral,3.0871434153966417,positive
2023-08-04 19:31:00.000,255.9,258.2,253.05,254.0,1985430.0,Biocon Biologics announces top leadership appointments,"Biocon Biologics Ltd has made several key leadership appointments, including appointing Rhonda Duffy as Chief Operating Officer and Sandeep Athalye as Chief Development Officer. The subsidiary of Biocon Ltd has also hired David Gibson as Global Head - Business Development, who will lead all licensin…",neutral,neutral,-0.74247753028527,neutral,3.0871434153966417,positive
2023-08-07 06:52:10.000,255.9,264.3,253.3,263.8,6169814.0,"Buzzing Stocks: Britannia, Delhivery, Shipping Corp, BHEL, Biocon, others in news","Stocks to watch: Check out the companies making headlines before the opening bell today, July 27, 2023",neutral,neutral,3.0871434153966417,positive,3.3118849356548066,positive
2023-08-07 08:55:25.000,255.9,264.3,253.3,263.8,6169814.0,"Stocks to watch on August 7, 2023","Buzzing stocks of Aurobindo Pharma, BHEL, Ganesha Eco, Oil India, Infosys, Biocon, Adani Enterprises, Delta Corp, Fortis Healthcare, Reliance Industries, ICICI Bank, ICICI Lombard GIC, India Cements, Barbeque, GIC Housing, Max Healthcare, Gland Pharma, Indigo Paints, Policybazaar, Sobha, Tata Chen, …",neutral,neutral,3.0871434153966417,positive,3.3118849356548066,positive
2023-08-10 21:51:17.000,256.95,265.25,249.7,256.4,20501333.0,"Biocon Q1 Results: Profit Drops 30%, Misses Estimates",The drugmaker’s profit declined to Rs 101 crore in the quarter ended June.,neutral,negative,-0.214049425958362,neutral,-1.6269610691458412,negative
2023-08-11 05:00:00.000,256.95,265.25,249.7,256.4,20501333.0,"Stocks To Watch: HCL Tech, DLF, Zee, Hero MotoCorp, LIC, Biocon, SAIL, HAL, ONGC, Glenmark, Jindal Steel",Here are the stocks to watch before going into trade today.,neutral,neutral,-0.214049425958362,neutral,-1.6269610691458412,negative
2023-08-11 09:36:56.000,256.95,265.25,249.7,256.4,20501333.0,Biocon shares fall 3% after Q1 net profit slumps 30%,"Despite a drop in net profit, revenue for Biocon continued to surge on the back of two-fold increase in the biosimilars business, accompanied by a double-digit growth in the generics and research services segments.",negative,positive,-0.214049425958362,neutral,-1.6269610691458412,negative
2023-08-11 14:04:00.000,256.95,265.25,249.7,256.4,20501333.0,"We expect the profitability to improve in coming quarters: Siddharth Mittal, Biocon","Typically, licensing income tends to be lumpy. When we out-license any of our molecule to our customers, we receive the licensing income and we have had an out-licensing deal or transaction with a partner which led to this large income during this quarter",positive,neutral,-0.214049425958362,neutral,-1.6269610691458412,negative
2023-08-11 18:53:00.000,256.95,265.25,249.7,256.4,20501333.0,Competition Commission of India clears Kotak-Biocon Biologics deal,The investment will help Biocon Biologics’ acquisition of the biosimilars business of its partner Viatris.,neutral,positive,-0.214049425958362,neutral,-1.6269610691458412,negative
2023-08-11 21:00:22.000,256.95,265.25,249.7,256.4,20501333.0,Biocon may list biosimilars business by 2025 first half - CEO,"Biocon Biologics, a fully integrated subsidiary of Biocon Ltd, focuses on making biosimilars, with key revenue-generating markets being the United States and Europe.",neutral,neutral,-0.214049425958362,neutral,-1.6269610691458412,negative
2023-08-14 15:34:17.000,258.15,263.7,253.3,253.95,6850425.0,U.S. FDA Flags Eight Lapses At Biocon’s Insulin Facility In Malaysia,"These observations primarily relate to enhancing operational procedures and strengthening training programs, the company said.",neutral,neutral,-1.6269610691458412,negative,0.9055118110236264,positive
2023-08-14 23:46:00.000,258.15,263.7,253.3,253.95,6850425.0,‘Biocon Biologics to integrate Viatris’ US biosimilar business by Q2 end’,"Biocon Biologics plans to complete the integration of Viatris’ biosimilar business in North America by the end of Q2FY24, which is ahead of the original transition plan. The early transition would enable the company to ramp up its business in North America more rapidly.",positive,positive,-1.6269610691458412,negative,0.9055118110236264,positive
2023-08-23 18:54:00.000,260.4,264.0,259.9,260.35,2364715.0,"Chandrayaan-3 lands on the moon & makes India Inc proud! Anand Mahindra gets philosophical, Biocon’s Kiran Mazumdar-Shaw salutes ISRO scientists","India successfully achieved a historic feat with the Chandrayaan-3 mission, making it the first country to land on the South Pole of the moon. This success was particularly significant after the Chandrayaan-2 crash-landed four years ago.",neutral,positive,-0.0192012288786307,neutral,-1.7705927636643657,negative
2023-09-07 05:00:00.000,271.75,271.75,266.2,267.9,2833299.0,"Stocks To Watch: TCS, Jio, RIL, Adani Total Gas, Lupin, REC, Tata Consumer Products, 360 One Wam, Biocon",Here are the stocks to watch before going into trade today.,neutral,neutral,-1.4167433302667978,negative,-0.5409438537586229,neutral
2023-09-07 08:51:08.000,271.75,271.75,266.2,267.9,2833299.0,"Stocks to Watch: Reliance, TCS, TVS Motor, Biocon, Safari, Tata Consumer, and Others - News18","Stocks to watch: Shares of firms like Reliance, TCS, TVS Motor, Biocon, Safari, Tata Consumer, and others will be in focus on Thursday’s trade.",neutral,neutral,-1.4167433302667978,negative,-0.5409438537586229,neutral
